data_2k9g_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k9g _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.838 0.351 . . . . 54.340000000000003 110.838 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -128.11 149.39 50.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 73.510000000000005 110.863 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 25.7 m -138.55 148.19 43.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.098 -0.501 . . . . 73.329999999999998 110.843 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -102.95 123.05 45.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 71.510000000000005 110.912 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 22.4 t -61.0 109.02 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 71.540000000000006 111.131 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 36.0 pt -83.64 -28.22 7.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 75.019999999999996 111.133 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -145.41 159.3 48.89 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.624 0.726 . . . . 75.319999999999993 110.851 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 159.78 52.15 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.651 2.234 . . . . 60.439999999999998 112.364 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -176.1 110.39 0.1 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.435 . . . . 74.239999999999995 110.929 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 21.7 tp10 -89.46 135.04 33.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.089 -0.505 . . . . 73.099999999999994 110.945 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -65.82 113.26 4.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 71.099999999999994 111.038 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -58.06 -26.44 62.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.436 . . . . 74.329999999999998 110.986 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -154.95 170.77 20.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 65.510000000000005 110.885 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -56.22 -25.99 49.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 72.239999999999995 110.882 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -70.05 -26.55 64.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.155 -0.475 . . . . 73.299999999999997 110.929 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -94.99 169.56 10.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 72.409999999999997 110.89 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 14.0 tp -120.57 137.24 54.5 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.16 -0.473 . . . . 72.420000000000002 110.931 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 91.5 m -90.9 145.25 24.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 75.209999999999994 111.109 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 48.1 pt -150.26 142.95 17.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 73.150000000000006 111.094 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 44.4 mttm -114.36 139.8 49.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 72.230000000000004 110.894 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -51.94 129.84 27.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.15 -0.477 . . . . 71.040000000000006 110.919 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 102.27 -25.59 27.18 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.744 -0.741 . . . . 71.0 112.534 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -76.49 174.53 10.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.752 0.31 . . . . 60.409999999999997 110.856 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 31.4 mm -124.94 125.99 70.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 74.120000000000005 111.139 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 78.5 t -107.82 135.1 47.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 75.450000000000003 111.114 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 88.8 m -88.17 111.52 21.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.209 -0.45 . . . . 75.329999999999998 111.176 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 7.6 tp -69.97 118.96 13.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 73.129999999999995 110.899 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 61.7 mt -104.73 -47.6 9.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.142 -0.481 . . . . 75.450000000000003 111.167 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -135.21 178.13 7.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 74.209999999999994 110.896 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 66.1 mttt -141.41 112.82 7.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.104 -0.498 . . . . 73.310000000000002 110.955 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -50.53 165.18 0.1 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 74.230000000000004 110.961 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 3.2 t -115.14 -69.2 0.87 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.21 -0.45 . . . . 73.319999999999993 110.887 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 1.9 mp -67.92 -12.4 15.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 75.519999999999996 111.159 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -95.86 68.18 2.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.18 -0.463 . . . . 72.040000000000006 110.878 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 6.6 p -51.51 122.76 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 72.109999999999999 111.135 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.69 21.92 38.44 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.679 -0.772 . . . . 60.140000000000001 112.459 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 56.5 m95 -140.0 138.07 35.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.761 0.315 . . . . 73.120000000000005 110.833 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 20.6 m0 -133.18 155.91 48.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.167 -0.47 . . . . 73.049999999999997 110.893 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -99.38 121.95 41.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.277 -0.42 . . . . 72.409999999999997 110.9 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -140.69 -174.41 13.98 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.77 -0.729 . . . . 73.400000000000006 112.51 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -134.41 145.76 49.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.956 0.407 . . . . 75.049999999999997 110.846 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 5.1 tp -155.73 131.81 10.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.073 -0.512 . . . . 75.340000000000003 110.922 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 56.96 29.96 17.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 73.319999999999993 110.918 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 79.14 19.14 72.96 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.717 -0.754 . . . . 64.409999999999997 112.539 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -120.71 114.26 21.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.859 0.361 . . . . 74.450000000000003 110.86 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 42.0 ttt180 -96.97 132.13 43.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.113 -0.494 . . . . 75.319999999999993 110.878 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -170.72 -159.94 17.96 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.741 -0.742 . . . . 72.219999999999999 112.476 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 27.7 m -116.76 147.64 20.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.781 0.324 . . . . 71.129999999999995 111.163 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -149.74 156.77 38.69 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.701 0.762 . . . . 72.549999999999997 110.82 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.8 121.76 8.44 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.651 2.234 . . . . 75.030000000000001 112.332 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -61.04 -19.01 60.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 75.049999999999997 110.921 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -73.85 -9.74 58.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.491 . . . . 74.329999999999998 110.883 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -113.64 22.03 14.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 75.340000000000003 110.828 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 18.7 m -148.94 156.38 7.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 74.019999999999996 111.098 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 20.4 tttt -121.87 114.81 21.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.473 . . . . 75.120000000000005 110.854 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.98 125.9 26.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 72.209999999999994 110.89 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 20.4 mt . . . . . 0 C--N 1.328 -0.345 0 CA-C-O 121.559 0.695 . . . . 63.140000000000001 110.916 179.898 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.771 0.32 . . . . 74.200000000000003 110.913 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -129.62 152.86 48.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 63.439999999999998 110.9 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 31.8 m -139.17 153.2 47.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 71.549999999999997 110.87 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 38.8 tttt -110.57 119.18 38.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 73.140000000000001 110.913 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 26.2 t -56.0 111.32 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 75.109999999999999 111.128 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 34.5 pt -87.43 -27.31 5.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 74.430000000000007 111.103 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -144.44 160.09 49.4 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.64 0.733 . . . . 71.109999999999999 110.856 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 158.57 56.52 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.676 2.251 . . . . 75.099999999999994 112.327 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -173.95 107.42 0.13 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.455 . . . . 74.310000000000002 110.868 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -91.94 118.06 30.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.14 -0.482 . . . . 74.340000000000003 110.866 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -51.74 119.86 4.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 72.209999999999994 111.087 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -66.44 -26.19 67.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.439 . . . . 73.420000000000002 110.916 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -150.46 168.79 23.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.209 -0.45 . . . . 75.340000000000003 110.914 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -56.62 -25.9 54.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 64.109999999999999 110.875 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -70.05 -25.81 63.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 75.140000000000001 110.854 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -95.03 166.32 12.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.243 -0.435 . . . . 73.430000000000007 110.887 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 14.1 tp -115.97 137.1 52.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.157 -0.474 . . . . 71.530000000000001 110.944 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 91.4 m -91.15 144.48 25.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 65.519999999999996 111.139 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 34.0 pt -150.47 146.77 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 64.140000000000001 111.092 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 25.7 mtpt -122.27 143.6 49.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 72.420000000000002 110.85 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 66.5 tt0 -52.0 130.08 28.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 73.019999999999996 110.871 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 100.79 -25.53 28.01 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.738 -0.744 . . . . 74.209999999999994 112.503 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.69 170.91 15.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.78 0.324 . . . . 75.219999999999999 110.861 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 48.5 mm -123.4 128.49 74.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 72.219999999999999 111.187 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 94.1 t -108.62 138.06 37.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.234 -0.439 . . . . 62.530000000000001 111.162 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 47.1 m -94.07 113.35 25.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.208 -0.451 . . . . 73.239999999999995 111.116 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 4.1 tp -69.95 117.6 11.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.214 -0.448 . . . . 72.299999999999997 110.948 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 69.2 mt -107.06 -28.32 2.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.439 . . . . 72.129999999999995 111.127 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -155.05 178.11 10.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 74.5 110.861 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 8.7 mttm -141.53 112.94 7.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 75.450000000000003 110.915 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -49.92 162.31 0.2 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.284 -0.417 . . . . 73.200000000000003 110.833 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.8 t -113.58 -68.97 0.89 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 74.209999999999994 110.888 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 38.9 mt -67.17 -12.99 16.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 75.420000000000002 111.149 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -96.7 70.36 2.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.485 . . . . 73.209999999999994 110.873 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 6.5 p -51.48 122.17 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 71.5 111.232 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.09 19.51 50.27 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.812 -0.709 . . . . 73.319999999999993 112.497 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -135.47 137.79 42.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.772 0.32 . . . . 74.230000000000004 110.917 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 22.5 m0 -131.76 158.78 40.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.25 -0.432 . . . . 75.310000000000002 110.943 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -103.5 120.38 40.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.307 -0.406 . . . . 70.340000000000003 110.841 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -136.53 -169.74 11.79 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.789 -0.719 . . . . 64.340000000000003 112.458 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -137.89 147.87 44.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.826 0.346 . . . . 72.430000000000007 110.9 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 9.9 tp -150.22 123.19 8.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 64.150000000000006 110.913 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 55.55 30.61 15.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.256 -0.429 . . . . 75.109999999999999 110.895 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 92.13 -16.58 59.31 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.758 -0.734 . . . . 74.530000000000001 112.441 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -85.52 112.53 21.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.87 0.367 . . . . 73.510000000000005 110.872 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 42.3 mtp180 -99.83 135.45 41.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.101 -0.5 . . . . 74.439999999999998 110.869 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -172.61 -163.33 26.24 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.733 -0.746 . . . . 74.349999999999994 112.488 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 27.7 m -109.59 160.55 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.866 0.365 . . . . 71.439999999999998 111.116 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -165.2 156.21 12.57 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.621 0.724 . . . . 74.439999999999998 110.885 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 118.77 5.88 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.685 2.256 . . . . 75.230000000000004 112.268 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -60.13 -19.74 55.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 72.340000000000003 110.874 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -73.26 -8.48 55.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 65.340000000000003 110.863 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -114.78 21.38 14.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 75.120000000000005 110.888 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 18.5 m -148.74 146.34 17.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.113 -0.494 . . . . 74.329999999999998 111.056 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 15.2 ttmm -106.83 109.77 21.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.114 -0.493 . . . . 74.109999999999999 110.95 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 2.6 tt -64.93 119.03 9.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 73.019999999999996 110.954 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 20.3 mt . . . . . 0 C--N 1.328 -0.346 0 CA-C-O 121.549 0.69 . . . . 74.450000000000003 110.9 179.932 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.847 0.356 . . . . 61.439999999999998 110.813 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -116.43 148.06 41.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 71.140000000000001 110.951 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 24.8 m -133.42 146.69 51.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.076 -0.511 . . . . 73.409999999999997 110.915 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 49.9 tttt -106.06 122.12 45.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 72.540000000000006 110.885 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 23.0 t -61.66 113.21 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 73.140000000000001 111.121 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 28.3 pt -88.21 -29.97 5.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.138 -0.483 . . . . 72.430000000000007 111.068 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -140.1 158.76 66.39 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.622 0.725 . . . . 72.319999999999993 110.855 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 156.04 64.42 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.636 2.224 . . . . 63.229999999999997 112.375 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -173.68 107.96 0.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 75.150000000000006 110.883 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -87.99 142.4 27.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.109 -0.496 . . . . 75.420000000000002 110.894 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -70.52 113.02 7.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.126 -0.488 . . . . 74.25 111.091 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -58.01 -25.84 61.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 74.129999999999995 110.929 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -155.72 170.25 22.46 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.195 -0.457 . . . . 74.549999999999997 110.898 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -56.51 -25.21 50.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 63.299999999999997 110.818 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -72.13 -25.02 61.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 64.109999999999999 110.843 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -95.02 167.1 11.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 73.030000000000001 110.871 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 14.3 tp -115.01 136.82 52.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 71.219999999999999 110.958 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 86.6 m -92.12 142.07 27.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 74.129999999999995 111.115 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 31.9 pt -148.78 146.48 17.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 73.310000000000002 111.143 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -119.33 140.72 49.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 64.239999999999995 110.828 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -51.97 128.67 24.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 72.140000000000001 110.916 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 104.14 -23.97 30.52 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.691 -0.766 . . . . 45.119999999999997 112.426 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.16 175.3 10.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.744 0.306 . . . . 52.130000000000003 110.913 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 39.9 mm -125.34 128.81 72.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.199 -0.455 . . . . 72.400000000000006 111.117 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 98.3 t -109.77 137.99 39.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.49 . . . . 74.5 111.172 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 40.5 m -91.16 111.68 23.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 73.200000000000003 111.186 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 5.9 tp -70.07 117.56 11.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.238 -0.437 . . . . 73.150000000000006 110.858 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 64.4 mt -106.97 -34.67 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 74.150000000000006 111.186 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -147.45 178.18 8.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.134 -0.484 . . . . 63.030000000000001 110.84 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 35.8 mttp -141.45 112.95 7.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 74.019999999999996 110.893 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -49.74 165.79 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 63.439999999999998 110.899 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.5 t -118.15 -69.38 0.85 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.214 -0.448 . . . . 53.350000000000001 110.872 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 47.2 mt -65.27 -14.36 16.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 74.430000000000007 111.165 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -98.32 71.7 2.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 60.229999999999997 110.9 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 59.3 t -51.52 122.31 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 72.340000000000003 111.138 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.61 20.45 44.25 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.731 -0.747 . . . . 44.030000000000001 112.488 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 50.8 m95 -135.23 134.27 39.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.713 0.292 . . . . 70.420000000000002 110.952 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 24.4 m0 -129.66 156.64 43.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.25 -0.432 . . . . 73.310000000000002 110.955 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -101.98 126.28 48.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.277 -0.42 . . . . 75.329999999999998 110.868 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -143.77 -167.84 11.98 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.705 -0.759 . . . . 73.329999999999998 112.454 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -138.32 147.53 43.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.875 0.369 . . . . 75.409999999999997 110.936 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 4.8 tp -157.95 132.05 8.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 74.420000000000002 110.932 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 56.35 29.99 16.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 74.439999999999998 110.911 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 79.79 18.44 72.83 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.723 -0.751 . . . . 71.400000000000006 112.579 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 16.0 mmt180 -121.58 113.53 19.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.767 0.318 . . . . 74.400000000000006 110.878 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -97.22 132.05 43.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.244 -0.434 . . . . 74.510000000000005 110.895 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -170.07 -163.67 24.49 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.827 -0.702 . . . . 63.229999999999997 112.54 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 8.3 m -108.12 157.27 8.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.86 0.362 . . . . 74.040000000000006 111.113 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -163.17 156.08 16.26 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.714 0.769 . . . . 74.409999999999997 110.83 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.69 117.47 5.1 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.691 2.261 . . . . 73.329999999999998 112.398 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -57.77 -22.56 47.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.252 -0.431 . . . . 65.5 110.92 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -68.85 -12.26 61.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 70.120000000000005 110.861 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -108.46 14.72 24.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 72.519999999999996 110.857 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 17.9 m -148.69 138.11 15.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.475 . . . . 72.530000000000001 111.11 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.74 123.06 48.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 73.310000000000002 110.905 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 2.5 mt -64.93 122.67 17.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.439 . . . . 73.239999999999995 110.918 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 20.2 mt . . . . . 0 C--N 1.328 -0.343 0 CA-C-O 121.533 0.682 . . . . 74.409999999999997 110.922 179.886 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.838 0.351 . . . . 74.340000000000003 110.853 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -128.23 152.88 47.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.453 . . . . 74.040000000000006 110.948 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 26.2 m -138.78 146.48 41.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.118 -0.492 . . . . 73.439999999999998 110.888 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 14.3 tttp -103.0 117.35 34.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 74.430000000000007 110.823 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 26.2 t -55.91 112.32 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 70.219999999999999 111.132 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 37.9 pt -88.33 -28.08 5.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.175 -0.466 . . . . 63.140000000000001 111.134 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -142.6 159.71 56.43 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.61 0.719 . . . . 72.219999999999999 110.884 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 160.05 51.15 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.738 2.292 . . . . 74.329999999999998 112.263 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -173.29 109.78 0.18 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 75.200000000000003 110.91 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -91.08 127.0 36.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.115 -0.493 . . . . 71.319999999999993 110.887 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -58.82 117.63 4.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 63.219999999999999 111.074 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -65.84 -25.8 67.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 74.120000000000005 110.871 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 -153.0 168.41 25.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 73.409999999999997 110.923 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -56.14 -26.3 49.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 73.219999999999999 110.886 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -71.02 -25.22 62.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 63.310000000000002 110.88 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -94.86 164.79 12.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 71.239999999999995 110.95 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 14.1 tp -115.21 137.12 52.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.46 . . . . 74.409999999999997 110.962 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 85.0 m -91.81 144.74 25.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.221 -0.445 . . . . 75.349999999999994 111.143 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 44.4 pt -150.34 144.7 17.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 62.420000000000002 111.13 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 18.2 mtmm -116.14 140.05 49.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 75.010000000000005 110.87 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -51.89 128.56 24.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 73.5 110.895 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 104.02 -21.3 38.38 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.679 -0.772 . . . . 73.420000000000002 112.382 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -81.58 172.52 13.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.795 0.331 . . . . 64.409999999999997 110.846 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 76.2 mt -123.61 126.51 73.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.488 . . . . 75.25 111.127 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 93.1 t -109.63 136.05 46.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 74.310000000000002 111.116 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 95.4 m -87.72 113.02 23.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.21 -0.45 . . . . 73.299999999999997 111.138 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 8.0 tp -70.01 112.65 6.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.277 -0.42 . . . . 72.230000000000004 110.943 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 50.5 mt -98.29 -49.19 11.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 74.420000000000002 111.217 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -132.71 178.43 6.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 74.219999999999999 110.805 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 17.6 mttp -141.82 112.96 7.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 73.420000000000002 110.936 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -50.15 162.15 0.23 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.27 -0.423 . . . . 74.219999999999999 110.857 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 3.0 t -113.87 -68.92 0.89 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 73.430000000000007 110.907 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 34.1 mt -68.54 -12.01 15.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 74.439999999999998 111.075 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -97.96 69.72 2.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 65.209999999999994 110.935 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 6.6 p -51.47 122.6 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 72.409999999999997 111.129 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 91.04 17.28 51.81 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.692 -0.766 . . . . 74.409999999999997 112.413 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 34.7 m95 -133.98 135.89 43.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.743 0.306 . . . . 75.329999999999998 110.949 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 22.4 m0 -132.84 155.26 49.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.431 . . . . 74.319999999999993 110.883 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -97.04 121.31 38.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 75.310000000000002 110.836 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -138.68 179.82 18.07 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.735 -0.745 . . . . 74.239999999999995 112.437 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -133.72 141.67 47.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.918 0.389 . . . . 70.540000000000006 110.841 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 24.8 tp -155.39 136.8 14.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.11 -0.496 . . . . 72.310000000000002 110.86 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 56.92 30.55 18.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 73.299999999999997 110.9 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 75.82 19.46 78.91 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.788 -0.72 . . . . 71.200000000000003 112.464 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -118.61 117.82 29.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.726 0.298 . . . . 74.519999999999996 110.82 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 60.6 ttt180 -99.89 129.63 45.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 74.439999999999998 110.866 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -170.7 -162.76 23.58 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.792 -0.718 . . . . 54.219999999999999 112.512 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 12.4 m -115.48 150.2 17.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.919 0.39 . . . . 74.540000000000006 111.068 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -155.16 155.89 30.54 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.63 0.728 . . . . 74.540000000000006 110.952 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 117.94 5.38 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.698 2.266 . . . . 73.409999999999997 112.313 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -59.41 -20.7 56.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 74.340000000000003 110.885 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -68.97 -12.08 61.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 73.209999999999994 110.881 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -108.84 16.64 22.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 73.430000000000007 110.913 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 18.6 m -148.81 150.87 13.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.104 -0.498 . . . . 73.319999999999993 111.09 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 47.8 tttp -109.18 115.3 29.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 74.340000000000003 110.855 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 2.8 tt -65.19 116.03 6.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 75.340000000000003 110.964 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 20.4 mt . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 121.634 0.73 . . . . 74.019999999999996 110.885 179.965 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.824 0.345 . . . . 63.310000000000002 110.818 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -111.27 153.77 25.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 74.549999999999997 110.937 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 26.7 m -136.0 145.63 46.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.105 -0.498 . . . . 73.530000000000001 110.821 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 3.0 ttpp -103.34 126.47 50.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 72.319999999999993 110.886 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 22.0 t -61.1 114.46 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 72.129999999999995 111.106 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 29.8 pt -89.16 -25.67 5.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 75.129999999999995 111.097 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -147.71 159.24 41.47 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.671 0.748 . . . . 75.430000000000007 110.897 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 155.48 65.75 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.624 2.216 . . . . 74.409999999999997 112.336 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -170.8 112.22 0.39 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 71.329999999999998 110.964 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -93.81 130.39 39.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.445 . . . . 74.409999999999997 110.868 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -64.08 117.32 6.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.148 -0.478 . . . . 72.319999999999993 111.167 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 78.4 mm-40 -60.33 -25.57 65.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.238 -0.437 . . . . 73.340000000000003 110.924 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -155.91 176.26 12.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 75.150000000000006 110.865 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -58.48 -25.9 62.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.144 -0.48 . . . . 74.120000000000005 110.869 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -70.43 -26.38 63.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.172 -0.467 . . . . 74.120000000000005 110.849 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -96.55 161.79 13.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 63.100000000000001 110.884 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 14.0 tp -115.25 136.65 52.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 75.439999999999998 110.94 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 90.5 m -90.57 144.85 25.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 74.450000000000003 111.086 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 44.8 pt -150.32 141.82 16.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 74.430000000000007 111.145 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.28 145.16 42.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 74.219999999999999 110.892 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -51.86 131.85 31.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 71.319999999999993 110.879 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.98 -26.23 24.29 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.759 -0.734 . . . . 72.519999999999996 112.454 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -69.55 176.07 3.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.793 0.33 . . . . 74.319999999999993 110.843 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 68.8 mt -134.19 125.45 47.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 72.010000000000005 111.173 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 98.3 t -111.28 138.08 41.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.159 -0.473 . . . . 65.219999999999999 111.107 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 6.3 m -87.39 118.51 26.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.188 -0.46 . . . . 74.230000000000004 111.131 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 6.1 tp -69.87 111.02 5.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 75.219999999999999 110.939 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 23.9 mm -100.49 -29.95 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 73.409999999999997 111.139 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -157.36 178.12 10.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 74.420000000000002 110.884 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 21.8 mttt -141.4 112.98 7.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.207 -0.451 . . . . 73.310000000000002 110.876 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -49.77 162.01 0.2 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 61.340000000000003 110.847 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.9 t -113.79 -68.98 0.89 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 62.030000000000001 110.882 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 30.3 mm -67.49 -12.44 15.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.441 . . . . 72.25 111.108 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -97.49 70.46 2.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 61.409999999999997 110.871 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 6.0 p -51.4 121.24 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 64.230000000000004 111.107 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.39 24.8 30.14 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.697 -0.763 . . . . 70.200000000000003 112.475 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 57.5 m95 -140.23 133.43 29.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.751 0.31 . . . . 74.040000000000006 110.877 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 22.6 m0 -129.25 154.55 46.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.25 -0.432 . . . . 73.219999999999999 110.95 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -99.04 116.33 31.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.239 -0.437 . . . . 62.409999999999997 110.944 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -127.99 -173.72 13.55 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.724 -0.751 . . . . 65.329999999999998 112.529 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -135.97 134.95 39.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.836 0.351 . . . . 74.510000000000005 110.888 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 10.1 tp -143.99 130.75 20.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 73.540000000000006 110.95 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 59.04 29.95 19.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.151 -0.477 . . . . 73.040000000000006 110.84 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 83.33 -1.48 88.64 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.692 -0.766 . . . . 74.430000000000007 112.451 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.01 119.33 38.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.829 0.347 . . . . 75.129999999999995 110.876 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 70.1 mtt180 -98.82 131.0 45.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 72.219999999999999 110.906 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -162.09 -162.77 13.69 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.784 -0.722 . . . . 72.430000000000007 112.515 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 25.1 m -115.22 153.13 16.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.884 0.373 . . . . 72.310000000000002 111.111 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -157.36 157.42 30.22 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.657 0.741 . . . . 71.430000000000007 110.815 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 119.96 6.82 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.679 2.253 . . . . 73.340000000000003 112.302 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -57.42 -23.36 49.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 64.430000000000007 110.878 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 10.8 m-20 -69.53 -11.58 60.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 73.129999999999995 110.922 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -109.45 15.48 22.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 72.409999999999997 110.85 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 18.0 m -148.7 149.56 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 75.519999999999996 111.217 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -117.02 117.6 30.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 74.010000000000005 110.862 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.1 tt -65.03 125.01 23.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 73.140000000000001 110.893 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 20.7 mt . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 121.582 0.706 . . . . 75.329999999999998 110.992 179.849 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.777 0.322 . . . . 73.200000000000003 110.889 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -138.71 154.15 48.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.46 . . . . 72.230000000000004 110.931 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 56.5 m -135.67 152.99 51.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.121 -0.491 . . . . 72.150000000000006 110.838 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 18.5 tptm -102.78 129.75 49.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 74.319999999999993 110.883 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 25.7 t -73.05 108.35 4.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.282 -0.417 . . . . 75.340000000000003 111.116 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 21.7 pt -86.96 -30.3 5.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 74.109999999999999 111.178 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -138.83 158.79 69.33 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.663 0.744 . . . . 73.319999999999993 110.875 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.84 165.85 29.68 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.659 2.239 . . . . 73.519999999999996 112.354 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -174.43 107.32 0.11 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.245 -0.434 . . . . 71.340000000000003 110.886 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -92.66 111.65 23.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.106 -0.497 . . . . 62.119999999999997 110.885 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -51.69 117.22 2.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 74.439999999999998 111.103 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 52.0 mm-40 -63.23 -25.43 68.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.274 -0.421 . . . . 74.439999999999998 110.912 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 24.9 m-20 -150.7 167.77 26.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.441 . . . . 74.549999999999997 110.909 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -58.07 -24.16 57.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 74.549999999999997 110.866 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -70.06 -24.91 63.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.247 -0.433 . . . . 64.420000000000002 110.808 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -95.01 169.51 10.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 75.129999999999995 110.895 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 22.3 tp -114.95 131.21 56.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.137 -0.483 . . . . 75.400000000000006 110.9 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 97.6 m -92.08 139.09 30.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 63.130000000000003 111.158 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 26.0 pt -147.0 157.33 10.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 74.439999999999998 111.122 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -133.56 142.67 48.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 74.230000000000004 110.91 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -50.84 133.12 26.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 74.519999999999996 110.93 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 100.65 -22.13 41.02 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.864 -0.684 . . . . 73.519999999999996 112.564 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -85.23 173.48 10.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.824 0.345 . . . . 75.230000000000004 110.824 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 41.6 mm -123.55 133.91 67.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 74.299999999999997 111.08 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 93.3 t -108.11 127.63 64.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 74.409999999999997 111.179 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 29.1 m -82.98 107.8 15.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 65.129999999999995 111.162 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 7.5 tp -69.84 117.54 11.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 73.219999999999999 110.911 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 63.8 mt -109.73 -36.55 2.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.209 -0.451 . . . . 73.409999999999997 111.14 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -144.03 177.47 8.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.131 -0.486 . . . . 75.400000000000006 110.878 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 31.9 mttp -141.75 113.01 7.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 74.230000000000004 110.881 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -49.6 160.15 0.3 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 74.420000000000002 110.791 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.6 t -113.68 -69.01 0.89 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 61.450000000000003 110.892 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 41.8 mt -66.35 -13.54 16.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.19 -0.459 . . . . 75.310000000000002 111.114 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.53 71.63 2.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 75.340000000000003 110.84 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 5.9 p -51.23 120.7 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.474 . . . . 74.450000000000003 111.117 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.37 25.79 27.4 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.726 -0.75 . . . . 72.420000000000002 112.523 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 57.8 m95 -140.38 135.27 31.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.727 0.299 . . . . 72.450000000000003 110.963 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 22.6 m0 -130.26 156.75 44.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 75.420000000000002 110.956 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -103.8 126.3 50.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 73.329999999999998 110.851 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -140.25 -163.76 9.64 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.672 -0.775 . . . . 71.540000000000006 112.439 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -142.79 146.28 34.08 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.844 0.354 . . . . 71.0 110.837 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 3.5 tp -160.05 129.05 5.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.12 -0.491 . . . . 72.219999999999999 110.924 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 55.46 38.25 30.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 62.539999999999999 110.92 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 72.3 18.73 78.34 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.78 -0.724 . . . . 64.340000000000003 112.434 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -128.47 115.0 17.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.792 0.329 . . . . 75.409999999999997 110.881 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 2.9 ptt85 -116.9 139.45 50.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 74.219999999999999 110.865 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -162.6 -112.78 0.29 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.757 -0.735 . . . . 75.319999999999993 112.517 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 24.2 m -151.25 143.88 16.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.847 0.356 . . . . 74.209999999999994 111.178 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -150.54 155.76 36.37 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.679 0.752 . . . . 74.319999999999993 110.841 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 120.69 7.44 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.674 2.249 . . . . 63.219999999999999 112.315 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -60.31 -19.81 56.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 72.140000000000001 110.832 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -73.54 -8.21 54.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 71.420000000000002 110.866 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -114.47 16.99 17.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 74.239999999999995 110.876 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 23.4 m -150.21 141.42 16.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 72.239999999999995 111.152 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -105.27 118.01 35.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 72.349999999999994 110.93 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.7 tt -64.82 132.3 49.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 72.299999999999997 110.894 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 20.3 mt . . . . . 0 C--N 1.328 -0.339 0 CA-C-O 121.578 0.704 . . . . 70.310000000000002 110.943 179.831 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.797 0.332 . . . . 74.450000000000003 110.856 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -142.68 148.31 37.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.192 -0.458 . . . . 71.349999999999994 110.907 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 33.7 m -137.0 147.66 46.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.05 -0.523 . . . . 63.210000000000001 110.902 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 31.8 tttt -103.07 117.61 34.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 73.450000000000003 110.918 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 24.5 t -55.78 115.9 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 74.420000000000002 111.177 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 33.6 pt -90.04 -27.74 5.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 71.430000000000007 111.148 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -144.45 159.28 52.18 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.662 0.744 . . . . 75.040000000000006 110.893 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.78 158.75 55.87 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.718 2.279 . . . . 74.120000000000005 112.3 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -173.43 108.32 0.15 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.142 -0.481 . . . . 73.239999999999995 110.958 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -90.74 129.37 36.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 75.430000000000007 110.915 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -64.4 133.95 53.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 72.319999999999993 111.099 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -76.16 -12.65 60.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.43 . . . . 73.549999999999997 110.866 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . 0.558 ' N ' HD21 ' A' ' 282' ' ' ASN . 0.0 OUTLIER -175.54 -178.47 1.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 75.109999999999999 110.963 -179.964 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -58.66 -26.24 63.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.258 -0.428 . . . . 72.310000000000002 110.874 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -70.26 -25.84 63.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 73.519999999999996 110.927 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -100.04 167.28 10.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 73.439999999999998 110.851 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 28.2 tp -121.04 131.49 54.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.133 -0.485 . . . . 75.340000000000003 110.965 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 87.6 m -88.45 143.08 27.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 73.010000000000005 111.161 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 51.0 pt -150.34 143.49 17.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.295 -0.412 . . . . 73.299999999999997 111.071 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 37.4 mtpt -112.31 140.4 47.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 64.349999999999994 110.897 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -52.01 133.32 32.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.197 -0.456 . . . . 74.420000000000002 110.915 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.59 -19.68 53.65 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.747 -0.74 . . . . 71.5 112.458 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -79.31 173.23 12.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.745 0.307 . . . . 75.140000000000001 110.867 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 66.8 mt -124.17 125.15 70.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 73.420000000000002 111.212 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 84.2 t -107.99 134.02 51.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.179 -0.464 . . . . 62.43 111.084 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 39.0 m -84.76 111.14 19.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 71.530000000000001 111.103 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 8.7 tp -69.96 118.56 12.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 72.239999999999995 110.952 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 76.2 mt -106.46 -47.69 8.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 74.109999999999999 111.123 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -134.85 178.17 7.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.44 . . . . 70.109999999999999 110.842 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 25.0 mttp -141.36 112.95 7.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 74.540000000000006 110.957 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.94 165.25 0.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.441 . . . . 62.420000000000002 110.914 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.6 t -118.3 -69.34 0.86 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 54.5 110.804 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 2.0 mp -65.89 -13.89 16.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.184 -0.462 . . . . 75.319999999999993 111.088 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -98.8 70.31 1.86 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 73.420000000000002 110.79 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 7.3 p -51.35 123.96 3.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 71.310000000000002 111.129 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.39 23.31 34.55 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.707 -0.759 . . . . 71.219999999999999 112.466 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 56.5 m95 -140.09 135.49 32.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.797 0.332 . . . . 72.239999999999995 110.919 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 22.5 m0 -131.23 154.87 47.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.22 -0.446 . . . . 74.150000000000006 110.876 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -99.99 124.65 45.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 74.340000000000003 110.947 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -141.87 -167.09 11.14 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.66 -0.781 . . . . 64.430000000000007 112.478 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -140.43 147.4 39.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.897 0.379 . . . . 72.129999999999995 110.909 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 6.7 tp -157.65 132.18 8.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 74.329999999999998 110.839 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 57.36 30.2 18.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 75.430000000000007 110.877 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 79.15 18.64 74.03 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.749 -0.739 . . . . 70.230000000000004 112.482 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 25.5 mmm180 -122.69 115.1 21.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.745 0.307 . . . . 75.120000000000005 110.869 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 33.3 mtm180 -96.99 141.02 30.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 73.5 110.883 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -178.32 -162.54 28.23 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.772 -0.728 . . . . 74.409999999999997 112.48 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 27.5 m -111.64 155.68 12.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.873 0.368 . . . . 75.409999999999997 111.182 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -159.13 156.53 26.37 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.684 0.754 . . . . 74.109999999999999 110.828 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 120.23 7.05 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.634 2.223 . . . . 75.329999999999998 112.385 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -59.12 -21.16 58.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.265 -0.425 . . . . 73.239999999999995 110.861 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -71.53 -11.23 60.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 73.010000000000005 110.837 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -110.62 18.35 19.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 70.439999999999998 110.846 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 18.9 m -149.3 149.52 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 74.430000000000007 111.148 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -115.49 116.86 28.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 75.239999999999995 110.899 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.94 128.17 34.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.252 -0.431 . . . . 73.310000000000002 110.99 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 20.2 mt . . . . . 0 C--N 1.329 -0.319 0 CA-C-O 121.595 0.712 . . . . 74.510000000000005 110.904 179.949 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.801 0.334 . . . . 72.150000000000006 110.856 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -111.15 143.85 41.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 75.430000000000007 110.896 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 22.6 m -128.29 149.36 50.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.107 -0.497 . . . . 74.329999999999998 110.86 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 7.9 tttm -108.03 117.42 34.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 75.239999999999995 110.92 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 27.7 t -58.41 113.49 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 72.519999999999996 111.15 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 26.6 pt -87.09 -30.49 5.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 75.230000000000004 111.123 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -142.46 158.39 60.64 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.657 0.741 . . . . 75.140000000000001 110.88 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.68 158.69 56.19 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.642 2.228 . . . . 73.310000000000002 112.364 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -174.38 113.51 0.17 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.237 -0.438 . . . . 75.200000000000003 110.912 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -93.61 120.54 34.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.09 -0.505 . . . . 73.5 110.891 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -51.83 113.49 1.01 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 63.140000000000001 111.078 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -54.58 -29.76 52.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 74.109999999999999 110.905 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -155.47 172.25 18.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 74.129999999999995 110.891 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -58.2 -22.77 53.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.154 -0.476 . . . . 73.439999999999998 110.86 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -70.0 -21.01 63.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 65.239999999999995 110.833 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -105.28 177.24 4.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 72.439999999999998 110.935 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 13.1 tp -122.61 135.95 54.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.466 . . . . 73.150000000000006 110.902 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 77.9 m -88.28 146.32 25.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.121 -0.49 . . . . 71.430000000000007 111.114 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 47.6 pt -150.28 143.89 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 75.239999999999995 111.189 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 33.8 mtmt -117.53 140.9 49.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 75.299999999999997 110.906 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 -51.92 135.03 31.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.232 -0.44 . . . . 45.350000000000001 110.857 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 93.82 -23.64 29.94 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.721 -0.752 . . . . 63.539999999999999 112.469 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -76.55 171.3 14.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.832 0.348 . . . . 65.400000000000006 110.902 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 37.4 mm -122.67 125.78 73.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 70.430000000000007 111.137 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 97.8 t -103.27 138.11 28.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 71.209999999999994 111.092 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 59.4 m -93.56 109.06 20.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 75.540000000000006 111.151 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 7.0 tp -69.89 124.84 25.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.271 -0.422 . . . . 75.239999999999995 110.894 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 40.5 mt -111.1 -47.37 6.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.449 . . . . 73.030000000000001 111.119 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -137.74 169.99 16.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 74.040000000000006 110.898 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 19.1 mttt -137.35 112.37 9.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.218 -0.446 . . . . 72.329999999999998 110.963 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -56.04 179.78 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.187 -0.46 . . . . 74.230000000000004 110.862 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 1.7 t -129.05 -69.53 0.7 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 73.409999999999997 110.876 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 60.1 mt -59.4 -18.43 14.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 73.219999999999999 111.146 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -99.02 62.11 1.28 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.463 . . . . 65.049999999999997 110.899 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 71.6 t -51.51 136.36 11.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.244 -0.435 . . . . 63.43 111.154 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 88.69 14.27 61.57 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.76 -0.733 . . . . 64.230000000000004 112.543 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 51.1 m95 -139.27 148.15 42.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.758 0.313 . . . . 74.109999999999999 110.925 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 10.2 m0 -139.36 148.23 42.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.294 -0.412 . . . . 73.129999999999995 110.947 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -94.29 119.08 32.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.283 -0.417 . . . . 73.329999999999998 110.849 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -139.22 -163.41 9.49 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.736 -0.745 . . . . 53.039999999999999 112.456 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 61.6 tt0 -143.79 149.1 36.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.885 0.374 . . . . 73.430000000000007 110.916 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 4.9 tp -159.98 133.29 6.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.201 -0.454 . . . . 73.099999999999994 110.94 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 58.14 29.94 18.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 63.399999999999999 110.856 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 78.93 17.38 77.22 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.783 -0.722 . . . . 75.540000000000006 112.494 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 23.6 mmt85 -122.33 117.47 26.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.843 0.354 . . . . 74.549999999999997 110.874 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 27.3 mtm-85 -98.21 136.22 38.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 72.030000000000001 110.859 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -172.06 -158.42 16.15 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.737 -0.745 . . . . 75.299999999999997 112.504 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 24.3 m -117.72 148.02 20.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.881 0.372 . . . . 73.200000000000003 111.126 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -149.49 156.97 39.34 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.689 0.757 . . . . 74.140000000000001 110.824 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 121.5 8.19 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.655 2.237 . . . . 72.099999999999994 112.314 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -61.75 -17.74 57.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 71.549999999999997 110.862 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -75.95 -5.82 48.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 64.230000000000004 110.88 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -119.76 23.61 11.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.12 -0.491 . . . . 65.239999999999995 110.879 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 18.2 m -149.04 144.14 18.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.154 -0.475 . . . . 75.120000000000005 111.065 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 55.2 tttt -110.45 111.17 22.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 74.109999999999999 110.926 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.92 126.61 28.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 72.430000000000007 110.837 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 20.4 mt . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 121.541 0.686 . . . . 73.140000000000001 110.958 179.833 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.794 0.331 . . . . 75.349999999999994 110.884 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -130.85 154.1 48.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.211 -0.45 . . . . 73.409999999999997 110.955 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 22.8 m -139.0 147.36 42.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.113 -0.494 . . . . 75.109999999999999 110.866 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 14.3 tttp -103.66 119.08 38.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.204 -0.453 . . . . 74.400000000000006 110.862 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 53.1 t -60.3 109.13 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 64.239999999999995 111.076 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 26.5 pt -85.98 -30.63 6.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.12 -0.491 . . . . 73.400000000000006 111.095 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -138.33 159.97 65.78 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.659 0.742 . . . . 74.439999999999998 110.915 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 158.93 55.26 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.736 2.291 . . . . 73.150000000000006 112.352 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -172.81 106.02 0.16 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 71.310000000000002 111.018 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -91.23 127.54 36.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 74.019999999999996 110.869 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -63.86 113.04 3.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.476 . . . . 72.230000000000004 111.126 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -59.26 -26.07 64.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.264 -0.425 . . . . 74.439999999999998 110.95 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -149.48 168.7 22.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 71.439999999999998 110.875 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -57.02 -24.91 57.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.483 . . . . 62.299999999999997 110.859 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -70.01 -25.68 63.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.217 -0.447 . . . . 64.25 110.877 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -95.02 166.47 11.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.171 -0.468 . . . . 72.439999999999998 110.903 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 21.5 tp -114.89 133.6 55.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 74.319999999999993 110.932 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 95.5 m -91.61 140.69 29.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 74.420000000000002 111.129 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 50.4 pt -150.14 143.25 17.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 64.239999999999995 111.136 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 16.5 mmtm -114.53 141.03 48.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 74.239999999999995 110.877 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -52.02 122.54 8.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.446 . . . . 71.200000000000003 110.866 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 113.31 -22.82 14.81 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.8 -0.714 . . . . 75.349999999999994 112.448 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -86.46 160.4 19.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.708 0.289 . . . . 74.439999999999998 110.925 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 80.7 mt -110.94 129.4 66.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 62.5 111.087 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 100.0 t -107.15 138.07 34.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.106 -0.497 . . . . 72.299999999999997 111.138 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 56.1 m -89.31 111.47 22.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.126 -0.488 . . . . 72.040000000000006 111.116 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 7.5 tp -69.98 118.54 12.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.276 -0.42 . . . . 72.129999999999995 110.91 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 64.4 mt -105.79 -48.62 8.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 72.439999999999998 111.092 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -133.53 178.17 7.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 61.450000000000003 110.892 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 24.2 mttt -141.32 113.02 7.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 72.230000000000004 110.885 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -49.9 161.77 0.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.457 . . . . 74.549999999999997 110.92 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.9 t -113.37 -69.02 0.89 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.222 -0.444 . . . . 62.219999999999999 110.869 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 35.1 mt -67.77 -12.51 15.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 75.319999999999993 111.166 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -97.52 69.31 2.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 55.109999999999999 110.879 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 6.9 p -51.17 123.21 2.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.244 -0.435 . . . . 73.109999999999999 111.18 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.5 19.43 48.98 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.755 -0.736 . . . . 65.319999999999993 112.549 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 49.2 m95 -136.29 136.39 39.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.742 0.306 . . . . 74.349999999999994 110.902 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 22.6 m0 -132.1 156.09 46.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 74.120000000000005 110.936 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -100.63 120.78 40.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.228 -0.442 . . . . 74.299999999999997 110.802 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -134.67 -168.71 11.76 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.782 -0.723 . . . . 71.420000000000002 112.509 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -141.74 141.4 33.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.868 0.366 . . . . 75.319999999999993 110.873 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 5.4 tp -140.81 118.52 11.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.133 -0.485 . . . . 74.010000000000005 110.879 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 58.55 32.74 22.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 72.420000000000002 110.85 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 91.88 -16.96 58.19 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.785 -0.721 . . . . 74.0 112.532 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.33 110.1 17.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.786 0.326 . . . . 75.120000000000005 110.898 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 48.3 mtp180 -98.66 133.73 42.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 73.349999999999994 110.911 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -169.16 -155.67 10.02 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.716 -0.754 . . . . 64.140000000000001 112.396 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 12.8 m -120.25 155.88 23.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.826 0.346 . . . . 73.530000000000001 111.206 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -161.29 155.94 19.82 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.64 0.733 . . . . 74.239999999999995 110.853 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 117.85 5.33 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.676 2.251 . . . . 65.120000000000005 112.395 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -59.19 -21.21 59.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.269 -0.423 . . . . 74.219999999999999 110.871 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -70.79 -10.76 60.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 71.420000000000002 110.819 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -111.14 19.27 18.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 71.409999999999997 110.856 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 18.5 m -148.77 150.7 13.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 72.219999999999999 111.114 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 4.4 ttmt -110.9 115.09 28.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 75.0 110.903 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.1 tt -64.91 120.32 12.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.228 -0.442 . . . . 73.430000000000007 110.91 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 20.3 mt . . . . . 0 C--N 1.328 -0.368 0 CA-C-O 121.606 0.717 . . . . 75.329999999999998 110.899 179.898 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.813 0.339 . . . . 75.200000000000003 110.878 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -124.63 156.23 37.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.147 -0.479 . . . . 65.439999999999998 110.89 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 30.1 m -139.74 153.01 47.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 74.129999999999995 110.898 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -111.0 121.47 45.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 75.340000000000003 110.843 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 21.7 t -58.89 114.14 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.48 . . . . 62.399999999999999 111.118 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 25.7 pt -88.71 -30.47 5.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 73.340000000000003 111.095 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -139.72 158.85 67.17 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.679 0.752 . . . . 74.239999999999995 110.881 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 155.21 66.55 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.681 2.254 . . . . 75.239999999999995 112.339 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -174.59 108.63 0.12 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.212 -0.449 . . . . 71.129999999999995 110.935 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -88.1 150.07 23.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.5 . . . . 65.129999999999995 110.837 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -80.36 114.27 19.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 74.010000000000005 111.164 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -63.68 -25.67 68.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 74.310000000000002 110.874 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -150.66 168.6 23.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 71.230000000000004 110.888 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -58.75 -25.58 63.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 62.219999999999999 110.897 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -69.95 -25.4 63.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.47 . . . . 74.519999999999996 110.89 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -94.93 167.41 11.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.447 . . . . 71.310000000000002 110.866 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 13.7 tp -115.27 136.52 53.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.464 . . . . 75.349999999999994 110.952 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 95.7 m -90.71 138.36 31.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 73.5 111.11 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -147.29 145.55 19.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 63.539999999999999 111.129 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -119.53 139.33 52.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.108 -0.496 . . . . 74.129999999999995 110.829 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 69.7 tt0 -52.02 123.98 11.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 72.409999999999997 110.876 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 110.32 -20.54 25.54 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.756 -0.735 . . . . 64.140000000000001 112.55 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -85.13 175.57 8.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.801 0.334 . . . . 73.129999999999995 110.888 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 41.0 mm -123.81 138.37 53.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 74.010000000000005 111.157 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 66.3 t -120.57 138.0 52.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.172 -0.467 . . . . 71.140000000000001 111.122 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 91.0 m -92.05 116.01 28.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 71.319999999999993 111.206 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 4.5 tp -69.82 112.79 6.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.302 -0.408 . . . . 73.230000000000004 110.893 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 62.3 mt -102.0 -28.26 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.439 . . . . 45.340000000000003 111.086 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -156.42 178.05 10.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.214 -0.448 . . . . 72.200000000000003 110.901 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 29.6 mttp -141.33 112.92 7.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 74.030000000000001 110.904 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -50.21 163.54 0.15 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 75.310000000000002 110.847 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.7 t -114.52 -69.24 0.87 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.461 . . . . 71.450000000000003 110.855 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 2.0 mp -66.57 -13.31 16.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.494 . . . . 73.450000000000003 111.151 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -96.42 70.66 2.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.139 -0.482 . . . . 62.210000000000001 110.842 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 60.4 t -51.38 120.85 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 73.120000000000005 111.183 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.65 20.53 43.74 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.74 -0.743 . . . . 70.340000000000003 112.497 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 39.1 m95 -135.4 135.84 40.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.772 0.32 . . . . 73.349999999999994 110.898 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 23.5 m0 -130.85 157.32 43.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 74.340000000000003 110.871 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -101.43 116.13 32.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 60.310000000000002 110.888 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -130.08 -173.1 13.29 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.734 -0.746 . . . . 63.340000000000003 112.485 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -136.57 141.29 43.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.86 0.362 . . . . 75.010000000000005 110.848 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 5.5 tp -141.97 121.26 13.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.127 -0.488 . . . . 73.530000000000001 110.901 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 55.06 33.11 19.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 74.209999999999994 110.866 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 92.09 -16.59 59.26 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.714 -0.755 . . . . 71.209999999999994 112.487 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -82.99 109.23 16.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.857 0.36 . . . . 73.030000000000001 110.845 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.33 125.85 46.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.484 . . . . 73.310000000000002 110.904 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -163.43 -158.99 10.23 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.76 -0.734 . . . . 72.349999999999994 112.521 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 6.6 m -114.19 156.7 15.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.86 0.362 . . . . 73.109999999999999 111.137 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -163.67 156.05 15.3 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.645 0.736 . . . . 75.310000000000002 110.869 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 117.71 5.25 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.659 2.239 . . . . 73.019999999999996 112.326 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -58.34 -22.04 51.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.259 -0.428 . . . . 71.129999999999995 110.843 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -69.27 -11.78 61.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 73.129999999999995 110.987 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -109.18 17.04 22.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.472 . . . . 74.349999999999994 110.874 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 18.4 m -148.81 150.58 13.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.144 -0.48 . . . . 64.430000000000007 111.173 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -112.09 119.28 37.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.223 -0.444 . . . . 74.349999999999994 110.872 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.89 116.29 6.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.226 -0.443 . . . . 75.010000000000005 110.857 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 21.2 mt . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 121.608 0.718 . . . . 75.230000000000004 110.916 179.836 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.799 0.333 . . . . 73.209999999999994 110.882 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -133.5 152.94 51.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.207 -0.452 . . . . 74.400000000000006 110.932 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 34.4 m -139.98 147.93 41.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.093 -0.503 . . . . 72.510000000000005 110.941 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 33.3 tttt -102.99 121.98 43.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 74.549999999999997 110.908 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 46.9 t -62.22 110.99 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 54.049999999999997 111.123 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 26.8 pt -85.52 -32.82 7.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 75.129999999999995 111.139 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -135.95 158.0 74.78 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.629 0.728 . . . . 70.420000000000002 110.918 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 150.17 68.13 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.715 2.277 . . . . 74.530000000000001 112.327 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -171.17 106.06 0.24 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.235 -0.439 . . . . 73.230000000000004 110.963 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -93.03 147.01 23.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.073 -0.512 . . . . 75.530000000000001 110.851 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -82.04 124.56 29.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 71.439999999999998 111.091 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -72.31 -32.1 66.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 74.439999999999998 110.899 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -137.36 172.35 13.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 70.219999999999999 110.929 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -62.22 -17.91 59.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 71.299999999999997 110.824 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -75.57 -19.39 59.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.241 -0.436 . . . . 72.450000000000003 110.838 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -105.62 164.1 12.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.224 -0.444 . . . . 70.299999999999997 110.868 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 14.6 tp -115.47 135.61 53.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.158 -0.473 . . . . 64.540000000000006 110.899 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 46.2 m -88.31 141.42 28.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 73.120000000000005 111.12 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 33.6 pt -150.09 139.66 15.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 74.400000000000006 111.104 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 29.2 mttm -109.99 138.31 46.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 73.340000000000003 110.867 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -51.65 126.85 18.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 75.109999999999999 110.922 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 107.15 -23.51 27.05 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.657 -0.782 . . . . 72.450000000000003 112.476 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -84.99 160.44 20.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.763 0.316 . . . . 74.319999999999993 110.873 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 35.1 mm -110.82 128.92 66.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.16 -0.473 . . . . 73.319999999999993 111.07 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 94.5 t -103.51 138.02 29.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.103 -0.499 . . . . 75.530000000000001 111.131 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 59.8 m -87.48 110.57 20.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 74.109999999999999 111.212 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 7.6 tp -70.01 116.07 9.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 73.209999999999994 110.904 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 54.4 mt -102.46 -47.59 11.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 72.319999999999993 111.177 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -135.29 178.21 7.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 71.510000000000005 110.966 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 23.3 mttt -141.15 112.88 7.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 71.099999999999994 110.859 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -49.98 160.49 0.33 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 72.409999999999997 110.849 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.7 t -113.09 -69.01 0.89 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.237 -0.438 . . . . 73.129999999999995 110.858 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 1.9 mp -66.72 -13.24 16.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.475 . . . . 75.420000000000002 111.103 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.66 69.78 1.88 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.192 -0.458 . . . . 74.540000000000006 110.85 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 88.0 t -51.43 124.24 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.443 . . . . 72.219999999999999 111.095 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.41 19.12 50.73 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.703 -0.761 . . . . 72.310000000000002 112.539 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 46.4 m95 -136.02 135.21 39.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.781 0.325 . . . . 75.400000000000006 110.881 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 23.4 m0 -131.19 154.94 47.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 64.209999999999994 110.967 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -99.13 118.31 35.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.291 -0.413 . . . . 72.430000000000007 110.877 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -130.08 -171.83 13.01 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.824 -0.703 . . . . 72.299999999999997 112.556 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -140.71 144.24 35.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.895 0.379 . . . . 74.25 110.851 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 2.3 tp -160.04 135.45 8.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 74.340000000000003 110.886 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 59.52 29.99 19.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.13 -0.486 . . . . 63.240000000000002 110.951 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 77.87 10.05 86.5 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.7 -0.762 . . . . 70.150000000000006 112.536 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -115.41 111.82 21.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.818 0.342 . . . . 72.120000000000005 110.861 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 10.3 ttp85 -96.63 124.32 40.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 72.400000000000006 110.832 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -154.9 -157.09 8.03 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.779 -0.724 . . . . 62.340000000000003 112.511 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 20.2 m -118.87 154.02 21.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.833 0.349 . . . . 64.230000000000004 111.185 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -160.52 155.82 21.43 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.629 0.728 . . . . 73.420000000000002 110.899 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 117.91 5.36 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.724 2.283 . . . . 72.0 112.339 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -59.12 -21.21 58.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 73.349999999999994 110.871 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -68.92 -12.11 61.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 73.430000000000007 110.885 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -108.81 16.56 22.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 75.510000000000005 110.816 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 18.0 m -148.66 150.82 13.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.442 . . . . 74.200000000000003 111.134 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -109.75 118.6 36.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 75.200000000000003 110.936 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.2 tt -64.97 121.13 13.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.441 . . . . 75.510000000000005 110.96 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 20.3 mt . . . . . 0 C--N 1.329 -0.322 0 CA-C-O 121.631 0.729 . . . . 74.140000000000001 110.896 179.947 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.753 0.311 . . . . 74.040000000000006 110.859 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -117.16 153.08 33.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.248 -0.433 . . . . 73.5 110.884 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 22.9 m -136.66 148.43 47.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.084 -0.507 . . . . 71.099999999999994 110.883 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 39.1 tttt -106.47 123.41 48.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.172 -0.467 . . . . 75.120000000000005 110.964 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 21.4 t -61.57 114.12 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 74.340000000000003 111.1 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 28.1 pt -85.88 -30.02 6.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 74.230000000000004 111.101 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -144.03 157.98 56.43 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.578 0.704 . . . . 74.109999999999999 110.905 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 154.03 67.99 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.624 2.216 . . . . 65.010000000000005 112.349 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -172.92 111.74 0.22 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 74.299999999999997 110.921 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -92.36 131.02 37.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.118 -0.492 . . . . 73.510000000000005 110.933 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -57.54 119.32 6.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 51.420000000000002 111.148 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.46 -25.79 68.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 71.099999999999994 110.861 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -154.63 172.77 17.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.25 -0.432 . . . . 72.25 110.94 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -58.48 -25.65 62.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 75.409999999999997 110.855 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.35 -25.73 62.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.213 -0.449 . . . . 72.230000000000004 110.799 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -94.88 166.97 11.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 71.140000000000001 110.941 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 12.9 tp -116.94 135.64 53.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.448 . . . . 71.400000000000006 110.967 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 60.1 m -86.92 146.69 26.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 72.340000000000003 111.172 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 31.1 pt -150.35 137.89 13.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 65.540000000000006 111.13 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -111.28 139.24 46.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 75.310000000000002 110.896 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -51.94 135.87 29.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 75.040000000000006 110.878 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 92.9 -22.37 34.44 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.766 -0.73 . . . . 63.200000000000003 112.527 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -77.08 178.32 7.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.783 0.325 . . . . 71.209999999999994 110.858 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 51.2 mt -130.09 125.81 60.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.151 -0.477 . . . . 73.530000000000001 111.161 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 21.5 t -101.4 138.08 26.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.154 -0.476 . . . . 71.099999999999994 111.153 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 37.9 m -92.49 110.68 22.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 65.239999999999995 111.102 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 4.7 tp -69.89 121.48 17.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 73.209999999999994 110.936 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 62.7 mt -110.13 -37.3 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 73.510000000000005 111.162 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -150.08 170.53 18.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.484 . . . . 75.099999999999994 110.928 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 15.8 mttt -137.3 112.34 9.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 73.140000000000001 110.923 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -56.0 179.76 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.239 -0.437 . . . . 64.140000000000001 110.887 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 1.7 t -128.99 -69.41 0.71 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 72.200000000000003 110.861 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 42.0 mm -59.83 -18.0 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 74.430000000000007 111.153 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -99.44 61.77 1.2 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 75.140000000000001 110.845 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 62.5 t -51.35 136.53 10.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.464 . . . . 71.299999999999997 111.197 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 88.62 14.46 61.44 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.793 -0.718 . . . . 74.409999999999997 112.477 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 52.4 m95 -139.7 148.67 42.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.785 0.326 . . . . 74.239999999999995 110.869 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 10.3 m0 -139.12 148.66 43.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.47 . . . . 72.439999999999998 110.919 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -94.62 122.27 37.05 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.217 -0.447 . . . . 73.409999999999997 110.887 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -144.55 -164.43 10.53 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.781 -0.723 . . . . 72.120000000000005 112.49 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -142.37 148.2 37.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.87 0.366 . . . . 73.109999999999999 110.884 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 3.9 tp -159.02 130.15 6.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.474 . . . . 74.409999999999997 110.946 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 58.97 30.01 19.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.277 -0.42 . . . . 71.239999999999995 110.911 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 82.8 2.51 90.66 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.774 -0.727 . . . . 73.310000000000002 112.427 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -105.61 121.31 43.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.825 0.345 . . . . 73.439999999999998 110.897 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 55.1 mtm180 -105.65 133.74 49.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 74.329999999999998 110.806 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -171.93 -151.15 7.61 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.712 -0.756 . . . . 71.129999999999995 112.446 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 33.7 m -124.25 145.79 30.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.868 0.366 . . . . 72.129999999999995 111.14 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -144.56 157.01 56.41 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.644 0.735 . . . . 74.349999999999994 110.877 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 121.73 8.41 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.678 2.252 . . . . 74.450000000000003 112.375 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -62.2 -17.32 57.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 65.409999999999997 110.888 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -76.61 -5.23 46.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.115 -0.493 . . . . 72.430000000000007 110.813 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -121.01 24.5 10.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 74.409999999999997 110.849 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 17.5 m -148.61 147.39 16.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.175 -0.466 . . . . 71.299999999999997 111.105 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -114.07 114.35 26.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.474 . . . . 74.439999999999998 110.95 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.99 125.65 25.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.187 -0.461 . . . . 74.519999999999996 110.915 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 21.5 mt . . . . . 0 C--N 1.328 -0.326 0 CA-C-O 121.58 0.705 . . . . 72.450000000000003 110.901 179.959 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.766 0.317 . . . . 70.129999999999995 110.851 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -110.65 137.8 47.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.173 -0.467 . . . . 75.239999999999995 110.962 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 25.3 m -126.92 145.61 50.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.148 -0.478 . . . . 64.140000000000001 110.923 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 17.6 ttpt -103.65 127.78 51.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 74.239999999999995 110.892 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 21.5 t -61.58 114.42 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.29 -0.414 . . . . 71.010000000000005 111.076 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 34.4 pt -88.97 -27.06 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 75.230000000000004 111.128 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -145.94 159.25 47.22 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.635 0.731 . . . . 74.450000000000003 110.853 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 151.94 68.89 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.706 2.27 . . . . 63.43 112.276 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -166.41 111.47 0.8 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 75.340000000000003 110.916 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -94.88 129.01 42.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 73.239999999999995 110.887 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -63.41 113.82 3.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 73.010000000000005 111.104 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -59.58 -26.44 65.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 75.019999999999996 110.899 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -150.7 170.25 19.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.221 -0.445 . . . . 51.009999999999998 110.842 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -56.57 -25.95 53.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 74.329999999999998 110.829 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -70.08 -25.86 63.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 72.310000000000002 110.851 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -94.96 164.66 12.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 74.25 110.9 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 14.4 tp -116.41 136.71 52.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.09 -0.505 . . . . 75.450000000000003 110.893 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 85.1 m -92.59 144.86 24.91 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.151 -0.477 . . . . 75.239999999999995 111.132 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 48.4 pt -150.37 142.9 17.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 72.510000000000005 111.143 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 31.8 mtpt -112.38 141.04 46.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.153 -0.476 . . . . 74.329999999999998 110.931 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -51.95 131.56 31.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 74.299999999999997 110.851 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 99.96 -22.22 41.22 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.702 -0.761 . . . . 74.530000000000001 112.438 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -76.12 178.12 6.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.757 0.313 . . . . 70.019999999999996 110.874 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 81.2 mt -133.02 122.1 45.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 74.230000000000004 111.179 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 90.1 t -105.66 138.1 32.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 73.129999999999995 111.149 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 52.3 m -87.77 114.34 24.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 63.399999999999999 111.136 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 5.5 tp -70.01 112.43 6.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.258 -0.428 . . . . 74.209999999999994 110.909 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 61.2 mt -101.43 -29.03 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.107 -0.497 . . . . 72.25 111.128 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -155.69 178.08 10.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.444 . . . . 54.109999999999999 110.9 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 27.7 mttp -141.33 112.97 7.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 71.040000000000006 110.938 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -49.68 160.78 0.26 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.213 -0.449 . . . . 71.319999999999993 110.888 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.8 t -113.29 -68.97 0.89 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 50.420000000000002 110.897 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 31.0 mm -66.97 -12.86 15.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 71.200000000000003 111.109 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -97.17 70.81 2.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 70.129999999999995 110.947 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 5.9 p -51.31 120.75 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 73.129999999999995 111.145 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.54 24.47 30.74 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.758 -0.734 . . . . 63.149999999999999 112.461 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 56.3 m95 -139.72 135.94 33.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.809 0.337 . . . . 73.5 110.913 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 22.3 m0 -130.69 156.66 44.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 73.230000000000004 110.867 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -101.38 115.51 30.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.194 -0.457 . . . . 75.230000000000004 110.925 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -128.66 -172.64 13.23 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.755 -0.736 . . . . 51.530000000000001 112.503 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -141.32 140.43 33.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.861 0.362 . . . . 73.349999999999994 110.931 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 4.5 tp -145.69 128.94 16.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 73.140000000000001 110.838 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 56.8 29.88 16.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 72.239999999999995 110.816 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 87.52 -8.62 76.64 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.716 -0.754 . . . . 73.129999999999995 112.527 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 4.3 tpt180 -93.08 109.01 20.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.722 0.296 . . . . 74.040000000000006 110.887 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 10.4 ttp85 -96.69 133.35 41.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 74.230000000000004 110.904 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -166.43 -158.87 11.47 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.669 -0.777 . . . . 75.530000000000001 112.41 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 19.2 m -116.76 154.47 18.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.883 0.373 . . . . 74.230000000000004 111.129 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -159.79 157.07 25.57 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.621 0.724 . . . . 71.299999999999997 110.865 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 121.65 8.33 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.705 2.27 . . . . 74.030000000000001 112.348 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -58.35 -22.31 53.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 65.140000000000001 110.937 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -69.85 -15.78 63.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 75.430000000000007 110.863 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -104.36 15.62 27.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 74.219999999999999 110.859 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 18.9 m -149.16 150.59 13.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 75.329999999999998 111.12 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 24.8 ttpt -125.35 125.75 43.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 74.230000000000004 110.895 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 2.5 mt -64.95 130.78 44.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 71.230000000000004 110.98 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 20.2 mt . . . . . 0 C--N 1.329 -0.322 0 CA-C-O 121.592 0.711 . . . . 73.120000000000005 110.871 179.951 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.87 0.367 . . . . 70.209999999999994 110.833 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -130.46 143.09 50.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.211 -0.45 . . . . 73.549999999999997 110.922 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 22.1 m -133.04 149.37 52.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.116 -0.493 . . . . 74.329999999999998 110.887 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 15.5 tttp -103.89 121.75 43.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 74.349999999999994 110.935 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 57.8 t -61.65 111.71 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 70.450000000000003 111.141 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 28.5 pt -84.1 -32.12 8.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 71.219999999999999 111.098 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -140.39 157.78 67.76 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.661 0.743 . . . . 73.099999999999994 110.927 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.81 159.23 54.13 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.695 2.264 . . . . 73.409999999999997 112.25 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -174.16 109.64 0.14 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 73.420000000000002 110.915 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -89.33 139.47 30.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 70.319999999999993 110.829 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -87.5 121.42 29.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 74.209999999999994 111.042 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -60.22 -42.46 95.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 63.420000000000002 110.933 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -148.64 -174.66 4.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 73.349999999999994 110.89 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -57.98 -19.75 32.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 73.150000000000006 110.909 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -72.07 -8.39 54.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 53.509999999999998 110.882 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -132.61 158.91 41.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 74.010000000000005 110.855 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 17.0 tp -114.89 133.44 55.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 74.219999999999999 110.979 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 86.7 m -84.32 145.04 28.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 64.209999999999994 111.144 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 38.6 pt -150.88 138.83 14.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 64.239999999999995 111.064 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 31.2 mttm -110.43 136.1 50.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.131 -0.486 . . . . 75.430000000000007 110.962 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -51.68 128.7 24.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.45 . . . . 71.310000000000002 110.877 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 105.26 -26.21 22.57 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.699 -0.762 . . . . 63.009999999999998 112.483 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -83.28 156.16 23.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.694 0.283 . . . . 74.420000000000002 110.934 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 56.6 mt -106.64 126.26 62.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.194 -0.457 . . . . 75.430000000000007 111.107 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 62.1 t -96.11 138.13 22.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 70.439999999999998 111.077 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 56.2 m -91.1 109.43 20.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.16 -0.473 . . . . 74.019999999999996 111.145 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 4.2 tp -69.85 121.2 16.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.187 -0.46 . . . . 73.310000000000002 110.892 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 38.9 mt -107.93 -36.69 3.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.233 -0.44 . . . . 64.450000000000003 111.171 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -151.02 170.69 18.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.128 -0.487 . . . . 74.0 110.907 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 21.7 mttt -137.28 112.28 9.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 74.219999999999999 110.858 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -55.49 178.61 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.436 . . . . 75.319999999999993 110.891 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 1.7 t -128.04 -69.36 0.73 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.207 -0.452 . . . . 64.439999999999998 110.936 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 60.8 mt -59.71 -18.26 14.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 70.510000000000005 111.137 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.35 61.67 1.21 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.462 . . . . 63.530000000000001 110.919 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 54.9 t -51.44 136.8 10.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 74.019999999999996 111.119 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 88.75 14.17 61.61 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.721 -0.752 . . . . 72.430000000000007 112.533 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 52.2 m95 -139.68 149.04 43.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.729 0.3 . . . . 75.439999999999998 110.871 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 10.4 m0 -139.22 148.78 43.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 73.530000000000001 110.89 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -94.47 117.56 30.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 72.400000000000006 110.969 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -138.4 -168.87 11.42 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.711 -0.757 . . . . 71.409999999999997 112.509 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 71.1 tt0 -138.49 148.1 43.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.834 0.35 . . . . 71.400000000000006 110.95 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 6.3 tp -158.6 129.55 6.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.19 -0.459 . . . . 74.349999999999994 110.953 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 58.94 30.0 19.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 60.409999999999997 110.864 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 84.47 -5.13 82.35 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.72 -0.752 . . . . 74.430000000000007 112.46 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -98.3 122.35 41.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.757 0.313 . . . . 73.099999999999994 110.915 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 63.0 mtm180 -106.97 132.03 53.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 75.530000000000001 110.835 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -168.04 -149.5 6.14 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.7 -0.762 . . . . 75.420000000000002 112.468 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 18.7 m -127.17 146.45 33.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.896 0.379 . . . . 75.049999999999997 111.119 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -144.95 157.37 54.43 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.656 0.741 . . . . 74.420000000000002 110.841 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.66 121.24 7.95 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.727 2.285 . . . . 73.400000000000006 112.344 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -60.66 -18.73 55.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 73.109999999999999 110.831 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -74.85 -6.7 50.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.481 . . . . 74.109999999999999 110.921 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -118.06 22.12 12.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 75.310000000000002 110.83 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 17.5 m -149.02 145.12 18.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 74.420000000000002 111.15 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -111.19 117.38 33.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 71.200000000000003 110.919 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.87 125.47 24.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 73.430000000000007 110.932 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 20.3 mt . . . . . 0 C--N 1.329 -0.322 0 CA-C-O 121.59 0.71 . . . . 73.5 110.936 179.89 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.859 0.361 . . . . 73.109999999999999 110.876 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -124.1 156.61 36.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 65.209999999999994 110.917 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 23.5 m -138.92 152.44 47.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.123 -0.489 . . . . 65.209999999999994 110.886 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt -108.21 126.67 53.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.141 -0.481 . . . . 74.219999999999999 110.916 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 38.9 t -63.21 109.32 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 74.409999999999997 111.107 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 30.0 pt -83.25 -31.53 8.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 75.400000000000006 111.14 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -140.84 159.2 63.22 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.654 0.74 . . . . 73.140000000000001 110.86 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 152.08 69.02 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.675 2.25 . . . . 74.25 112.318 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -174.38 105.96 0.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 74.040000000000006 110.839 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -89.2 141.06 28.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.108 -0.496 . . . . 64.5 110.915 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -54.54 113.03 1.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 64.319999999999993 111.176 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -69.05 -26.45 64.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.303 -0.408 . . . . 75.439999999999998 110.945 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 18.9 m-80 -144.03 174.74 10.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.134 -0.485 . . . . 74.040000000000006 110.91 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -63.53 -26.13 68.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 75.310000000000002 110.854 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -88.06 6.14 37.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 74.040000000000006 110.838 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -105.65 164.64 11.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.253 -0.43 . . . . 75.239999999999995 110.889 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 21.3 tp -115.75 131.23 57.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.491 . . . . 74.120000000000005 110.903 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 91.5 m -87.43 136.14 33.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 72.540000000000006 111.078 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -147.49 146.15 18.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 72.439999999999998 111.149 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 27.4 mtmm -120.64 145.98 46.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 74.450000000000003 110.945 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -52.0 131.82 31.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.27 -0.423 . . . . 74.129999999999995 110.847 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.03 -27.1 19.81 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.804 -0.712 . . . . 40.5 112.52 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -71.71 173.34 8.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.778 0.323 . . . . 73.019999999999996 110.839 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 28.5 mm -124.24 135.9 62.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 75.239999999999995 111.156 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 19.5 t -111.69 132.43 60.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.247 -0.433 . . . . 62.240000000000002 111.067 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 17.4 m -87.89 112.09 22.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.089 -0.505 . . . . 72.340000000000003 111.136 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 6.0 tp -69.59 119.69 14.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 74.400000000000006 110.977 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 58.9 mt -115.72 -25.18 3.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.283 -0.417 . . . . 65.219999999999999 111.095 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -158.29 176.84 11.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.014 0.435 . . . . 74.099999999999994 110.779 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 48.7 mttt -141.18 113.03 7.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.048 -0.524 . . . . 70.439999999999998 110.897 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.01 166.75 0.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 75.439999999999998 110.903 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.2 t -119.6 -69.35 0.85 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.241 -0.436 . . . . 64.299999999999997 110.919 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 36.0 mm -64.26 -14.72 16.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 73.439999999999998 111.133 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -96.51 74.47 2.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 72.340000000000003 110.848 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 58.9 t -51.37 117.36 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 71.530000000000001 111.129 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 88.89 29.68 17.32 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.793 -0.718 . . . . 73.430000000000007 112.477 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 58.8 m95 -140.67 135.05 31.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.68 0.276 . . . . 74.340000000000003 110.977 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 24.2 m0 -129.26 157.55 41.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.254 -0.43 . . . . 75.209999999999994 110.934 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -104.78 124.77 49.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.305 -0.407 . . . . 73.299999999999997 110.887 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -140.24 -164.82 10.05 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.706 -0.759 . . . . 71.230000000000004 112.451 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -142.94 143.68 32.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.915 0.388 . . . . 73.200000000000003 110.865 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 2.0 tp -146.56 122.77 10.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 75.439999999999998 110.959 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 58.55 29.94 19.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 73.150000000000006 110.892 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 89.61 -8.63 79.43 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.715 -0.755 . . . . 72.019999999999996 112.459 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 17.2 tpp180 -94.14 114.24 26.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.703 0.287 . . . . 75.530000000000001 110.913 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 36.7 mtm180 -98.86 138.19 36.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.202 -0.454 . . . . 74.219999999999999 110.828 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -171.93 -160.61 20.86 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.797 -0.716 . . . . 74.519999999999996 112.475 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 32.6 m -118.36 154.0 20.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.857 0.36 . . . . 75.430000000000007 111.145 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -156.04 156.34 30.31 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.639 0.733 . . . . 73.200000000000003 110.882 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 119.5 6.44 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.701 2.267 . . . . 72.310000000000002 112.351 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -60.89 -18.86 58.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.431 . . . . 73.329999999999998 110.888 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -74.55 -7.15 52.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.157 -0.474 . . . . 61.030000000000001 110.82 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -117.63 24.19 11.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 74.450000000000003 110.776 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 18.1 m -148.89 153.13 11.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 73.109999999999999 111.122 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -116.8 113.39 22.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 72.099999999999994 110.957 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.2 tt -65.1 126.48 28.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 72.329999999999998 110.906 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 20.3 mt . . . . . 0 C--N 1.328 -0.363 0 CA-C-O 121.642 0.734 . . . . 75.25 110.855 179.896 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.794 0.331 . . . . 74.230000000000004 110.839 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -129.26 150.99 50.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 74.25 110.857 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 26.4 m -139.19 150.7 45.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.058 -0.519 . . . . 74.409999999999997 110.911 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -107.77 122.92 47.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.447 . . . . 74.319999999999993 110.896 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 24.1 t -56.01 116.18 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.292 -0.413 . . . . 74.349999999999994 111.193 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 29.7 pt -97.95 -17.55 6.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 71.409999999999997 111.127 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -145.52 151.98 48.31 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.627 0.727 . . . . 73.409999999999997 110.903 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.67 151.52 69.62 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.655 2.237 . . . . 74.530000000000001 112.363 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -174.45 140.43 0.63 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.451 . . . . 73.140000000000001 110.932 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -121.17 143.18 49.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.054 -0.521 . . . . 75.25 110.882 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -76.61 127.79 33.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 73.420000000000002 111.116 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -71.48 -25.82 62.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.242 -0.435 . . . . 74.129999999999995 110.878 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -155.75 177.54 11.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 51.100000000000001 110.887 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -56.94 -25.75 58.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.177 -0.465 . . . . 65.530000000000001 110.878 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -72.29 -24.85 61.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.474 . . . . 72.409999999999997 110.864 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -94.97 163.5 13.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.172 -0.467 . . . . 71.120000000000005 110.895 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 20.3 tp -119.78 131.24 55.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.13 -0.486 . . . . 74.230000000000004 110.923 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 96.7 m -85.97 143.3 28.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.154 -0.475 . . . . 75.010000000000005 111.139 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 47.9 pt -150.26 142.36 17.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 75.040000000000006 111.115 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 17.3 mmtp -122.07 144.73 48.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 72.140000000000001 110.897 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -51.5 128.81 23.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 74.310000000000002 110.863 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 101.43 -30.89 9.41 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.753 -0.737 . . . . 75.219999999999999 112.493 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -69.77 171.83 8.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.736 0.303 . . . . 73.530000000000001 110.917 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 67.4 mt -126.71 126.16 68.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 73.329999999999998 111.087 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 64.6 t -104.37 138.21 30.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 74.310000000000002 111.135 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 49.2 m -92.63 111.4 22.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.154 -0.475 . . . . 64.049999999999997 111.129 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 5.3 tp -69.82 122.28 18.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 74.209999999999994 110.937 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 67.6 mt -110.53 -39.8 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 73.010000000000005 111.124 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -145.71 171.67 14.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 65.549999999999997 110.872 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -136.09 111.87 9.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 72.099999999999994 110.899 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.08 177.5 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 71.420000000000002 110.938 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 1.9 t -126.46 -69.33 0.77 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 64.230000000000004 110.91 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 38.6 mm -62.64 -15.89 15.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 72.219999999999999 111.185 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.26 61.35 2.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 73.540000000000006 110.9 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 56.6 t -51.12 130.97 11.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 71.200000000000003 111.118 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.91 14.71 58.97 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.779 -0.724 . . . . 73.5 112.484 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 44.0 m95 -137.01 162.86 32.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.816 0.341 . . . . 73.209999999999994 110.872 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 5.0 m0 -151.0 156.44 41.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 70.310000000000002 110.866 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -102.66 119.06 38.17 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.246 -0.434 . . . . 73.329999999999998 110.903 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -140.55 -162.92 9.31 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.75 -0.738 . . . . 62.25 112.51 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -145.65 148.64 33.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.934 0.397 . . . . 65.030000000000001 110.834 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 14.5 tp -157.98 134.95 9.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.074 -0.512 . . . . 72.120000000000005 110.894 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 57.23 30.44 18.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 74.450000000000003 110.926 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 77.95 18.88 76.19 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.784 -0.722 . . . . 62.43 112.416 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 31.5 mmm-85 -124.99 121.01 33.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.867 0.365 . . . . 74.430000000000007 110.849 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 39.8 mtp180 -99.55 142.54 30.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 73.450000000000003 110.876 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -176.52 -160.06 23.09 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.793 -0.718 . . . . 73.430000000000007 112.523 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 29.5 m -115.51 151.07 17.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.923 0.392 . . . . 70.439999999999998 111.17 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -154.69 155.77 30.83 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.64 0.733 . . . . 74.129999999999995 110.916 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 119.8 6.69 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.744 2.296 . . . . 75.310000000000002 112.31 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -61.06 -18.61 58.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.242 -0.435 . . . . 73.340000000000003 110.855 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 75.1 m-80 -74.88 -6.98 52.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 74.549999999999997 110.887 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -117.54 22.77 12.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 75.420000000000002 110.892 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 18.3 m -148.82 144.28 18.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.464 . . . . 73.530000000000001 111.17 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 52.6 tttt -109.45 116.95 32.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.464 . . . . 70.099999999999994 110.891 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.02 119.36 10.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 75.120000000000005 110.952 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 20.2 mt . . . . . 0 C--N 1.328 -0.348 0 CA-C-O 121.615 0.722 . . . . 73.530000000000001 110.896 179.91 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.81 0.338 . . . . 72.140000000000001 110.845 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -142.85 147.19 35.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.452 . . . . 75.25 110.942 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 23.7 m -135.26 149.22 49.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 73.299999999999997 110.85 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 47.4 tttt -103.49 115.17 30.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.181 -0.463 . . . . 75.310000000000002 110.886 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 58.9 t -57.47 118.26 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.262 -0.426 . . . . 74.510000000000005 111.08 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 26.2 pt -93.42 -30.98 4.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.489 . . . . 71.420000000000002 111.13 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -136.56 159.4 70.63 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.642 0.734 . . . . 63.340000000000003 110.929 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 159.63 52.69 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.648 2.232 . . . . 72.310000000000002 112.367 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -172.76 110.02 0.21 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.27 -0.423 . . . . 72.329999999999998 110.948 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -93.23 128.02 39.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 71.129999999999995 110.868 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -61.82 116.27 4.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 75.219999999999999 111.109 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -57.9 -26.73 62.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 74.310000000000002 110.99 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -152.43 173.87 14.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 71.329999999999998 110.949 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -58.78 -26.28 63.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 74.040000000000006 110.945 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -70.11 -24.92 63.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.1 -0.5 . . . . 65.129999999999995 110.856 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -95.07 167.32 11.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 75.010000000000005 110.865 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 15.1 tp -116.78 137.43 52.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 73.420000000000002 110.921 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 85.4 m -95.18 144.35 25.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 64.25 111.128 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 41.8 pt -150.34 149.72 14.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 62.25 111.128 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -121.93 140.79 52.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 73.319999999999993 110.909 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 8.1 tm-20 -51.83 122.95 9.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 73.230000000000004 110.861 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 113.26 -23.16 14.33 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.726 -0.749 . . . . 15.41 112.466 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -88.42 152.14 22.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.817 0.341 . . . . 71.319999999999993 110.867 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 62.7 mt -104.55 123.65 58.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 75.299999999999997 111.147 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 90.9 t -100.17 138.04 25.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 73.019999999999996 111.114 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 33.9 m -86.5 109.35 19.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.166 -0.47 . . . . 74.030000000000001 111.154 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 7.4 tp -69.86 117.76 11.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 74.430000000000007 110.904 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 69.0 mt -104.45 -48.41 9.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 73.519999999999996 111.086 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -134.38 178.13 7.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 73.430000000000007 110.895 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -141.46 112.77 7.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.157 -0.474 . . . . 73.400000000000006 110.91 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -50.56 165.77 0.09 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.229 -0.441 . . . . 72.409999999999997 110.805 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.8 t -115.69 -69.14 0.87 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.479 . . . . 74.040000000000006 110.864 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 2.0 mp -67.57 -12.61 15.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.434 . . . . 72.519999999999996 111.194 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.84 69.3 3.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 73.409999999999997 110.894 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 76.7 t -51.43 121.41 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 74.120000000000005 111.136 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.33 20.34 45.73 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.733 -0.746 . . . . 73.219999999999999 112.551 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 42.0 m95 -136.27 138.7 42.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.708 0.289 . . . . 75.129999999999995 110.909 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 19.5 m0 -134.3 157.19 46.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.454 . . . . 73.319999999999993 110.918 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -100.52 117.25 34.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.288 -0.415 . . . . 73.109999999999999 110.888 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -129.77 -170.13 12.67 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.768 -0.73 . . . . 70.329999999999998 112.505 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -143.83 146.82 33.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.864 0.364 . . . . 74.329999999999998 110.947 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 2.6 tp -155.77 132.27 10.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.181 -0.463 . . . . 73.219999999999999 110.92 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 56.81 29.86 16.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 72.319999999999993 110.854 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 84.76 -6.8 76.73 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.747 -0.74 . . . . 74.219999999999999 112.485 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 14.1 tpp180 -96.09 108.6 21.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.773 0.321 . . . . 63.210000000000001 110.857 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 8.9 ttp180 -96.61 129.75 43.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 74.340000000000003 110.952 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -161.34 -157.96 9.11 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.78 -0.724 . . . . 70.530000000000001 112.507 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 15.8 m -117.25 154.59 18.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.843 0.354 . . . . 74.519999999999996 111.119 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -162.19 155.83 17.9 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.648 0.737 . . . . 73.140000000000001 110.904 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.85 118.5 5.72 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.699 2.266 . . . . 72.150000000000006 112.293 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -59.67 -20.32 55.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 71.409999999999997 110.83 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -68.4 -12.65 61.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 61.420000000000002 110.887 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -107.96 14.15 25.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 73.040000000000006 110.856 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 17.7 m -148.56 145.21 18.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.487 . . . . 74.409999999999997 111.09 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 21.6 ttpp -106.52 118.77 37.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 75.450000000000003 110.958 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.9 tt -64.98 132.0 48.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 72.450000000000003 110.934 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 20.4 mt . . . . . 0 C--N 1.328 -0.365 0 CA-C-O 121.572 0.701 . . . . 75.439999999999998 110.936 179.882 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.89 0.376 . . . . 75.099999999999994 110.862 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -132.33 139.61 48.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 74.430000000000007 110.903 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 36.0 m -127.76 148.61 50.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.479 . . . . 63.240000000000002 110.887 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 38.6 tttt -102.9 118.04 35.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 74.519999999999996 110.878 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 61.6 t -58.82 112.99 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.252 -0.431 . . . . 74.409999999999997 111.15 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 30.9 pt -86.5 -31.47 6.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 74.450000000000003 111.099 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -139.71 158.14 68.56 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.603 0.716 . . . . 71.319999999999993 110.867 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 153.94 68.43 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.702 2.268 . . . . 74.040000000000006 112.361 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -171.48 105.95 0.22 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 75.030000000000001 110.927 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -88.57 143.84 26.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 74.150000000000006 110.837 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -78.09 123.39 26.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.096 -0.502 . . . . 53.109999999999999 111.095 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -74.85 -26.13 59.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 74.129999999999995 110.943 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -144.49 170.07 16.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 74.030000000000001 110.883 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -57.35 -26.18 60.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.139 -0.482 . . . . 74.510000000000005 110.928 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -70.95 -25.56 62.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 52.240000000000002 110.922 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -95.16 161.28 14.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 64.439999999999998 110.928 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 13.4 tp -120.1 136.54 54.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.235 -0.439 . . . . 74.099999999999994 110.941 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 73.2 m -86.2 146.1 26.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 74.540000000000006 111.087 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 44.3 pt -150.41 145.04 17.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.439 . . . . 73.219999999999999 111.106 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -117.64 136.98 52.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 72.049999999999997 110.873 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -51.76 126.15 17.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 72.450000000000003 110.88 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 108.51 -26.02 17.7 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.713 -0.756 . . . . 75.129999999999995 112.476 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -85.38 153.95 22.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.766 0.317 . . . . 73.239999999999995 110.917 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 29.2 mm -105.08 123.14 59.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.298 -0.41 . . . . 74.439999999999998 111.104 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 87.8 t -93.25 138.04 21.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 72.010000000000005 111.123 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 89.4 m -86.46 108.55 18.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 74.150000000000006 111.156 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 3.3 tp -69.91 115.1 8.74 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.256 -0.429 . . . . 71.200000000000003 110.924 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 79.2 mt -103.71 -26.91 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 74.420000000000002 111.091 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -157.39 178.0 10.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 72.340000000000003 110.85 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 24.9 mttt -141.34 113.01 7.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.126 -0.488 . . . . 71.540000000000006 110.9 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -49.77 162.43 0.18 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.215 -0.448 . . . . 71.549999999999997 110.91 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.8 t -114.51 -68.99 0.88 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.261 -0.427 . . . . 71.510000000000005 110.931 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 40.2 mt -67.0 -13.12 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 73.530000000000001 111.063 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -95.77 71.04 3.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 74.430000000000007 110.876 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 42.1 t -51.28 119.99 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 74.0 111.178 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.32 24.79 30.31 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.715 -0.755 . . . . 74.299999999999997 112.463 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 55.6 m95 -139.67 138.26 35.9 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.743 0.306 . . . . 72.099999999999994 110.986 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 20.8 m0 -132.53 158.45 42.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.278 -0.419 . . . . 71.219999999999999 110.857 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -103.03 115.18 30.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 73.099999999999994 110.949 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -130.34 -171.76 12.99 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.677 -0.773 . . . . 63.549999999999997 112.462 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -141.85 143.64 33.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.906 0.384 . . . . 74.120000000000005 110.878 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 1.8 tp -160.03 147.05 16.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 73.230000000000004 110.937 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 56.6 29.94 16.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 74.209999999999994 110.862 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 76.24 7.83 84.99 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.696 -0.764 . . . . 71.230000000000004 112.431 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.9 126.29 52.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.835 0.35 . . . . 71.129999999999995 110.877 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 7.8 ttp180 -100.9 141.21 34.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 74.109999999999999 110.928 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -172.78 -158.84 18.09 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.741 -0.742 . . . . 53.439999999999998 112.493 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 35.4 m -117.86 162.99 15.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.932 0.396 . . . . 73.120000000000005 111.087 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -166.71 157.04 10.54 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.66 0.743 . . . . 75.510000000000005 110.866 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.83 122.31 8.97 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.63 2.22 . . . . 72.120000000000005 112.365 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -59.2 -21.31 59.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.238 -0.437 . . . . 74.340000000000003 110.876 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -69.93 -16.99 63.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 71.219999999999999 110.898 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -102.95 15.13 30.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 72.430000000000007 110.863 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 18.2 m -148.99 150.45 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 73.209999999999994 111.217 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 17.2 mmtm -114.8 117.32 30.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 74.400000000000006 110.894 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.9 tt -64.92 127.38 31.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.246 -0.434 . . . . 72.219999999999999 110.908 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 20.4 mt . . . . . 0 C--N 1.329 -0.313 0 CA-C-O 121.575 0.702 . . . . 70.430000000000007 110.932 179.917 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.773 0.321 . . . . 73.439999999999998 110.897 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -127.64 146.78 50.43 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.213 -0.449 . . . . 75.0 110.926 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 45.5 m -133.64 147.9 51.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 71.310000000000002 110.863 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 28.9 tttt -102.9 119.23 38.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 74.150000000000006 110.928 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 58.8 t -59.37 112.6 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.31 -0.405 . . . . 74.019999999999996 111.075 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 29.2 pt -86.59 -31.89 6.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 74.129999999999995 111.092 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -138.71 158.73 69.62 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.669 0.747 . . . . 74.349999999999994 110.91 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 161.49 45.72 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.679 2.253 . . . . 71.239999999999995 112.338 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -174.87 111.92 0.14 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.274 -0.421 . . . . 74.299999999999997 110.934 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -92.17 131.97 36.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.101 -0.5 . . . . 75.430000000000007 110.872 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -68.26 115.67 7.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 72.030000000000001 111.077 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -58.08 -30.35 66.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 72.340000000000003 110.936 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -149.72 175.18 11.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 74.5 110.9 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -58.65 -25.64 62.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 72.540000000000006 110.891 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -69.93 -25.88 63.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 75.200000000000003 110.897 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -94.93 163.41 13.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 74.099999999999994 110.916 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 23.2 tp -116.08 131.54 56.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 71.209999999999994 110.949 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 60.4 m -88.24 144.61 26.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 73.540000000000006 111.141 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 43.9 pt -150.34 146.87 16.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 72.310000000000002 111.12 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -119.11 139.57 51.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.478 . . . . 73.540000000000006 110.871 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -51.91 124.01 11.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.475 . . . . 73.400000000000006 110.878 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 111.65 -24.97 14.09 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.768 -0.73 . . . . 73.340000000000003 112.46 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -85.98 156.16 20.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.789 0.328 . . . . 73.430000000000007 110.893 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 36.7 mm -108.63 127.14 65.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.288 -0.415 . . . . 75.049999999999997 111.18 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 61.1 t -102.59 138.1 28.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 74.530000000000001 111.121 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 97.8 m -82.38 103.8 12.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 74.420000000000002 111.139 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 9.0 tp -69.89 113.15 6.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.144 -0.48 . . . . 75.439999999999998 110.897 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 19.7 mt -92.8 -49.17 13.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 72.340000000000003 111.155 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -149.88 178.62 8.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 65.310000000000002 110.863 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -129.17 112.3 13.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 72.120000000000005 110.85 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -49.8 166.6 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 72.340000000000003 110.878 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.0 t -111.02 -69.11 0.89 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.203 -0.453 . . . . 74.230000000000004 110.894 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 51.4 mt -63.62 -15.3 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 74.030000000000001 111.192 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -93.31 65.26 3.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.112 -0.494 . . . . 64.319999999999993 110.897 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 57.7 t -51.19 118.69 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 74.230000000000004 111.119 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.54 23.07 34.84 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.788 -0.72 . . . . 50.420000000000002 112.496 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 52.8 m95 -139.06 133.01 31.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.735 0.303 . . . . 74.319999999999993 110.925 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 28.6 m0 -124.34 149.62 46.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.257 -0.429 . . . . 74.439999999999998 110.882 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -97.62 119.78 36.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.435 . . . . 74.409999999999997 110.944 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -136.74 -167.24 11.08 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.668 -0.777 . . . . 74.540000000000006 112.408 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -139.34 138.48 36.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.926 0.394 . . . . 74.310000000000002 110.844 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 13.2 tp -145.78 129.98 17.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.489 . . . . 72.439999999999998 110.895 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 58.89 29.95 19.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 71.230000000000004 110.805 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 84.03 -4.72 82.3 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.753 -0.737 . . . . 73.420000000000002 112.458 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 9.5 ttp85 -100.44 120.15 39.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.842 0.353 . . . . 63.229999999999997 110.842 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 32.4 mtm180 -99.9 140.54 33.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.469 . . . . 73.200000000000003 110.847 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -173.29 -159.85 20.66 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.689 -0.767 . . . . 72.239999999999995 112.479 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 17.0 m -117.02 148.63 19.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.859 0.362 . . . . 75.340000000000003 111.098 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -151.01 156.76 35.52 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.722 0.772 . . . . 72.239999999999995 110.847 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 120.01 6.87 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.71 2.273 . . . . 70.430000000000007 112.332 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -58.58 -21.91 54.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.276 -0.42 . . . . 71.439999999999998 110.844 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -71.14 -10.2 59.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.471 . . . . 74.299999999999997 110.877 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -111.88 17.68 19.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 74.150000000000006 110.905 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 18.0 m -149.07 151.89 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.11 -0.496 . . . . 62.130000000000003 111.125 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 8.9 mtpp -118.94 118.63 32.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 75.329999999999998 110.934 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.02 130.56 43.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.208 -0.451 . . . . 75.430000000000007 110.855 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 20.2 mt . . . . . 0 C--N 1.327 -0.384 0 CA-C-O 121.631 0.729 . . . . 74.099999999999994 110.855 179.951 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.805 0.336 . . . . 73.519999999999996 110.844 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -115.94 142.78 46.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.243 -0.435 . . . . 75.129999999999995 110.943 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 22.7 m -127.29 146.32 50.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.113 -0.494 . . . . 73.120000000000005 110.919 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -102.9 126.11 49.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 73.519999999999996 110.912 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 47.8 t -64.84 112.23 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.309 -0.405 . . . . 72.420000000000002 111.136 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 27.0 pt -85.74 -32.09 6.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.269 -0.423 . . . . 74.150000000000006 111.127 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -138.53 157.96 71.28 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.624 0.726 . . . . 75.109999999999999 110.878 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 156.66 62.77 Favored 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 122.674 2.249 . . . . 72.230000000000004 112.345 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -172.41 108.21 0.2 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 72.510000000000005 110.924 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -88.15 138.97 30.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 70.109999999999999 110.866 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -68.45 116.52 9.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 74.430000000000007 111.099 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -56.47 -28.08 58.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 74.510000000000005 110.907 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -153.73 175.93 12.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 71.329999999999998 110.885 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -58.8 -25.81 63.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.145 -0.48 . . . . 74.519999999999996 110.855 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.16 -23.57 61.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 65.319999999999993 110.86 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -94.96 167.96 11.08 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.179 -0.464 . . . . 73.409999999999997 110.909 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 14.6 tp -119.01 136.67 54.0 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.163 -0.471 . . . . 75.209999999999994 110.9 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 85.6 m -91.89 146.08 24.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.159 -0.473 . . . . 74.340000000000003 111.144 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 33.7 pt -149.49 143.3 18.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.281 -0.418 . . . . 74.420000000000002 111.183 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 20.2 mtpp -117.26 140.05 50.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.148 -0.478 . . . . 70.040000000000006 110.919 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -51.43 121.84 6.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 71.400000000000006 110.924 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 115.2 -31.03 6.42 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.727 -0.749 . . . . 70.209999999999994 112.48 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -79.4 160.39 26.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.725 0.298 . . . . 74.230000000000004 110.889 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 3.2 mp -115.95 128.05 73.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 75.349999999999994 111.115 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 99.8 t -105.03 138.15 31.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 72.510000000000005 111.127 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 3.3 m -85.98 117.7 25.0 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.174 -0.466 . . . . 61.340000000000003 111.151 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 5.2 tp -69.88 110.66 5.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.243 -0.435 . . . . 71.019999999999996 110.865 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 27.5 mm -100.12 -26.12 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 74.030000000000001 111.079 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -162.11 178.31 8.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 74.340000000000003 110.862 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 40.9 mttt -141.38 112.95 7.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 75.239999999999995 110.885 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -49.66 161.74 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 74.230000000000004 110.902 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.8 t -113.53 -69.05 0.89 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 74.439999999999998 110.86 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 38.6 mt -66.97 -12.98 15.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.432 . . . . 75.140000000000001 111.172 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -97.36 70.46 2.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.135 -0.484 . . . . 74.329999999999998 110.843 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 6.3 p -51.35 121.89 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 73.540000000000006 111.176 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.24 21.0 43.14 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.695 -0.764 . . . . 54.240000000000002 112.461 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 42.5 m95 -136.42 134.27 37.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.781 0.324 . . . . 74.409999999999997 110.896 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 22.0 m0 -129.2 156.96 43.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.112 -0.495 . . . . 75.319999999999993 110.932 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -101.33 113.41 26.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.283 -0.417 . . . . 74.540000000000006 110.869 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -124.7 -173.93 13.89 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.802 -0.713 . . . . 54.240000000000002 112.493 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 72.8 tt0 -137.74 136.22 37.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.897 0.379 . . . . 73.409999999999997 110.91 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 3.1 tp -149.2 134.4 18.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.454 . . . . 73.200000000000003 111.003 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 58.86 29.94 19.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 73.150000000000006 110.901 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 81.2 -0.91 86.81 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.733 -0.746 . . . . 54.130000000000003 112.457 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 9.5 ttp85 -103.5 111.46 23.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.869 0.366 . . . . 74.340000000000003 110.893 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 9.5 ttp180 -96.66 117.03 30.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 75.219999999999999 110.861 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -146.89 -155.23 6.45 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.793 -0.717 . . . . 72.519999999999996 112.539 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 23.1 m -118.48 155.41 20.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.817 0.342 . . . . 73.540000000000006 111.159 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -163.72 156.11 15.23 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.569 0.7 . . . . 75.109999999999999 110.92 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.82 119.24 6.21 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.682 2.255 . . . . 74.019999999999996 112.337 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -60.42 -18.97 54.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.191 -0.459 . . . . 74.140000000000001 110.841 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -68.24 -12.51 61.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 74.450000000000003 110.884 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -108.29 14.47 24.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 75.140000000000001 110.872 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 18.0 m -148.86 149.54 14.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 74.0 111.085 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 10.2 ttmm -121.49 134.17 55.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 71.25 110.876 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.95 126.42 27.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 64.319999999999993 110.91 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 20.4 mt . . . . . 0 C--N 1.329 -0.314 0 CA-C-O 121.611 0.72 . . . . 73.329999999999998 110.909 179.919 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 4.1 p . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.821 0.343 . . . . 71.510000000000005 110.813 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.33 112.33 3.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 74.420000000000002 110.816 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -135.58 168.19 19.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 71.409999999999997 110.822 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 6.1 p -110.18 131.66 54.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.473 . . . . 73.530000000000001 110.873 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 4.1 tpm_? -131.55 67.11 1.53 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.064 -0.516 . . . . 75.310000000000002 110.81 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 7.1 t -148.25 156.05 42.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 73.230000000000004 111.097 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -90.74 -42.03 10.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 70.409999999999997 110.878 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 2.1 m -77.76 78.73 4.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.128 -0.487 . . . . 74.019999999999996 110.913 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -116.17 -176.06 2.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 74.129999999999995 110.854 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -155.15 141.59 18.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 54.340000000000003 110.838 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -128.11 149.39 50.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 73.510000000000005 110.863 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 25.7 m -138.55 148.19 43.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.098 -0.501 . . . . 73.329999999999998 110.843 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -102.95 123.05 45.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 71.510000000000005 110.912 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 22.4 t -61.0 109.02 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 71.540000000000006 111.131 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 36.0 pt -83.64 -28.22 7.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 75.019999999999996 111.133 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -145.41 159.3 48.89 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.624 0.726 . . . . 75.319999999999993 110.851 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 159.78 52.15 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.651 2.234 . . . . 60.439999999999998 112.364 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -176.1 110.39 0.1 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.435 . . . . 74.239999999999995 110.929 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 21.7 tp10 -89.46 135.04 33.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.089 -0.505 . . . . 73.099999999999994 110.945 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -65.82 113.26 4.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 71.099999999999994 111.038 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -58.06 -26.44 62.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.436 . . . . 74.329999999999998 110.986 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -154.95 170.77 20.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 65.510000000000005 110.885 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -56.22 -25.99 49.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 72.239999999999995 110.882 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -70.05 -26.55 64.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.155 -0.475 . . . . 73.299999999999997 110.929 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -94.99 169.56 10.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 72.409999999999997 110.89 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 14.0 tp -120.57 137.24 54.5 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.16 -0.473 . . . . 72.420000000000002 110.931 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 91.5 m -90.9 145.25 24.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 75.209999999999994 111.109 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 48.1 pt -150.26 142.95 17.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 73.150000000000006 111.094 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 44.4 mttm -114.36 139.8 49.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 72.230000000000004 110.894 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -51.94 129.84 27.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.15 -0.477 . . . . 71.040000000000006 110.919 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 102.27 -25.59 27.18 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.744 -0.741 . . . . 71.0 112.534 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -76.49 174.53 10.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.752 0.31 . . . . 60.409999999999997 110.856 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 31.4 mm -124.94 125.99 70.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 74.120000000000005 111.139 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 78.5 t -107.82 135.1 47.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 75.450000000000003 111.114 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 88.8 m -88.17 111.52 21.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.209 -0.45 . . . . 75.329999999999998 111.176 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 7.6 tp -69.97 118.96 13.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 73.129999999999995 110.899 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 61.7 mt -104.73 -47.6 9.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.142 -0.481 . . . . 75.450000000000003 111.167 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -135.21 178.13 7.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 74.209999999999994 110.896 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 66.1 mttt -141.41 112.82 7.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.104 -0.498 . . . . 73.310000000000002 110.955 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -50.53 165.18 0.1 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 74.230000000000004 110.961 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 3.2 t -115.14 -69.2 0.87 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.21 -0.45 . . . . 73.319999999999993 110.887 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 1.9 mp -67.92 -12.4 15.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 75.519999999999996 111.159 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -95.86 68.18 2.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.18 -0.463 . . . . 72.040000000000006 110.878 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 6.6 p -51.51 122.76 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 72.109999999999999 111.135 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.69 21.92 38.44 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.679 -0.772 . . . . 60.140000000000001 112.459 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 56.5 m95 -140.0 138.07 35.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.761 0.315 . . . . 73.120000000000005 110.833 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 20.6 m0 -133.18 155.91 48.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.167 -0.47 . . . . 73.049999999999997 110.893 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -99.38 121.95 41.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.277 -0.42 . . . . 72.409999999999997 110.9 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -140.69 -174.41 13.98 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.77 -0.729 . . . . 73.400000000000006 112.51 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -134.41 145.76 49.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.956 0.407 . . . . 75.049999999999997 110.846 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 5.1 tp -155.73 131.81 10.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.073 -0.512 . . . . 75.340000000000003 110.922 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 56.96 29.96 17.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 73.319999999999993 110.918 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 79.14 19.14 72.96 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.717 -0.754 . . . . 64.409999999999997 112.539 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -120.71 114.26 21.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.859 0.361 . . . . 74.450000000000003 110.86 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 42.0 ttt180 -96.97 132.13 43.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.113 -0.494 . . . . 75.319999999999993 110.878 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -170.72 -159.94 17.96 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.741 -0.742 . . . . 72.219999999999999 112.476 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 27.7 m -116.76 147.64 20.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.781 0.324 . . . . 71.129999999999995 111.163 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -149.74 156.77 38.69 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.701 0.762 . . . . 72.549999999999997 110.82 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.8 121.76 8.44 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.651 2.234 . . . . 75.030000000000001 112.332 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -61.04 -19.01 60.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 75.049999999999997 110.921 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -73.85 -9.74 58.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.491 . . . . 74.329999999999998 110.883 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -113.64 22.03 14.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 75.340000000000003 110.828 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 18.7 m -148.94 156.38 7.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 74.019999999999996 111.098 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 20.4 tttt -121.87 114.81 21.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.473 . . . . 75.120000000000005 110.854 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.98 125.9 26.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 72.209999999999994 110.89 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 20.4 mt -68.9 159.13 84.01 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.559 0.695 . . . . 63.140000000000001 110.916 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.66 167.75 23.4 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.694 2.263 . . . . 72.040000000000006 112.353 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -16.71 37.41 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.71 2.273 . . . . 72.150000000000006 112.302 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -84.45 -42.94 15.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 71.120000000000005 110.906 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -65.69 112.81 3.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 75.420000000000002 110.803 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -139.27 107.62 5.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.122 -0.49 . . . . 75.430000000000007 110.812 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 21.2 ttmm -61.28 -58.83 6.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.098 -0.501 . . . . 72.049999999999997 110.894 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.225 -0.443 . . . . 74.530000000000001 110.839 179.997 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 6.4 t . . . . . 0 CA--C 1.526 0.043 0 CA-C-O 120.936 0.398 . . . . 73.409999999999997 110.77 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 4.6 ptt? -153.63 170.79 20.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.056 -0.52 . . . . 74.340000000000003 110.889 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -105.49 -65.16 1.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 75.519999999999996 110.863 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 66.7 p -86.73 115.47 24.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 73.409999999999997 110.886 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 15.1 mmt85 -55.85 157.52 4.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 75.25 110.867 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 17.5 m -54.51 146.26 16.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.093 -0.503 . . . . 75.109999999999999 111.118 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -113.95 49.09 1.02 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 72.140000000000001 110.897 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 46.5 m 55.13 42.42 30.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 75.329999999999998 110.9 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -70.55 177.93 3.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.152 -0.476 . . . . 75.540000000000006 110.925 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -143.44 132.17 22.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 74.200000000000003 110.913 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -129.62 152.86 48.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 63.439999999999998 110.9 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 31.8 m -139.17 153.2 47.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 71.549999999999997 110.87 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 38.8 tttt -110.57 119.18 38.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 73.140000000000001 110.913 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 26.2 t -56.0 111.32 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 75.109999999999999 111.128 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 34.5 pt -87.43 -27.31 5.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 74.430000000000007 111.103 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -144.44 160.09 49.4 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.64 0.733 . . . . 71.109999999999999 110.856 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 158.57 56.52 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.676 2.251 . . . . 75.099999999999994 112.327 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -173.95 107.42 0.13 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.455 . . . . 74.310000000000002 110.868 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -91.94 118.06 30.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.14 -0.482 . . . . 74.340000000000003 110.866 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -51.74 119.86 4.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 72.209999999999994 111.087 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -66.44 -26.19 67.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.439 . . . . 73.420000000000002 110.916 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -150.46 168.79 23.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.209 -0.45 . . . . 75.340000000000003 110.914 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -56.62 -25.9 54.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 64.109999999999999 110.875 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -70.05 -25.81 63.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 75.140000000000001 110.854 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -95.03 166.32 12.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.243 -0.435 . . . . 73.430000000000007 110.887 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 14.1 tp -115.97 137.1 52.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.157 -0.474 . . . . 71.530000000000001 110.944 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 91.4 m -91.15 144.48 25.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 65.519999999999996 111.139 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 34.0 pt -150.47 146.77 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 64.140000000000001 111.092 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 25.7 mtpt -122.27 143.6 49.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 72.420000000000002 110.85 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 66.5 tt0 -52.0 130.08 28.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 73.019999999999996 110.871 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 100.79 -25.53 28.01 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.738 -0.744 . . . . 74.209999999999994 112.503 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.69 170.91 15.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.78 0.324 . . . . 75.219999999999999 110.861 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 48.5 mm -123.4 128.49 74.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 72.219999999999999 111.187 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 94.1 t -108.62 138.06 37.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.234 -0.439 . . . . 62.530000000000001 111.162 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 47.1 m -94.07 113.35 25.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.208 -0.451 . . . . 73.239999999999995 111.116 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 4.1 tp -69.95 117.6 11.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.214 -0.448 . . . . 72.299999999999997 110.948 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 69.2 mt -107.06 -28.32 2.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.439 . . . . 72.129999999999995 111.127 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -155.05 178.11 10.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 74.5 110.861 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 8.7 mttm -141.53 112.94 7.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 75.450000000000003 110.915 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -49.92 162.31 0.2 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.284 -0.417 . . . . 73.200000000000003 110.833 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.8 t -113.58 -68.97 0.89 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 74.209999999999994 110.888 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 38.9 mt -67.17 -12.99 16.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 75.420000000000002 111.149 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -96.7 70.36 2.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.485 . . . . 73.209999999999994 110.873 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 6.5 p -51.48 122.17 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 71.5 111.232 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.09 19.51 50.27 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.812 -0.709 . . . . 73.319999999999993 112.497 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -135.47 137.79 42.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.772 0.32 . . . . 74.230000000000004 110.917 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 22.5 m0 -131.76 158.78 40.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.25 -0.432 . . . . 75.310000000000002 110.943 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -103.5 120.38 40.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.307 -0.406 . . . . 70.340000000000003 110.841 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -136.53 -169.74 11.79 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.789 -0.719 . . . . 64.340000000000003 112.458 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -137.89 147.87 44.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.826 0.346 . . . . 72.430000000000007 110.9 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 9.9 tp -150.22 123.19 8.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 64.150000000000006 110.913 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 55.55 30.61 15.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.256 -0.429 . . . . 75.109999999999999 110.895 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 92.13 -16.58 59.31 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.758 -0.734 . . . . 74.530000000000001 112.441 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -85.52 112.53 21.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.87 0.367 . . . . 73.510000000000005 110.872 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 42.3 mtp180 -99.83 135.45 41.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.101 -0.5 . . . . 74.439999999999998 110.869 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -172.61 -163.33 26.24 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.733 -0.746 . . . . 74.349999999999994 112.488 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 27.7 m -109.59 160.55 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.866 0.365 . . . . 71.439999999999998 111.116 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -165.2 156.21 12.57 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.621 0.724 . . . . 74.439999999999998 110.885 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 118.77 5.88 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.685 2.256 . . . . 75.230000000000004 112.268 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -60.13 -19.74 55.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 72.340000000000003 110.874 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -73.26 -8.48 55.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 65.340000000000003 110.863 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -114.78 21.38 14.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 75.120000000000005 110.888 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 18.5 m -148.74 146.34 17.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.113 -0.494 . . . . 74.329999999999998 111.056 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 15.2 ttmm -106.83 109.77 21.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.114 -0.493 . . . . 74.109999999999999 110.95 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 2.6 tt -64.93 119.03 9.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 73.019999999999996 110.954 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 20.3 mt -61.45 159.25 33.18 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.549 0.69 . . . . 74.450000000000003 110.9 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 167.81 23.46 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.579 2.186 . . . . 74.209999999999994 112.336 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -17.24 37.56 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.696 2.264 . . . . 52.119999999999997 112.324 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -77.69 -41.47 37.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.216 -0.447 . . . . 70.349999999999994 110.869 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -64.64 114.24 4.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 73.25 110.865 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 -147.71 107.58 4.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 73.140000000000001 110.909 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -95.23 -66.14 0.93 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.164 -0.471 . . . . 65.239999999999995 110.886 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.245 -0.434 . . . . 65.25 110.905 179.957 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 9.5 m . . . . . 0 CA--C 1.526 0.034 0 CA-C-O 120.885 0.374 . . . . 73.549999999999997 110.825 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -102.04 112.21 24.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.101 -0.5 . . . . 74.329999999999998 110.916 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -170.21 135.44 1.31 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 73.129999999999995 110.889 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.13 156.93 3.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 74.310000000000002 110.926 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.48 122.76 26.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.46 . . . . 75.209999999999994 110.862 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 8.9 t -67.3 -31.63 72.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 75.099999999999994 111.192 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 19.5 ttpt 52.15 31.06 8.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 74.439999999999998 110.969 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 8.2 t -141.13 29.67 1.82 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.146 -0.479 . . . . 70.450000000000003 110.795 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 7.5 tttp -56.52 176.29 0.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 74.510000000000005 110.877 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -139.97 117.79 11.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 61.439999999999998 110.813 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -116.43 148.06 41.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 71.140000000000001 110.951 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 24.8 m -133.42 146.69 51.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.076 -0.511 . . . . 73.409999999999997 110.915 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 49.9 tttt -106.06 122.12 45.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 72.540000000000006 110.885 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 23.0 t -61.66 113.21 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 73.140000000000001 111.121 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 28.3 pt -88.21 -29.97 5.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.138 -0.483 . . . . 72.430000000000007 111.068 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -140.1 158.76 66.39 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.622 0.725 . . . . 72.319999999999993 110.855 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 156.04 64.42 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.636 2.224 . . . . 63.229999999999997 112.375 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -173.68 107.96 0.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 75.150000000000006 110.883 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -87.99 142.4 27.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.109 -0.496 . . . . 75.420000000000002 110.894 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -70.52 113.02 7.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.126 -0.488 . . . . 74.25 111.091 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -58.01 -25.84 61.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 74.129999999999995 110.929 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -155.72 170.25 22.46 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.195 -0.457 . . . . 74.549999999999997 110.898 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -56.51 -25.21 50.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 63.299999999999997 110.818 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -72.13 -25.02 61.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 64.109999999999999 110.843 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -95.02 167.1 11.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 73.030000000000001 110.871 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 14.3 tp -115.01 136.82 52.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 71.219999999999999 110.958 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 86.6 m -92.12 142.07 27.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 74.129999999999995 111.115 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 31.9 pt -148.78 146.48 17.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 73.310000000000002 111.143 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -119.33 140.72 49.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 64.239999999999995 110.828 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -51.97 128.67 24.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 72.140000000000001 110.916 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 104.14 -23.97 30.52 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.691 -0.766 . . . . 45.119999999999997 112.426 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.16 175.3 10.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.744 0.306 . . . . 52.130000000000003 110.913 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 39.9 mm -125.34 128.81 72.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.199 -0.455 . . . . 72.400000000000006 111.117 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 98.3 t -109.77 137.99 39.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.49 . . . . 74.5 111.172 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 40.5 m -91.16 111.68 23.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 73.200000000000003 111.186 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 5.9 tp -70.07 117.56 11.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.238 -0.437 . . . . 73.150000000000006 110.858 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 64.4 mt -106.97 -34.67 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 74.150000000000006 111.186 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -147.45 178.18 8.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.134 -0.484 . . . . 63.030000000000001 110.84 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 35.8 mttp -141.45 112.95 7.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 74.019999999999996 110.893 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -49.74 165.79 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 63.439999999999998 110.899 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.5 t -118.15 -69.38 0.85 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.214 -0.448 . . . . 53.350000000000001 110.872 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 47.2 mt -65.27 -14.36 16.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 74.430000000000007 111.165 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -98.32 71.7 2.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 60.229999999999997 110.9 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 59.3 t -51.52 122.31 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 72.340000000000003 111.138 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.61 20.45 44.25 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.731 -0.747 . . . . 44.030000000000001 112.488 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 50.8 m95 -135.23 134.27 39.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.713 0.292 . . . . 70.420000000000002 110.952 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 24.4 m0 -129.66 156.64 43.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.25 -0.432 . . . . 73.310000000000002 110.955 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -101.98 126.28 48.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.277 -0.42 . . . . 75.329999999999998 110.868 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -143.77 -167.84 11.98 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.705 -0.759 . . . . 73.329999999999998 112.454 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -138.32 147.53 43.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.875 0.369 . . . . 75.409999999999997 110.936 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 4.8 tp -157.95 132.05 8.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 74.420000000000002 110.932 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 56.35 29.99 16.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 74.439999999999998 110.911 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 79.79 18.44 72.83 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.723 -0.751 . . . . 71.400000000000006 112.579 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 16.0 mmt180 -121.58 113.53 19.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.767 0.318 . . . . 74.400000000000006 110.878 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -97.22 132.05 43.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.244 -0.434 . . . . 74.510000000000005 110.895 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -170.07 -163.67 24.49 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.827 -0.702 . . . . 63.229999999999997 112.54 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 8.3 m -108.12 157.27 8.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.86 0.362 . . . . 74.040000000000006 111.113 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -163.17 156.08 16.26 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.714 0.769 . . . . 74.409999999999997 110.83 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.69 117.47 5.1 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.691 2.261 . . . . 73.329999999999998 112.398 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -57.77 -22.56 47.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.252 -0.431 . . . . 65.5 110.92 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -68.85 -12.26 61.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 70.120000000000005 110.861 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -108.46 14.72 24.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 72.519999999999996 110.857 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 17.9 m -148.69 138.11 15.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.475 . . . . 72.530000000000001 111.11 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.74 123.06 48.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 73.310000000000002 110.905 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 2.5 mt -64.93 122.67 17.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.439 . . . . 73.239999999999995 110.918 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 20.2 mt -55.66 159.21 5.25 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.533 0.682 . . . . 74.409999999999997 110.922 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.74 167.76 23.47 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.654 2.236 . . . . 73.329999999999998 112.422 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -20.49 34.74 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.695 2.264 . . . . 63.310000000000002 112.342 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -79.54 -32.83 42.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 75.129999999999995 110.871 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -78.38 115.28 17.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 72.010000000000005 110.825 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -141.56 107.05 5.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 75.450000000000003 110.92 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 15.9 ttmt -76.75 -52.95 8.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 72.329999999999998 110.903 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.236 -0.438 . . . . 71.109999999999999 110.861 -179.997 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 3.1 p . . . . . 0 N--CA 1.458 -0.062 0 CA-C-O 120.859 0.362 . . . . 71.519999999999996 110.882 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 1.7 ptp -110.39 138.15 47.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.1 -0.5 . . . . 74.230000000000004 110.897 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -120.2 109.19 15.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 74.209999999999994 110.866 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 58.6 m -99.67 57.43 1.01 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 75.209999999999994 110.853 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 14.1 tpp180 -118.01 48.8 1.33 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.058 -0.519 . . . . 73.430000000000007 110.86 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 15.3 t -61.27 138.47 58.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 74.439999999999998 111.11 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 46.5 tttm -74.16 -47.0 38.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 71.420000000000002 110.881 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 9.4 t -81.39 84.33 6.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 72.450000000000003 110.879 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 28.6 mtpt -101.53 -178.36 3.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.463 . . . . 75.230000000000004 110.936 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -140.31 128.21 21.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.269 -0.423 . . . . 74.340000000000003 110.853 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -128.23 152.88 47.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.453 . . . . 74.040000000000006 110.948 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 26.2 m -138.78 146.48 41.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.118 -0.492 . . . . 73.439999999999998 110.888 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 14.3 tttp -103.0 117.35 34.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 74.430000000000007 110.823 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 26.2 t -55.91 112.32 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 70.219999999999999 111.132 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 37.9 pt -88.33 -28.08 5.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.175 -0.466 . . . . 63.140000000000001 111.134 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -142.6 159.71 56.43 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.61 0.719 . . . . 72.219999999999999 110.884 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 160.05 51.15 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.738 2.292 . . . . 74.329999999999998 112.263 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -173.29 109.78 0.18 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 75.200000000000003 110.91 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -91.08 127.0 36.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.115 -0.493 . . . . 71.319999999999993 110.887 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -58.82 117.63 4.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 63.219999999999999 111.074 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -65.84 -25.8 67.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 74.120000000000005 110.871 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 -153.0 168.41 25.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 73.409999999999997 110.923 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -56.14 -26.3 49.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 73.219999999999999 110.886 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -71.02 -25.22 62.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 63.310000000000002 110.88 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -94.86 164.79 12.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 71.239999999999995 110.95 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 14.1 tp -115.21 137.12 52.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.46 . . . . 74.409999999999997 110.962 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 85.0 m -91.81 144.74 25.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.221 -0.445 . . . . 75.349999999999994 111.143 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 44.4 pt -150.34 144.7 17.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 62.420000000000002 111.13 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 18.2 mtmm -116.14 140.05 49.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 75.010000000000005 110.87 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -51.89 128.56 24.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 73.5 110.895 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 104.02 -21.3 38.38 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.679 -0.772 . . . . 73.420000000000002 112.382 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -81.58 172.52 13.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.795 0.331 . . . . 64.409999999999997 110.846 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 76.2 mt -123.61 126.51 73.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.488 . . . . 75.25 111.127 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 93.1 t -109.63 136.05 46.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 74.310000000000002 111.116 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 95.4 m -87.72 113.02 23.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.21 -0.45 . . . . 73.299999999999997 111.138 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 8.0 tp -70.01 112.65 6.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.277 -0.42 . . . . 72.230000000000004 110.943 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 50.5 mt -98.29 -49.19 11.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 74.420000000000002 111.217 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -132.71 178.43 6.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 74.219999999999999 110.805 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 17.6 mttp -141.82 112.96 7.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 73.420000000000002 110.936 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -50.15 162.15 0.23 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.27 -0.423 . . . . 74.219999999999999 110.857 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 3.0 t -113.87 -68.92 0.89 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 73.430000000000007 110.907 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 34.1 mt -68.54 -12.01 15.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 74.439999999999998 111.075 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -97.96 69.72 2.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 65.209999999999994 110.935 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 6.6 p -51.47 122.6 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 72.409999999999997 111.129 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 91.04 17.28 51.81 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.692 -0.766 . . . . 74.409999999999997 112.413 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 34.7 m95 -133.98 135.89 43.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.743 0.306 . . . . 75.329999999999998 110.949 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 22.4 m0 -132.84 155.26 49.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.431 . . . . 74.319999999999993 110.883 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -97.04 121.31 38.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 75.310000000000002 110.836 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -138.68 179.82 18.07 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.735 -0.745 . . . . 74.239999999999995 112.437 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -133.72 141.67 47.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.918 0.389 . . . . 70.540000000000006 110.841 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 24.8 tp -155.39 136.8 14.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.11 -0.496 . . . . 72.310000000000002 110.86 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 56.92 30.55 18.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 73.299999999999997 110.9 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 75.82 19.46 78.91 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.788 -0.72 . . . . 71.200000000000003 112.464 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -118.61 117.82 29.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.726 0.298 . . . . 74.519999999999996 110.82 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 60.6 ttt180 -99.89 129.63 45.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 74.439999999999998 110.866 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -170.7 -162.76 23.58 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.792 -0.718 . . . . 54.219999999999999 112.512 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 12.4 m -115.48 150.2 17.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.919 0.39 . . . . 74.540000000000006 111.068 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -155.16 155.89 30.54 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.63 0.728 . . . . 74.540000000000006 110.952 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 117.94 5.38 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.698 2.266 . . . . 73.409999999999997 112.313 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -59.41 -20.7 56.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 74.340000000000003 110.885 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -68.97 -12.08 61.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 73.209999999999994 110.881 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -108.84 16.64 22.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 73.430000000000007 110.913 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 18.6 m -148.81 150.87 13.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.104 -0.498 . . . . 73.319999999999993 111.09 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 47.8 tttp -109.18 115.3 29.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 74.340000000000003 110.855 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 2.8 tt -65.19 116.03 6.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 75.340000000000003 110.964 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 20.4 mt -55.81 159.26 5.51 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.634 0.73 . . . . 74.019999999999996 110.885 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.77 167.74 23.59 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.686 2.257 . . . . 75.439999999999998 112.332 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.75 -18.25 37.14 Favored 'Trans proline' 0 N--CA 1.466 -0.117 0 C-N-CA 122.708 2.272 . . . . 74.439999999999998 112.319 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -79.79 -40.6 28.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 65.109999999999999 110.906 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -64.16 114.12 3.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 74.549999999999997 110.863 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -149.17 107.2 3.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 73.439999999999998 110.964 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? -88.25 -52.08 5.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 73.200000000000003 110.946 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 74.209999999999994 110.905 179.979 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 16.1 t . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.9 0.381 . . . . 55.009999999999998 110.808 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 4.8 ptp -110.59 37.81 2.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.087 -0.506 . . . . 71.510000000000005 110.93 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -104.41 136.05 44.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.466 . . . . 73.329999999999998 110.827 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 79.4 p -84.28 152.02 24.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 75.549999999999997 110.891 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 62.8 mmt-85 -86.12 176.35 8.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.098 -0.501 . . . . 75.310000000000002 110.804 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.41 95.18 6.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.103 -0.499 . . . . 73.319999999999993 111.167 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 22.5 ttmt -58.4 -67.39 0.36 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 71.420000000000002 110.945 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 6.5 t -163.75 109.2 1.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.438 . . . . 63.509999999999998 110.839 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -102.08 179.25 4.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.14 -0.482 . . . . 73.120000000000005 110.922 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -144.49 118.84 9.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 63.310000000000002 110.818 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -111.27 153.77 25.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 74.549999999999997 110.937 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 26.7 m -136.0 145.63 46.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.105 -0.498 . . . . 73.530000000000001 110.821 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 3.0 ttpp -103.34 126.47 50.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 72.319999999999993 110.886 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 22.0 t -61.1 114.46 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 72.129999999999995 111.106 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 29.8 pt -89.16 -25.67 5.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 75.129999999999995 111.097 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -147.71 159.24 41.47 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.671 0.748 . . . . 75.430000000000007 110.897 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 155.48 65.75 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.624 2.216 . . . . 74.409999999999997 112.336 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -170.8 112.22 0.39 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 71.329999999999998 110.964 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -93.81 130.39 39.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.445 . . . . 74.409999999999997 110.868 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -64.08 117.32 6.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.148 -0.478 . . . . 72.319999999999993 111.167 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 78.4 mm-40 -60.33 -25.57 65.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.238 -0.437 . . . . 73.340000000000003 110.924 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -155.91 176.26 12.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 75.150000000000006 110.865 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -58.48 -25.9 62.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.144 -0.48 . . . . 74.120000000000005 110.869 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -70.43 -26.38 63.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.172 -0.467 . . . . 74.120000000000005 110.849 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -96.55 161.79 13.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 63.100000000000001 110.884 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 14.0 tp -115.25 136.65 52.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 75.439999999999998 110.94 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 90.5 m -90.57 144.85 25.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 74.450000000000003 111.086 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 44.8 pt -150.32 141.82 16.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 74.430000000000007 111.145 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.28 145.16 42.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 74.219999999999999 110.892 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -51.86 131.85 31.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 71.319999999999993 110.879 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.98 -26.23 24.29 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.759 -0.734 . . . . 72.519999999999996 112.454 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -69.55 176.07 3.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.793 0.33 . . . . 74.319999999999993 110.843 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 68.8 mt -134.19 125.45 47.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 72.010000000000005 111.173 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 98.3 t -111.28 138.08 41.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.159 -0.473 . . . . 65.219999999999999 111.107 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 6.3 m -87.39 118.51 26.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.188 -0.46 . . . . 74.230000000000004 111.131 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 6.1 tp -69.87 111.02 5.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 75.219999999999999 110.939 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 23.9 mm -100.49 -29.95 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 73.409999999999997 111.139 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -157.36 178.12 10.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 74.420000000000002 110.884 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 21.8 mttt -141.4 112.98 7.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.207 -0.451 . . . . 73.310000000000002 110.876 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -49.77 162.01 0.2 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 61.340000000000003 110.847 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.9 t -113.79 -68.98 0.89 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 62.030000000000001 110.882 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 30.3 mm -67.49 -12.44 15.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.441 . . . . 72.25 111.108 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -97.49 70.46 2.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 61.409999999999997 110.871 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 6.0 p -51.4 121.24 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 64.230000000000004 111.107 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.39 24.8 30.14 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.697 -0.763 . . . . 70.200000000000003 112.475 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 57.5 m95 -140.23 133.43 29.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.751 0.31 . . . . 74.040000000000006 110.877 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 22.6 m0 -129.25 154.55 46.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.25 -0.432 . . . . 73.219999999999999 110.95 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -99.04 116.33 31.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.239 -0.437 . . . . 62.409999999999997 110.944 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -127.99 -173.72 13.55 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.724 -0.751 . . . . 65.329999999999998 112.529 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -135.97 134.95 39.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.836 0.351 . . . . 74.510000000000005 110.888 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 10.1 tp -143.99 130.75 20.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 73.540000000000006 110.95 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 59.04 29.95 19.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.151 -0.477 . . . . 73.040000000000006 110.84 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 83.33 -1.48 88.64 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.692 -0.766 . . . . 74.430000000000007 112.451 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.01 119.33 38.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.829 0.347 . . . . 75.129999999999995 110.876 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 70.1 mtt180 -98.82 131.0 45.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 72.219999999999999 110.906 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -162.09 -162.77 13.69 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.784 -0.722 . . . . 72.430000000000007 112.515 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 25.1 m -115.22 153.13 16.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.884 0.373 . . . . 72.310000000000002 111.111 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -157.36 157.42 30.22 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.657 0.741 . . . . 71.430000000000007 110.815 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 119.96 6.82 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.679 2.253 . . . . 73.340000000000003 112.302 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -57.42 -23.36 49.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 64.430000000000007 110.878 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 10.8 m-20 -69.53 -11.58 60.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 73.129999999999995 110.922 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -109.45 15.48 22.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 72.409999999999997 110.85 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 18.0 m -148.7 149.56 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 75.519999999999996 111.217 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -117.02 117.6 30.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 74.010000000000005 110.862 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.1 tt -65.03 125.01 23.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 73.140000000000001 110.893 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 20.7 mt -61.21 159.23 30.92 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.582 0.706 . . . . 75.329999999999998 110.992 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 167.83 23.34 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.638 2.226 . . . . 74.010000000000005 112.327 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -25.31 28.64 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.711 2.274 . . . . 72.25 112.341 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -76.21 -37.87 57.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 70.329999999999998 110.942 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -73.07 110.47 7.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 73.400000000000006 110.849 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -137.9 107.49 6.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.083 -0.508 . . . . 72.239999999999995 110.883 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -67.11 -35.46 79.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 74.420000000000002 110.933 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 73.310000000000002 110.929 179.945 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 34.6 m . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.862 0.363 . . . . 61.350000000000001 110.833 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.39 48.95 1.66 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.124 -0.489 . . . . 72.420000000000002 110.878 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -146.33 125.69 13.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.297 -0.41 . . . . 73.310000000000002 110.853 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 41.6 t -78.82 -40.34 33.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.177 -0.465 . . . . 71.420000000000002 110.881 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -131.68 103.54 6.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 74.239999999999995 110.96 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 15.1 t -81.06 168.73 18.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 74.219999999999999 111.143 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 31.4 tttp -52.69 154.56 2.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.429 . . . . 74.299999999999997 110.893 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 5.5 m -64.71 102.98 0.63 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 74.409999999999997 110.834 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 33.7 mmtt -103.9 169.1 8.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 74.329999999999998 110.875 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -151.69 138.39 18.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.444 . . . . 73.200000000000003 110.889 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -138.71 154.15 48.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.46 . . . . 72.230000000000004 110.931 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 56.5 m -135.67 152.99 51.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.121 -0.491 . . . . 72.150000000000006 110.838 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 18.5 tptm -102.78 129.75 49.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 74.319999999999993 110.883 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 25.7 t -73.05 108.35 4.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.282 -0.417 . . . . 75.340000000000003 111.116 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 21.7 pt -86.96 -30.3 5.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 74.109999999999999 111.178 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -138.83 158.79 69.33 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.663 0.744 . . . . 73.319999999999993 110.875 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.84 165.85 29.68 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.659 2.239 . . . . 73.519999999999996 112.354 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -174.43 107.32 0.11 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.245 -0.434 . . . . 71.340000000000003 110.886 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -92.66 111.65 23.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.106 -0.497 . . . . 62.119999999999997 110.885 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -51.69 117.22 2.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 74.439999999999998 111.103 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 52.0 mm-40 -63.23 -25.43 68.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.274 -0.421 . . . . 74.439999999999998 110.912 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 24.9 m-20 -150.7 167.77 26.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.441 . . . . 74.549999999999997 110.909 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -58.07 -24.16 57.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 74.549999999999997 110.866 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -70.06 -24.91 63.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.247 -0.433 . . . . 64.420000000000002 110.808 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -95.01 169.51 10.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 75.129999999999995 110.895 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 22.3 tp -114.95 131.21 56.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.137 -0.483 . . . . 75.400000000000006 110.9 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 97.6 m -92.08 139.09 30.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 63.130000000000003 111.158 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 26.0 pt -147.0 157.33 10.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 74.439999999999998 111.122 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -133.56 142.67 48.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 74.230000000000004 110.91 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -50.84 133.12 26.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 74.519999999999996 110.93 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 100.65 -22.13 41.02 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.864 -0.684 . . . . 73.519999999999996 112.564 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -85.23 173.48 10.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.824 0.345 . . . . 75.230000000000004 110.824 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 41.6 mm -123.55 133.91 67.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 74.299999999999997 111.08 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 93.3 t -108.11 127.63 64.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 74.409999999999997 111.179 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 29.1 m -82.98 107.8 15.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 65.129999999999995 111.162 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 7.5 tp -69.84 117.54 11.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 73.219999999999999 110.911 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 63.8 mt -109.73 -36.55 2.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.209 -0.451 . . . . 73.409999999999997 111.14 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -144.03 177.47 8.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.131 -0.486 . . . . 75.400000000000006 110.878 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 31.9 mttp -141.75 113.01 7.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 74.230000000000004 110.881 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -49.6 160.15 0.3 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 74.420000000000002 110.791 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.6 t -113.68 -69.01 0.89 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 61.450000000000003 110.892 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 41.8 mt -66.35 -13.54 16.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.19 -0.459 . . . . 75.310000000000002 111.114 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.53 71.63 2.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 75.340000000000003 110.84 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 5.9 p -51.23 120.7 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.474 . . . . 74.450000000000003 111.117 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.37 25.79 27.4 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.726 -0.75 . . . . 72.420000000000002 112.523 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 57.8 m95 -140.38 135.27 31.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.727 0.299 . . . . 72.450000000000003 110.963 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 22.6 m0 -130.26 156.75 44.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 75.420000000000002 110.956 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -103.8 126.3 50.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 73.329999999999998 110.851 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -140.25 -163.76 9.64 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.672 -0.775 . . . . 71.540000000000006 112.439 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -142.79 146.28 34.08 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.844 0.354 . . . . 71.0 110.837 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 3.5 tp -160.05 129.05 5.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.12 -0.491 . . . . 72.219999999999999 110.924 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 55.46 38.25 30.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 62.539999999999999 110.92 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 72.3 18.73 78.34 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.78 -0.724 . . . . 64.340000000000003 112.434 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -128.47 115.0 17.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.792 0.329 . . . . 75.409999999999997 110.881 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 2.9 ptt85 -116.9 139.45 50.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 74.219999999999999 110.865 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -162.6 -112.78 0.29 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.757 -0.735 . . . . 75.319999999999993 112.517 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 24.2 m -151.25 143.88 16.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.847 0.356 . . . . 74.209999999999994 111.178 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -150.54 155.76 36.37 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.679 0.752 . . . . 74.319999999999993 110.841 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 120.69 7.44 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.674 2.249 . . . . 63.219999999999999 112.315 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -60.31 -19.81 56.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 72.140000000000001 110.832 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -73.54 -8.21 54.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 71.420000000000002 110.866 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -114.47 16.99 17.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 74.239999999999995 110.876 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 23.4 m -150.21 141.42 16.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 72.239999999999995 111.152 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -105.27 118.01 35.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 72.349999999999994 110.93 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.7 tt -64.82 132.3 49.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 72.299999999999997 110.894 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 20.3 mt -73.33 159.18 85.49 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.578 0.704 . . . . 70.310000000000002 110.943 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.75 167.82 23.34 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.652 2.235 . . . . 75.329999999999998 112.386 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 -18.65 36.65 Favored 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.67 2.247 . . . . 74.340000000000003 112.373 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -77.99 -42.95 31.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.203 -0.453 . . . . 64.030000000000001 110.854 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -68.45 115.82 8.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.18 -0.464 . . . . 75.219999999999999 110.814 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -152.34 107.16 3.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 52.509999999999998 110.848 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -83.76 -59.5 2.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 74.25 110.891 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 64.349999999999994 110.858 179.941 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 96.1 p . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.805 0.336 . . . . 62.420000000000002 110.826 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 8.7 ptp -150.8 -178.31 6.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 73.310000000000002 110.876 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -136.39 121.91 19.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 62.350000000000001 110.803 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 48.6 m -154.12 152.06 29.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 64.099999999999994 110.853 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 6.6 tpp85 -64.09 120.69 12.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.204 -0.453 . . . . 72.430000000000007 110.883 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 88.4 m -111.36 117.05 32.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 64.420000000000002 111.199 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 4.9 ttmm -52.47 167.72 0.13 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.439 . . . . 73.530000000000001 110.898 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 18.1 t -74.15 77.84 1.76 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.252 -0.431 . . . . 74.030000000000001 110.933 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 3.9 mtpm? -102.91 -175.69 2.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.48 . . . . 73.329999999999998 110.92 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -149.37 144.45 26.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 74.450000000000003 110.856 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -142.68 148.31 37.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.192 -0.458 . . . . 71.349999999999994 110.907 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 33.7 m -137.0 147.66 46.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.05 -0.523 . . . . 63.210000000000001 110.902 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 31.8 tttt -103.07 117.61 34.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 73.450000000000003 110.918 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 24.5 t -55.78 115.9 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 74.420000000000002 111.177 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 33.6 pt -90.04 -27.74 5.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 71.430000000000007 111.148 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -144.45 159.28 52.18 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.662 0.744 . . . . 75.040000000000006 110.893 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.78 158.75 55.87 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.718 2.279 . . . . 74.120000000000005 112.3 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -173.43 108.32 0.15 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.142 -0.481 . . . . 73.239999999999995 110.958 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -90.74 129.37 36.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 75.430000000000007 110.915 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -64.4 133.95 53.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 72.319999999999993 111.099 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -76.16 -12.65 60.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.43 . . . . 73.549999999999997 110.866 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . 0.558 ' N ' HD21 ' A' ' 282' ' ' ASN . 0.0 OUTLIER -175.54 -178.47 1.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 75.109999999999999 110.963 -179.964 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -58.66 -26.24 63.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.258 -0.428 . . . . 72.310000000000002 110.874 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -70.26 -25.84 63.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 73.519999999999996 110.927 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -100.04 167.28 10.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 73.439999999999998 110.851 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 28.2 tp -121.04 131.49 54.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.133 -0.485 . . . . 75.340000000000003 110.965 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 87.6 m -88.45 143.08 27.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 73.010000000000005 111.161 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 51.0 pt -150.34 143.49 17.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.295 -0.412 . . . . 73.299999999999997 111.071 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 37.4 mtpt -112.31 140.4 47.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 64.349999999999994 110.897 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -52.01 133.32 32.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.197 -0.456 . . . . 74.420000000000002 110.915 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.59 -19.68 53.65 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.747 -0.74 . . . . 71.5 112.458 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -79.31 173.23 12.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.745 0.307 . . . . 75.140000000000001 110.867 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 66.8 mt -124.17 125.15 70.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 73.420000000000002 111.212 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 84.2 t -107.99 134.02 51.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.179 -0.464 . . . . 62.43 111.084 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 39.0 m -84.76 111.14 19.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 71.530000000000001 111.103 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 8.7 tp -69.96 118.56 12.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 72.239999999999995 110.952 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 76.2 mt -106.46 -47.69 8.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 74.109999999999999 111.123 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -134.85 178.17 7.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.44 . . . . 70.109999999999999 110.842 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 25.0 mttp -141.36 112.95 7.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 74.540000000000006 110.957 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.94 165.25 0.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.441 . . . . 62.420000000000002 110.914 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.6 t -118.3 -69.34 0.86 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 54.5 110.804 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 2.0 mp -65.89 -13.89 16.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.184 -0.462 . . . . 75.319999999999993 111.088 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -98.8 70.31 1.86 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 73.420000000000002 110.79 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 7.3 p -51.35 123.96 3.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 71.310000000000002 111.129 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.39 23.31 34.55 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.707 -0.759 . . . . 71.219999999999999 112.466 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 56.5 m95 -140.09 135.49 32.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.797 0.332 . . . . 72.239999999999995 110.919 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 22.5 m0 -131.23 154.87 47.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.22 -0.446 . . . . 74.150000000000006 110.876 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -99.99 124.65 45.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 74.340000000000003 110.947 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -141.87 -167.09 11.14 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.66 -0.781 . . . . 64.430000000000007 112.478 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -140.43 147.4 39.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.897 0.379 . . . . 72.129999999999995 110.909 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 6.7 tp -157.65 132.18 8.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 74.329999999999998 110.839 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 57.36 30.2 18.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 75.430000000000007 110.877 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 79.15 18.64 74.03 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.749 -0.739 . . . . 70.230000000000004 112.482 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 25.5 mmm180 -122.69 115.1 21.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.745 0.307 . . . . 75.120000000000005 110.869 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 33.3 mtm180 -96.99 141.02 30.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 73.5 110.883 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -178.32 -162.54 28.23 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.772 -0.728 . . . . 74.409999999999997 112.48 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 27.5 m -111.64 155.68 12.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.873 0.368 . . . . 75.409999999999997 111.182 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -159.13 156.53 26.37 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.684 0.754 . . . . 74.109999999999999 110.828 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 120.23 7.05 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.634 2.223 . . . . 75.329999999999998 112.385 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -59.12 -21.16 58.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.265 -0.425 . . . . 73.239999999999995 110.861 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -71.53 -11.23 60.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 73.010000000000005 110.837 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -110.62 18.35 19.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 70.439999999999998 110.846 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 18.9 m -149.3 149.52 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 74.430000000000007 111.148 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -115.49 116.86 28.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 75.239999999999995 110.899 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.94 128.17 34.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.252 -0.431 . . . . 73.310000000000002 110.99 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 20.2 mt -68.85 159.18 83.64 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.595 0.712 . . . . 74.510000000000005 110.904 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.61 167.7 23.49 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.8 2.333 . . . . 72.030000000000001 112.344 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 -16.93 37.47 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.63 2.22 . . . . 74.040000000000006 112.358 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.57 -34.56 30.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 71.120000000000005 110.84 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -66.06 115.06 5.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.191 -0.459 . . . . 73.230000000000004 110.891 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -136.29 106.99 6.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 64.420000000000002 110.919 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 10.6 ttmm -83.14 -69.03 0.66 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 74.420000000000002 110.931 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 65.109999999999999 110.914 179.904 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 14.4 m . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.899 0.381 . . . . 72.209999999999994 110.907 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -60.29 167.89 2.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 65.400000000000006 110.822 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -67.64 121.17 15.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.441 . . . . 73.340000000000003 110.917 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 6.6 t -110.61 98.49 7.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 73.120000000000005 110.871 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -118.5 153.25 34.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 72.409999999999997 110.94 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 6.9 m -55.41 121.93 10.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.279 -0.419 . . . . 72.409999999999997 111.099 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 10.9 ptpp? -88.52 -34.49 17.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 74.439999999999998 110.876 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 3.0 t -95.61 55.45 1.67 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 72.340000000000003 110.862 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 19.2 tttt -53.78 167.04 0.27 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.231 -0.44 . . . . 75.519999999999996 110.914 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -145.38 121.53 10.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.455 . . . . 72.150000000000006 110.856 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -111.15 143.85 41.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 75.430000000000007 110.896 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 22.6 m -128.29 149.36 50.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.107 -0.497 . . . . 74.329999999999998 110.86 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 7.9 tttm -108.03 117.42 34.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 75.239999999999995 110.92 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 27.7 t -58.41 113.49 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 72.519999999999996 111.15 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 26.6 pt -87.09 -30.49 5.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 75.230000000000004 111.123 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -142.46 158.39 60.64 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.657 0.741 . . . . 75.140000000000001 110.88 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.68 158.69 56.19 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.642 2.228 . . . . 73.310000000000002 112.364 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -174.38 113.51 0.17 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.237 -0.438 . . . . 75.200000000000003 110.912 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -93.61 120.54 34.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.09 -0.505 . . . . 73.5 110.891 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -51.83 113.49 1.01 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 63.140000000000001 111.078 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -54.58 -29.76 52.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 74.109999999999999 110.905 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -155.47 172.25 18.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 74.129999999999995 110.891 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -58.2 -22.77 53.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.154 -0.476 . . . . 73.439999999999998 110.86 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -70.0 -21.01 63.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 65.239999999999995 110.833 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -105.28 177.24 4.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 72.439999999999998 110.935 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 13.1 tp -122.61 135.95 54.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.466 . . . . 73.150000000000006 110.902 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 77.9 m -88.28 146.32 25.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.121 -0.49 . . . . 71.430000000000007 111.114 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 47.6 pt -150.28 143.89 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 75.239999999999995 111.189 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 33.8 mtmt -117.53 140.9 49.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 75.299999999999997 110.906 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 -51.92 135.03 31.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.232 -0.44 . . . . 45.350000000000001 110.857 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 93.82 -23.64 29.94 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.721 -0.752 . . . . 63.539999999999999 112.469 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -76.55 171.3 14.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.832 0.348 . . . . 65.400000000000006 110.902 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 37.4 mm -122.67 125.78 73.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 70.430000000000007 111.137 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 97.8 t -103.27 138.11 28.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 71.209999999999994 111.092 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 59.4 m -93.56 109.06 20.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 75.540000000000006 111.151 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 7.0 tp -69.89 124.84 25.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.271 -0.422 . . . . 75.239999999999995 110.894 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 40.5 mt -111.1 -47.37 6.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.449 . . . . 73.030000000000001 111.119 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -137.74 169.99 16.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 74.040000000000006 110.898 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 19.1 mttt -137.35 112.37 9.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.218 -0.446 . . . . 72.329999999999998 110.963 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -56.04 179.78 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.187 -0.46 . . . . 74.230000000000004 110.862 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 1.7 t -129.05 -69.53 0.7 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 73.409999999999997 110.876 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 60.1 mt -59.4 -18.43 14.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 73.219999999999999 111.146 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -99.02 62.11 1.28 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.463 . . . . 65.049999999999997 110.899 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 71.6 t -51.51 136.36 11.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.244 -0.435 . . . . 63.43 111.154 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 88.69 14.27 61.57 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.76 -0.733 . . . . 64.230000000000004 112.543 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 51.1 m95 -139.27 148.15 42.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.758 0.313 . . . . 74.109999999999999 110.925 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 10.2 m0 -139.36 148.23 42.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.294 -0.412 . . . . 73.129999999999995 110.947 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -94.29 119.08 32.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.283 -0.417 . . . . 73.329999999999998 110.849 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -139.22 -163.41 9.49 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.736 -0.745 . . . . 53.039999999999999 112.456 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 61.6 tt0 -143.79 149.1 36.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.885 0.374 . . . . 73.430000000000007 110.916 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 4.9 tp -159.98 133.29 6.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.201 -0.454 . . . . 73.099999999999994 110.94 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 58.14 29.94 18.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 63.399999999999999 110.856 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 78.93 17.38 77.22 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.783 -0.722 . . . . 75.540000000000006 112.494 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 23.6 mmt85 -122.33 117.47 26.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.843 0.354 . . . . 74.549999999999997 110.874 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 27.3 mtm-85 -98.21 136.22 38.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 72.030000000000001 110.859 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -172.06 -158.42 16.15 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.737 -0.745 . . . . 75.299999999999997 112.504 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 24.3 m -117.72 148.02 20.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.881 0.372 . . . . 73.200000000000003 111.126 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -149.49 156.97 39.34 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.689 0.757 . . . . 74.140000000000001 110.824 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 121.5 8.19 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.655 2.237 . . . . 72.099999999999994 112.314 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -61.75 -17.74 57.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 71.549999999999997 110.862 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -75.95 -5.82 48.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 64.230000000000004 110.88 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -119.76 23.61 11.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.12 -0.491 . . . . 65.239999999999995 110.879 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 18.2 m -149.04 144.14 18.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.154 -0.475 . . . . 75.120000000000005 111.065 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 55.2 tttt -110.45 111.17 22.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 74.109999999999999 110.926 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.92 126.61 28.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 72.430000000000007 110.837 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 20.4 mt -60.79 159.26 27.18 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.541 0.686 . . . . 73.140000000000001 110.958 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.83 167.78 23.56 Favored 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 122.706 2.27 . . . . 75.109999999999999 112.323 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -18.6 36.81 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.689 2.259 . . . . 75.409999999999997 112.325 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.32 -42.75 20.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 74.540000000000006 110.929 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -64.92 115.77 5.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.262 -0.426 . . . . 75.329999999999998 110.935 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -149.33 107.01 3.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.079 -0.51 . . . . 62.549999999999997 110.868 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 1.6 ttmm -64.88 -57.87 7.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.116 -0.493 . . . . 74.349999999999994 110.877 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 57.7 tt0 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 75.209999999999994 110.903 179.981 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 28.5 p . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.879 0.371 . . . . 75.109999999999999 110.913 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 7.4 ptm 39.44 41.71 0.75 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 73.340000000000003 110.851 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -80.08 145.9 32.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.27 -0.423 . . . . 75.120000000000005 110.913 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 5.6 t -113.69 -62.15 1.64 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 74.310000000000002 110.799 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 78.8 mmt-85 54.29 44.84 28.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.158 -0.474 . . . . 73.230000000000004 110.889 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 15.3 t -92.15 166.98 12.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 71.540000000000006 111.112 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 7.8 mptt -107.52 -27.91 10.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 75.530000000000001 110.852 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 13.7 p -88.1 80.85 7.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 74.030000000000001 110.865 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 22.7 mttm -107.85 179.33 4.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.127 -0.488 . . . . 73.430000000000007 110.887 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -142.4 131.61 23.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 75.349999999999994 110.884 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -130.85 154.1 48.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.211 -0.45 . . . . 73.409999999999997 110.955 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 22.8 m -139.0 147.36 42.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.113 -0.494 . . . . 75.109999999999999 110.866 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 14.3 tttp -103.66 119.08 38.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.204 -0.453 . . . . 74.400000000000006 110.862 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 53.1 t -60.3 109.13 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 64.239999999999995 111.076 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 26.5 pt -85.98 -30.63 6.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.12 -0.491 . . . . 73.400000000000006 111.095 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -138.33 159.97 65.78 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.659 0.742 . . . . 74.439999999999998 110.915 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 158.93 55.26 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.736 2.291 . . . . 73.150000000000006 112.352 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -172.81 106.02 0.16 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 71.310000000000002 111.018 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -91.23 127.54 36.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 74.019999999999996 110.869 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -63.86 113.04 3.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.476 . . . . 72.230000000000004 111.126 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -59.26 -26.07 64.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.264 -0.425 . . . . 74.439999999999998 110.95 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -149.48 168.7 22.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 71.439999999999998 110.875 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -57.02 -24.91 57.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.483 . . . . 62.299999999999997 110.859 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -70.01 -25.68 63.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.217 -0.447 . . . . 64.25 110.877 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -95.02 166.47 11.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.171 -0.468 . . . . 72.439999999999998 110.903 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 21.5 tp -114.89 133.6 55.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 74.319999999999993 110.932 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 95.5 m -91.61 140.69 29.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 74.420000000000002 111.129 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 50.4 pt -150.14 143.25 17.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 64.239999999999995 111.136 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 16.5 mmtm -114.53 141.03 48.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 74.239999999999995 110.877 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -52.02 122.54 8.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.446 . . . . 71.200000000000003 110.866 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 113.31 -22.82 14.81 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.8 -0.714 . . . . 75.349999999999994 112.448 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -86.46 160.4 19.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.708 0.289 . . . . 74.439999999999998 110.925 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 80.7 mt -110.94 129.4 66.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 62.5 111.087 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 100.0 t -107.15 138.07 34.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.106 -0.497 . . . . 72.299999999999997 111.138 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 56.1 m -89.31 111.47 22.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.126 -0.488 . . . . 72.040000000000006 111.116 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 7.5 tp -69.98 118.54 12.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.276 -0.42 . . . . 72.129999999999995 110.91 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 64.4 mt -105.79 -48.62 8.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 72.439999999999998 111.092 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -133.53 178.17 7.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 61.450000000000003 110.892 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 24.2 mttt -141.32 113.02 7.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 72.230000000000004 110.885 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -49.9 161.77 0.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.457 . . . . 74.549999999999997 110.92 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.9 t -113.37 -69.02 0.89 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.222 -0.444 . . . . 62.219999999999999 110.869 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 35.1 mt -67.77 -12.51 15.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 75.319999999999993 111.166 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -97.52 69.31 2.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 55.109999999999999 110.879 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 6.9 p -51.17 123.21 2.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.244 -0.435 . . . . 73.109999999999999 111.18 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.5 19.43 48.98 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.755 -0.736 . . . . 65.319999999999993 112.549 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 49.2 m95 -136.29 136.39 39.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.742 0.306 . . . . 74.349999999999994 110.902 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 22.6 m0 -132.1 156.09 46.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 74.120000000000005 110.936 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -100.63 120.78 40.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.228 -0.442 . . . . 74.299999999999997 110.802 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -134.67 -168.71 11.76 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.782 -0.723 . . . . 71.420000000000002 112.509 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -141.74 141.4 33.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.868 0.366 . . . . 75.319999999999993 110.873 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 5.4 tp -140.81 118.52 11.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.133 -0.485 . . . . 74.010000000000005 110.879 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 58.55 32.74 22.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 72.420000000000002 110.85 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 91.88 -16.96 58.19 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.785 -0.721 . . . . 74.0 112.532 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.33 110.1 17.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.786 0.326 . . . . 75.120000000000005 110.898 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 48.3 mtp180 -98.66 133.73 42.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 73.349999999999994 110.911 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -169.16 -155.67 10.02 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.716 -0.754 . . . . 64.140000000000001 112.396 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 12.8 m -120.25 155.88 23.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.826 0.346 . . . . 73.530000000000001 111.206 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -161.29 155.94 19.82 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.64 0.733 . . . . 74.239999999999995 110.853 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 117.85 5.33 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.676 2.251 . . . . 65.120000000000005 112.395 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -59.19 -21.21 59.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.269 -0.423 . . . . 74.219999999999999 110.871 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -70.79 -10.76 60.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 71.420000000000002 110.819 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -111.14 19.27 18.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 71.409999999999997 110.856 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 18.5 m -148.77 150.7 13.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 72.219999999999999 111.114 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 4.4 ttmt -110.9 115.09 28.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 75.0 110.903 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.1 tt -64.91 120.32 12.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.228 -0.442 . . . . 73.430000000000007 110.91 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 20.3 mt -64.14 159.2 58.79 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.606 0.717 . . . . 75.329999999999998 110.899 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.7 167.74 23.49 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.623 2.215 . . . . 71.209999999999994 112.377 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 -16.6 37.74 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.694 2.263 . . . . 71.5 112.38 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -82.84 -30.5 28.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 64.109999999999999 110.884 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -65.96 114.46 5.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 62.409999999999997 110.889 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -130.31 107.19 9.08 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.068 -0.515 . . . . 73.519999999999996 110.843 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 4.0 tmtt? -84.19 -45.84 12.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 74.200000000000003 110.902 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 15.5 pm0 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 71.129999999999995 110.867 179.966 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 45.7 m . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.814 0.34 . . . . 53.43 110.912 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 14.3 mmt -103.31 150.48 23.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 73.409999999999997 110.905 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -73.87 146.54 44.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.121 -0.491 . . . . 70.439999999999998 110.913 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 6.0 p -96.65 -47.66 5.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.293 -0.412 . . . . 74.420000000000002 110.872 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 27.2 mtm180 -121.41 168.31 11.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.13 -0.486 . . . . 74.439999999999998 110.825 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 15.0 t -111.98 170.01 8.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 74.420000000000002 111.114 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 33.8 mtpt -56.65 178.2 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.467 . . . . 75.239999999999995 110.87 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 69.3 m -60.84 101.09 0.13 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.234 -0.439 . . . . 75.099999999999994 110.815 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 14.6 pttm -110.26 -177.88 3.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 74.349999999999994 110.93 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -164.39 132.33 3.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.218 -0.446 . . . . 75.200000000000003 110.878 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -124.63 156.23 37.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.147 -0.479 . . . . 65.439999999999998 110.89 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 30.1 m -139.74 153.01 47.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 74.129999999999995 110.898 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -111.0 121.47 45.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 75.340000000000003 110.843 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 21.7 t -58.89 114.14 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.48 . . . . 62.399999999999999 111.118 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 25.7 pt -88.71 -30.47 5.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 73.340000000000003 111.095 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -139.72 158.85 67.17 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.679 0.752 . . . . 74.239999999999995 110.881 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 155.21 66.55 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.681 2.254 . . . . 75.239999999999995 112.339 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -174.59 108.63 0.12 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.212 -0.449 . . . . 71.129999999999995 110.935 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -88.1 150.07 23.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.5 . . . . 65.129999999999995 110.837 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -80.36 114.27 19.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 74.010000000000005 111.164 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -63.68 -25.67 68.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 74.310000000000002 110.874 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -150.66 168.6 23.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 71.230000000000004 110.888 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -58.75 -25.58 63.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 62.219999999999999 110.897 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -69.95 -25.4 63.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.47 . . . . 74.519999999999996 110.89 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -94.93 167.41 11.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.447 . . . . 71.310000000000002 110.866 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 13.7 tp -115.27 136.52 53.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.464 . . . . 75.349999999999994 110.952 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 95.7 m -90.71 138.36 31.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 73.5 111.11 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -147.29 145.55 19.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 63.539999999999999 111.129 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -119.53 139.33 52.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.108 -0.496 . . . . 74.129999999999995 110.829 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 69.7 tt0 -52.02 123.98 11.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 72.409999999999997 110.876 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 110.32 -20.54 25.54 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.756 -0.735 . . . . 64.140000000000001 112.55 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -85.13 175.57 8.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.801 0.334 . . . . 73.129999999999995 110.888 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 41.0 mm -123.81 138.37 53.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 74.010000000000005 111.157 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 66.3 t -120.57 138.0 52.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.172 -0.467 . . . . 71.140000000000001 111.122 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 91.0 m -92.05 116.01 28.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 71.319999999999993 111.206 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 4.5 tp -69.82 112.79 6.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.302 -0.408 . . . . 73.230000000000004 110.893 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 62.3 mt -102.0 -28.26 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.439 . . . . 45.340000000000003 111.086 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -156.42 178.05 10.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.214 -0.448 . . . . 72.200000000000003 110.901 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 29.6 mttp -141.33 112.92 7.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 74.030000000000001 110.904 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -50.21 163.54 0.15 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 75.310000000000002 110.847 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.7 t -114.52 -69.24 0.87 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.461 . . . . 71.450000000000003 110.855 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 2.0 mp -66.57 -13.31 16.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.494 . . . . 73.450000000000003 111.151 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -96.42 70.66 2.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.139 -0.482 . . . . 62.210000000000001 110.842 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 60.4 t -51.38 120.85 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 73.120000000000005 111.183 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.65 20.53 43.74 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.74 -0.743 . . . . 70.340000000000003 112.497 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 39.1 m95 -135.4 135.84 40.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.772 0.32 . . . . 73.349999999999994 110.898 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 23.5 m0 -130.85 157.32 43.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 74.340000000000003 110.871 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -101.43 116.13 32.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 60.310000000000002 110.888 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -130.08 -173.1 13.29 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.734 -0.746 . . . . 63.340000000000003 112.485 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -136.57 141.29 43.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.86 0.362 . . . . 75.010000000000005 110.848 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 5.5 tp -141.97 121.26 13.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.127 -0.488 . . . . 73.530000000000001 110.901 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 55.06 33.11 19.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 74.209999999999994 110.866 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 92.09 -16.59 59.26 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.714 -0.755 . . . . 71.209999999999994 112.487 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -82.99 109.23 16.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.857 0.36 . . . . 73.030000000000001 110.845 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.33 125.85 46.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.484 . . . . 73.310000000000002 110.904 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -163.43 -158.99 10.23 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.76 -0.734 . . . . 72.349999999999994 112.521 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 6.6 m -114.19 156.7 15.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.86 0.362 . . . . 73.109999999999999 111.137 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -163.67 156.05 15.3 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.645 0.736 . . . . 75.310000000000002 110.869 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 117.71 5.25 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.659 2.239 . . . . 73.019999999999996 112.326 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -58.34 -22.04 51.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.259 -0.428 . . . . 71.129999999999995 110.843 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -69.27 -11.78 61.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 73.129999999999995 110.987 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -109.18 17.04 22.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.472 . . . . 74.349999999999994 110.874 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 18.4 m -148.81 150.58 13.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.144 -0.48 . . . . 64.430000000000007 111.173 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -112.09 119.28 37.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.223 -0.444 . . . . 74.349999999999994 110.872 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.89 116.29 6.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.226 -0.443 . . . . 75.010000000000005 110.857 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 21.2 mt -65.01 159.06 67.59 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.608 0.718 . . . . 75.230000000000004 110.916 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 167.74 23.64 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.645 2.23 . . . . 75.120000000000005 112.334 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -28.0 25.69 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.651 2.234 . . . . 72.230000000000004 112.325 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -66.56 -27.26 67.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.247 -0.433 . . . . 75.230000000000004 110.886 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -66.81 115.47 6.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 74.450000000000003 110.856 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -134.6 106.96 7.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 73.140000000000001 110.899 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -108.02 -48.78 3.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 73.120000000000005 110.916 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 70.329999999999998 110.898 179.981 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 23.8 p . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.843 0.354 . . . . 54.299999999999997 110.866 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 3.9 mmt -125.58 69.55 1.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 71.439999999999998 110.889 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -116.95 63.52 0.72 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.274 -0.421 . . . . 63.299999999999997 110.897 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 4.8 t -117.8 157.48 26.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 71.310000000000002 110.856 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 76.5 mtt-85 -87.38 173.54 9.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.095 -0.502 . . . . 73.239999999999995 110.836 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 14.0 m -81.3 136.75 35.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 75.340000000000003 111.087 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.62 -178.48 5.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 74.310000000000002 110.873 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 22.6 t 55.12 26.88 8.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 75.439999999999998 110.848 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 6.2 ptpp? -94.34 -169.93 2.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 72.099999999999994 110.903 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -154.24 143.7 21.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.184 -0.462 . . . . 73.209999999999994 110.882 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -133.5 152.94 51.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.207 -0.452 . . . . 74.400000000000006 110.932 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 34.4 m -139.98 147.93 41.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.093 -0.503 . . . . 72.510000000000005 110.941 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 33.3 tttt -102.99 121.98 43.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 74.549999999999997 110.908 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 46.9 t -62.22 110.99 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 54.049999999999997 111.123 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 26.8 pt -85.52 -32.82 7.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 75.129999999999995 111.139 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -135.95 158.0 74.78 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.629 0.728 . . . . 70.420000000000002 110.918 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 150.17 68.13 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.715 2.277 . . . . 74.530000000000001 112.327 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -171.17 106.06 0.24 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.235 -0.439 . . . . 73.230000000000004 110.963 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -93.03 147.01 23.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.073 -0.512 . . . . 75.530000000000001 110.851 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -82.04 124.56 29.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 71.439999999999998 111.091 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -72.31 -32.1 66.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 74.439999999999998 110.899 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -137.36 172.35 13.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 70.219999999999999 110.929 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -62.22 -17.91 59.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 71.299999999999997 110.824 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -75.57 -19.39 59.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.241 -0.436 . . . . 72.450000000000003 110.838 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -105.62 164.1 12.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.224 -0.444 . . . . 70.299999999999997 110.868 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 14.6 tp -115.47 135.61 53.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.158 -0.473 . . . . 64.540000000000006 110.899 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 46.2 m -88.31 141.42 28.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 73.120000000000005 111.12 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 33.6 pt -150.09 139.66 15.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 74.400000000000006 111.104 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 29.2 mttm -109.99 138.31 46.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 73.340000000000003 110.867 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -51.65 126.85 18.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 75.109999999999999 110.922 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 107.15 -23.51 27.05 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.657 -0.782 . . . . 72.450000000000003 112.476 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -84.99 160.44 20.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.763 0.316 . . . . 74.319999999999993 110.873 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 35.1 mm -110.82 128.92 66.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.16 -0.473 . . . . 73.319999999999993 111.07 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 94.5 t -103.51 138.02 29.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.103 -0.499 . . . . 75.530000000000001 111.131 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 59.8 m -87.48 110.57 20.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 74.109999999999999 111.212 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 7.6 tp -70.01 116.07 9.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 73.209999999999994 110.904 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 54.4 mt -102.46 -47.59 11.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 72.319999999999993 111.177 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -135.29 178.21 7.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 71.510000000000005 110.966 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 23.3 mttt -141.15 112.88 7.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 71.099999999999994 110.859 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -49.98 160.49 0.33 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 72.409999999999997 110.849 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.7 t -113.09 -69.01 0.89 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.237 -0.438 . . . . 73.129999999999995 110.858 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 1.9 mp -66.72 -13.24 16.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.475 . . . . 75.420000000000002 111.103 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.66 69.78 1.88 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.192 -0.458 . . . . 74.540000000000006 110.85 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 88.0 t -51.43 124.24 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.443 . . . . 72.219999999999999 111.095 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.41 19.12 50.73 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.703 -0.761 . . . . 72.310000000000002 112.539 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 46.4 m95 -136.02 135.21 39.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.781 0.325 . . . . 75.400000000000006 110.881 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 23.4 m0 -131.19 154.94 47.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 64.209999999999994 110.967 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -99.13 118.31 35.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.291 -0.413 . . . . 72.430000000000007 110.877 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -130.08 -171.83 13.01 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.824 -0.703 . . . . 72.299999999999997 112.556 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -140.71 144.24 35.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.895 0.379 . . . . 74.25 110.851 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 2.3 tp -160.04 135.45 8.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 74.340000000000003 110.886 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 59.52 29.99 19.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.13 -0.486 . . . . 63.240000000000002 110.951 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 77.87 10.05 86.5 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.7 -0.762 . . . . 70.150000000000006 112.536 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -115.41 111.82 21.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.818 0.342 . . . . 72.120000000000005 110.861 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 10.3 ttp85 -96.63 124.32 40.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 72.400000000000006 110.832 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -154.9 -157.09 8.03 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.779 -0.724 . . . . 62.340000000000003 112.511 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 20.2 m -118.87 154.02 21.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.833 0.349 . . . . 64.230000000000004 111.185 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -160.52 155.82 21.43 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.629 0.728 . . . . 73.420000000000002 110.899 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 117.91 5.36 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.724 2.283 . . . . 72.0 112.339 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -59.12 -21.21 58.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 73.349999999999994 110.871 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -68.92 -12.11 61.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 73.430000000000007 110.885 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -108.81 16.56 22.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 75.510000000000005 110.816 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 18.0 m -148.66 150.82 13.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.442 . . . . 74.200000000000003 111.134 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -109.75 118.6 36.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 75.200000000000003 110.936 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.2 tt -64.97 121.13 13.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.441 . . . . 75.510000000000005 110.96 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 20.3 mt -66.57 159.32 74.61 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.631 0.729 . . . . 74.140000000000001 110.896 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.83 167.72 23.73 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.634 2.223 . . . . 75.209999999999994 112.358 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.67 -16.6 38.01 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.757 2.305 . . . . 75.120000000000005 112.342 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -82.65 -29.4 30.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 72.439999999999998 110.832 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 330' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -66.19 115.49 6.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.46 . . . . 72.099999999999994 110.899 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -139.67 107.02 5.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.133 -0.485 . . . . 72.099999999999994 110.866 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 14.2 mtpp -91.7 -74.39 0.51 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.123 -0.49 . . . . 74.519999999999996 110.91 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 72.239999999999995 110.88 179.938 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 55.2 m . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.853 0.359 . . . . 73.329999999999998 110.849 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.41 -22.34 53.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 73.129999999999995 110.869 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 58.7 58.94 3.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.218 -0.446 . . . . 73.019999999999996 110.829 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 4.2 m -106.63 -30.67 8.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 64.109999999999999 110.892 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 58.5 mtm180 -70.17 110.65 5.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 75.420000000000002 110.86 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -139.62 141.21 37.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.129 -0.487 . . . . 73.049999999999997 111.185 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.48 133.68 55.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 71.230000000000004 110.936 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 6.3 t 60.0 33.25 21.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 74.140000000000001 110.793 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 2.4 tttm -58.13 176.85 0.14 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.122 -0.49 . . . . 75.25 110.957 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -139.04 120.93 15.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.269 -0.423 . . . . 74.040000000000006 110.859 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -117.16 153.08 33.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.248 -0.433 . . . . 73.5 110.884 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 22.9 m -136.66 148.43 47.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.084 -0.507 . . . . 71.099999999999994 110.883 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 39.1 tttt -106.47 123.41 48.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.172 -0.467 . . . . 75.120000000000005 110.964 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 21.4 t -61.57 114.12 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 74.340000000000003 111.1 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 28.1 pt -85.88 -30.02 6.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 74.230000000000004 111.101 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -144.03 157.98 56.43 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.578 0.704 . . . . 74.109999999999999 110.905 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 154.03 67.99 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.624 2.216 . . . . 65.010000000000005 112.349 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -172.92 111.74 0.22 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 74.299999999999997 110.921 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -92.36 131.02 37.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.118 -0.492 . . . . 73.510000000000005 110.933 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -57.54 119.32 6.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 51.420000000000002 111.148 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.46 -25.79 68.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 71.099999999999994 110.861 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -154.63 172.77 17.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.25 -0.432 . . . . 72.25 110.94 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -58.48 -25.65 62.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 75.409999999999997 110.855 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.35 -25.73 62.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.213 -0.449 . . . . 72.230000000000004 110.799 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -94.88 166.97 11.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 71.140000000000001 110.941 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 12.9 tp -116.94 135.64 53.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.448 . . . . 71.400000000000006 110.967 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 60.1 m -86.92 146.69 26.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 72.340000000000003 111.172 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 31.1 pt -150.35 137.89 13.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 65.540000000000006 111.13 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -111.28 139.24 46.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 75.310000000000002 110.896 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -51.94 135.87 29.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 75.040000000000006 110.878 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 92.9 -22.37 34.44 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.766 -0.73 . . . . 63.200000000000003 112.527 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -77.08 178.32 7.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.783 0.325 . . . . 71.209999999999994 110.858 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 51.2 mt -130.09 125.81 60.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.151 -0.477 . . . . 73.530000000000001 111.161 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 21.5 t -101.4 138.08 26.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.154 -0.476 . . . . 71.099999999999994 111.153 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 37.9 m -92.49 110.68 22.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 65.239999999999995 111.102 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 4.7 tp -69.89 121.48 17.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 73.209999999999994 110.936 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 62.7 mt -110.13 -37.3 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 73.510000000000005 111.162 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -150.08 170.53 18.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.484 . . . . 75.099999999999994 110.928 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 15.8 mttt -137.3 112.34 9.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 73.140000000000001 110.923 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -56.0 179.76 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.239 -0.437 . . . . 64.140000000000001 110.887 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 1.7 t -128.99 -69.41 0.71 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 72.200000000000003 110.861 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 42.0 mm -59.83 -18.0 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 74.430000000000007 111.153 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -99.44 61.77 1.2 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 75.140000000000001 110.845 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 62.5 t -51.35 136.53 10.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.464 . . . . 71.299999999999997 111.197 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 88.62 14.46 61.44 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.793 -0.718 . . . . 74.409999999999997 112.477 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 52.4 m95 -139.7 148.67 42.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.785 0.326 . . . . 74.239999999999995 110.869 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 10.3 m0 -139.12 148.66 43.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.47 . . . . 72.439999999999998 110.919 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -94.62 122.27 37.05 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.217 -0.447 . . . . 73.409999999999997 110.887 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -144.55 -164.43 10.53 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.781 -0.723 . . . . 72.120000000000005 112.49 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -142.37 148.2 37.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.87 0.366 . . . . 73.109999999999999 110.884 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 3.9 tp -159.02 130.15 6.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.474 . . . . 74.409999999999997 110.946 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 58.97 30.01 19.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.277 -0.42 . . . . 71.239999999999995 110.911 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 82.8 2.51 90.66 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.774 -0.727 . . . . 73.310000000000002 112.427 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -105.61 121.31 43.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.825 0.345 . . . . 73.439999999999998 110.897 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 55.1 mtm180 -105.65 133.74 49.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 74.329999999999998 110.806 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -171.93 -151.15 7.61 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.712 -0.756 . . . . 71.129999999999995 112.446 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 33.7 m -124.25 145.79 30.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.868 0.366 . . . . 72.129999999999995 111.14 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -144.56 157.01 56.41 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.644 0.735 . . . . 74.349999999999994 110.877 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 121.73 8.41 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.678 2.252 . . . . 74.450000000000003 112.375 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -62.2 -17.32 57.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 65.409999999999997 110.888 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -76.61 -5.23 46.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.115 -0.493 . . . . 72.430000000000007 110.813 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -121.01 24.5 10.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 74.409999999999997 110.849 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 17.5 m -148.61 147.39 16.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.175 -0.466 . . . . 71.299999999999997 111.105 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -114.07 114.35 26.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.474 . . . . 74.439999999999998 110.95 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.99 125.65 25.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.187 -0.461 . . . . 74.519999999999996 110.915 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 21.5 mt -67.94 159.02 81.66 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.58 0.705 . . . . 72.450000000000003 110.901 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.84 167.79 23.52 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.607 2.204 . . . . 73.430000000000007 112.33 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.9 -16.93 37.18 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.684 2.256 . . . . 63.530000000000001 112.255 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -85.17 -43.03 14.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.281 -0.418 . . . . 53.240000000000002 110.879 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 330' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -69.16 116.06 9.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 73.219999999999999 110.876 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -147.21 106.99 3.95 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.117 -0.492 . . . . 72.209999999999994 110.884 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -59.87 -54.81 41.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 73.340000000000003 110.919 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 72.010000000000005 110.854 179.969 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 3.3 m . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.849 0.357 . . . . 71.519999999999996 110.884 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 14.5 mmt 53.94 36.37 24.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.47 . . . . 70.150000000000006 110.887 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -77.96 -27.75 49.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 54.240000000000002 110.895 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 62.5 m -82.17 93.2 7.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 64.430000000000007 110.842 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.26 -26.14 13.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.472 . . . . 74.140000000000001 110.882 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 28.8 m -62.13 114.3 3.35 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.198 -0.456 . . . . 75.519999999999996 111.085 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.04 -28.21 8.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 72.409999999999997 110.895 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 15.2 p -90.62 49.83 1.73 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 73.319999999999993 110.857 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.57 178.96 7.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 75.510000000000005 110.851 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -165.56 123.07 1.51 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 70.129999999999995 110.851 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -110.65 137.8 47.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.173 -0.467 . . . . 75.239999999999995 110.962 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 25.3 m -126.92 145.61 50.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.148 -0.478 . . . . 64.140000000000001 110.923 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 17.6 ttpt -103.65 127.78 51.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 74.239999999999995 110.892 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 21.5 t -61.58 114.42 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.29 -0.414 . . . . 71.010000000000005 111.076 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 34.4 pt -88.97 -27.06 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 75.230000000000004 111.128 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -145.94 159.25 47.22 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.635 0.731 . . . . 74.450000000000003 110.853 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 151.94 68.89 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.706 2.27 . . . . 63.43 112.276 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -166.41 111.47 0.8 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 75.340000000000003 110.916 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -94.88 129.01 42.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 73.239999999999995 110.887 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -63.41 113.82 3.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 73.010000000000005 111.104 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -59.58 -26.44 65.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 75.019999999999996 110.899 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -150.7 170.25 19.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.221 -0.445 . . . . 51.009999999999998 110.842 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -56.57 -25.95 53.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 74.329999999999998 110.829 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -70.08 -25.86 63.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 72.310000000000002 110.851 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -94.96 164.66 12.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 74.25 110.9 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 14.4 tp -116.41 136.71 52.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.09 -0.505 . . . . 75.450000000000003 110.893 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 85.1 m -92.59 144.86 24.91 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.151 -0.477 . . . . 75.239999999999995 111.132 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 48.4 pt -150.37 142.9 17.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 72.510000000000005 111.143 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 31.8 mtpt -112.38 141.04 46.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.153 -0.476 . . . . 74.329999999999998 110.931 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -51.95 131.56 31.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 74.299999999999997 110.851 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 99.96 -22.22 41.22 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.702 -0.761 . . . . 74.530000000000001 112.438 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -76.12 178.12 6.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.757 0.313 . . . . 70.019999999999996 110.874 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 81.2 mt -133.02 122.1 45.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 74.230000000000004 111.179 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 90.1 t -105.66 138.1 32.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 73.129999999999995 111.149 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 52.3 m -87.77 114.34 24.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 63.399999999999999 111.136 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 5.5 tp -70.01 112.43 6.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.258 -0.428 . . . . 74.209999999999994 110.909 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 61.2 mt -101.43 -29.03 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.107 -0.497 . . . . 72.25 111.128 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -155.69 178.08 10.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.444 . . . . 54.109999999999999 110.9 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 27.7 mttp -141.33 112.97 7.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 71.040000000000006 110.938 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -49.68 160.78 0.26 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.213 -0.449 . . . . 71.319999999999993 110.888 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.8 t -113.29 -68.97 0.89 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 50.420000000000002 110.897 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 31.0 mm -66.97 -12.86 15.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 71.200000000000003 111.109 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -97.17 70.81 2.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 70.129999999999995 110.947 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 5.9 p -51.31 120.75 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 73.129999999999995 111.145 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.54 24.47 30.74 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.758 -0.734 . . . . 63.149999999999999 112.461 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 56.3 m95 -139.72 135.94 33.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.809 0.337 . . . . 73.5 110.913 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 22.3 m0 -130.69 156.66 44.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 73.230000000000004 110.867 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -101.38 115.51 30.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.194 -0.457 . . . . 75.230000000000004 110.925 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -128.66 -172.64 13.23 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.755 -0.736 . . . . 51.530000000000001 112.503 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -141.32 140.43 33.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.861 0.362 . . . . 73.349999999999994 110.931 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 4.5 tp -145.69 128.94 16.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 73.140000000000001 110.838 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 56.8 29.88 16.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 72.239999999999995 110.816 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 87.52 -8.62 76.64 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.716 -0.754 . . . . 73.129999999999995 112.527 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 4.3 tpt180 -93.08 109.01 20.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.722 0.296 . . . . 74.040000000000006 110.887 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 10.4 ttp85 -96.69 133.35 41.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 74.230000000000004 110.904 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -166.43 -158.87 11.47 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.669 -0.777 . . . . 75.530000000000001 112.41 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 19.2 m -116.76 154.47 18.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.883 0.373 . . . . 74.230000000000004 111.129 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -159.79 157.07 25.57 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.621 0.724 . . . . 71.299999999999997 110.865 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 121.65 8.33 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.705 2.27 . . . . 74.030000000000001 112.348 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -58.35 -22.31 53.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 65.140000000000001 110.937 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -69.85 -15.78 63.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 75.430000000000007 110.863 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -104.36 15.62 27.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 74.219999999999999 110.859 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 18.9 m -149.16 150.59 13.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 75.329999999999998 111.12 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 24.8 ttpt -125.35 125.75 43.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 74.230000000000004 110.895 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 2.5 mt -64.95 130.78 44.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 71.230000000000004 110.98 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 20.2 mt -56.51 159.24 6.87 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.592 0.711 . . . . 73.120000000000005 110.871 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 167.73 23.49 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.676 2.251 . . . . 74.319999999999993 112.35 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -17.1 37.79 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.657 2.238 . . . . 75.129999999999995 112.386 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -81.75 -33.9 30.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.197 -0.456 . . . . 65.25 110.893 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 330' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -69.99 114.88 8.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 74.209999999999994 110.899 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -138.62 107.06 5.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 65.439999999999998 110.839 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 15.0 tptm -70.87 -74.0 0.16 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 74.120000000000005 110.83 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.261 -0.427 . . . . 71.120000000000005 110.891 -179.967 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 12.6 t . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.896 0.379 . . . . 65.340000000000003 110.834 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 3.5 mmm -133.84 151.8 51.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.12 -0.491 . . . . 75.150000000000006 110.913 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -85.28 -43.31 13.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 74.239999999999995 110.86 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 55.56 53.14 10.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.458 . . . . 72.519999999999996 110.842 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -124.39 133.09 53.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.106 -0.497 . . . . 73.430000000000007 110.837 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 96.1 m -96.23 -72.99 0.61 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.197 -0.456 . . . . 74.230000000000004 111.117 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 6.0 mmtm -164.93 -177.72 4.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 74.439999999999998 110.877 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 6.5 p -78.23 60.36 2.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 73.219999999999999 110.866 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 5.5 mmtp -126.23 161.78 26.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 75.230000000000004 110.9 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -142.5 134.91 27.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 70.209999999999994 110.833 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -130.46 143.09 50.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.211 -0.45 . . . . 73.549999999999997 110.922 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 22.1 m -133.04 149.37 52.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.116 -0.493 . . . . 74.329999999999998 110.887 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 15.5 tttp -103.89 121.75 43.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 74.349999999999994 110.935 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 57.8 t -61.65 111.71 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 70.450000000000003 111.141 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 28.5 pt -84.1 -32.12 8.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 71.219999999999999 111.098 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -140.39 157.78 67.76 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.661 0.743 . . . . 73.099999999999994 110.927 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.81 159.23 54.13 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.695 2.264 . . . . 73.409999999999997 112.25 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -174.16 109.64 0.14 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 73.420000000000002 110.915 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -89.33 139.47 30.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 70.319999999999993 110.829 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -87.5 121.42 29.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 74.209999999999994 111.042 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -60.22 -42.46 95.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 63.420000000000002 110.933 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -148.64 -174.66 4.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 73.349999999999994 110.89 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -57.98 -19.75 32.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 73.150000000000006 110.909 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -72.07 -8.39 54.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 53.509999999999998 110.882 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -132.61 158.91 41.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 74.010000000000005 110.855 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 17.0 tp -114.89 133.44 55.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 74.219999999999999 110.979 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 86.7 m -84.32 145.04 28.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 64.209999999999994 111.144 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 38.6 pt -150.88 138.83 14.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 64.239999999999995 111.064 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 31.2 mttm -110.43 136.1 50.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.131 -0.486 . . . . 75.430000000000007 110.962 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -51.68 128.7 24.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.45 . . . . 71.310000000000002 110.877 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 105.26 -26.21 22.57 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.699 -0.762 . . . . 63.009999999999998 112.483 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -83.28 156.16 23.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.694 0.283 . . . . 74.420000000000002 110.934 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 56.6 mt -106.64 126.26 62.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.194 -0.457 . . . . 75.430000000000007 111.107 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 62.1 t -96.11 138.13 22.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 70.439999999999998 111.077 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 56.2 m -91.1 109.43 20.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.16 -0.473 . . . . 74.019999999999996 111.145 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 4.2 tp -69.85 121.2 16.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.187 -0.46 . . . . 73.310000000000002 110.892 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 38.9 mt -107.93 -36.69 3.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.233 -0.44 . . . . 64.450000000000003 111.171 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -151.02 170.69 18.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.128 -0.487 . . . . 74.0 110.907 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 21.7 mttt -137.28 112.28 9.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 74.219999999999999 110.858 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -55.49 178.61 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.436 . . . . 75.319999999999993 110.891 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 1.7 t -128.04 -69.36 0.73 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.207 -0.452 . . . . 64.439999999999998 110.936 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 60.8 mt -59.71 -18.26 14.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 70.510000000000005 111.137 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.35 61.67 1.21 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.462 . . . . 63.530000000000001 110.919 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 54.9 t -51.44 136.8 10.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 74.019999999999996 111.119 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 88.75 14.17 61.61 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.721 -0.752 . . . . 72.430000000000007 112.533 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 52.2 m95 -139.68 149.04 43.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.729 0.3 . . . . 75.439999999999998 110.871 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 10.4 m0 -139.22 148.78 43.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 73.530000000000001 110.89 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -94.47 117.56 30.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 72.400000000000006 110.969 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -138.4 -168.87 11.42 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.711 -0.757 . . . . 71.409999999999997 112.509 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 71.1 tt0 -138.49 148.1 43.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.834 0.35 . . . . 71.400000000000006 110.95 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 6.3 tp -158.6 129.55 6.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.19 -0.459 . . . . 74.349999999999994 110.953 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 58.94 30.0 19.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 60.409999999999997 110.864 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 84.47 -5.13 82.35 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.72 -0.752 . . . . 74.430000000000007 112.46 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -98.3 122.35 41.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.757 0.313 . . . . 73.099999999999994 110.915 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 63.0 mtm180 -106.97 132.03 53.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 75.530000000000001 110.835 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -168.04 -149.5 6.14 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.7 -0.762 . . . . 75.420000000000002 112.468 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 18.7 m -127.17 146.45 33.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.896 0.379 . . . . 75.049999999999997 111.119 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -144.95 157.37 54.43 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.656 0.741 . . . . 74.420000000000002 110.841 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.66 121.24 7.95 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.727 2.285 . . . . 73.400000000000006 112.344 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -60.66 -18.73 55.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 73.109999999999999 110.831 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -74.85 -6.7 50.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.481 . . . . 74.109999999999999 110.921 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -118.06 22.12 12.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 75.310000000000002 110.83 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 17.5 m -149.02 145.12 18.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 74.420000000000002 111.15 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -111.19 117.38 33.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 71.200000000000003 110.919 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.87 125.47 24.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 73.430000000000007 110.932 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 20.3 mt -64.13 159.21 58.62 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.59 0.71 . . . . 73.5 110.936 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 167.7 23.63 Favored 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 122.741 2.294 . . . . 70.129999999999995 112.382 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 -15.99 37.56 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.693 2.262 . . . . 73.310000000000002 112.377 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -84.08 -42.9 15.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.457 . . . . 71.109999999999999 110.887 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 330' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -72.22 108.05 5.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 74.140000000000001 110.947 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -146.11 107.24 4.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 73.25 110.891 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 32.3 mttm -86.48 -74.47 0.42 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 73.200000000000003 110.843 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 72.120000000000005 110.869 -179.995 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.892 0.377 . . . . 54.119999999999997 110.86 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 10.6 mmt -113.79 176.55 4.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 73.340000000000003 110.908 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -116.8 26.69 9.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 72.349999999999994 110.832 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 53.9 p -139.69 -179.87 6.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 54.340000000000003 110.872 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 14.9 mmp_? -55.84 105.33 0.18 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.156 -0.474 . . . . 73.349999999999994 110.857 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 2.1 t -117.76 -40.53 3.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 72.540000000000006 111.163 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 30.6 mttp 52.38 33.1 12.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.454 . . . . 74.310000000000002 110.815 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 1.3 t -144.88 28.18 1.27 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.242 -0.435 . . . . 65.129999999999995 110.893 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -56.51 168.19 0.61 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.088 -0.506 . . . . 73.329999999999998 110.905 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -119.82 118.14 30.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.208 -0.451 . . . . 73.109999999999999 110.876 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -124.1 156.61 36.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 65.209999999999994 110.917 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 23.5 m -138.92 152.44 47.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.123 -0.489 . . . . 65.209999999999994 110.886 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt -108.21 126.67 53.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.141 -0.481 . . . . 74.219999999999999 110.916 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 38.9 t -63.21 109.32 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 74.409999999999997 111.107 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 30.0 pt -83.25 -31.53 8.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 75.400000000000006 111.14 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -140.84 159.2 63.22 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.654 0.74 . . . . 73.140000000000001 110.86 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 152.08 69.02 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.675 2.25 . . . . 74.25 112.318 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -174.38 105.96 0.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 74.040000000000006 110.839 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -89.2 141.06 28.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.108 -0.496 . . . . 64.5 110.915 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -54.54 113.03 1.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 64.319999999999993 111.176 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -69.05 -26.45 64.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.303 -0.408 . . . . 75.439999999999998 110.945 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 18.9 m-80 -144.03 174.74 10.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.134 -0.485 . . . . 74.040000000000006 110.91 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -63.53 -26.13 68.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 75.310000000000002 110.854 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -88.06 6.14 37.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 74.040000000000006 110.838 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -105.65 164.64 11.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.253 -0.43 . . . . 75.239999999999995 110.889 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 21.3 tp -115.75 131.23 57.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.491 . . . . 74.120000000000005 110.903 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 91.5 m -87.43 136.14 33.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 72.540000000000006 111.078 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -147.49 146.15 18.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 72.439999999999998 111.149 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 27.4 mtmm -120.64 145.98 46.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 74.450000000000003 110.945 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -52.0 131.82 31.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.27 -0.423 . . . . 74.129999999999995 110.847 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.03 -27.1 19.81 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.804 -0.712 . . . . 40.5 112.52 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -71.71 173.34 8.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.778 0.323 . . . . 73.019999999999996 110.839 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 28.5 mm -124.24 135.9 62.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 75.239999999999995 111.156 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 19.5 t -111.69 132.43 60.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.247 -0.433 . . . . 62.240000000000002 111.067 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 17.4 m -87.89 112.09 22.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.089 -0.505 . . . . 72.340000000000003 111.136 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 6.0 tp -69.59 119.69 14.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 74.400000000000006 110.977 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 58.9 mt -115.72 -25.18 3.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.283 -0.417 . . . . 65.219999999999999 111.095 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -158.29 176.84 11.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.014 0.435 . . . . 74.099999999999994 110.779 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 48.7 mttt -141.18 113.03 7.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.048 -0.524 . . . . 70.439999999999998 110.897 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.01 166.75 0.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 75.439999999999998 110.903 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.2 t -119.6 -69.35 0.85 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.241 -0.436 . . . . 64.299999999999997 110.919 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 36.0 mm -64.26 -14.72 16.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 73.439999999999998 111.133 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -96.51 74.47 2.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 72.340000000000003 110.848 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 58.9 t -51.37 117.36 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 71.530000000000001 111.129 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 88.89 29.68 17.32 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.793 -0.718 . . . . 73.430000000000007 112.477 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 58.8 m95 -140.67 135.05 31.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.68 0.276 . . . . 74.340000000000003 110.977 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 24.2 m0 -129.26 157.55 41.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.254 -0.43 . . . . 75.209999999999994 110.934 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -104.78 124.77 49.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.305 -0.407 . . . . 73.299999999999997 110.887 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -140.24 -164.82 10.05 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.706 -0.759 . . . . 71.230000000000004 112.451 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -142.94 143.68 32.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.915 0.388 . . . . 73.200000000000003 110.865 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 2.0 tp -146.56 122.77 10.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 75.439999999999998 110.959 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 58.55 29.94 19.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 73.150000000000006 110.892 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 89.61 -8.63 79.43 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.715 -0.755 . . . . 72.019999999999996 112.459 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 17.2 tpp180 -94.14 114.24 26.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.703 0.287 . . . . 75.530000000000001 110.913 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 36.7 mtm180 -98.86 138.19 36.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.202 -0.454 . . . . 74.219999999999999 110.828 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -171.93 -160.61 20.86 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.797 -0.716 . . . . 74.519999999999996 112.475 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 32.6 m -118.36 154.0 20.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.857 0.36 . . . . 75.430000000000007 111.145 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -156.04 156.34 30.31 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.639 0.733 . . . . 73.200000000000003 110.882 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 119.5 6.44 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.701 2.267 . . . . 72.310000000000002 112.351 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -60.89 -18.86 58.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.431 . . . . 73.329999999999998 110.888 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -74.55 -7.15 52.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.157 -0.474 . . . . 61.030000000000001 110.82 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -117.63 24.19 11.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 74.450000000000003 110.776 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 18.1 m -148.89 153.13 11.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 73.109999999999999 111.122 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -116.8 113.39 22.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 72.099999999999994 110.957 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.2 tt -65.1 126.48 28.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 72.329999999999998 110.906 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 20.3 mt -68.57 159.2 82.71 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.642 0.734 . . . . 75.25 110.855 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 167.73 23.52 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.701 2.267 . . . . 73.340000000000003 112.375 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 -16.6 37.34 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.694 2.263 . . . . 74.400000000000006 112.282 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -82.63 -28.35 30.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.219 -0.446 . . . . 64.340000000000003 110.861 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 330' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -78.67 115.43 18.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.142 -0.481 . . . . 74.519999999999996 110.883 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -137.17 106.97 6.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.087 -0.506 . . . . 74.310000000000002 110.861 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.92 -73.73 0.09 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 74.340000000000003 110.864 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.284 -0.416 . . . . 75.400000000000006 110.877 179.969 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 3.0 p . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.91 0.386 . . . . 75.329999999999998 110.9 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 58.7 mtt -112.22 147.89 35.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 73.530000000000001 110.897 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -78.81 148.08 33.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 72.230000000000004 110.888 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 1.2 m -152.79 141.06 20.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 71.239999999999995 110.778 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -116.37 92.78 3.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.085 -0.507 . . . . 74.329999999999998 110.89 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 95.2 m -60.62 -73.52 0.09 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.175 -0.466 . . . . 63.329999999999998 111.168 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 23.0 ttpt 54.3 38.98 30.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 72.420000000000002 110.889 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 58.7 m -135.73 31.05 3.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.265 -0.425 . . . . 63.43 110.801 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -124.47 -178.2 4.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.159 -0.473 . . . . 74.219999999999999 110.863 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -123.82 124.39 42.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 74.230000000000004 110.839 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -129.26 150.99 50.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 74.25 110.857 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 26.4 m -139.19 150.7 45.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.058 -0.519 . . . . 74.409999999999997 110.911 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -107.77 122.92 47.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.447 . . . . 74.319999999999993 110.896 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 24.1 t -56.01 116.18 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.292 -0.413 . . . . 74.349999999999994 111.193 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 29.7 pt -97.95 -17.55 6.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 71.409999999999997 111.127 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -145.52 151.98 48.31 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.627 0.727 . . . . 73.409999999999997 110.903 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.67 151.52 69.62 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.655 2.237 . . . . 74.530000000000001 112.363 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -174.45 140.43 0.63 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.451 . . . . 73.140000000000001 110.932 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -121.17 143.18 49.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.054 -0.521 . . . . 75.25 110.882 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -76.61 127.79 33.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 73.420000000000002 111.116 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -71.48 -25.82 62.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.242 -0.435 . . . . 74.129999999999995 110.878 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -155.75 177.54 11.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 51.100000000000001 110.887 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -56.94 -25.75 58.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.177 -0.465 . . . . 65.530000000000001 110.878 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -72.29 -24.85 61.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.474 . . . . 72.409999999999997 110.864 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -94.97 163.5 13.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.172 -0.467 . . . . 71.120000000000005 110.895 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 20.3 tp -119.78 131.24 55.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.13 -0.486 . . . . 74.230000000000004 110.923 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 96.7 m -85.97 143.3 28.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.154 -0.475 . . . . 75.010000000000005 111.139 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 47.9 pt -150.26 142.36 17.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 75.040000000000006 111.115 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 17.3 mmtp -122.07 144.73 48.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 72.140000000000001 110.897 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -51.5 128.81 23.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 74.310000000000002 110.863 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 101.43 -30.89 9.41 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.753 -0.737 . . . . 75.219999999999999 112.493 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -69.77 171.83 8.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.736 0.303 . . . . 73.530000000000001 110.917 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 67.4 mt -126.71 126.16 68.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 73.329999999999998 111.087 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 64.6 t -104.37 138.21 30.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 74.310000000000002 111.135 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 49.2 m -92.63 111.4 22.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.154 -0.475 . . . . 64.049999999999997 111.129 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 5.3 tp -69.82 122.28 18.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 74.209999999999994 110.937 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 67.6 mt -110.53 -39.8 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 73.010000000000005 111.124 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -145.71 171.67 14.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 65.549999999999997 110.872 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -136.09 111.87 9.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 72.099999999999994 110.899 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.08 177.5 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 71.420000000000002 110.938 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 1.9 t -126.46 -69.33 0.77 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 64.230000000000004 110.91 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 38.6 mm -62.64 -15.89 15.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 72.219999999999999 111.185 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.26 61.35 2.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 73.540000000000006 110.9 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 56.6 t -51.12 130.97 11.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 71.200000000000003 111.118 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.91 14.71 58.97 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.779 -0.724 . . . . 73.5 112.484 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 44.0 m95 -137.01 162.86 32.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.816 0.341 . . . . 73.209999999999994 110.872 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 5.0 m0 -151.0 156.44 41.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 70.310000000000002 110.866 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -102.66 119.06 38.17 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.246 -0.434 . . . . 73.329999999999998 110.903 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -140.55 -162.92 9.31 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.75 -0.738 . . . . 62.25 112.51 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -145.65 148.64 33.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.934 0.397 . . . . 65.030000000000001 110.834 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 14.5 tp -157.98 134.95 9.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.074 -0.512 . . . . 72.120000000000005 110.894 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 57.23 30.44 18.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 74.450000000000003 110.926 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 77.95 18.88 76.19 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.784 -0.722 . . . . 62.43 112.416 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 31.5 mmm-85 -124.99 121.01 33.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.867 0.365 . . . . 74.430000000000007 110.849 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 39.8 mtp180 -99.55 142.54 30.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 73.450000000000003 110.876 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -176.52 -160.06 23.09 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.793 -0.718 . . . . 73.430000000000007 112.523 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 29.5 m -115.51 151.07 17.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.923 0.392 . . . . 70.439999999999998 111.17 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -154.69 155.77 30.83 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.64 0.733 . . . . 74.129999999999995 110.916 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 119.8 6.69 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.744 2.296 . . . . 75.310000000000002 112.31 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -61.06 -18.61 58.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.242 -0.435 . . . . 73.340000000000003 110.855 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 75.1 m-80 -74.88 -6.98 52.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 74.549999999999997 110.887 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -117.54 22.77 12.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 75.420000000000002 110.892 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 18.3 m -148.82 144.28 18.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.464 . . . . 73.530000000000001 111.17 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 52.6 tttt -109.45 116.95 32.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.464 . . . . 70.099999999999994 110.891 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.02 119.36 10.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 75.120000000000005 110.952 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 20.2 mt -66.61 159.22 75.46 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.615 0.722 . . . . 73.530000000000001 110.896 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 167.79 23.43 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.638 2.225 . . . . 64.129999999999995 112.408 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 -19.84 35.43 Favored 'Trans proline' 0 C--O 1.23 0.113 0 C-N-CA 122.707 2.271 . . . . 73.409999999999997 112.349 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.28 -33.19 49.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 74.409999999999997 110.93 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 330' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -64.03 115.46 4.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 73.25 110.842 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -133.36 106.93 7.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 71.219999999999999 110.934 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.16 -46.83 8.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.183 -0.462 . . . . 71.319999999999993 110.907 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 21.5 pm0 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.253 -0.431 . . . . 74.230000000000004 110.871 179.985 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 1.3 t . . . . . 0 N--CA 1.458 -0.059 0 CA-C-O 120.892 0.377 . . . . 61.450000000000003 110.874 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 36.7 mtt -97.17 174.07 6.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.084 -0.507 . . . . 74.530000000000001 110.879 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -67.66 145.17 55.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 75.340000000000003 110.878 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 7.1 m -90.97 -58.96 2.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 73.540000000000006 110.81 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 47.6 ttp180 -94.51 123.48 37.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.108 -0.496 . . . . 73.099999999999994 110.866 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 3.7 m -113.97 141.15 47.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 73.319999999999993 111.154 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 36.0 mttt -76.25 -176.16 3.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 74.0 110.861 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 8.7 m -81.19 68.46 7.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 75.010000000000005 110.858 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 24.8 mtpt -102.58 -176.5 3.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.472 . . . . 74.109999999999999 110.905 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -163.18 154.11 16.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 72.140000000000001 110.845 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -142.85 147.19 35.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.452 . . . . 75.25 110.942 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 23.7 m -135.26 149.22 49.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 73.299999999999997 110.85 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 47.4 tttt -103.49 115.17 30.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.181 -0.463 . . . . 75.310000000000002 110.886 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 58.9 t -57.47 118.26 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.262 -0.426 . . . . 74.510000000000005 111.08 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 26.2 pt -93.42 -30.98 4.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.489 . . . . 71.420000000000002 111.13 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -136.56 159.4 70.63 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.642 0.734 . . . . 63.340000000000003 110.929 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 159.63 52.69 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.648 2.232 . . . . 72.310000000000002 112.367 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -172.76 110.02 0.21 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.27 -0.423 . . . . 72.329999999999998 110.948 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -93.23 128.02 39.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 71.129999999999995 110.868 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -61.82 116.27 4.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 75.219999999999999 111.109 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -57.9 -26.73 62.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 74.310000000000002 110.99 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -152.43 173.87 14.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 71.329999999999998 110.949 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -58.78 -26.28 63.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 74.040000000000006 110.945 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -70.11 -24.92 63.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.1 -0.5 . . . . 65.129999999999995 110.856 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -95.07 167.32 11.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 75.010000000000005 110.865 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 15.1 tp -116.78 137.43 52.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 73.420000000000002 110.921 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 85.4 m -95.18 144.35 25.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 64.25 111.128 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 41.8 pt -150.34 149.72 14.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 62.25 111.128 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -121.93 140.79 52.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 73.319999999999993 110.909 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 8.1 tm-20 -51.83 122.95 9.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 73.230000000000004 110.861 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 113.26 -23.16 14.33 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.726 -0.749 . . . . 15.41 112.466 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -88.42 152.14 22.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.817 0.341 . . . . 71.319999999999993 110.867 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 62.7 mt -104.55 123.65 58.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 75.299999999999997 111.147 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 90.9 t -100.17 138.04 25.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 73.019999999999996 111.114 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 33.9 m -86.5 109.35 19.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.166 -0.47 . . . . 74.030000000000001 111.154 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 7.4 tp -69.86 117.76 11.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 74.430000000000007 110.904 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 69.0 mt -104.45 -48.41 9.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 73.519999999999996 111.086 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -134.38 178.13 7.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 73.430000000000007 110.895 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -141.46 112.77 7.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.157 -0.474 . . . . 73.400000000000006 110.91 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -50.56 165.77 0.09 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.229 -0.441 . . . . 72.409999999999997 110.805 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.8 t -115.69 -69.14 0.87 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.479 . . . . 74.040000000000006 110.864 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 2.0 mp -67.57 -12.61 15.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.434 . . . . 72.519999999999996 111.194 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.84 69.3 3.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 73.409999999999997 110.894 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 76.7 t -51.43 121.41 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 74.120000000000005 111.136 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.33 20.34 45.73 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.733 -0.746 . . . . 73.219999999999999 112.551 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 42.0 m95 -136.27 138.7 42.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.708 0.289 . . . . 75.129999999999995 110.909 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 19.5 m0 -134.3 157.19 46.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.454 . . . . 73.319999999999993 110.918 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -100.52 117.25 34.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.288 -0.415 . . . . 73.109999999999999 110.888 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -129.77 -170.13 12.67 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.768 -0.73 . . . . 70.329999999999998 112.505 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -143.83 146.82 33.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.864 0.364 . . . . 74.329999999999998 110.947 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 2.6 tp -155.77 132.27 10.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.181 -0.463 . . . . 73.219999999999999 110.92 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 56.81 29.86 16.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 72.319999999999993 110.854 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 84.76 -6.8 76.73 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.747 -0.74 . . . . 74.219999999999999 112.485 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 14.1 tpp180 -96.09 108.6 21.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.773 0.321 . . . . 63.210000000000001 110.857 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 8.9 ttp180 -96.61 129.75 43.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 74.340000000000003 110.952 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -161.34 -157.96 9.11 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.78 -0.724 . . . . 70.530000000000001 112.507 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 15.8 m -117.25 154.59 18.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.843 0.354 . . . . 74.519999999999996 111.119 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -162.19 155.83 17.9 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.648 0.737 . . . . 73.140000000000001 110.904 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.85 118.5 5.72 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.699 2.266 . . . . 72.150000000000006 112.293 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -59.67 -20.32 55.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 71.409999999999997 110.83 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -68.4 -12.65 61.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 61.420000000000002 110.887 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -107.96 14.15 25.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 73.040000000000006 110.856 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 17.7 m -148.56 145.21 18.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.487 . . . . 74.409999999999997 111.09 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 21.6 ttpp -106.52 118.77 37.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 75.450000000000003 110.958 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.9 tt -64.98 132.0 48.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 72.450000000000003 110.934 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 20.4 mt -68.92 159.23 83.6 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.572 0.701 . . . . 75.439999999999998 110.936 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 167.67 23.84 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.715 2.276 . . . . 74.409999999999997 112.37 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.7 -17.29 37.95 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.709 2.272 . . . . 73.450000000000003 112.298 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -81.07 -30.19 34.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.303 -0.408 . . . . 70.209999999999994 110.888 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 330' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -72.57 109.38 6.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 75.540000000000006 110.888 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -135.92 107.45 6.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 74.319999999999993 110.929 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.37 -60.96 2.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 75.019999999999996 110.844 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.213 -0.449 . . . . 74.430000000000007 110.909 179.975 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 93.2 p . . . . . 0 C--O 1.23 0.059 0 CA-C-O 120.88 0.371 . . . . 74.409999999999997 110.888 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 24.3 mmm -118.49 65.38 0.76 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 61.409999999999997 110.869 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -58.34 135.27 57.14 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.236 -0.438 . . . . 72.010000000000005 110.868 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 7.6 t -144.74 122.78 12.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 54.520000000000003 110.865 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 14.6 mmp_? -98.57 163.25 12.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.128 -0.487 . . . . 73.319999999999993 110.843 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 14.7 t -106.09 143.24 34.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 63.450000000000003 111.122 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -97.17 -26.35 14.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 73.319999999999993 110.903 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 11.4 p -79.3 62.95 3.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 74.549999999999997 110.832 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -101.47 -177.79 3.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.111 -0.495 . . . . 74.409999999999997 110.93 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -137.15 134.3 36.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 75.099999999999994 110.862 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -132.33 139.61 48.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 74.430000000000007 110.903 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 36.0 m -127.76 148.61 50.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.479 . . . . 63.240000000000002 110.887 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 38.6 tttt -102.9 118.04 35.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 74.519999999999996 110.878 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 61.6 t -58.82 112.99 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.252 -0.431 . . . . 74.409999999999997 111.15 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 30.9 pt -86.5 -31.47 6.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 74.450000000000003 111.099 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -139.71 158.14 68.56 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.603 0.716 . . . . 71.319999999999993 110.867 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 153.94 68.43 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.702 2.268 . . . . 74.040000000000006 112.361 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -171.48 105.95 0.22 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 75.030000000000001 110.927 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -88.57 143.84 26.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 74.150000000000006 110.837 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -78.09 123.39 26.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.096 -0.502 . . . . 53.109999999999999 111.095 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -74.85 -26.13 59.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 74.129999999999995 110.943 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -144.49 170.07 16.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 74.030000000000001 110.883 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -57.35 -26.18 60.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.139 -0.482 . . . . 74.510000000000005 110.928 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -70.95 -25.56 62.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 52.240000000000002 110.922 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -95.16 161.28 14.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 64.439999999999998 110.928 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 13.4 tp -120.1 136.54 54.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.235 -0.439 . . . . 74.099999999999994 110.941 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 73.2 m -86.2 146.1 26.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 74.540000000000006 111.087 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 44.3 pt -150.41 145.04 17.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.439 . . . . 73.219999999999999 111.106 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -117.64 136.98 52.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 72.049999999999997 110.873 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -51.76 126.15 17.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 72.450000000000003 110.88 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 108.51 -26.02 17.7 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.713 -0.756 . . . . 75.129999999999995 112.476 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -85.38 153.95 22.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.766 0.317 . . . . 73.239999999999995 110.917 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 29.2 mm -105.08 123.14 59.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.298 -0.41 . . . . 74.439999999999998 111.104 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 87.8 t -93.25 138.04 21.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 72.010000000000005 111.123 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 89.4 m -86.46 108.55 18.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 74.150000000000006 111.156 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 3.3 tp -69.91 115.1 8.74 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.256 -0.429 . . . . 71.200000000000003 110.924 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 79.2 mt -103.71 -26.91 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 74.420000000000002 111.091 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -157.39 178.0 10.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 72.340000000000003 110.85 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 24.9 mttt -141.34 113.01 7.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.126 -0.488 . . . . 71.540000000000006 110.9 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -49.77 162.43 0.18 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.215 -0.448 . . . . 71.549999999999997 110.91 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.8 t -114.51 -68.99 0.88 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.261 -0.427 . . . . 71.510000000000005 110.931 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 40.2 mt -67.0 -13.12 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 73.530000000000001 111.063 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -95.77 71.04 3.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 74.430000000000007 110.876 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 42.1 t -51.28 119.99 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 74.0 111.178 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.32 24.79 30.31 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.715 -0.755 . . . . 74.299999999999997 112.463 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 55.6 m95 -139.67 138.26 35.9 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.743 0.306 . . . . 72.099999999999994 110.986 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 20.8 m0 -132.53 158.45 42.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.278 -0.419 . . . . 71.219999999999999 110.857 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -103.03 115.18 30.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 73.099999999999994 110.949 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -130.34 -171.76 12.99 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.677 -0.773 . . . . 63.549999999999997 112.462 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -141.85 143.64 33.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.906 0.384 . . . . 74.120000000000005 110.878 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 1.8 tp -160.03 147.05 16.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 73.230000000000004 110.937 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 56.6 29.94 16.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 74.209999999999994 110.862 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 76.24 7.83 84.99 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.696 -0.764 . . . . 71.230000000000004 112.431 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.9 126.29 52.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.835 0.35 . . . . 71.129999999999995 110.877 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 7.8 ttp180 -100.9 141.21 34.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 74.109999999999999 110.928 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -172.78 -158.84 18.09 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.741 -0.742 . . . . 53.439999999999998 112.493 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 35.4 m -117.86 162.99 15.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.932 0.396 . . . . 73.120000000000005 111.087 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -166.71 157.04 10.54 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.66 0.743 . . . . 75.510000000000005 110.866 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.83 122.31 8.97 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.63 2.22 . . . . 72.120000000000005 112.365 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -59.2 -21.31 59.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.238 -0.437 . . . . 74.340000000000003 110.876 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -69.93 -16.99 63.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 71.219999999999999 110.898 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -102.95 15.13 30.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 72.430000000000007 110.863 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 18.2 m -148.99 150.45 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 73.209999999999994 111.217 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 17.2 mmtm -114.8 117.32 30.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 74.400000000000006 110.894 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.9 tt -64.92 127.38 31.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.246 -0.434 . . . . 72.219999999999999 110.908 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 20.4 mt -59.38 159.27 16.87 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.575 0.702 . . . . 70.430000000000007 110.932 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.84 167.76 23.6 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.656 2.238 . . . . 73.430000000000007 112.336 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.68 -16.76 38.05 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.728 2.285 . . . . 53.109999999999999 112.365 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -82.64 -40.87 20.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.182 -0.463 . . . . 74.209999999999994 110.911 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 330' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -66.6 115.69 6.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 75.209999999999994 110.873 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -141.61 106.92 5.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.155 -0.475 . . . . 71.099999999999994 110.907 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.21 -65.34 0.97 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.097 -0.501 . . . . 63.329999999999998 110.965 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 72.510000000000005 110.879 179.961 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 31.0 t . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.898 0.38 . . . . 73.109999999999999 110.835 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 6.0 mmm -79.63 98.44 6.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 70.519999999999996 110.88 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.55 104.8 13.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 71.209999999999994 110.915 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 70.2 m -75.94 159.01 31.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.255 -0.429 . . . . 61.140000000000001 110.788 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.52 -28.54 8.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.092 -0.504 . . . . 74.239999999999995 110.858 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 3.0 m -71.88 117.17 13.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.199 -0.455 . . . . 71.129999999999995 111.165 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 23.8 mtpp -89.61 -53.99 4.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.226 -0.443 . . . . 75.209999999999994 110.857 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 1.2 p -122.04 129.08 52.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 64.209999999999994 110.812 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 3.0 mtpm? -112.23 -178.21 3.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.095 -0.502 . . . . 73.530000000000001 110.861 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -127.48 125.0 39.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 73.439999999999998 110.897 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -127.64 146.78 50.43 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.213 -0.449 . . . . 75.0 110.926 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 45.5 m -133.64 147.9 51.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 71.310000000000002 110.863 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 28.9 tttt -102.9 119.23 38.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 74.150000000000006 110.928 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 58.8 t -59.37 112.6 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.31 -0.405 . . . . 74.019999999999996 111.075 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 29.2 pt -86.59 -31.89 6.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 74.129999999999995 111.092 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -138.71 158.73 69.62 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.669 0.747 . . . . 74.349999999999994 110.91 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 161.49 45.72 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.679 2.253 . . . . 71.239999999999995 112.338 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -174.87 111.92 0.14 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.274 -0.421 . . . . 74.299999999999997 110.934 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -92.17 131.97 36.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.101 -0.5 . . . . 75.430000000000007 110.872 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -68.26 115.67 7.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 72.030000000000001 111.077 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -58.08 -30.35 66.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 72.340000000000003 110.936 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -149.72 175.18 11.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 74.5 110.9 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -58.65 -25.64 62.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 72.540000000000006 110.891 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -69.93 -25.88 63.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 75.200000000000003 110.897 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -94.93 163.41 13.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 74.099999999999994 110.916 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 23.2 tp -116.08 131.54 56.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 71.209999999999994 110.949 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 60.4 m -88.24 144.61 26.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 73.540000000000006 111.141 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 43.9 pt -150.34 146.87 16.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 72.310000000000002 111.12 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -119.11 139.57 51.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.478 . . . . 73.540000000000006 110.871 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -51.91 124.01 11.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.475 . . . . 73.400000000000006 110.878 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 111.65 -24.97 14.09 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.768 -0.73 . . . . 73.340000000000003 112.46 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -85.98 156.16 20.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.789 0.328 . . . . 73.430000000000007 110.893 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 36.7 mm -108.63 127.14 65.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.288 -0.415 . . . . 75.049999999999997 111.18 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 61.1 t -102.59 138.1 28.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 74.530000000000001 111.121 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 97.8 m -82.38 103.8 12.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 74.420000000000002 111.139 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 9.0 tp -69.89 113.15 6.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.144 -0.48 . . . . 75.439999999999998 110.897 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 19.7 mt -92.8 -49.17 13.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 72.340000000000003 111.155 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -149.88 178.62 8.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 65.310000000000002 110.863 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -129.17 112.3 13.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 72.120000000000005 110.85 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -49.8 166.6 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 72.340000000000003 110.878 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.0 t -111.02 -69.11 0.89 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.203 -0.453 . . . . 74.230000000000004 110.894 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 51.4 mt -63.62 -15.3 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 74.030000000000001 111.192 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -93.31 65.26 3.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.112 -0.494 . . . . 64.319999999999993 110.897 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 57.7 t -51.19 118.69 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 74.230000000000004 111.119 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.54 23.07 34.84 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.788 -0.72 . . . . 50.420000000000002 112.496 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 52.8 m95 -139.06 133.01 31.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.735 0.303 . . . . 74.319999999999993 110.925 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 28.6 m0 -124.34 149.62 46.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.257 -0.429 . . . . 74.439999999999998 110.882 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -97.62 119.78 36.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.435 . . . . 74.409999999999997 110.944 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -136.74 -167.24 11.08 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.668 -0.777 . . . . 74.540000000000006 112.408 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -139.34 138.48 36.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.926 0.394 . . . . 74.310000000000002 110.844 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 13.2 tp -145.78 129.98 17.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.489 . . . . 72.439999999999998 110.895 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 58.89 29.95 19.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 71.230000000000004 110.805 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 84.03 -4.72 82.3 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.753 -0.737 . . . . 73.420000000000002 112.458 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 9.5 ttp85 -100.44 120.15 39.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.842 0.353 . . . . 63.229999999999997 110.842 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 32.4 mtm180 -99.9 140.54 33.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.469 . . . . 73.200000000000003 110.847 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -173.29 -159.85 20.66 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.689 -0.767 . . . . 72.239999999999995 112.479 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 17.0 m -117.02 148.63 19.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.859 0.362 . . . . 75.340000000000003 111.098 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -151.01 156.76 35.52 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.722 0.772 . . . . 72.239999999999995 110.847 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 120.01 6.87 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.71 2.273 . . . . 70.430000000000007 112.332 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -58.58 -21.91 54.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.276 -0.42 . . . . 71.439999999999998 110.844 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -71.14 -10.2 59.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.471 . . . . 74.299999999999997 110.877 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -111.88 17.68 19.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 74.150000000000006 110.905 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 18.0 m -149.07 151.89 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.11 -0.496 . . . . 62.130000000000003 111.125 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 8.9 mtpp -118.94 118.63 32.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 75.329999999999998 110.934 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.02 130.56 43.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.208 -0.451 . . . . 75.430000000000007 110.855 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 20.2 mt -63.96 159.21 57.05 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 121.631 0.729 . . . . 74.099999999999994 110.855 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 167.71 23.63 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.729 2.286 . . . . 74.109999999999999 112.38 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -21.35 33.72 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.657 2.238 . . . . 64.319999999999993 112.391 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -77.1 -37.73 53.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.46 . . . . 73.340000000000003 110.877 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 330' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -75.37 114.37 13.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 71.340000000000003 110.873 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -151.2 107.38 3.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.169 -0.469 . . . . 73.340000000000003 110.868 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 19.2 mtpp -82.87 -72.12 0.46 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.11 -0.495 . . . . 74.340000000000003 110.886 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 72.310000000000002 110.861 -179.97 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 34.1 m . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.832 0.348 . . . . 61.149999999999999 110.847 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 2.6 mpp? -135.71 113.99 11.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 73.450000000000003 110.894 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -115.44 110.78 19.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.283 -0.417 . . . . 71.230000000000004 110.821 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 3.8 m -69.37 147.71 50.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 72.140000000000001 110.809 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 6.2 tpt85 -99.3 -26.62 14.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.113 -0.494 . . . . 75.450000000000003 110.852 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 7.5 t -105.18 143.64 33.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 71.310000000000002 111.107 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 17.9 tttt -88.48 -37.29 15.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 75.140000000000001 110.915 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 13.4 t -74.28 81.43 1.85 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.256 -0.429 . . . . 71.349999999999994 110.891 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 4.2 pttm -129.67 -174.27 3.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 72.030000000000001 110.869 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -152.77 130.13 11.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 73.519999999999996 110.844 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -115.94 142.78 46.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.243 -0.435 . . . . 75.129999999999995 110.943 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 22.7 m -127.29 146.32 50.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.113 -0.494 . . . . 73.120000000000005 110.919 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -102.9 126.11 49.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 73.519999999999996 110.912 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 47.8 t -64.84 112.23 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.309 -0.405 . . . . 72.420000000000002 111.136 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 27.0 pt -85.74 -32.09 6.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.269 -0.423 . . . . 74.150000000000006 111.127 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -138.53 157.96 71.28 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.624 0.726 . . . . 75.109999999999999 110.878 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 156.66 62.77 Favored 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 122.674 2.249 . . . . 72.230000000000004 112.345 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -172.41 108.21 0.2 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 72.510000000000005 110.924 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -88.15 138.97 30.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 70.109999999999999 110.866 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -68.45 116.52 9.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 74.430000000000007 111.099 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -56.47 -28.08 58.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 74.510000000000005 110.907 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -153.73 175.93 12.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 71.329999999999998 110.885 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -58.8 -25.81 63.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.145 -0.48 . . . . 74.519999999999996 110.855 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.16 -23.57 61.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 65.319999999999993 110.86 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -94.96 167.96 11.08 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.179 -0.464 . . . . 73.409999999999997 110.909 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 14.6 tp -119.01 136.67 54.0 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.163 -0.471 . . . . 75.209999999999994 110.9 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 85.6 m -91.89 146.08 24.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.159 -0.473 . . . . 74.340000000000003 111.144 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 33.7 pt -149.49 143.3 18.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.281 -0.418 . . . . 74.420000000000002 111.183 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 20.2 mtpp -117.26 140.05 50.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.148 -0.478 . . . . 70.040000000000006 110.919 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -51.43 121.84 6.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 71.400000000000006 110.924 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 115.2 -31.03 6.42 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.727 -0.749 . . . . 70.209999999999994 112.48 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -79.4 160.39 26.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.725 0.298 . . . . 74.230000000000004 110.889 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 3.2 mp -115.95 128.05 73.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 75.349999999999994 111.115 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 99.8 t -105.03 138.15 31.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 72.510000000000005 111.127 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 3.3 m -85.98 117.7 25.0 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.174 -0.466 . . . . 61.340000000000003 111.151 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 5.2 tp -69.88 110.66 5.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.243 -0.435 . . . . 71.019999999999996 110.865 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 27.5 mm -100.12 -26.12 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 74.030000000000001 111.079 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -162.11 178.31 8.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 74.340000000000003 110.862 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 40.9 mttt -141.38 112.95 7.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 75.239999999999995 110.885 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -49.66 161.74 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 74.230000000000004 110.902 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.8 t -113.53 -69.05 0.89 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 74.439999999999998 110.86 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 38.6 mt -66.97 -12.98 15.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.432 . . . . 75.140000000000001 111.172 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -97.36 70.46 2.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.135 -0.484 . . . . 74.329999999999998 110.843 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 6.3 p -51.35 121.89 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 73.540000000000006 111.176 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.24 21.0 43.14 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.695 -0.764 . . . . 54.240000000000002 112.461 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 42.5 m95 -136.42 134.27 37.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.781 0.324 . . . . 74.409999999999997 110.896 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 22.0 m0 -129.2 156.96 43.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.112 -0.495 . . . . 75.319999999999993 110.932 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -101.33 113.41 26.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.283 -0.417 . . . . 74.540000000000006 110.869 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -124.7 -173.93 13.89 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.802 -0.713 . . . . 54.240000000000002 112.493 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 72.8 tt0 -137.74 136.22 37.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.897 0.379 . . . . 73.409999999999997 110.91 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 3.1 tp -149.2 134.4 18.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.454 . . . . 73.200000000000003 111.003 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 58.86 29.94 19.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 73.150000000000006 110.901 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 81.2 -0.91 86.81 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.733 -0.746 . . . . 54.130000000000003 112.457 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 9.5 ttp85 -103.5 111.46 23.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.869 0.366 . . . . 74.340000000000003 110.893 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 9.5 ttp180 -96.66 117.03 30.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 75.219999999999999 110.861 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -146.89 -155.23 6.45 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.793 -0.717 . . . . 72.519999999999996 112.539 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 23.1 m -118.48 155.41 20.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.817 0.342 . . . . 73.540000000000006 111.159 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -163.72 156.11 15.23 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.569 0.7 . . . . 75.109999999999999 110.92 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.82 119.24 6.21 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.682 2.255 . . . . 74.019999999999996 112.337 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -60.42 -18.97 54.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.191 -0.459 . . . . 74.140000000000001 110.841 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -68.24 -12.51 61.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 74.450000000000003 110.884 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -108.29 14.47 24.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 75.140000000000001 110.872 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 18.0 m -148.86 149.54 14.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 74.0 111.085 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 10.2 ttmm -121.49 134.17 55.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 71.25 110.876 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.95 126.42 27.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 64.319999999999993 110.91 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 20.4 mt -63.53 159.16 53.66 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.611 0.72 . . . . 73.329999999999998 110.909 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 167.6 23.96 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.742 2.295 . . . . 74.140000000000001 112.373 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.73 -16.15 37.53 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.632 2.221 . . . . 72.430000000000007 112.306 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -84.95 -42.07 15.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 75.340000000000003 110.868 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 330' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -63.93 118.57 8.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 72.299999999999997 110.889 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -136.89 106.78 6.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.081 -0.509 . . . . 75.430000000000007 110.836 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 18.3 tttm -60.57 -45.56 93.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.08 -0.509 . . . . 75.040000000000006 110.94 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 64.109999999999999 110.904 179.914 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.838 0.351 . . . . 54.34 110.838 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 271' ' ' TYR . . . . . 0.542 ' HB3' HD12 ' A' ' 326' ' ' LEU . 8.6 m-85 -128.11 149.39 50.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 73.51 110.863 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 25.7 m -138.55 148.19 43.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.098 -0.501 . . . . 73.33 110.843 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -102.95 123.05 45.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 71.51 110.912 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 274' ' ' VAL . . . . . 0.655 HG13 HD12 ' A' ' 288' ' ' ILE . 22.4 t -61.0 109.02 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 61.21 111.131 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 36.0 pt -83.64 -28.22 7.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 60.52 111.133 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -145.41 159.3 48.89 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.624 0.726 . . . . 75.32 110.851 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 159.78 52.15 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.651 2.234 . . . . 60.44 112.364 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -176.1 110.39 0.1 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.435 . . . . 74.24 110.929 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 279' ' ' GLU . . . . . 0.716 ' HA ' HG23 ' A' ' 287' ' ' THR . 21.7 tp10 -89.46 135.04 33.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.089 -0.505 . . . . 70.32 110.945 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -65.82 113.26 4.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 61.44 111.038 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -58.06 -26.44 62.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.436 . . . . 73.4 110.986 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -154.95 170.77 20.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 65.51 110.885 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -56.22 -25.99 49.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 60.24 110.882 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -70.05 -26.55 64.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.155 -0.475 . . . . 73.3 110.929 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -94.99 169.56 10.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 64.15 110.89 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.598 HD23 ' CD2' ' A' ' 318' ' ' PHE . 14.0 tp -120.57 137.24 54.5 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.16 -0.473 . . . . 71.55 110.931 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.716 HG23 ' HA ' ' A' ' 279' ' ' GLU . 91.5 m -90.9 145.25 24.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 72.11 111.109 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 288' ' ' ILE . . . . . 0.655 HD12 HG13 ' A' ' 274' ' ' VAL . 48.1 pt -150.26 142.95 17.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 72.14 111.094 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 44.4 mttm -114.36 139.8 49.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 63.3 110.894 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -51.94 129.84 27.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.15 -0.477 . . . . 62.05 110.919 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 102.27 -25.59 27.18 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.744 -0.741 . . . . 51.02 112.534 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.496 ' O ' HD13 ' A' ' 293' ' ' ILE . 6.6 m-20 -76.49 174.53 10.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.752 0.31 . . . . 60.41 110.856 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.496 HD13 ' O ' ' A' ' 292' ' ' ASP . 31.4 mm -124.94 125.99 70.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 74.12 111.139 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 294' ' ' VAL . . . . . 0.682 HG11 ' CE2' ' A' ' 318' ' ' PHE . 78.5 t -107.82 135.1 47.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 71.23 111.114 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 88.8 m -88.17 111.52 21.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.209 -0.45 . . . . 75.33 111.176 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.559 HD11 ' HB3' ' A' ' 307' ' ' TRP . 7.6 tp -69.97 118.96 13.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 71.5 110.899 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 61.7 mt -104.73 -47.6 9.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.142 -0.481 . . . . 45.12 111.167 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -135.21 178.13 7.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 74.21 110.896 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 66.1 mttt -141.41 112.82 7.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.104 -0.498 . . . . 72.43 110.955 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -50.53 165.18 0.1 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 74.23 110.961 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 3.2 t -115.14 -69.2 0.87 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.21 -0.45 . . . . 73.32 110.887 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 1.9 mp -67.92 -12.4 15.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 75.52 111.159 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -95.86 68.18 2.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.18 -0.463 . . . . 72.04 110.878 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 6.6 p -51.51 122.76 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 71.33 111.135 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.69 21.92 38.44 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.679 -0.772 . . . . 55.41 112.459 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 56.5 m95 -140.0 138.07 35.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.761 0.315 . . . . 73.12 110.833 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 307' ' ' TRP . . . . . 0.76 ' CZ3' HD12 ' A' ' 325' ' ' LEU . 20.6 m0 -133.18 155.91 48.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.167 -0.47 . . . . 73.05 110.893 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -99.38 121.95 41.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.277 -0.42 . . . . 72.41 110.9 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -140.69 -174.41 13.98 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.77 -0.729 . . . . 15.42 112.51 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -134.41 145.76 49.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.956 0.407 . . . . 72.14 110.846 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.414 HD13 HG22 ' A' ' 294' ' ' VAL . 5.1 tp -155.73 131.81 10.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.073 -0.512 . . . . 75.34 110.922 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 2.9 m120 56.96 29.96 17.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 73.32 110.918 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 79.14 19.14 72.96 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.717 -0.754 . . . . 64.41 112.539 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -120.71 114.26 21.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.859 0.361 . . . . 74.45 110.86 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 42.0 ttt180 -96.97 132.13 43.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.113 -0.494 . . . . 72.44 110.878 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -170.72 -159.94 17.96 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.741 -0.742 . . . . 72.22 112.476 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 27.7 m -116.76 147.64 20.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.781 0.324 . . . . 54.14 111.163 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 318' ' ' PHE . . . . . 0.682 ' CE2' HG11 ' A' ' 294' ' ' VAL . 7.1 p90 -149.74 156.77 38.69 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.701 0.762 . . . . 72.55 110.82 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.8 121.76 8.44 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.651 2.234 . . . . 71.01 112.332 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 320' ' ' ASP . . . . . 0.531 ' HA ' HG22 ' A' ' 323' ' ' VAL . 1.7 p-10 -61.04 -19.01 60.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 75.05 110.921 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -73.85 -9.74 58.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.491 . . . . 63.5 110.883 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -113.64 22.03 14.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 73.54 110.828 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 323' ' ' VAL . . . . . 0.531 HG22 ' HA ' ' A' ' 320' ' ' ASP . 18.7 m -148.94 156.38 7.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 74.02 111.098 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 20.4 tttt -121.87 114.81 21.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.473 . . . . 74.14 110.854 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.76 HD12 ' CZ3' ' A' ' 307' ' ' TRP . 0.8 OUTLIER -64.98 125.9 26.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 72.21 110.89 179.922 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.542 HD12 ' HB3' ' A' ' 271' ' ' TYR . 20.4 mt . . . . . 0 C--N 1.328 -0.345 0 CA-C-O 121.559 0.695 . . . . 63.14 110.916 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.771 0.32 . . . . 74.2 110.913 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 271' ' ' TYR . . . . . 0.492 ' HB3' HD12 ' A' ' 326' ' ' LEU . 16.7 m-85 -129.62 152.86 48.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 63.44 110.9 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 272' ' ' CYS . . . . . 0.447 ' SG ' HD13 ' A' ' 296' ' ' LEU . 31.8 m -139.17 153.2 47.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 71.55 110.87 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 38.8 tttt -110.57 119.18 38.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 52.41 110.913 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 274' ' ' VAL . . . . . 0.819 HG13 HD12 ' A' ' 288' ' ' ILE . 26.2 t -56.0 111.32 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 75.11 111.128 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 34.5 pt -87.43 -27.31 5.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 74.43 111.103 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -144.44 160.09 49.4 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.64 0.733 . . . . 71.11 110.856 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 158.57 56.52 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.676 2.251 . . . . 75.1 112.327 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -173.95 107.42 0.13 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.455 . . . . 74.31 110.868 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 279' ' ' GLU . . . . . 0.613 ' HA ' HG23 ' A' ' 287' ' ' THR . 30.0 tt0 -91.94 118.06 30.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.14 -0.482 . . . . 64.52 110.866 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -51.74 119.86 4.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 45.53 111.087 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -66.44 -26.19 67.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.439 . . . . 73.42 110.916 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -150.46 168.79 23.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.209 -0.45 . . . . 75.34 110.914 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -56.62 -25.9 54.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 64.11 110.875 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -70.05 -25.81 63.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 54.32 110.854 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -95.03 166.32 12.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.243 -0.435 . . . . 73.43 110.887 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.641 HD23 ' CD2' ' A' ' 318' ' ' PHE . 14.1 tp -115.97 137.1 52.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.157 -0.474 . . . . 71.24 110.944 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.613 HG23 ' HA ' ' A' ' 279' ' ' GLU . 91.4 m -91.15 144.48 25.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 64.15 111.139 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 288' ' ' ILE . . . . . 0.819 HD12 HG13 ' A' ' 274' ' ' VAL . 34.0 pt -150.47 146.77 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 61.42 111.092 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 289' ' ' LYS . . . . . 0.401 ' C ' HG11 ' A' ' 274' ' ' VAL . 25.7 mtpt -122.27 143.6 49.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 51.44 110.85 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 66.5 tt0 -52.0 130.08 28.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 73.02 110.871 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 100.79 -25.53 28.01 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.738 -0.744 . . . . 74.21 112.503 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.69 170.91 15.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.78 0.324 . . . . 73.51 110.861 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 48.5 mm -123.4 128.49 74.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 54.03 111.187 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 294' ' ' VAL . . . . . 0.704 HG11 ' CE2' ' A' ' 318' ' ' PHE . 94.1 t -108.62 138.06 37.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.234 -0.439 . . . . 62.53 111.162 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 47.1 m -94.07 113.35 25.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.208 -0.451 . . . . 73.24 111.116 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.447 HD13 ' SG ' ' A' ' 272' ' ' CYS . 4.1 tp -69.95 117.6 11.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.214 -0.448 . . . . 72.3 110.948 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 69.2 mt -107.06 -28.32 2.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.439 . . . . 63.12 111.127 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -155.05 178.11 10.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 73.13 110.861 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 8.7 mttm -141.53 112.94 7.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 75.45 110.915 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -49.92 162.31 0.2 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.284 -0.417 . . . . 73.2 110.833 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.8 t -113.58 -68.97 0.89 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 74.21 110.888 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 38.9 mt -67.17 -12.99 16.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 73.41 111.149 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -96.7 70.36 2.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.485 . . . . 54.11 110.873 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.404 ' O ' HG13 ' A' ' 304' ' ' VAL . 6.5 p -51.48 122.17 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 71.5 111.232 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.09 19.51 50.27 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.812 -0.709 . . . . 73.32 112.497 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -135.47 137.79 42.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.772 0.32 . . . . 74.22 110.917 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 307' ' ' TRP . . . . . 0.789 ' CZ3' HD12 ' A' ' 325' ' ' LEU . 22.5 m0 -131.76 158.78 40.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.25 -0.432 . . . . 75.31 110.943 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -103.5 120.38 40.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.307 -0.406 . . . . 42.22 110.841 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -136.53 -169.74 11.79 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.789 -0.719 . . . . 64.34 112.458 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -137.89 147.87 44.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.826 0.346 . . . . 72.43 110.9 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.595 HD13 HG22 ' A' ' 294' ' ' VAL . 9.9 tp -150.22 123.19 8.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 63.52 110.913 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 3.3 m120 55.55 30.61 15.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.256 -0.429 . . . . 75.11 110.895 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 92.13 -16.58 59.31 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.758 -0.734 . . . . 74.53 112.441 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -85.52 112.53 21.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.87 0.367 . . . . 73.51 110.872 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 42.3 mtp180 -99.83 135.45 41.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.101 -0.5 . . . . 61.24 110.869 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -172.61 -163.33 26.24 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.733 -0.746 . . . . 74.35 112.488 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 27.7 m -109.59 160.55 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.866 0.365 . . . . 71.44 111.116 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 318' ' ' PHE . . . . . 0.704 ' CE2' HG11 ' A' ' 294' ' ' VAL . 4.6 p90 -165.2 156.21 12.57 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.621 0.724 . . . . 74.44 110.885 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 118.77 5.88 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.685 2.256 . . . . 70.12 112.268 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 320' ' ' ASP . . . . . 0.535 ' HA ' HG22 ' A' ' 323' ' ' VAL . 2.9 t70 -60.13 -19.74 55.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 72.34 110.874 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -73.26 -8.48 55.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 61.14 110.863 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -114.78 21.38 14.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 75.12 110.888 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 323' ' ' VAL . . . . . 0.535 HG22 ' HA ' ' A' ' 320' ' ' ASP . 18.5 m -148.74 146.34 17.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.113 -0.494 . . . . 71.41 111.056 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 15.2 ttmm -106.83 109.77 21.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.114 -0.493 . . . . 62.22 110.95 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.789 HD12 ' CZ3' ' A' ' 307' ' ' TRP . 2.6 tt -64.93 119.03 9.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 73.02 110.954 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.492 HD12 ' HB3' ' A' ' 271' ' ' TYR . 20.3 mt . . . . . 0 C--N 1.328 -0.346 0 CA-C-O 121.549 0.69 . . . . 74.45 110.9 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.847 0.356 . . . . 61.44 110.813 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 271' ' ' TYR . . . . . 0.567 ' HB3' HD12 ' A' ' 326' ' ' LEU . 14.8 m-85 -116.43 148.06 41.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 71.14 110.951 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 24.8 m -133.42 146.69 51.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.076 -0.511 . . . . 45.44 110.915 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 49.9 tttt -106.06 122.12 45.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 72.54 110.885 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 274' ' ' VAL . . . . . 0.467 HG13 HD12 ' A' ' 288' ' ' ILE . 23.0 t -61.66 113.21 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 73.14 111.121 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 28.3 pt -88.21 -29.97 5.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.138 -0.483 . . . . 72.43 111.068 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -140.1 158.76 66.39 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.622 0.725 . . . . 72.32 110.855 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 156.04 64.42 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.636 2.224 . . . . 41.23 112.375 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -173.68 107.96 0.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 75.15 110.883 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 279' ' ' GLU . . . . . 0.682 ' HA ' HG23 ' A' ' 287' ' ' THR . 13.9 tt0 -87.99 142.4 27.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.109 -0.496 . . . . 75.42 110.894 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -70.52 113.02 7.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.126 -0.488 . . . . 54.24 111.091 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -58.01 -25.84 61.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 74.13 110.929 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -155.72 170.25 22.46 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.195 -0.457 . . . . 74.55 110.898 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -56.51 -25.21 50.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 63.3 110.818 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -72.13 -25.02 61.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 61.42 110.843 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -95.02 167.1 11.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 73.03 110.871 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.644 HD23 ' CD2' ' A' ' 318' ' ' PHE . 14.3 tp -115.01 136.82 52.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 71.22 110.958 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.682 HG23 ' HA ' ' A' ' 279' ' ' GLU . 86.6 m -92.12 142.07 27.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 72.12 111.115 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 288' ' ' ILE . . . . . 0.531 HG21 HG21 ' A' ' 294' ' ' VAL . 31.9 pt -148.78 146.48 17.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 73.31 111.143 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -119.33 140.72 49.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 62.3 110.828 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -51.97 128.67 24.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 71.2 110.916 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 104.14 -23.97 30.52 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.691 -0.766 . . . . 42.52 112.426 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.16 175.3 10.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.744 0.306 . . . . 52.13 110.913 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 39.9 mm -125.34 128.81 72.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.199 -0.455 . . . . 72.4 111.117 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 294' ' ' VAL . . . . . 0.692 HG11 ' CE2' ' A' ' 318' ' ' PHE . 98.3 t -109.77 137.99 39.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.49 . . . . 74.5 111.172 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 40.5 m -91.16 111.68 23.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 64.41 111.186 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.44 HD11 ' HB3' ' A' ' 307' ' ' TRP . 5.9 tp -70.07 117.56 11.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.238 -0.437 . . . . 52.53 110.858 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 64.4 mt -106.97 -34.67 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 71.24 111.186 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -147.45 178.18 8.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.134 -0.484 . . . . 60.1 110.84 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 35.8 mttp -141.45 112.95 7.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 74.02 110.893 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -49.74 165.79 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 63.44 110.899 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.5 t -118.15 -69.38 0.85 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.214 -0.448 . . . . 53.13 110.872 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 47.2 mt -65.27 -14.36 16.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 72.14 111.165 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -98.32 71.7 2.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 44.34 110.9 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 59.3 t -51.52 122.31 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 72.34 111.138 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.61 20.45 44.25 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.731 -0.747 . . . . 42.13 112.488 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 50.8 m95 -135.23 134.27 39.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.713 0.292 . . . . 70.33 110.952 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 307' ' ' TRP . . . . . 0.44 ' HB3' HD11 ' A' ' 296' ' ' LEU . 24.4 m0 -129.66 156.64 43.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.25 -0.432 . . . . 64.44 110.955 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -101.98 126.28 48.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.277 -0.42 . . . . 75.33 110.868 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -143.77 -167.84 11.98 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.705 -0.759 . . . . 73.33 112.454 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -138.32 147.53 43.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.875 0.369 . . . . 75.41 110.936 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 4.8 tp -157.95 132.05 8.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 70.24 110.932 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 2.9 m120 56.35 29.99 16.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 74.44 110.911 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 79.79 18.44 72.83 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.723 -0.751 . . . . 63.24 112.579 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 16.0 mmt180 -121.58 113.53 19.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.767 0.318 . . . . 70.4 110.878 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -97.22 132.05 43.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.244 -0.434 . . . . 74.3 110.895 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -170.07 -163.67 24.49 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.827 -0.702 . . . . 63.23 112.54 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 8.3 m -108.12 157.27 8.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.86 0.362 . . . . 65.42 111.113 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 318' ' ' PHE . . . . . 0.692 ' CE2' HG11 ' A' ' 294' ' ' VAL . 5.9 p90 -163.17 156.08 16.26 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.714 0.769 . . . . 74.41 110.83 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.69 117.47 5.1 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.691 2.261 . . . . 51.21 112.398 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 320' ' ' ASP . . . . . 0.577 ' HA ' HG22 ' A' ' 323' ' ' VAL . 2.9 t70 -57.77 -22.56 47.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.252 -0.431 . . . . 65.5 110.92 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -68.85 -12.26 61.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 70.12 110.861 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -108.46 14.72 24.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 72.52 110.857 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 323' ' ' VAL . . . . . 0.577 HG22 ' HA ' ' A' ' 320' ' ' ASP . 17.9 m -148.69 138.11 15.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.475 . . . . 72.53 111.11 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.74 123.06 48.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 72.31 110.905 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 2.5 mt -64.93 122.67 17.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.439 . . . . 70.31 110.918 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.567 HD12 ' HB3' ' A' ' 271' ' ' TYR . 20.2 mt . . . . . 0 C--N 1.328 -0.343 0 CA-C-O 121.533 0.682 . . . . 60.44 110.922 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.838 0.351 . . . . 74.34 110.853 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 271' ' ' TYR . . . . . 0.532 ' HB3' HD12 ' A' ' 326' ' ' LEU . 11.5 m-85 -128.23 152.88 47.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.453 . . . . 72.2 110.948 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 26.2 m -138.78 146.48 41.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.118 -0.492 . . . . 73.44 110.888 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 14.3 tttp -103.0 117.35 34.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 74.43 110.823 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 274' ' ' VAL . . . . . 0.713 HG13 HD12 ' A' ' 288' ' ' ILE . 26.2 t -55.91 112.32 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 70.13 111.132 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 37.9 pt -88.33 -28.08 5.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.175 -0.466 . . . . 54.2 111.134 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -142.6 159.71 56.43 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.61 0.719 . . . . 53.42 110.884 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 160.05 51.15 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.738 2.292 . . . . 74.33 112.263 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -173.29 109.78 0.18 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 74.41 110.91 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 279' ' ' GLU . . . . . 0.656 ' HA ' HG23 ' A' ' 287' ' ' THR . 42.9 tt0 -91.08 127.0 36.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.115 -0.493 . . . . 51.52 110.887 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -58.82 117.63 4.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 63.22 111.074 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -65.84 -25.8 67.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 74.12 110.871 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 -153.0 168.41 25.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 73.41 110.923 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -56.14 -26.3 49.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 44.34 110.886 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -71.02 -25.22 62.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 63.31 110.88 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 285' ' ' GLU . . . . . 0.504 ' OE1' HG23 ' A' ' 317' ' ' VAL . 6.2 mm-40 -94.86 164.79 12.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 71.24 110.95 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.594 HD12 ' H ' ' A' ' 287' ' ' THR . 14.1 tp -115.21 137.12 52.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.46 . . . . 60.32 110.962 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.656 HG23 ' HA ' ' A' ' 279' ' ' GLU . 85.0 m -91.81 144.74 25.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.221 -0.445 . . . . 75.35 111.143 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 288' ' ' ILE . . . . . 0.713 HD12 HG13 ' A' ' 274' ' ' VAL . 44.4 pt -150.34 144.7 17.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 52.12 111.13 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 18.2 mtmm -116.14 140.05 49.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 70.12 110.87 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -51.89 128.56 24.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 72.24 110.895 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 104.02 -21.3 38.38 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.679 -0.772 . . . . 62.34 112.382 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -81.58 172.52 13.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.795 0.331 . . . . 54.4 110.846 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.523 ' O ' HD13 ' A' ' 311' ' ' LEU . 76.2 mt -123.61 126.51 73.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.488 . . . . 75.25 111.127 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 294' ' ' VAL . . . . . 0.72 HG11 ' CE2' ' A' ' 318' ' ' PHE . 93.1 t -109.63 136.05 46.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 74.31 111.116 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 95.4 m -87.72 113.02 23.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.21 -0.45 . . . . 73.3 111.138 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.578 HD11 ' HB3' ' A' ' 307' ' ' TRP . 8.0 tp -70.01 112.65 6.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.277 -0.42 . . . . 72.23 110.943 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 297' ' ' ILE . . . . . 0.406 HD11 ' HB2' ' A' ' 310' ' ' GLU . 50.5 mt -98.29 -49.19 11.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 71.43 111.217 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -132.71 178.43 6.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 74.22 110.805 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 17.6 mttp -141.82 112.96 7.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 73.31 110.936 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -50.15 162.15 0.23 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.27 -0.423 . . . . 74.22 110.857 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 3.0 t -113.87 -68.92 0.89 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 73.43 110.907 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 302' ' ' ILE . . . . . 0.406 HG22 ' O ' ' A' ' 302' ' ' ILE . 34.1 mt -68.54 -12.01 15.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 74.44 111.075 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -97.96 69.72 2.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 61.44 110.935 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 6.6 p -51.47 122.6 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 51.21 111.129 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 91.04 17.28 51.81 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.692 -0.766 . . . . 31.13 112.413 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 34.7 m95 -133.98 135.89 43.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.743 0.306 . . . . 75.33 110.949 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 307' ' ' TRP . . . . . 0.798 ' CZ3' HD12 ' A' ' 325' ' ' LEU . 22.4 m0 -132.84 155.26 49.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.431 . . . . 74.32 110.883 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -97.04 121.31 38.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 75.31 110.836 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 309' ' ' GLY . . . . . 0.45 ' O ' HD22 ' A' ' 286' ' ' LEU . . . -138.68 179.82 18.07 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.735 -0.745 . . . . 74.24 112.437 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 310' ' ' GLU . . . . . 0.406 ' HB2' HD11 ' A' ' 297' ' ' ILE . 34.1 tt0 -133.72 141.67 47.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.918 0.389 . . . . 70.54 110.841 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.523 HD13 ' O ' ' A' ' 293' ' ' ILE . 24.8 tp -155.39 136.8 14.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.11 -0.496 . . . . 63.24 110.86 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 3.0 m120 56.92 30.55 18.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 61.41 110.9 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 75.82 19.46 78.91 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.788 -0.72 . . . . 71.2 112.464 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -118.61 117.82 29.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.726 0.298 . . . . 64.13 110.82 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 60.6 ttt180 -99.89 129.63 45.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 74.44 110.866 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -170.7 -162.76 23.58 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.792 -0.718 . . . . 54.22 112.512 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.504 HG23 ' OE1' ' A' ' 285' ' ' GLU . 12.4 m -115.48 150.2 17.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.919 0.39 . . . . 54.42 111.068 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 318' ' ' PHE . . . . . 0.72 ' CE2' HG11 ' A' ' 294' ' ' VAL . 8.5 p90 -155.16 155.89 30.54 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.63 0.728 . . . . 74.54 110.952 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 117.94 5.38 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.698 2.266 . . . . 71.41 112.313 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 320' ' ' ASP . . . . . 0.565 ' HA ' HG22 ' A' ' 323' ' ' VAL . 3.1 t70 -59.41 -20.7 56.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 74.34 110.885 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -68.97 -12.08 61.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 72.03 110.881 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -108.84 16.64 22.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 62.2 110.913 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 323' ' ' VAL . . . . . 0.565 HG22 ' HA ' ' A' ' 320' ' ' ASP . 18.6 m -148.81 150.87 13.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.104 -0.498 . . . . 32.51 111.09 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 47.8 tttp -109.18 115.3 29.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 73.23 110.855 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.798 HD12 ' CZ3' ' A' ' 307' ' ' TRP . 2.8 tt -65.19 116.03 6.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 75.34 110.964 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.532 HD12 ' HB3' ' A' ' 271' ' ' TYR . 20.4 mt . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 121.634 0.73 . . . . 71.3 110.885 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.824 0.345 . . . . 63.31 110.818 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 271' ' ' TYR . . . . . 0.58 ' CE1' HG23 ' A' ' 295' ' ' THR . 10.0 m-85 -111.27 153.77 25.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 74.55 110.937 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 272' ' ' CYS . . . . . 0.432 ' SG ' HD13 ' A' ' 296' ' ' LEU . 26.7 m -136.0 145.63 46.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.105 -0.498 . . . . 73.13 110.821 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 3.0 ttpp -103.34 126.47 50.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 72.32 110.886 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 274' ' ' VAL . . . . . 0.517 HG13 HD12 ' A' ' 288' ' ' ILE . 22.0 t -61.1 114.46 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 72.13 111.106 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 0.414 HD11 ' O ' ' A' ' 321' ' ' ASN . 29.8 pt -89.16 -25.67 5.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 43.12 111.097 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -147.71 159.24 41.47 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.671 0.748 . . . . 75.43 110.897 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 155.48 65.75 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.624 2.216 . . . . 74.41 112.336 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -170.8 112.22 0.39 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 71.33 110.964 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 279' ' ' GLU . . . . . 0.605 ' HA ' HG23 ' A' ' 287' ' ' THR . 11.9 tt0 -93.81 130.39 39.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.445 . . . . 74.41 110.868 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -64.08 117.32 6.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.148 -0.478 . . . . 44.45 111.167 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 78.4 mm-40 -60.33 -25.57 65.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.238 -0.437 . . . . 73.34 110.924 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -155.91 176.26 12.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 75.15 110.865 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -58.48 -25.9 62.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.144 -0.48 . . . . 70.31 110.869 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -70.43 -26.38 63.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.172 -0.467 . . . . 74.12 110.849 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 285' ' ' GLU . . . . . 0.497 ' OE1' HG23 ' A' ' 317' ' ' VAL . 28.1 mm-40 -96.55 161.79 13.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 63.1 110.884 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.6 HD12 ' H ' ' A' ' 287' ' ' THR . 14.0 tp -115.25 136.65 52.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 75.44 110.94 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.605 HG23 ' HA ' ' A' ' 279' ' ' GLU . 90.5 m -90.57 144.85 25.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 61.2 111.086 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 288' ' ' ILE . . . . . 0.517 HD12 HG13 ' A' ' 274' ' ' VAL . 44.8 pt -150.32 141.82 16.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 74.43 111.145 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.28 145.16 42.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 72.2 110.892 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -51.86 131.85 31.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 44.43 110.879 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.98 -26.23 24.29 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.759 -0.734 . . . . 72.52 112.454 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.405 ' HB2' HG21 ' A' ' 274' ' ' VAL . 14.4 m-20 -69.55 176.07 3.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.793 0.33 . . . . 74.32 110.843 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 68.8 mt -134.19 125.45 47.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 65.44 111.173 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 294' ' ' VAL . . . . . 0.748 HG11 ' CE2' ' A' ' 318' ' ' PHE . 98.3 t -111.28 138.08 41.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.159 -0.473 . . . . 65.22 111.107 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 295' ' ' THR . . . . . 0.58 HG23 ' CE1' ' A' ' 271' ' ' TYR . 6.3 m -87.39 118.51 26.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.188 -0.46 . . . . 74.23 111.131 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.432 HD13 ' SG ' ' A' ' 272' ' ' CYS . 6.1 tp -69.87 111.02 5.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 75.22 110.939 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 23.9 mm -100.49 -29.95 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 54.13 111.139 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -157.36 178.12 10.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 64.04 110.884 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 21.8 mttt -141.4 112.98 7.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.207 -0.451 . . . . 73.31 110.876 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -49.77 162.01 0.2 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 61.34 110.847 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.9 t -113.79 -68.98 0.89 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 62.03 110.882 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 30.3 mm -67.49 -12.44 15.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.441 . . . . 72.25 111.108 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -97.49 70.46 2.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 61.41 110.871 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.406 ' O ' HG13 ' A' ' 304' ' ' VAL . 6.0 p -51.4 121.24 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 62.2 111.107 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.39 24.8 30.14 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.697 -0.763 . . . . 70.2 112.475 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 57.5 m95 -140.23 133.43 29.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.751 0.31 . . . . 73.33 110.877 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 307' ' ' TRP . . . . . 0.713 ' CZ3' HD12 ' A' ' 325' ' ' LEU . 22.6 m0 -129.25 154.55 46.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.25 -0.432 . . . . 72.34 110.95 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -99.04 116.33 31.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.239 -0.437 . . . . 62.41 110.944 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -127.99 -173.72 13.55 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.724 -0.751 . . . . 65.33 112.529 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -135.97 134.95 39.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.836 0.351 . . . . 74.51 110.888 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.509 HD13 HG22 ' A' ' 294' ' ' VAL . 10.1 tp -143.99 130.75 20.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 53.11 110.95 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 2.9 m120 59.04 29.95 19.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.151 -0.477 . . . . 73.04 110.84 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 83.33 -1.48 88.64 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.692 -0.766 . . . . 74.43 112.451 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 314' ' ' ARG . . . . . 0.423 ' HG2' HD13 ' A' ' 286' ' ' LEU . 0.0 OUTLIER -103.01 119.33 38.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.829 0.347 . . . . 75.13 110.876 -179.873 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 70.1 mtt180 -98.82 131.0 45.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 71.23 110.906 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -162.09 -162.77 13.69 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.784 -0.722 . . . . 72.43 112.515 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.497 HG23 ' OE1' ' A' ' 285' ' ' GLU . 25.1 m -115.22 153.13 16.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.884 0.373 . . . . 51.34 111.111 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 318' ' ' PHE . . . . . 0.748 ' CE2' HG11 ' A' ' 294' ' ' VAL . 5.1 p90 -157.36 157.42 30.22 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.657 0.741 . . . . 60.43 110.815 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 119.96 6.82 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.679 2.253 . . . . 73.14 112.302 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 320' ' ' ASP . . . . . 0.57 ' HA ' HG22 ' A' ' 323' ' ' VAL . 1.5 p-10 -57.42 -23.36 49.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 64.43 110.878 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 321' ' ' ASN . . . . . 0.414 ' O ' HD11 ' A' ' 275' ' ' ILE . 10.8 m-20 -69.53 -11.58 60.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 73.13 110.922 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -109.45 15.48 22.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 72.41 110.85 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 323' ' ' VAL . . . . . 0.57 HG22 ' HA ' ' A' ' 320' ' ' ASP . 18.0 m -148.7 149.56 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 62.11 111.217 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -117.02 117.6 30.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 71.1 110.862 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.713 HD12 ' CZ3' ' A' ' 307' ' ' TRP . 1.1 tt -65.03 125.01 23.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 64.04 110.893 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.409 HD12 ' CB ' ' A' ' 271' ' ' TYR . 20.7 mt . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 121.582 0.706 . . . . 71.54 110.992 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.777 0.322 . . . . 73.2 110.889 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 271' ' ' TYR . . . . . 0.563 ' CZ ' HG23 ' A' ' 295' ' ' THR . 22.8 m-85 -138.71 154.15 48.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.46 . . . . 70.13 110.931 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 56.5 m -135.67 152.99 51.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.121 -0.491 . . . . 64.25 110.838 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 18.5 tptm -102.78 129.75 49.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 74.32 110.883 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 274' ' ' VAL . . . . . 0.906 HG13 HD12 ' A' ' 288' ' ' ILE . 25.7 t -73.05 108.35 4.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.282 -0.417 . . . . 60.04 111.116 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 21.7 pt -86.96 -30.3 5.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 74.11 111.178 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -138.83 158.79 69.33 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.663 0.744 . . . . 64.02 110.875 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.84 165.85 29.68 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.659 2.239 . . . . 61.45 112.354 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -174.43 107.32 0.11 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.245 -0.434 . . . . 64.32 110.886 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 279' ' ' GLU . . . . . 0.526 ' HA ' HG23 ' A' ' 287' ' ' THR . 73.6 tt0 -92.66 111.65 23.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.106 -0.497 . . . . 62.12 110.885 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -51.69 117.22 2.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 74.44 111.103 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 52.0 mm-40 -63.23 -25.43 68.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.274 -0.421 . . . . 74.44 110.912 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 24.9 m-20 -150.7 167.77 26.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.441 . . . . 74.55 110.909 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -58.07 -24.16 57.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 74.55 110.866 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -70.06 -24.91 63.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.247 -0.433 . . . . 64.42 110.808 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -95.01 169.51 10.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 75.13 110.895 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.774 HD23 ' CD2' ' A' ' 318' ' ' PHE . 22.3 tp -114.95 131.21 56.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.137 -0.483 . . . . 73.4 110.9 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.526 HG23 ' HA ' ' A' ' 279' ' ' GLU . 97.6 m -92.08 139.09 30.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 62.33 111.158 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 288' ' ' ILE . . . . . 0.906 HD12 HG13 ' A' ' 274' ' ' VAL . 26.0 pt -147.0 157.33 10.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 43.03 111.122 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 289' ' ' LYS . . . . . 0.408 ' C ' HG11 ' A' ' 274' ' ' VAL . 23.3 mtpp -133.56 142.67 48.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 71.4 110.91 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -50.84 133.12 26.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 73.32 110.93 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 100.65 -22.13 41.02 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.864 -0.684 . . . . 73.52 112.564 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -85.23 173.48 10.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.824 0.345 . . . . 73.32 110.824 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 41.6 mm -123.55 133.91 67.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 74.3 111.08 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 294' ' ' VAL . . . . . 0.645 HG11 ' CE2' ' A' ' 318' ' ' PHE . 93.3 t -108.11 127.63 64.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 63.21 111.179 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 295' ' ' THR . . . . . 0.563 HG23 ' CZ ' ' A' ' 271' ' ' TYR . 29.1 m -82.98 107.8 15.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 64.05 111.162 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.511 HD11 ' HB3' ' A' ' 307' ' ' TRP . 7.5 tp -69.84 117.54 11.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 73.22 110.911 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 63.8 mt -109.73 -36.55 2.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.209 -0.451 . . . . 63.34 111.14 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -144.03 177.47 8.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.131 -0.486 . . . . 75.4 110.878 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 31.9 mttp -141.75 113.01 7.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 62.01 110.881 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -49.6 160.15 0.3 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 74.42 110.791 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.6 t -113.68 -69.01 0.89 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 52.42 110.892 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 41.8 mt -66.35 -13.54 16.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.19 -0.459 . . . . 75.31 111.114 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.53 71.63 2.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 75.34 110.84 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.416 ' O ' HG13 ' A' ' 304' ' ' VAL . 5.9 p -51.23 120.7 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.474 . . . . 65.22 111.117 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.37 25.79 27.4 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.726 -0.75 . . . . 72.42 112.523 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 57.8 m95 -140.38 135.27 31.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.727 0.299 . . . . 72.45 110.963 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 307' ' ' TRP . . . . . 0.778 ' CZ3' HD12 ' A' ' 325' ' ' LEU . 22.6 m0 -130.26 156.75 44.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 72.32 110.956 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -103.8 126.3 50.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 73.33 110.851 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -140.25 -163.76 9.64 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.672 -0.775 . . . . 71.54 112.439 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -142.79 146.28 34.08 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.844 0.354 . . . . 63.2 110.837 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.401 HD22 HG22 ' A' ' 288' ' ' ILE . 3.5 tp -160.05 129.05 5.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.12 -0.491 . . . . 72.22 110.924 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 3.0 m120 55.46 38.25 30.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 53.52 110.92 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 72.3 18.73 78.34 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.78 -0.724 . . . . 64.34 112.434 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -128.47 115.0 17.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.792 0.329 . . . . 75.41 110.881 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 2.9 ptt85 -116.9 139.45 50.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 74.22 110.865 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -162.6 -112.78 0.29 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.757 -0.735 . . . . 74.31 112.517 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 24.2 m -151.25 143.88 16.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.847 0.356 . . . . 74.21 111.178 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 318' ' ' PHE . . . . . 0.774 ' CD2' HD23 ' A' ' 286' ' ' LEU . 31.1 p90 -150.54 155.76 36.37 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.679 0.752 . . . . 74.15 110.841 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 120.69 7.44 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.674 2.249 . . . . 53.13 112.315 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 320' ' ' ASP . . . . . 0.513 ' HA ' HG22 ' A' ' 323' ' ' VAL . 1.5 p-10 -60.31 -19.81 56.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 72.14 110.832 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -73.54 -8.21 54.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 71.42 110.866 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -114.47 16.99 17.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 72.43 110.876 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 323' ' ' VAL . . . . . 0.515 HG21 ' HE1' ' A' ' 318' ' ' PHE . 23.4 m -150.21 141.42 16.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 65.42 111.152 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -105.27 118.01 35.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 62.12 110.93 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.778 HD12 ' CZ3' ' A' ' 307' ' ' TRP . 1.7 tt -64.82 132.3 49.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 72.3 110.894 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 20.3 mt . . . . . 0 C--N 1.328 -0.339 0 CA-C-O 121.578 0.704 . . . . 70.31 110.943 179.831 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.797 0.332 . . . . 71.11 110.856 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -142.68 148.31 37.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.192 -0.458 . . . . 71.35 110.907 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 33.7 m -137.0 147.66 46.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.05 -0.523 . . . . 63.21 110.902 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 31.8 tttt -103.07 117.61 34.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 73.45 110.918 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 274' ' ' VAL . . . . . 0.684 HG13 HD12 ' A' ' 288' ' ' ILE . 24.5 t -55.78 115.9 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 74.42 111.177 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 0.425 HD11 ' O ' ' A' ' 321' ' ' ASN . 33.6 pt -90.04 -27.74 5.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 71.43 111.148 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -144.45 159.28 52.18 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.662 0.744 . . . . 73.21 110.893 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.78 158.75 55.87 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.718 2.279 . . . . 64.23 112.3 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -173.43 108.32 0.15 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.142 -0.481 . . . . 73.24 110.958 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 279' ' ' GLU . . . . . 0.678 ' HA ' HG23 ' A' ' 287' ' ' THR . 10.5 tt0 -90.74 129.37 36.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 71.44 110.915 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -64.4 133.95 53.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 71.14 111.099 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -76.16 -12.65 60.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.43 . . . . 63.4 110.866 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 282' ' ' ASN . . . . . 0.56 HD22 ' N ' ' A' ' 282' ' ' ASN . 0.0 OUTLIER -175.54 -178.47 1.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 75.11 110.963 -179.964 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -58.66 -26.24 63.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.258 -0.428 . . . . 72.31 110.874 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 284' ' ' ASP . . . . . 0.463 ' O ' HG22 ' A' ' 317' ' ' VAL . 22.5 t0 -70.26 -25.84 63.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 73.52 110.927 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 285' ' ' GLU . . . . . 0.473 ' OE1' HG23 ' A' ' 317' ' ' VAL . 68.6 mm-40 -100.04 167.28 10.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 73.44 110.851 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.627 HD23 ' CD2' ' A' ' 318' ' ' PHE . 28.2 tp -121.04 131.49 54.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.133 -0.485 . . . . 75.34 110.965 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.678 HG23 ' HA ' ' A' ' 279' ' ' GLU . 87.6 m -88.45 143.08 27.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 72.22 111.161 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 288' ' ' ILE . . . . . 0.684 HD12 HG13 ' A' ' 274' ' ' VAL . 51.0 pt -150.34 143.49 17.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.295 -0.412 . . . . 71.43 111.071 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 37.4 mtpt -112.31 140.4 47.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 50.0 110.897 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -52.01 133.32 32.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.197 -0.456 . . . . 71.21 110.915 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.59 -19.68 53.65 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.747 -0.74 . . . . 43.21 112.458 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -79.31 173.23 12.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.745 0.307 . . . . 61.03 110.867 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 66.8 mt -124.17 125.15 70.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 64.45 111.212 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 294' ' ' VAL . . . . . 0.677 HG11 ' CE2' ' A' ' 318' ' ' PHE . 84.2 t -107.99 134.02 51.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.179 -0.464 . . . . 62.43 111.084 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 39.0 m -84.76 111.14 19.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 54.34 111.103 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.56 HD11 ' HB3' ' A' ' 307' ' ' TRP . 8.7 tp -69.96 118.56 12.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 45.22 110.952 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 76.2 mt -106.46 -47.69 8.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 74.11 111.123 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -134.85 178.17 7.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.44 . . . . 50.12 110.842 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 25.0 mttp -141.36 112.95 7.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 74.54 110.957 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.94 165.25 0.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.441 . . . . 62.42 110.914 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.6 t -118.3 -69.34 0.86 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 54.5 110.804 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 2.0 mp -65.89 -13.89 16.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.184 -0.462 . . . . 75.32 111.088 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -98.8 70.31 1.86 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 73.42 110.79 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 7.3 p -51.35 123.96 3.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 71.21 111.129 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.39 23.31 34.55 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.707 -0.759 . . . . 71.22 112.466 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 56.5 m95 -140.09 135.49 32.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.797 0.332 . . . . 72.24 110.919 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 307' ' ' TRP . . . . . 0.76 ' CZ3' HD12 ' A' ' 325' ' ' LEU . 22.5 m0 -131.23 154.87 47.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.22 -0.446 . . . . 74.13 110.876 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -99.99 124.65 45.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 63.41 110.947 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -141.87 -167.09 11.14 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.66 -0.781 . . . . 64.43 112.478 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -140.43 147.4 39.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.897 0.379 . . . . 72.13 110.909 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.409 HD22 HG22 ' A' ' 288' ' ' ILE . 6.7 tp -157.65 132.18 8.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 74.33 110.839 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 2.9 m120 57.36 30.2 18.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 61.21 110.877 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 79.15 18.64 74.03 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.749 -0.739 . . . . 70.23 112.482 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 25.5 mmm180 -122.69 115.1 21.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.745 0.307 . . . . 73.14 110.869 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 33.3 mtm180 -96.99 141.02 30.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 73.14 110.883 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -178.32 -162.54 28.23 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.772 -0.728 . . . . 72.34 112.48 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.473 HG23 ' OE1' ' A' ' 285' ' ' GLU . 27.5 m -111.64 155.68 12.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.873 0.368 . . . . 74.3 111.182 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 318' ' ' PHE . . . . . 0.677 ' CE2' HG11 ' A' ' 294' ' ' VAL . 5.4 p90 -159.13 156.53 26.37 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.684 0.754 . . . . 74.11 110.828 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 120.23 7.05 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.634 2.223 . . . . 73.23 112.385 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 320' ' ' ASP . . . . . 0.559 ' HA ' HG22 ' A' ' 323' ' ' VAL . 1.6 p-10 -59.12 -21.16 58.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.265 -0.425 . . . . 73.24 110.861 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 321' ' ' ASN . . . . . 0.425 ' O ' HD11 ' A' ' 275' ' ' ILE . 2.8 t-20 -71.53 -11.23 60.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 73.01 110.837 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -110.62 18.35 19.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 70.44 110.846 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 323' ' ' VAL . . . . . 0.559 HG22 ' HA ' ' A' ' 320' ' ' ASP . 18.9 m -149.3 149.52 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 64.14 111.148 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -115.49 116.86 28.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 75.24 110.899 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.76 HD12 ' CZ3' ' A' ' 307' ' ' TRP . 0.9 OUTLIER -64.94 128.17 34.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.252 -0.431 . . . . 73.31 110.99 179.848 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 20.2 mt . . . . . 0 C--N 1.329 -0.319 0 CA-C-O 121.595 0.712 . . . . 74.51 110.904 179.949 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.801 0.334 . . . . 54.32 110.856 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 271' ' ' TYR . . . . . 0.665 ' CB ' HD12 ' A' ' 326' ' ' LEU . 8.5 m-85 -111.15 143.85 41.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 65.11 110.896 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 22.6 m -128.29 149.36 50.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.107 -0.497 . . . . 72.11 110.86 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 7.9 tttm -108.03 117.42 34.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 75.24 110.92 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 274' ' ' VAL . . . . . 0.599 HG13 HD12 ' A' ' 288' ' ' ILE . 27.7 t -58.41 113.49 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 72.52 111.15 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 26.6 pt -87.09 -30.49 5.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 73.53 111.123 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -142.46 158.39 60.64 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.657 0.741 . . . . 75.14 110.88 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.68 158.69 56.19 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.642 2.228 . . . . 63.44 112.364 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -174.38 113.51 0.17 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.237 -0.438 . . . . 75.2 110.912 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 279' ' ' GLU . . . . . 0.689 ' HA ' HG23 ' A' ' 287' ' ' THR . 11.8 tt0 -93.61 120.54 34.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.09 -0.505 . . . . 73.5 110.891 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 280' ' ' ALA . . . . . 0.412 ' HB2' ' C ' ' A' ' 286' ' ' LEU . . . -51.83 113.49 1.01 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 60.22 111.078 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -54.58 -29.76 52.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 74.11 110.905 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -155.47 172.25 18.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 71.11 110.891 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -58.2 -22.77 53.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.154 -0.476 . . . . 73.44 110.86 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -70.0 -21.01 63.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 65.24 110.833 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -105.28 177.24 4.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 72.44 110.935 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.648 HD23 ' CD2' ' A' ' 318' ' ' PHE . 13.1 tp -122.61 135.95 54.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.466 . . . . 50.15 110.902 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.689 HG23 ' HA ' ' A' ' 279' ' ' GLU . 77.9 m -88.28 146.32 25.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.121 -0.49 . . . . 71.43 111.114 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 288' ' ' ILE . . . . . 0.599 HD12 HG13 ' A' ' 274' ' ' VAL . 47.6 pt -150.28 143.89 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 74.01 111.189 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 33.8 mtmt -117.53 140.9 49.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 63.14 110.906 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 -51.92 135.03 31.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.232 -0.44 . . . . 45.35 110.857 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 93.82 -23.64 29.94 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.721 -0.752 . . . . 63.54 112.469 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -76.55 171.3 14.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.832 0.348 . . . . 65.4 110.902 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 37.4 mm -122.67 125.78 73.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 33.43 111.137 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 294' ' ' VAL . . . . . 0.678 HG11 ' CE2' ' A' ' 318' ' ' PHE . 97.8 t -103.27 138.11 28.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 61.32 111.092 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 59.4 m -93.56 109.06 20.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 75.54 111.151 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.694 HD11 ' HB3' ' A' ' 307' ' ' TRP . 7.0 tp -69.89 124.84 25.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.271 -0.422 . . . . 72.42 110.894 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 297' ' ' ILE . . . . . 0.405 HD11 ' HB2' ' A' ' 310' ' ' GLU . 40.5 mt -111.1 -47.37 6.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.449 . . . . 73.03 111.119 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -137.74 169.99 16.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 71.43 110.898 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 19.1 mttt -137.35 112.37 9.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.218 -0.446 . . . . 62.04 110.963 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -56.04 179.78 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.187 -0.46 . . . . 71.5 110.862 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 1.7 t -129.05 -69.53 0.7 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 64.15 110.876 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 60.1 mt -59.4 -18.43 14.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 73.02 111.146 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -99.02 62.11 1.28 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.463 . . . . 65.05 110.899 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 71.6 t -51.51 136.36 11.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.244 -0.435 . . . . 51.35 111.154 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 88.69 14.27 61.57 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.76 -0.733 . . . . 63.33 112.543 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 51.1 m95 -139.27 148.15 42.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.758 0.313 . . . . 74.11 110.925 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 307' ' ' TRP . . . . . 0.757 ' CZ3' HD12 ' A' ' 325' ' ' LEU . 10.2 m0 -139.36 148.23 42.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.294 -0.412 . . . . 73.13 110.947 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -94.29 119.08 32.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.283 -0.417 . . . . 73.33 110.849 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -139.22 -163.41 9.49 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.736 -0.745 . . . . 51.12 112.456 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 310' ' ' GLU . . . . . 0.405 ' HB2' HD11 ' A' ' 297' ' ' ILE . 61.6 tt0 -143.79 149.1 36.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.885 0.374 . . . . 73.43 110.916 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 4.9 tp -159.98 133.29 6.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.201 -0.454 . . . . 64.24 110.94 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 2.8 m120 58.14 29.94 18.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 63.4 110.856 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 78.93 17.38 77.22 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.783 -0.722 . . . . 75.54 112.494 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 23.6 mmt85 -122.33 117.47 26.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.843 0.354 . . . . 74.25 110.874 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 27.3 mtm-85 -98.21 136.22 38.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 72.03 110.859 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -172.06 -158.42 16.15 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.737 -0.745 . . . . 43.3 112.504 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 24.3 m -117.72 148.02 20.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.881 0.372 . . . . 71.31 111.126 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 318' ' ' PHE . . . . . 0.678 ' CE2' HG11 ' A' ' 294' ' ' VAL . 9.8 p90 -149.49 156.97 39.34 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.689 0.757 . . . . 73.11 110.824 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 121.5 8.19 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.655 2.237 . . . . 72.1 112.314 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 320' ' ' ASP . . . . . 0.542 ' HA ' HG22 ' A' ' 323' ' ' VAL . 1.7 p-10 -61.75 -17.74 57.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 71.55 110.862 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -75.95 -5.82 48.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 64.23 110.88 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -119.76 23.61 11.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.12 -0.491 . . . . 65.24 110.879 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 323' ' ' VAL . . . . . 0.542 HG22 ' HA ' ' A' ' 320' ' ' ASP . 18.2 m -149.04 144.14 18.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.154 -0.475 . . . . 75.12 111.065 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 55.2 tttt -110.45 111.17 22.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 74.11 110.926 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.757 HD12 ' CZ3' ' A' ' 307' ' ' TRP . 1.0 OUTLIER -64.92 126.61 28.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 55.1 110.837 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.665 HD12 ' CB ' ' A' ' 271' ' ' TYR . 20.4 mt . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 121.541 0.686 . . . . 73.14 110.958 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.794 0.331 . . . . 74.04 110.884 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 271' ' ' TYR . . . . . 0.431 ' HB3' HD12 ' A' ' 326' ' ' LEU . 15.5 m-85 -130.85 154.1 48.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.211 -0.45 . . . . 73.3 110.955 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 272' ' ' CYS . . . . . 0.423 ' SG ' HD13 ' A' ' 296' ' ' LEU . 22.8 m -139.0 147.36 42.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.113 -0.494 . . . . 74.01 110.866 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 14.3 tttp -103.66 119.08 38.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.204 -0.453 . . . . 62.51 110.862 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 274' ' ' VAL . . . . . 0.552 HG13 HD12 ' A' ' 288' ' ' ILE . 53.1 t -60.3 109.13 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 64.24 111.076 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 26.5 pt -85.98 -30.63 6.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.12 -0.491 . . . . 72.01 111.095 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -138.33 159.97 65.78 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.659 0.742 . . . . 74.44 110.915 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 158.93 55.26 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.736 2.291 . . . . 73.15 112.352 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -172.81 106.02 0.16 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 71.31 111.018 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 279' ' ' GLU . . . . . 0.607 ' HA ' HG23 ' A' ' 287' ' ' THR . 19.5 tt0 -91.23 127.54 36.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 74.02 110.869 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 280' ' ' ALA . . . . . 0.502 ' HB1' ' HB2' ' A' ' 285' ' ' GLU . . . -63.86 113.04 3.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.476 . . . . 44.55 111.126 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -59.26 -26.07 64.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.264 -0.425 . . . . 65.42 110.95 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -149.48 168.7 22.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 71.3 110.875 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -57.02 -24.91 57.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.483 . . . . 45.42 110.859 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -70.01 -25.68 63.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.217 -0.447 . . . . 61.3 110.877 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 285' ' ' GLU . . . . . 0.502 ' HB2' ' HB1' ' A' ' 280' ' ' ALA . 70.1 mm-40 -95.02 166.47 11.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.171 -0.468 . . . . 72.44 110.903 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.646 HD23 ' CD2' ' A' ' 318' ' ' PHE . 21.5 tp -114.89 133.6 55.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 74.02 110.932 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.607 HG23 ' HA ' ' A' ' 279' ' ' GLU . 95.5 m -91.61 140.69 29.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 74.42 111.129 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 288' ' ' ILE . . . . . 0.654 HG21 HG21 ' A' ' 294' ' ' VAL . 50.4 pt -150.14 143.25 17.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 54.35 111.136 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 16.5 mmtm -114.53 141.03 48.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 74.24 110.877 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -52.02 122.54 8.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.446 . . . . 61.54 110.866 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 113.31 -22.82 14.81 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.8 -0.714 . . . . 31.11 112.448 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -86.46 160.4 19.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.708 0.289 . . . . 72.5 110.925 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 80.7 mt -110.94 129.4 66.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 62.5 111.087 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 294' ' ' VAL . . . . . 0.721 HG11 ' CE2' ' A' ' 318' ' ' PHE . 100.0 t -107.15 138.07 34.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.106 -0.497 . . . . 72.21 111.138 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 56.1 m -89.31 111.47 22.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.126 -0.488 . . . . 72.04 111.116 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.472 HD11 ' HB3' ' A' ' 307' ' ' TRP . 7.5 tp -69.98 118.54 12.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.276 -0.42 . . . . 72.13 110.91 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 297' ' ' ILE . . . . . 0.67 HG21 HH21 ' A' ' 315' ' ' ARG . 64.4 mt -105.79 -48.62 8.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 71.24 111.092 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -133.53 178.17 7.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 61.45 110.892 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 24.2 mttt -141.32 113.02 7.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 71.43 110.885 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -49.9 161.77 0.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.457 . . . . 72.41 110.92 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.9 t -113.37 -69.02 0.89 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.222 -0.444 . . . . 51.24 110.869 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 302' ' ' ILE . . . . . 0.4 HG22 ' O ' ' A' ' 302' ' ' ILE . 35.1 mt -67.77 -12.51 15.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 73.35 111.166 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -97.52 69.31 2.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 55.11 110.879 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 6.9 p -51.17 123.21 2.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.244 -0.435 . . . . 55.11 111.18 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.5 19.43 48.98 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.755 -0.736 . . . . 65.32 112.549 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 49.2 m95 -136.29 136.39 39.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.742 0.306 . . . . 72.43 110.902 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 307' ' ' TRP . . . . . 0.757 ' CZ3' HD12 ' A' ' 325' ' ' LEU . 22.6 m0 -132.1 156.09 46.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 65.44 110.936 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -100.63 120.78 40.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.228 -0.442 . . . . 73.31 110.802 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -134.67 -168.71 11.76 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.782 -0.723 . . . . 71.42 112.509 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -141.74 141.4 33.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.868 0.366 . . . . 74.21 110.873 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.711 HD13 HG22 ' A' ' 294' ' ' VAL . 5.4 tp -140.81 118.52 11.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.133 -0.485 . . . . 74.01 110.879 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 3.2 m120 58.55 32.74 22.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 71.32 110.85 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 91.88 -16.96 58.19 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.785 -0.721 . . . . 72.33 112.532 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.33 110.1 17.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.786 0.326 . . . . 72.35 110.898 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.67 HH21 HG21 ' A' ' 297' ' ' ILE . 48.3 mtp180 -98.66 133.73 42.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 73.35 110.911 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -169.16 -155.67 10.02 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.716 -0.754 . . . . 45.23 112.396 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.465 HG23 ' OE1' ' A' ' 285' ' ' GLU . 12.8 m -120.25 155.88 23.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.826 0.346 . . . . 73.53 111.206 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 318' ' ' PHE . . . . . 0.721 ' CE2' HG11 ' A' ' 294' ' ' VAL . 6.4 p90 -161.29 155.94 19.82 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.64 0.733 . . . . 74.24 110.853 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 117.85 5.33 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.676 2.251 . . . . 65.12 112.395 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 320' ' ' ASP . . . . . 0.541 ' HA ' HG22 ' A' ' 323' ' ' VAL . 3.2 t70 -59.19 -21.21 59.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.269 -0.423 . . . . 64.42 110.871 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -70.79 -10.76 60.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 71.42 110.819 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -111.14 19.27 18.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 65.2 110.856 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 323' ' ' VAL . . . . . 0.541 HG22 ' HA ' ' A' ' 320' ' ' ASP . 18.5 m -148.77 150.7 13.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 53.34 111.114 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 4.4 ttmt -110.9 115.09 28.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 54.22 110.903 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.757 HD12 ' CZ3' ' A' ' 307' ' ' TRP . 1.1 tt -64.91 120.32 12.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.228 -0.442 . . . . 65.33 110.91 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.431 HD12 ' HB3' ' A' ' 271' ' ' TYR . 20.3 mt . . . . . 0 C--N 1.328 -0.368 0 CA-C-O 121.606 0.717 . . . . 72.22 110.899 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.813 0.339 . . . . 75.2 110.878 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 271' ' ' TYR . . . . . 0.445 ' CE1' HG23 ' A' ' 295' ' ' THR . 8.1 m-85 -124.63 156.23 37.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.147 -0.479 . . . . 65.24 110.89 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 272' ' ' CYS . . . . . 0.444 ' SG ' HD13 ' A' ' 296' ' ' LEU . 30.1 m -139.74 153.01 47.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 65.44 110.898 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -111.0 121.47 45.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 75.34 110.843 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 21.7 t -58.89 114.14 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.48 . . . . 41.12 111.118 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 25.7 pt -88.71 -30.47 5.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 73.34 111.095 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -139.72 158.85 67.17 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.679 0.752 . . . . 74.24 110.881 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 155.21 66.55 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.681 2.254 . . . . 75.24 112.339 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -174.59 108.63 0.12 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.212 -0.449 . . . . 65.45 110.935 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 279' ' ' GLU . . . . . 0.581 ' HA ' HG23 ' A' ' 287' ' ' THR . 50.5 tt0 -88.1 150.07 23.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.5 . . . . 65.13 110.837 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -80.36 114.27 19.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 74.01 111.164 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -63.68 -25.67 68.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 73.1 110.874 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -150.66 168.6 23.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 71.23 110.888 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -58.75 -25.58 63.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 62.22 110.897 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -69.95 -25.4 63.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.47 . . . . 74.52 110.89 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -94.93 167.41 11.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.447 . . . . 71.31 110.866 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.666 HD23 ' CD2' ' A' ' 318' ' ' PHE . 13.7 tp -115.27 136.52 53.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.464 . . . . 75.35 110.952 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.591 ' N ' HD12 ' A' ' 286' ' ' LEU . 95.7 m -90.71 138.36 31.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 73.5 111.11 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 288' ' ' ILE . . . . . 0.618 HG21 HG21 ' A' ' 294' ' ' VAL . 0.1 OUTLIER -147.29 145.55 19.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 63.54 111.129 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -119.53 139.33 52.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.108 -0.496 . . . . 74.13 110.829 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 69.7 tt0 -52.02 123.98 11.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 72.41 110.876 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 110.32 -20.54 25.54 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.756 -0.735 . . . . 64.14 112.55 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -85.13 175.57 8.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.801 0.334 . . . . 73.13 110.888 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.404 HG23 ' O ' ' A' ' 272' ' ' CYS . 41.0 mm -123.81 138.37 53.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 74.01 111.157 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 294' ' ' VAL . . . . . 0.725 HG11 ' CE2' ' A' ' 318' ' ' PHE . 66.3 t -120.57 138.0 52.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.172 -0.467 . . . . 71.14 111.122 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 295' ' ' THR . . . . . 0.445 HG23 ' CE1' ' A' ' 271' ' ' TYR . 91.0 m -92.05 116.01 28.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 70.42 111.206 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.444 HD13 ' SG ' ' A' ' 272' ' ' CYS . 4.5 tp -69.82 112.79 6.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.302 -0.408 . . . . 54.0 110.893 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 62.3 mt -102.0 -28.26 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.439 . . . . 45.34 111.086 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -156.42 178.05 10.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.214 -0.448 . . . . 65.33 110.901 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 29.6 mttp -141.33 112.92 7.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 62.33 110.904 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -50.21 163.54 0.15 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 70.51 110.847 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.7 t -114.52 -69.24 0.87 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.461 . . . . 71.45 110.855 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 2.0 mp -66.57 -13.31 16.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.494 . . . . 71.0 111.151 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -96.42 70.66 2.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.139 -0.482 . . . . 62.21 110.842 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 60.4 t -51.38 120.85 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 73.12 111.183 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.65 20.53 43.74 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.74 -0.743 . . . . 70.34 112.497 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 39.1 m95 -135.4 135.84 40.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.772 0.32 . . . . 63.41 110.898 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 307' ' ' TRP . . . . . 0.755 ' CZ3' HD12 ' A' ' 325' ' ' LEU . 23.5 m0 -130.85 157.32 43.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 74.34 110.871 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -101.43 116.13 32.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 44.41 110.888 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -130.08 -173.1 13.29 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.734 -0.746 . . . . 63.34 112.485 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -136.57 141.29 43.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.86 0.362 . . . . 74.43 110.848 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 293' ' ' ILE . 5.5 tp -141.97 121.26 13.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.127 -0.488 . . . . 72.23 110.901 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 3.0 m120 55.06 33.11 19.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 74.21 110.866 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 92.09 -16.59 59.26 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.714 -0.755 . . . . 65.11 112.487 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -82.99 109.23 16.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.857 0.36 . . . . 73.03 110.845 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.33 125.85 46.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.484 . . . . 71.15 110.904 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -163.43 -158.99 10.23 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.76 -0.734 . . . . 72.35 112.521 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 6.6 m -114.19 156.7 15.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.86 0.362 . . . . 62.31 111.137 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 318' ' ' PHE . . . . . 0.725 ' CE2' HG11 ' A' ' 294' ' ' VAL . 6.1 p90 -163.67 156.05 15.3 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.645 0.736 . . . . 64.13 110.869 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 117.71 5.25 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.659 2.239 . . . . 73.02 112.326 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 320' ' ' ASP . . . . . 0.556 ' HA ' HG22 ' A' ' 323' ' ' VAL . 2.9 t70 -58.34 -22.04 51.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.259 -0.428 . . . . 63.11 110.843 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -69.27 -11.78 61.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 73.13 110.987 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -109.18 17.04 22.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.472 . . . . 63.22 110.874 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 323' ' ' VAL . . . . . 0.556 HG22 ' HA ' ' A' ' 320' ' ' ASP . 18.4 m -148.81 150.58 13.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.144 -0.48 . . . . 64.43 111.173 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -112.09 119.28 37.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.223 -0.444 . . . . 65.1 110.872 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.755 HD12 ' CZ3' ' A' ' 307' ' ' TRP . 0.6 OUTLIER -64.89 116.29 6.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.226 -0.443 . . . . 71.44 110.857 179.938 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 21.2 mt . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 121.608 0.718 . . . . 75.23 110.916 179.836 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.799 0.333 . . . . 73.21 110.882 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 271' ' ' TYR . . . . . 0.663 ' CE1' HG23 ' A' ' 295' ' ' THR . 8.9 m-85 -133.5 152.94 51.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.207 -0.452 . . . . 74.4 110.932 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 34.4 m -139.98 147.93 41.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.093 -0.503 . . . . 44.11 110.941 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 33.3 tttt -102.99 121.98 43.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 71.41 110.908 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 274' ' ' VAL . . . . . 0.42 HG21 ' HB ' ' A' ' 288' ' ' ILE . 46.9 t -62.22 110.99 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 54.05 111.123 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 26.8 pt -85.52 -32.82 7.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 72.42 111.139 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -135.95 158.0 74.78 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.629 0.728 . . . . 61.14 110.918 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 150.17 68.13 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.715 2.277 . . . . 72.31 112.327 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -171.17 106.06 0.24 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.235 -0.439 . . . . 70.03 110.963 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 279' ' ' GLU . . . . . 0.772 ' HA ' HG23 ' A' ' 287' ' ' THR . 0.3 OUTLIER -93.03 147.01 23.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.073 -0.512 . . . . 75.53 110.851 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 280' ' ' ALA . . . . . 0.545 ' HB1' ' HB2' ' A' ' 285' ' ' GLU . . . -82.04 124.56 29.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 71.44 111.091 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -72.31 -32.1 66.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 73.23 110.899 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -137.36 172.35 13.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 64.23 110.929 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -62.22 -17.91 59.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 71.3 110.824 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 284' ' ' ASP . . . . . 0.563 ' O ' HG22 ' A' ' 317' ' ' VAL . 13.9 t0 -75.57 -19.39 59.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.241 -0.436 . . . . 72.45 110.838 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 285' ' ' GLU . . . . . 0.545 ' HB2' ' HB1' ' A' ' 280' ' ' ALA . 2.0 mp0 -105.62 164.1 12.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.224 -0.444 . . . . 70.05 110.868 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.577 HD23 ' CD2' ' A' ' 318' ' ' PHE . 14.6 tp -115.47 135.61 53.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.158 -0.473 . . . . 64.54 110.899 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.772 HG23 ' HA ' ' A' ' 279' ' ' GLU . 46.2 m -88.31 141.42 28.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 55.03 111.12 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 288' ' ' ILE . . . . . 0.561 HG21 HG21 ' A' ' 294' ' ' VAL . 33.6 pt -150.09 139.66 15.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 60.41 111.104 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 29.2 mttm -109.99 138.31 46.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 73.34 110.867 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -51.65 126.85 18.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 75.11 110.922 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 107.15 -23.51 27.05 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.657 -0.782 . . . . 72.45 112.476 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -84.99 160.44 20.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.763 0.316 . . . . 74.32 110.873 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 35.1 mm -110.82 128.92 66.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.16 -0.473 . . . . 73.32 111.07 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 294' ' ' VAL . . . . . 0.732 HG11 ' CE2' ' A' ' 318' ' ' PHE . 94.5 t -103.51 138.02 29.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.103 -0.499 . . . . 61.52 111.131 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 295' ' ' THR . . . . . 0.663 HG23 ' CE1' ' A' ' 271' ' ' TYR . 59.8 m -87.48 110.57 20.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 74.11 111.212 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.524 HD11 ' HB3' ' A' ' 307' ' ' TRP . 7.6 tp -70.01 116.07 9.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 63.43 110.904 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 54.4 mt -102.46 -47.59 11.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 72.32 111.177 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -135.29 178.21 7.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 61.42 110.966 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 23.3 mttt -141.15 112.88 7.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 64.12 110.859 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -49.98 160.49 0.33 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 72.3 110.849 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.7 t -113.09 -69.01 0.89 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.237 -0.438 . . . . 54.03 110.858 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 1.9 mp -66.72 -13.24 16.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.475 . . . . 75.42 111.103 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.66 69.78 1.88 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.192 -0.458 . . . . 74.54 110.85 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 88.0 t -51.43 124.24 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.443 . . . . 63.22 111.095 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.41 19.12 50.73 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.703 -0.761 . . . . 72.31 112.539 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 46.4 m95 -136.02 135.21 39.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.781 0.325 . . . . 73.33 110.881 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 307' ' ' TRP . . . . . 0.758 ' CZ3' HD12 ' A' ' 325' ' ' LEU . 23.4 m0 -131.19 154.94 47.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 64.21 110.967 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -99.13 118.31 35.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.291 -0.413 . . . . 61.44 110.877 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -130.08 -171.83 13.01 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.824 -0.703 . . . . 72.3 112.556 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -140.71 144.24 35.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.895 0.379 . . . . 74.25 110.851 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.422 HD13 HG22 ' A' ' 294' ' ' VAL . 2.3 tp -160.04 135.45 8.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 72.34 110.886 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 2.7 m120 59.52 29.99 19.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.13 -0.486 . . . . 53.23 110.951 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 77.87 10.05 86.5 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.7 -0.762 . . . . 70.15 112.536 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -115.41 111.82 21.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.818 0.342 . . . . 72.12 110.861 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 10.3 ttp85 -96.63 124.32 40.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 72.4 110.832 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -154.9 -157.09 8.03 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.779 -0.724 . . . . 62.34 112.511 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.563 HG22 ' O ' ' A' ' 284' ' ' ASP . 20.2 m -118.87 154.02 21.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.833 0.349 . . . . 63.24 111.185 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 318' ' ' PHE . . . . . 0.732 ' CE2' HG11 ' A' ' 294' ' ' VAL . 7.2 p90 -160.52 155.82 21.43 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.629 0.728 . . . . 73.42 110.899 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 117.91 5.36 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.724 2.283 . . . . 71.22 112.339 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 320' ' ' ASP . . . . . 0.557 ' HA ' HG22 ' A' ' 323' ' ' VAL . 3.1 t70 -59.12 -21.21 58.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 72.04 110.871 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -68.92 -12.11 61.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 63.52 110.885 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -108.81 16.56 22.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 74.42 110.816 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 323' ' ' VAL . . . . . 0.557 HG22 ' HA ' ' A' ' 320' ' ' ASP . 18.0 m -148.66 150.82 13.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.442 . . . . 74.2 111.134 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -109.75 118.6 36.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 73.14 110.936 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.758 HD12 ' CZ3' ' A' ' 307' ' ' TRP . 1.2 tt -64.97 121.13 13.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.441 . . . . 63.53 110.96 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.405 HD12 ' HB3' ' A' ' 271' ' ' TYR . 20.3 mt . . . . . 0 C--N 1.329 -0.322 0 CA-C-O 121.631 0.729 . . . . 63.42 110.896 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.753 0.311 . . . . 74.04 110.859 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 271' ' ' TYR . . . . . 0.65 ' HB3' HD12 ' A' ' 326' ' ' LEU . 12.2 m-85 -117.16 153.08 33.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.248 -0.433 . . . . 73.5 110.884 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 272' ' ' CYS . . . . . 0.45 ' O ' HG23 ' A' ' 293' ' ' ILE . 22.9 m -136.66 148.43 47.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.084 -0.507 . . . . 52.13 110.883 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 39.1 tttt -106.47 123.41 48.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.172 -0.467 . . . . 75.12 110.964 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 21.4 t -61.57 114.12 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 62.34 111.1 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 28.1 pt -85.88 -30.02 6.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 74.23 111.101 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -144.03 157.98 56.43 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.578 0.704 . . . . 74.11 110.905 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 154.03 67.99 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.624 2.216 . . . . 65.01 112.349 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -172.92 111.74 0.22 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 74.3 110.921 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 279' ' ' GLU . . . . . 0.784 ' HA ' HG23 ' A' ' 287' ' ' THR . 7.2 tm-20 -92.36 131.02 37.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.118 -0.492 . . . . 73.51 110.933 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -57.54 119.32 6.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 51.42 111.148 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.46 -25.79 68.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 71.1 110.861 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -154.63 172.77 17.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.25 -0.432 . . . . 51.23 110.94 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -58.48 -25.65 62.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 75.41 110.855 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.35 -25.73 62.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.213 -0.449 . . . . 72.23 110.799 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -94.88 166.97 11.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 71.14 110.941 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.681 HD23 ' CD2' ' A' ' 318' ' ' PHE . 12.9 tp -116.94 135.64 53.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.448 . . . . 64.01 110.967 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.784 HG23 ' HA ' ' A' ' 279' ' ' GLU . 60.1 m -86.92 146.69 26.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 72.34 111.172 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 31.1 pt -150.35 137.89 13.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 65.54 111.13 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -111.28 139.24 46.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 63.44 110.896 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -51.94 135.87 29.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 75.04 110.878 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 92.9 -22.37 34.44 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.766 -0.73 . . . . 44.22 112.527 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -77.08 178.32 7.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.783 0.325 . . . . 71.21 110.858 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.45 HG23 ' O ' ' A' ' 272' ' ' CYS . 51.2 mt -130.09 125.81 60.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.151 -0.477 . . . . 73.53 111.161 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 294' ' ' VAL . . . . . 0.652 HG11 ' CE2' ' A' ' 318' ' ' PHE . 21.5 t -101.4 138.08 26.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.154 -0.476 . . . . 61.45 111.153 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 37.9 m -92.49 110.68 22.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 65.24 111.102 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.428 HD11 ' HB3' ' A' ' 307' ' ' TRP . 4.7 tp -69.89 121.48 17.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 63.42 110.936 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 297' ' ' ILE . . . . . 0.423 HG22 ' OD1' ' A' ' 298' ' ' ASN . 62.7 mt -110.13 -37.3 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 62.5 111.162 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 298' ' ' ASN . . . . . 0.423 ' OD1' HG22 ' A' ' 297' ' ' ILE . 7.5 m120 -150.08 170.53 18.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.484 . . . . 75.1 110.928 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 15.8 mttt -137.3 112.34 9.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 73.14 110.923 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -56.0 179.76 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.239 -0.437 . . . . 60.2 110.887 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 1.7 t -128.99 -69.41 0.71 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 72.2 110.861 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 42.0 mm -59.83 -18.0 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 73.3 111.153 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -99.44 61.77 1.2 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 53.31 110.845 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 62.5 t -51.35 136.53 10.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.464 . . . . 62.21 111.197 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 88.62 14.46 61.44 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.793 -0.718 . . . . 74.41 112.477 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 52.4 m95 -139.7 148.67 42.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.785 0.326 . . . . 74.24 110.869 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 307' ' ' TRP . . . . . 0.6 ' CZ3' HD12 ' A' ' 325' ' ' LEU . 10.3 m0 -139.12 148.66 43.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.47 . . . . 71.54 110.919 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -94.62 122.27 37.05 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.217 -0.447 . . . . 73.41 110.887 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -144.55 -164.43 10.53 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.781 -0.723 . . . . 61.21 112.49 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -142.37 148.2 37.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.87 0.366 . . . . 55.51 110.884 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 3.9 tp -159.02 130.15 6.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.474 . . . . 74.41 110.946 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 2.9 m120 58.97 30.01 19.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.277 -0.42 . . . . 61.04 110.911 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 82.8 2.51 90.66 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.774 -0.727 . . . . 53.23 112.427 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -105.61 121.31 43.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.825 0.345 . . . . 73.44 110.897 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 55.1 mtm180 -105.65 133.74 49.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 74.33 110.806 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -171.93 -151.15 7.61 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.712 -0.756 . . . . 71.13 112.446 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 33.7 m -124.25 145.79 30.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.868 0.366 . . . . 72.13 111.14 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 318' ' ' PHE . . . . . 0.681 ' CD2' HD23 ' A' ' 286' ' ' LEU . 18.2 p90 -144.56 157.01 56.41 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.644 0.735 . . . . 74.35 110.877 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 121.73 8.41 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.678 2.252 . . . . 74.45 112.375 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 320' ' ' ASP . . . . . 0.526 ' HA ' HG22 ' A' ' 323' ' ' VAL . 1.6 p-10 -62.2 -17.32 57.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 61.22 110.888 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -76.61 -5.23 46.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.115 -0.493 . . . . 72.43 110.813 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -121.01 24.5 10.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 74.41 110.849 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 323' ' ' VAL . . . . . 0.526 HG22 ' HA ' ' A' ' 320' ' ' ASP . 17.5 m -148.61 147.39 16.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.175 -0.466 . . . . 71.3 111.105 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -114.07 114.35 26.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.474 . . . . 73.43 110.95 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.6 HD12 ' CZ3' ' A' ' 307' ' ' TRP . 0.8 OUTLIER -64.99 125.65 25.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.187 -0.461 . . . . 74.52 110.915 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.65 HD12 ' HB3' ' A' ' 271' ' ' TYR . 21.5 mt . . . . . 0 C--N 1.328 -0.326 0 CA-C-O 121.58 0.705 . . . . 72.45 110.901 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.766 0.317 . . . . 70.13 110.851 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 271' ' ' TYR . . . . . 0.555 ' HB3' HD12 ' A' ' 326' ' ' LEU . 12.5 m-85 -110.65 137.8 47.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.173 -0.467 . . . . 73.4 110.962 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 25.3 m -126.92 145.61 50.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.148 -0.478 . . . . 64.14 110.923 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 17.6 ttpt -103.65 127.78 51.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 51.42 110.892 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 274' ' ' VAL . . . . . 0.631 HG13 HD12 ' A' ' 288' ' ' ILE . 21.5 t -61.58 114.42 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.29 -0.414 . . . . 61.21 111.076 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 0.538 HD11 ' O ' ' A' ' 321' ' ' ASN . 34.4 pt -88.97 -27.06 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 45.0 111.128 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -145.94 159.25 47.22 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.635 0.731 . . . . 74.45 110.853 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 151.94 68.89 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.706 2.27 . . . . 63.43 112.276 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -166.41 111.47 0.8 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 75.34 110.916 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 279' ' ' GLU . . . . . 0.639 ' HA ' HG23 ' A' ' 287' ' ' THR . 42.3 tt0 -94.88 129.01 42.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 73.24 110.887 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -63.41 113.82 3.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 71.32 111.104 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -59.58 -26.44 65.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 74.13 110.899 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -150.7 170.25 19.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.221 -0.445 . . . . 51.01 110.842 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -56.57 -25.95 53.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 74.33 110.829 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -70.08 -25.86 63.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 72.31 110.851 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 285' ' ' GLU . . . . . 0.426 ' OE1' HG23 ' A' ' 317' ' ' VAL . 46.5 mm-40 -94.96 164.66 12.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 73.21 110.9 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.665 HD13 ' HG3' ' A' ' 314' ' ' ARG . 14.4 tp -116.41 136.71 52.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.09 -0.505 . . . . 75.45 110.893 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.639 HG23 ' HA ' ' A' ' 279' ' ' GLU . 85.1 m -92.59 144.86 24.91 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.151 -0.477 . . . . 54.35 111.132 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 288' ' ' ILE . . . . . 0.631 HD12 HG13 ' A' ' 274' ' ' VAL . 48.4 pt -150.37 142.9 17.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 54.43 111.143 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 31.8 mtpt -112.38 141.04 46.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.153 -0.476 . . . . 72.32 110.931 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -51.95 131.56 31.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 74.3 110.851 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 99.96 -22.22 41.22 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.702 -0.761 . . . . 63.33 112.438 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -76.12 178.12 6.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.757 0.313 . . . . 60.12 110.874 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 81.2 mt -133.02 122.1 45.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 72.24 111.179 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 294' ' ' VAL . . . . . 0.745 HG11 ' CE2' ' A' ' 318' ' ' PHE . 90.1 t -105.66 138.1 32.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 63.13 111.149 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 52.3 m -87.77 114.34 24.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 63.4 111.136 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.404 HD11 ' HB3' ' A' ' 307' ' ' TRP . 5.5 tp -70.01 112.43 6.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.258 -0.428 . . . . 65.35 110.909 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 61.2 mt -101.43 -29.03 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.107 -0.497 . . . . 62.14 111.128 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -155.69 178.08 10.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.444 . . . . 41.43 110.9 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 27.7 mttp -141.33 112.97 7.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 71.04 110.938 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -49.68 160.78 0.26 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.213 -0.449 . . . . 52.33 110.888 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.8 t -113.29 -68.97 0.89 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 50.12 110.897 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 31.0 mm -66.97 -12.86 15.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 60.22 111.109 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -97.17 70.81 2.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 70.13 110.947 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.412 HG13 ' O ' ' A' ' 304' ' ' VAL . 5.9 p -51.31 120.75 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 73.13 111.145 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.54 24.47 30.74 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.758 -0.734 . . . . 63.15 112.461 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 56.3 m95 -139.72 135.94 33.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.809 0.337 . . . . 72.23 110.913 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 307' ' ' TRP . . . . . 0.404 ' HB3' HD11 ' A' ' 296' ' ' LEU . 22.3 m0 -130.69 156.66 44.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 64.31 110.867 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -101.38 115.51 30.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.194 -0.457 . . . . 75.23 110.925 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -128.66 -172.64 13.23 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.755 -0.736 . . . . 51.53 112.503 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -141.32 140.43 33.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.861 0.362 . . . . 71.41 110.931 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.456 HD13 HG22 ' A' ' 294' ' ' VAL . 4.5 tp -145.69 128.94 16.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 73.14 110.838 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 3.0 m120 56.8 29.88 16.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 61.4 110.816 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 87.52 -8.62 76.64 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.716 -0.754 . . . . 73.13 112.527 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 314' ' ' ARG . . . . . 0.665 ' HG3' HD13 ' A' ' 286' ' ' LEU . 4.3 tpt180 -93.08 109.01 20.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.722 0.296 . . . . 74.04 110.887 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 10.4 ttp85 -96.69 133.35 41.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 74.23 110.904 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -166.43 -158.87 11.47 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.669 -0.777 . . . . 70.11 112.41 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.426 HG23 ' OE1' ' A' ' 285' ' ' GLU . 19.2 m -116.76 154.47 18.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.883 0.373 . . . . 73.3 111.129 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 318' ' ' PHE . . . . . 0.745 ' CE2' HG11 ' A' ' 294' ' ' VAL . 5.5 p90 -159.79 157.07 25.57 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.621 0.724 . . . . 71.3 110.865 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 121.65 8.33 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.705 2.27 . . . . 62.02 112.348 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 320' ' ' ASP . . . . . 0.545 ' HA ' HG22 ' A' ' 323' ' ' VAL . 1.6 p-10 -58.35 -22.31 53.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 64.4 110.937 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 321' ' ' ASN . . . . . 0.538 ' O ' HD11 ' A' ' 275' ' ' ILE . 19.7 m120 -69.85 -15.78 63.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 75.43 110.863 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -104.36 15.62 27.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 70.4 110.859 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 323' ' ' VAL . . . . . 0.545 HG22 ' HA ' ' A' ' 320' ' ' ASP . 18.9 m -149.16 150.59 13.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 75.33 111.12 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 24.8 ttpt -125.35 125.75 43.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 74.23 110.895 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 2.5 mt -64.95 130.78 44.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 71.23 110.98 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.555 HD12 ' HB3' ' A' ' 271' ' ' TYR . 20.2 mt . . . . . 0 C--N 1.329 -0.322 0 CA-C-O 121.592 0.711 . . . . 70.15 110.871 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.87 0.367 . . . . 54.0 110.833 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 271' ' ' TYR . . . . . 0.589 ' HB3' HD12 ' A' ' 326' ' ' LEU . 14.4 m-85 -130.46 143.09 50.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.211 -0.45 . . . . 73.55 110.922 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 22.1 m -133.04 149.37 52.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.116 -0.493 . . . . 74.33 110.887 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 15.5 tttp -103.89 121.75 43.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 74.11 110.935 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 274' ' ' VAL . . . . . 0.54 ' CG2' HG23 ' A' ' 294' ' ' VAL . 57.8 t -61.65 111.71 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 62.33 111.141 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 28.5 pt -84.1 -32.12 8.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 71.22 111.098 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -140.39 157.78 67.76 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.661 0.743 . . . . 73.1 110.927 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.81 159.23 54.13 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.695 2.264 . . . . 73.41 112.25 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -174.16 109.64 0.14 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 54.14 110.915 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 279' ' ' GLU . . . . . 0.624 ' HA ' HG23 ' A' ' 287' ' ' THR . 9.2 tt0 -89.33 139.47 30.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 70.32 110.829 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 280' ' ' ALA . . . . . 0.429 ' HB2' ' C ' ' A' ' 286' ' ' LEU . . . -87.5 121.42 29.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 63.42 111.042 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -60.22 -42.46 95.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 63.42 110.933 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -148.64 -174.66 4.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 44.45 110.89 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -57.98 -19.75 32.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 73.15 110.909 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 284' ' ' ASP . . . . . 0.455 ' O ' HG22 ' A' ' 317' ' ' VAL . 2.2 t70 -72.07 -8.39 54.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 53.51 110.882 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 285' ' ' GLU . . . . . 0.421 ' HB2' ' HB1' ' A' ' 280' ' ' ALA . 9.3 mp0 -132.61 158.91 41.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 74.01 110.855 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.648 HD23 ' CD2' ' A' ' 318' ' ' PHE . 17.0 tp -114.89 133.44 55.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 74.22 110.979 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.624 HG23 ' HA ' ' A' ' 279' ' ' GLU . 86.7 m -84.32 145.04 28.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 64.21 111.144 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 288' ' ' ILE . . . . . 0.419 HG22 HD22 ' A' ' 311' ' ' LEU . 38.6 pt -150.88 138.83 14.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 55.34 111.064 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 31.2 mttm -110.43 136.1 50.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.131 -0.486 . . . . 75.43 110.962 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 290' ' ' GLU . . . . . 0.402 ' HA ' HG12 ' A' ' 274' ' ' VAL . 34.0 tt0 -51.68 128.7 24.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.45 . . . . 71.31 110.877 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 105.26 -26.21 22.57 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.699 -0.762 . . . . 54.21 112.483 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -83.28 156.16 23.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.694 0.283 . . . . 64.54 110.934 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 56.6 mt -106.64 126.26 62.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.194 -0.457 . . . . 52.33 111.107 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 294' ' ' VAL . . . . . 0.714 HG11 ' CE2' ' A' ' 318' ' ' PHE . 62.1 t -96.11 138.13 22.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 70.44 111.077 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 56.2 m -91.1 109.43 20.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.16 -0.473 . . . . 72.24 111.145 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.469 HD11 ' HB3' ' A' ' 307' ' ' TRP . 4.2 tp -69.85 121.2 16.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.187 -0.46 . . . . 64.5 110.892 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 297' ' ' ILE . . . . . 0.486 HD11 ' HB2' ' A' ' 310' ' ' GLU . 38.9 mt -107.93 -36.69 3.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.233 -0.44 . . . . 64.45 111.171 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -151.02 170.69 18.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.128 -0.487 . . . . 74.0 110.907 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 21.7 mttt -137.28 112.28 9.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 74.22 110.858 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -55.49 178.61 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.436 . . . . 75.32 110.891 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 1.7 t -128.04 -69.36 0.73 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.207 -0.452 . . . . 64.44 110.936 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 60.8 mt -59.71 -18.26 14.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 70.51 111.137 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.35 61.67 1.21 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.462 . . . . 63.53 110.919 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 54.9 t -51.44 136.8 10.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 74.02 111.119 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 88.75 14.17 61.61 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.721 -0.752 . . . . 72.43 112.533 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 52.2 m95 -139.68 149.04 43.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.729 0.3 . . . . 75.15 110.871 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 307' ' ' TRP . . . . . 0.61 ' CZ3' HD12 ' A' ' 325' ' ' LEU . 10.4 m0 -139.22 148.78 43.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 73.53 110.89 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -94.47 117.56 30.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 65.03 110.969 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -138.4 -168.87 11.42 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.711 -0.757 . . . . 54.1 112.509 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 310' ' ' GLU . . . . . 0.486 ' HB2' HD11 ' A' ' 297' ' ' ILE . 71.1 tt0 -138.49 148.1 43.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.834 0.35 . . . . 71.4 110.95 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.609 HD13 HG22 ' A' ' 294' ' ' VAL . 6.3 tp -158.6 129.55 6.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.19 -0.459 . . . . 64.55 110.953 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 2.9 m120 58.94 30.0 19.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 60.41 110.864 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 84.47 -5.13 82.35 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.72 -0.752 . . . . 74.41 112.46 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -98.3 122.35 41.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.757 0.313 . . . . 73.1 110.915 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 63.0 mtm180 -106.97 132.03 53.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 73.22 110.835 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -168.04 -149.5 6.14 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.7 -0.762 . . . . 24.31 112.468 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.455 HG22 ' O ' ' A' ' 284' ' ' ASP . 18.7 m -127.17 146.45 33.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.896 0.379 . . . . 71.33 111.119 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 318' ' ' PHE . . . . . 0.714 ' CE2' HG11 ' A' ' 294' ' ' VAL . 14.3 p90 -144.95 157.37 54.43 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.656 0.741 . . . . 72.33 110.841 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.66 121.24 7.95 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.727 2.285 . . . . 71.11 112.344 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 320' ' ' ASP . . . . . 0.552 ' HA ' HG22 ' A' ' 323' ' ' VAL . 1.6 p-10 -60.66 -18.73 55.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 73.11 110.831 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -74.85 -6.7 50.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.481 . . . . 74.11 110.921 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -118.06 22.12 12.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 73.12 110.83 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 323' ' ' VAL . . . . . 0.552 HG22 ' HA ' ' A' ' 320' ' ' ASP . 17.5 m -149.02 145.12 18.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 74.42 111.15 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -111.19 117.38 33.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 64.33 110.919 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.61 HD12 ' CZ3' ' A' ' 307' ' ' TRP . 0.8 OUTLIER -64.87 125.47 24.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 51.23 110.932 179.943 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.589 HD12 ' HB3' ' A' ' 271' ' ' TYR . 20.3 mt . . . . . 0 C--N 1.329 -0.322 0 CA-C-O 121.59 0.71 . . . . 52.14 110.936 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.859 0.361 . . . . 73.11 110.876 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 271' ' ' TYR . . . . . 0.703 ' CE1' HG23 ' A' ' 295' ' ' THR . 6.7 m-85 -124.1 156.61 36.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 50.34 110.917 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 272' ' ' CYS . . . . . 0.407 ' SG ' HD13 ' A' ' 296' ' ' LEU . 23.5 m -138.92 152.44 47.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.123 -0.489 . . . . 65.21 110.886 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt -108.21 126.67 53.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.141 -0.481 . . . . 74.22 110.916 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 38.9 t -63.21 109.32 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 72.15 111.107 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 30.0 pt -83.25 -31.53 8.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 75.4 111.14 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -140.84 159.2 63.22 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.654 0.74 . . . . 73.14 110.86 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 152.08 69.02 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.675 2.25 . . . . 54.53 112.318 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -174.38 105.96 0.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 65.12 110.839 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 279' ' ' GLU . . . . . 0.576 ' HA ' HG23 ' A' ' 287' ' ' THR . 1.4 mp0 -89.2 141.06 28.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.108 -0.496 . . . . 64.5 110.915 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -54.54 113.03 1.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 60.05 111.176 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -69.05 -26.45 64.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.303 -0.408 . . . . 75.44 110.945 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 18.9 m-80 -144.03 174.74 10.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.134 -0.485 . . . . 74.04 110.91 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -63.53 -26.13 68.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 75.31 110.854 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 284' ' ' ASP . . . . . 0.593 ' O ' HG22 ' A' ' 317' ' ' VAL . 14.6 m-20 -88.06 6.14 37.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 74.04 110.838 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -105.65 164.64 11.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.253 -0.43 . . . . 73.13 110.889 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.777 HD23 ' CD2' ' A' ' 318' ' ' PHE . 21.3 tp -115.75 131.23 57.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.491 . . . . 70.33 110.903 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.576 HG23 ' HA ' ' A' ' 279' ' ' GLU . 91.5 m -87.43 136.14 33.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 53.23 111.078 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 288' ' ' ILE . . . . . 0.478 HG21 HG21 ' A' ' 294' ' ' VAL . 0.1 OUTLIER -147.49 146.15 18.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 72.44 111.149 179.871 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 27.4 mtmm -120.64 145.98 46.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 72.14 110.945 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -52.0 131.82 31.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.27 -0.423 . . . . 73.14 110.847 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.03 -27.1 19.81 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.804 -0.712 . . . . 35.42 112.52 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -71.71 173.34 8.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.778 0.323 . . . . 73.02 110.839 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 28.5 mm -124.24 135.9 62.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 64.15 111.156 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 294' ' ' VAL . . . . . 0.634 HG11 ' CE2' ' A' ' 318' ' ' PHE . 19.5 t -111.69 132.43 60.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.247 -0.433 . . . . 62.24 111.067 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 295' ' ' THR . . . . . 0.703 HG23 ' CE1' ' A' ' 271' ' ' TYR . 17.4 m -87.89 112.09 22.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.089 -0.505 . . . . 72.34 111.136 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.407 HD13 ' SG ' ' A' ' 272' ' ' CYS . 6.0 tp -69.59 119.69 14.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 74.4 110.977 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 58.9 mt -115.72 -25.18 3.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.283 -0.417 . . . . 53.43 111.095 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -158.29 176.84 11.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.014 0.435 . . . . 74.1 110.779 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 48.7 mttt -141.18 113.03 7.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.048 -0.524 . . . . 65.12 110.897 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.01 166.75 0.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 75.44 110.903 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.2 t -119.6 -69.35 0.85 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.241 -0.436 . . . . 64.3 110.919 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 36.0 mm -64.26 -14.72 16.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 71.11 111.133 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -96.51 74.47 2.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 72.34 110.848 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 58.9 t -51.37 117.36 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 71.01 111.129 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 88.89 29.68 17.32 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.793 -0.718 . . . . 45.24 112.477 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 58.8 m95 -140.67 135.05 31.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.68 0.276 . . . . 63.44 110.977 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 307' ' ' TRP . . . . . 0.726 ' CZ3' HD12 ' A' ' 325' ' ' LEU . 24.2 m0 -129.26 157.55 41.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.254 -0.43 . . . . 72.25 110.934 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -104.78 124.77 49.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.305 -0.407 . . . . 54.21 110.887 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -140.24 -164.82 10.05 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.706 -0.759 . . . . 51.54 112.451 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -142.94 143.68 32.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.915 0.388 . . . . 55.21 110.865 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.432 HD22 ' O ' ' A' ' 287' ' ' THR . 2.0 tp -146.56 122.77 10.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 61.23 110.959 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 3.1 m120 58.55 29.94 19.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 73.15 110.892 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 89.61 -8.63 79.43 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.715 -0.755 . . . . 72.02 112.459 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 17.2 tpp180 -94.14 114.24 26.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.703 0.287 . . . . 75.53 110.913 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 36.7 mtm180 -98.86 138.19 36.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.202 -0.454 . . . . 73.44 110.828 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -171.93 -160.61 20.86 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.797 -0.716 . . . . 63.14 112.475 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 284' ' ' ASP . 32.6 m -118.36 154.0 20.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.857 0.36 . . . . 62.2 111.145 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 318' ' ' PHE . . . . . 0.777 ' CD2' HD23 ' A' ' 286' ' ' LEU . 26.0 p90 -156.04 156.34 30.31 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.639 0.733 . . . . 73.2 110.882 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 119.5 6.44 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.701 2.267 . . . . 63.23 112.351 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 320' ' ' ASP . . . . . 0.536 ' HA ' HG22 ' A' ' 323' ' ' VAL . 1.5 p-10 -60.89 -18.86 58.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.431 . . . . 73.33 110.888 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -74.55 -7.15 52.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.157 -0.474 . . . . 54.53 110.82 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -117.63 24.19 11.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 74.45 110.776 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 323' ' ' VAL . . . . . 0.536 HG22 ' HA ' ' A' ' 320' ' ' ASP . 18.1 m -148.89 153.13 11.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 44.43 111.122 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -116.8 113.39 22.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 64.12 110.957 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.726 HD12 ' CZ3' ' A' ' 307' ' ' TRP . 1.2 tt -65.1 126.48 28.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 72.33 110.906 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 20.3 mt . . . . . 0 C--N 1.328 -0.363 0 CA-C-O 121.642 0.734 . . . . 72.24 110.855 179.896 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.794 0.331 . . . . 74.23 110.839 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 271' ' ' TYR . . . . . 0.485 ' CE1' HG23 ' A' ' 295' ' ' THR . 8.8 m-85 -129.26 150.99 50.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 74.22 110.857 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 26.4 m -139.19 150.7 45.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.058 -0.519 . . . . 64.43 110.911 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -107.77 122.92 47.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.447 . . . . 73.53 110.896 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 274' ' ' VAL . . . . . 0.458 HG11 ' C ' ' A' ' 289' ' ' LYS . 24.1 t -56.01 116.18 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.292 -0.413 . . . . 74.35 111.193 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 0.418 HG21 ' HB2' ' A' ' 324' ' ' LYS . 29.7 pt -97.95 -17.55 6.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 71.41 111.127 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -145.52 151.98 48.31 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.627 0.727 . . . . 71.53 110.903 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.67 151.52 69.62 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.655 2.237 . . . . 54.31 112.363 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -174.45 140.43 0.63 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.451 . . . . 73.14 110.932 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 279' ' ' GLU . . . . . 0.531 ' HA ' HG23 ' A' ' 287' ' ' THR . 49.5 tt0 -121.17 143.18 49.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.054 -0.521 . . . . 75.25 110.882 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -76.61 127.79 33.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 72.41 111.116 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -71.48 -25.82 62.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.242 -0.435 . . . . 74.13 110.878 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -155.75 177.54 11.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 51.1 110.887 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -56.94 -25.75 58.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.177 -0.465 . . . . 61.14 110.878 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 284' ' ' ASP . . . . . 0.449 ' O ' HG22 ' A' ' 317' ' ' VAL . 18.9 t0 -72.29 -24.85 61.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.474 . . . . 72.41 110.864 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 285' ' ' GLU . . . . . 0.482 ' OE2' HG23 ' A' ' 317' ' ' VAL . 19.8 mm-40 -94.97 163.5 13.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.172 -0.467 . . . . 62.52 110.895 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.616 HD23 ' CD2' ' A' ' 318' ' ' PHE . 20.3 tp -119.78 131.24 55.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.13 -0.486 . . . . 71.44 110.923 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.531 HG23 ' HA ' ' A' ' 279' ' ' GLU . 96.7 m -85.97 143.3 28.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.154 -0.475 . . . . 75.01 111.139 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 288' ' ' ILE . . . . . 0.461 HG21 HG21 ' A' ' 294' ' ' VAL . 47.9 pt -150.26 142.36 17.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 71.31 111.115 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 289' ' ' LYS . . . . . 0.458 ' C ' HG11 ' A' ' 274' ' ' VAL . 17.3 mmtp -122.07 144.73 48.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 64.54 110.897 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -51.5 128.81 23.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 74.31 110.863 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 101.43 -30.89 9.41 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.753 -0.737 . . . . 75.22 112.493 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -69.77 171.83 8.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.736 0.303 . . . . 73.53 110.917 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 67.4 mt -126.71 126.16 68.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 71.15 111.087 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 294' ' ' VAL . . . . . 0.71 HG11 ' CE2' ' A' ' 318' ' ' PHE . 64.6 t -104.37 138.21 30.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 74.02 111.135 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 295' ' ' THR . . . . . 0.485 HG23 ' CE1' ' A' ' 271' ' ' TYR . 49.2 m -92.63 111.4 22.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.154 -0.475 . . . . 64.05 111.129 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.41 HD11 ' HB3' ' A' ' 307' ' ' TRP . 5.3 tp -69.82 122.28 18.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 71.42 110.937 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 67.6 mt -110.53 -39.8 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 73.01 111.124 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -145.71 171.67 14.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 65.55 110.872 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -136.09 111.87 9.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 72.1 110.899 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.08 177.5 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 71.42 110.938 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 1.9 t -126.46 -69.33 0.77 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 64.23 110.91 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 38.6 mm -62.64 -15.89 15.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 63.04 111.185 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.26 61.35 2.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 73.54 110.9 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 56.6 t -51.12 130.97 11.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 71.2 111.118 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.91 14.71 58.97 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.779 -0.724 . . . . 73.5 112.484 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 44.0 m95 -137.01 162.86 32.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.816 0.341 . . . . 73.21 110.872 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 307' ' ' TRP . . . . . 0.44 ' CZ3' HD12 ' A' ' 325' ' ' LEU . 5.0 m0 -151.0 156.44 41.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 70.31 110.866 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -102.66 119.06 38.17 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.246 -0.434 . . . . 73.33 110.903 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -140.55 -162.92 9.31 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.75 -0.738 . . . . 61.13 112.51 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -145.65 148.64 33.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.934 0.397 . . . . 65.03 110.834 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.438 HD23 ' O ' ' A' ' 287' ' ' THR . 14.5 tp -157.98 134.95 9.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.074 -0.512 . . . . 71.02 110.894 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 2.9 m120 57.23 30.44 18.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 74.45 110.926 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 77.95 18.88 76.19 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.784 -0.722 . . . . 62.43 112.416 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 31.5 mmm-85 -124.99 121.01 33.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.867 0.365 . . . . 74.43 110.849 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 39.8 mtp180 -99.55 142.54 30.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 73.45 110.876 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -176.52 -160.06 23.09 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.793 -0.718 . . . . 71.54 112.523 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.482 HG23 ' OE2' ' A' ' 285' ' ' GLU . 29.5 m -115.51 151.07 17.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.923 0.392 . . . . 70.44 111.17 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 318' ' ' PHE . . . . . 0.71 ' CE2' HG11 ' A' ' 294' ' ' VAL . 10.5 p90 -154.69 155.77 30.83 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.64 0.733 . . . . 72.01 110.916 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 119.8 6.69 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.744 2.296 . . . . 64.11 112.31 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 320' ' ' ASP . . . . . 0.528 ' HA ' HG22 ' A' ' 323' ' ' VAL . 1.7 p-10 -61.06 -18.61 58.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.242 -0.435 . . . . 73.34 110.855 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 75.1 m-80 -74.88 -6.98 52.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 71.42 110.887 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -117.54 22.77 12.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 74.21 110.892 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 323' ' ' VAL . . . . . 0.528 HG22 ' HA ' ' A' ' 320' ' ' ASP . 18.3 m -148.82 144.28 18.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.464 . . . . 73.53 111.17 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 324' ' ' LYS . . . . . 0.418 ' HB2' HG21 ' A' ' 275' ' ' ILE . 52.6 tttt -109.45 116.95 32.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.464 . . . . 70.1 110.891 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.44 HD12 ' CZ3' ' A' ' 307' ' ' TRP . 0.6 OUTLIER -65.02 119.36 10.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 53.4 110.952 179.89 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.425 HD12 ' HB3' ' A' ' 271' ' ' TYR . 20.2 mt . . . . . 0 C--N 1.328 -0.348 0 CA-C-O 121.615 0.722 . . . . 71.12 110.896 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.81 0.338 . . . . 72.14 110.845 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 271' ' ' TYR . . . . . 0.426 ' CZ ' HG23 ' A' ' 295' ' ' THR . 33.9 m-85 -142.85 147.19 35.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.452 . . . . 75.25 110.942 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 272' ' ' CYS . . . . . 0.446 ' SG ' HD22 ' A' ' 296' ' ' LEU . 23.7 m -135.26 149.22 49.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 73.23 110.85 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 47.4 tttt -103.49 115.17 30.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.181 -0.463 . . . . 75.31 110.886 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 274' ' ' VAL . . . . . 0.55 HG21 ' HB ' ' A' ' 288' ' ' ILE . 58.9 t -57.47 118.26 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.262 -0.426 . . . . 53.42 111.08 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 26.2 pt -93.42 -30.98 4.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.489 . . . . 62.15 111.13 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -136.56 159.4 70.63 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.642 0.734 . . . . 52.21 110.929 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 159.63 52.69 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.648 2.232 . . . . 62.31 112.367 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -172.76 110.02 0.21 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.27 -0.423 . . . . 72.33 110.948 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 279' ' ' GLU . . . . . 0.682 ' HA ' HG23 ' A' ' 287' ' ' THR . 34.0 tt0 -93.23 128.02 39.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 71.13 110.868 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -61.82 116.27 4.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 72.51 111.109 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -57.9 -26.73 62.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 74.31 110.99 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -152.43 173.87 14.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 61.23 110.949 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -58.78 -26.28 63.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 61.35 110.945 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -70.11 -24.92 63.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.1 -0.5 . . . . 65.13 110.856 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -95.07 167.32 11.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 75.01 110.865 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.636 HD23 ' CD2' ' A' ' 318' ' ' PHE . 15.1 tp -116.78 137.43 52.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 42.01 110.921 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.682 HG23 ' HA ' ' A' ' 279' ' ' GLU . 85.4 m -95.18 144.35 25.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 53.24 111.128 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 288' ' ' ILE . . . . . 0.651 HG21 HG21 ' A' ' 294' ' ' VAL . 41.8 pt -150.34 149.72 14.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 42.4 111.128 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -121.93 140.79 52.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 73.32 110.909 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 8.1 tm-20 -51.83 122.95 9.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 64.44 110.861 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 113.26 -23.16 14.33 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.726 -0.749 . . . . 15.41 112.466 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -88.42 152.14 22.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.817 0.341 . . . . 71.32 110.867 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 62.7 mt -104.55 123.65 58.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 71.34 111.147 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 294' ' ' VAL . . . . . 0.74 HG11 ' CE2' ' A' ' 318' ' ' PHE . 90.9 t -100.17 138.04 25.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 73.02 111.114 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 295' ' ' THR . . . . . 0.426 HG23 ' CZ ' ' A' ' 271' ' ' TYR . 33.9 m -86.5 109.35 19.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.166 -0.47 . . . . 74.03 111.154 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.474 HD11 ' HB3' ' A' ' 307' ' ' TRP . 7.4 tp -69.86 117.76 11.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 70.01 110.904 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 69.0 mt -104.45 -48.41 9.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 73.21 111.086 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -134.38 178.13 7.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 41.23 110.895 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -141.46 112.77 7.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.157 -0.474 . . . . 73.31 110.91 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -50.56 165.77 0.09 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.229 -0.441 . . . . 72.41 110.805 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.8 t -115.69 -69.14 0.87 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.479 . . . . 74.04 110.864 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 2.0 mp -67.57 -12.61 15.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.434 . . . . 71.43 111.194 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.84 69.3 3.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 63.33 110.894 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 76.7 t -51.43 121.41 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 62.21 111.136 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.33 20.34 45.73 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.733 -0.746 . . . . 73.22 112.551 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 42.0 m95 -136.27 138.7 42.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.708 0.289 . . . . 75.13 110.909 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 307' ' ' TRP . . . . . 0.76 ' CZ3' HD12 ' A' ' 325' ' ' LEU . 19.5 m0 -134.3 157.19 46.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.454 . . . . 73.32 110.918 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -100.52 117.25 34.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.288 -0.415 . . . . 73.11 110.888 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -129.77 -170.13 12.67 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.768 -0.73 . . . . 62.24 112.505 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -143.83 146.82 33.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.864 0.364 . . . . 74.3 110.947 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.652 HD13 HG22 ' A' ' 294' ' ' VAL . 2.6 tp -155.77 132.27 10.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.181 -0.463 . . . . 73.22 110.92 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 2.9 m120 56.81 29.86 16.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 72.32 110.854 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 84.76 -6.8 76.73 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.747 -0.74 . . . . 73.1 112.485 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 314' ' ' ARG . . . . . 0.543 ' HG3' HD13 ' A' ' 286' ' ' LEU . 14.1 tpp180 -96.09 108.6 21.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.773 0.321 . . . . 62.12 110.857 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 8.9 ttp180 -96.61 129.75 43.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 73.33 110.952 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -161.34 -157.96 9.11 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.78 -0.724 . . . . 70.53 112.507 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 15.8 m -117.25 154.59 18.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.843 0.354 . . . . 74.52 111.119 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 318' ' ' PHE . . . . . 0.74 ' CE2' HG11 ' A' ' 294' ' ' VAL . 7.6 p90 -162.19 155.83 17.9 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.648 0.737 . . . . 72.23 110.904 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.85 118.5 5.72 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.699 2.266 . . . . 72.14 112.293 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 320' ' ' ASP . . . . . 0.579 ' HA ' HG22 ' A' ' 323' ' ' VAL . 3.0 t70 -59.67 -20.32 55.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 71.41 110.83 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -68.4 -12.65 61.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 44.35 110.887 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -107.96 14.15 25.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 71.25 110.856 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 323' ' ' VAL . . . . . 0.579 HG22 ' HA ' ' A' ' 320' ' ' ASP . 17.7 m -148.56 145.21 18.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.487 . . . . 71.41 111.09 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 21.6 ttpp -106.52 118.77 37.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 65.34 110.958 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.76 HD12 ' CZ3' ' A' ' 307' ' ' TRP . 1.9 tt -64.98 132.0 48.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 63.4 110.934 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.434 ' O ' HD23 ' A' ' 325' ' ' LEU . 20.4 mt . . . . . 0 C--N 1.328 -0.365 0 CA-C-O 121.572 0.701 . . . . 73.11 110.936 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.89 0.376 . . . . 75.1 110.862 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 271' ' ' TYR . . . . . 0.536 ' CB ' HD12 ' A' ' 326' ' ' LEU . 10.3 m-85 -132.33 139.61 48.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 74.43 110.903 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 272' ' ' CYS . . . . . 0.508 ' SG ' HD13 ' A' ' 296' ' ' LEU . 36.0 m -127.76 148.61 50.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.479 . . . . 63.24 110.887 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 38.6 tttt -102.9 118.04 35.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 71.52 110.878 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 274' ' ' VAL . . . . . 0.652 HG13 HD12 ' A' ' 288' ' ' ILE . 61.6 t -58.82 112.99 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.252 -0.431 . . . . 61.2 111.15 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 0.422 HG21 ' HG2' ' A' ' 324' ' ' LYS . 30.9 pt -86.5 -31.47 6.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 74.45 111.099 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -139.71 158.14 68.56 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.603 0.716 . . . . 71.32 110.867 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 153.94 68.43 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.702 2.268 . . . . 60.22 112.361 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -171.48 105.95 0.22 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 71.44 110.927 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 279' ' ' GLU . . . . . 0.732 ' HA ' HG23 ' A' ' 287' ' ' THR . 9.7 tt0 -88.57 143.84 26.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 74.15 110.837 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -78.09 123.39 26.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.096 -0.502 . . . . 41.44 111.095 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -74.85 -26.13 59.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 74.13 110.943 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -144.49 170.07 16.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 74.03 110.883 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -57.35 -26.18 60.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.139 -0.482 . . . . 61.33 110.928 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 284' ' ' ASP . . . . . 0.559 ' O ' HG22 ' A' ' 317' ' ' VAL . 3.4 t70 -70.95 -25.56 62.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 52.24 110.922 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -95.16 161.28 14.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 64.43 110.928 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.599 HD12 ' N ' ' A' ' 287' ' ' THR . 13.4 tp -120.1 136.54 54.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.235 -0.439 . . . . 74.1 110.941 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.732 HG23 ' HA ' ' A' ' 279' ' ' GLU . 73.2 m -86.2 146.1 26.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 64.42 111.087 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 288' ' ' ILE . . . . . 0.652 HD12 HG13 ' A' ' 274' ' ' VAL . 44.3 pt -150.41 145.04 17.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.439 . . . . 73.22 111.106 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -117.64 136.98 52.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 62.01 110.873 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -51.76 126.15 17.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 62.24 110.88 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 108.51 -26.02 17.7 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.713 -0.756 . . . . 75.13 112.476 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -85.38 153.95 22.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.766 0.317 . . . . 73.24 110.917 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 29.2 mm -105.08 123.14 59.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.298 -0.41 . . . . 74.44 111.104 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 294' ' ' VAL . . . . . 0.722 HG11 ' CE2' ' A' ' 318' ' ' PHE . 87.8 t -93.25 138.04 21.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 72.01 111.123 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 89.4 m -86.46 108.55 18.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 51.14 111.156 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.508 HD13 ' SG ' ' A' ' 272' ' ' CYS . 3.3 tp -69.91 115.1 8.74 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.256 -0.429 . . . . 71.2 110.924 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 79.2 mt -103.71 -26.91 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 74.42 111.091 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -157.39 178.0 10.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 63.25 110.85 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 24.9 mttt -141.34 113.01 7.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.126 -0.488 . . . . 71.54 110.9 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -49.77 162.43 0.18 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.215 -0.448 . . . . 71.55 110.91 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.8 t -114.51 -68.99 0.88 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.261 -0.427 . . . . 61.12 110.931 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 40.2 mt -67.0 -13.12 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 73.53 111.063 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -95.77 71.04 3.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 74.35 110.876 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 42.1 t -51.28 119.99 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 74.0 111.178 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.32 24.79 30.31 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.715 -0.755 . . . . 51.12 112.463 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 55.6 m95 -139.67 138.26 35.9 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.743 0.306 . . . . 72.1 110.986 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 307' ' ' TRP . . . . . 0.762 ' CH2' HD12 ' A' ' 325' ' ' LEU . 20.8 m0 -132.53 158.45 42.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.278 -0.419 . . . . 71.22 110.857 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -103.03 115.18 30.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 73.1 110.949 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -130.34 -171.76 12.99 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.677 -0.773 . . . . 63.55 112.462 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -141.85 143.64 33.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.906 0.384 . . . . 74.12 110.878 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.6 HD13 HG22 ' A' ' 294' ' ' VAL . 1.8 tp -160.03 147.05 16.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 64.34 110.937 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 2.8 m120 56.6 29.94 16.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 62.23 110.862 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 76.24 7.83 84.99 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.696 -0.764 . . . . 71.23 112.431 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.9 126.29 52.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.835 0.35 . . . . 71.13 110.877 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 7.8 ttp180 -100.9 141.21 34.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 74.11 110.928 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -172.78 -158.84 18.09 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.741 -0.742 . . . . 53.44 112.493 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 284' ' ' ASP . 35.4 m -117.86 162.99 15.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.932 0.396 . . . . 71.52 111.087 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 318' ' ' PHE . . . . . 0.722 ' CE2' HG11 ' A' ' 294' ' ' VAL . 7.1 p90 -166.71 157.04 10.54 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.66 0.743 . . . . 75.51 110.866 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.83 122.31 8.97 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.63 2.22 . . . . 71.44 112.365 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 320' ' ' ASP . . . . . 0.541 ' HA ' HG22 ' A' ' 323' ' ' VAL . 1.6 p-10 -59.2 -21.31 59.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.238 -0.437 . . . . 74.34 110.876 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -69.93 -16.99 63.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 71.22 110.898 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -102.95 15.13 30.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 64.41 110.863 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 323' ' ' VAL . . . . . 0.541 HG22 ' HA ' ' A' ' 320' ' ' ASP . 18.2 m -148.99 150.45 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 72.34 111.217 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 324' ' ' LYS . . . . . 0.422 ' HG2' HG21 ' A' ' 275' ' ' ILE . 17.2 mmtm -114.8 117.32 30.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 72.1 110.894 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.762 HD12 ' CH2' ' A' ' 307' ' ' TRP . 1.9 tt -64.92 127.38 31.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.246 -0.434 . . . . 72.22 110.908 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.536 HD12 ' CB ' ' A' ' 271' ' ' TYR . 20.4 mt . . . . . 0 C--N 1.329 -0.313 0 CA-C-O 121.575 0.702 . . . . 63.41 110.932 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.773 0.321 . . . . 73.44 110.897 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 271' ' ' TYR . . . . . 0.484 ' CB ' HD12 ' A' ' 326' ' ' LEU . 7.5 m-85 -127.64 146.78 50.43 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.213 -0.449 . . . . 71.51 110.926 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 272' ' ' CYS . . . . . 0.524 ' SG ' HD22 ' A' ' 296' ' ' LEU . 45.5 m -133.64 147.9 51.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 40.41 110.863 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 28.9 tttt -102.9 119.23 38.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 74.15 110.928 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 274' ' ' VAL . . . . . 0.473 ' CG2' HG23 ' A' ' 294' ' ' VAL . 58.8 t -59.37 112.6 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.31 -0.405 . . . . 73.44 111.075 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 0.57 HG21 ' HG3' ' A' ' 324' ' ' LYS . 29.2 pt -86.59 -31.89 6.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 64.34 111.092 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -138.71 158.73 69.62 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.669 0.747 . . . . 74.35 110.91 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 161.49 45.72 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.679 2.253 . . . . 71.24 112.338 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -174.87 111.92 0.14 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.274 -0.421 . . . . 74.3 110.934 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 279' ' ' GLU . . . . . 0.727 ' HA ' HG23 ' A' ' 287' ' ' THR . 24.4 tt0 -92.17 131.97 36.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.101 -0.5 . . . . 75.43 110.872 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 280' ' ' ALA . . . . . 0.472 ' HB1' ' HB2' ' A' ' 285' ' ' GLU . . . -68.26 115.67 7.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 72.03 111.077 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -58.08 -30.35 66.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 72.34 110.936 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -149.72 175.18 11.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 73.14 110.9 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -58.65 -25.64 62.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 72.54 110.891 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -69.93 -25.88 63.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 75.2 110.897 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 285' ' ' GLU . . . . . 0.529 ' OE1' HG23 ' A' ' 317' ' ' VAL . 63.7 mm-40 -94.93 163.41 13.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 72.11 110.916 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.613 HD23 ' CD2' ' A' ' 318' ' ' PHE . 23.2 tp -116.08 131.54 56.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 62.42 110.949 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.727 HG23 ' HA ' ' A' ' 279' ' ' GLU . 60.4 m -88.24 144.61 26.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 73.54 111.141 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 288' ' ' ILE . . . . . 0.54 HG21 HG21 ' A' ' 294' ' ' VAL . 43.9 pt -150.34 146.87 16.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 70.21 111.12 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -119.11 139.57 51.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.478 . . . . 52.5 110.871 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -51.91 124.01 11.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.475 . . . . 71.55 110.878 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 111.65 -24.97 14.09 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.768 -0.73 . . . . 73.34 112.46 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -85.98 156.16 20.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.789 0.328 . . . . 73.43 110.893 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 36.7 mm -108.63 127.14 65.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.288 -0.415 . . . . 61.35 111.18 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 294' ' ' VAL . . . . . 0.708 HG11 ' CE2' ' A' ' 318' ' ' PHE . 61.1 t -102.59 138.1 28.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 74.14 111.121 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 97.8 m -82.38 103.8 12.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 74.33 111.139 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.648 HD11 ' HB3' ' A' ' 307' ' ' TRP . 9.0 tp -69.89 113.15 6.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.144 -0.48 . . . . 75.44 110.897 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 19.7 mt -92.8 -49.17 13.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 62.04 111.155 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -149.88 178.62 8.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 63.21 110.863 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -129.17 112.3 13.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 63.2 110.85 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -49.8 166.6 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 72.34 110.878 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.0 t -111.02 -69.11 0.89 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.203 -0.453 . . . . 43.35 110.894 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 51.4 mt -63.62 -15.3 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 72.01 111.192 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -93.31 65.26 3.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.112 -0.494 . . . . 64.32 110.897 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 57.7 t -51.19 118.69 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 74.23 111.119 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.54 23.07 34.84 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.788 -0.72 . . . . 50.42 112.496 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 52.8 m95 -139.06 133.01 31.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.735 0.303 . . . . 74.32 110.925 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 307' ' ' TRP . . . . . 0.758 ' CZ3' HD12 ' A' ' 325' ' ' LEU . 28.6 m0 -124.34 149.62 46.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.257 -0.429 . . . . 74.44 110.882 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -97.62 119.78 36.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.435 . . . . 73.11 110.944 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -136.74 -167.24 11.08 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.668 -0.777 . . . . 74.54 112.408 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -139.34 138.48 36.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.926 0.394 . . . . 74.31 110.844 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.657 HD13 HG22 ' A' ' 294' ' ' VAL . 13.2 tp -145.78 129.98 17.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.489 . . . . 64.41 110.895 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 2.9 m120 58.89 29.95 19.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 71.23 110.805 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 84.03 -4.72 82.3 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.753 -0.737 . . . . 73.42 112.458 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 9.5 ttp85 -100.44 120.15 39.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.842 0.353 . . . . 50.43 110.842 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 32.4 mtm180 -99.9 140.54 33.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.469 . . . . 73.2 110.847 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -173.29 -159.85 20.66 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.689 -0.767 . . . . 72.24 112.479 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.529 HG23 ' OE1' ' A' ' 285' ' ' GLU . 17.0 m -117.02 148.63 19.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.859 0.362 . . . . 65.34 111.098 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 318' ' ' PHE . . . . . 0.708 ' CE2' HG11 ' A' ' 294' ' ' VAL . 8.8 p90 -151.01 156.76 35.52 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.722 0.772 . . . . 54.34 110.847 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 120.01 6.87 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.71 2.273 . . . . 70.42 112.332 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 320' ' ' ASP . . . . . 0.567 ' HA ' HG22 ' A' ' 323' ' ' VAL . 1.6 p-10 -58.58 -21.91 54.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.276 -0.42 . . . . 71.44 110.844 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -71.14 -10.2 59.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.471 . . . . 74.3 110.877 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -111.88 17.68 19.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 73.13 110.905 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 323' ' ' VAL . . . . . 0.567 HG22 ' HA ' ' A' ' 320' ' ' ASP . 18.0 m -149.07 151.89 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.11 -0.496 . . . . 62.13 111.125 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 324' ' ' LYS . . . . . 0.57 ' HG3' HG21 ' A' ' 275' ' ' ILE . 8.9 mtpp -118.94 118.63 32.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 75.33 110.934 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.758 HD12 ' CZ3' ' A' ' 307' ' ' TRP . 0.7 OUTLIER -65.02 130.56 43.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.208 -0.451 . . . . 75.43 110.855 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.484 HD12 ' CB ' ' A' ' 271' ' ' TYR . 20.2 mt . . . . . 0 C--N 1.327 -0.384 0 CA-C-O 121.631 0.729 . . . . 63.4 110.855 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.805 0.336 . . . . 70.33 110.844 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 271' ' ' TYR . . . . . 0.592 ' HB3' HD12 ' A' ' 326' ' ' LEU . 7.6 m-85 -115.94 142.78 46.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.243 -0.435 . . . . 75.13 110.943 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 272' ' ' CYS . . . . . 0.476 ' SG ' HD13 ' A' ' 296' ' ' LEU . 22.7 m -127.29 146.32 50.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.113 -0.494 . . . . 73.12 110.919 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -102.9 126.11 49.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 64.3 110.912 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 274' ' ' VAL . . . . . 0.43 HG21 ' HB ' ' A' ' 288' ' ' ILE . 47.8 t -64.84 112.23 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.309 -0.405 . . . . 72.42 111.136 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 27.0 pt -85.74 -32.09 6.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.269 -0.423 . . . . 54.41 111.127 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -138.53 157.96 71.28 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.624 0.726 . . . . 75.11 110.878 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 156.66 62.77 Favored 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 122.674 2.249 . . . . 62.33 112.345 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -172.41 108.21 0.2 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 63.34 110.924 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 279' ' ' GLU . . . . . 0.712 ' HA ' HG23 ' A' ' 287' ' ' THR . 25.2 tt0 -88.15 138.97 30.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 70.11 110.866 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -68.45 116.52 9.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 74.43 111.099 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -56.47 -28.08 58.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 73.23 110.907 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -153.73 175.93 12.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 70.22 110.885 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -58.8 -25.81 63.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.145 -0.48 . . . . 74.52 110.855 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.16 -23.57 61.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 65.32 110.86 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -94.96 167.96 11.08 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.179 -0.464 . . . . 73.41 110.909 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.626 HD23 ' CD2' ' A' ' 318' ' ' PHE . 14.6 tp -119.01 136.67 54.0 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.163 -0.471 . . . . 61.43 110.9 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.712 HG23 ' HA ' ' A' ' 279' ' ' GLU . 85.6 m -91.89 146.08 24.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.159 -0.473 . . . . 74.34 111.144 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 288' ' ' ILE . . . . . 0.43 ' HB ' HG21 ' A' ' 274' ' ' VAL . 33.7 pt -149.49 143.3 18.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.281 -0.418 . . . . 63.2 111.183 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 20.2 mtpp -117.26 140.05 50.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.148 -0.478 . . . . 70.04 110.919 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -51.43 121.84 6.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 71.4 110.924 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 115.2 -31.03 6.42 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.727 -0.749 . . . . 70.21 112.48 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -79.4 160.39 26.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.725 0.298 . . . . 74.23 110.889 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.463 HG23 ' O ' ' A' ' 272' ' ' CYS . 3.2 mp -115.95 128.05 73.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 63.53 111.115 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 294' ' ' VAL . . . . . 0.852 HG22 HD13 ' A' ' 311' ' ' LEU . 99.8 t -105.03 138.15 31.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 70.35 111.127 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 295' ' ' THR . . . . . 0.569 HG23 ' CE1' ' A' ' 271' ' ' TYR . 3.3 m -85.98 117.7 25.0 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.174 -0.466 . . . . 61.34 111.151 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.476 HD13 ' SG ' ' A' ' 272' ' ' CYS . 5.2 tp -69.88 110.66 5.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.243 -0.435 . . . . 61.44 110.865 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 27.5 mm -100.12 -26.12 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 63.53 111.079 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -162.11 178.31 8.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 74.34 110.862 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 40.9 mttt -141.38 112.95 7.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 75.24 110.885 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -49.66 161.74 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 74.23 110.902 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.8 t -113.53 -69.05 0.89 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 74.44 110.86 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 38.6 mt -66.97 -12.98 15.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.432 . . . . 74.52 111.172 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -97.36 70.46 2.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.135 -0.484 . . . . 74.33 110.843 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.405 ' O ' HG13 ' A' ' 304' ' ' VAL . 6.3 p -51.35 121.89 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 73.54 111.176 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.24 21.0 43.14 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.695 -0.764 . . . . 54.24 112.461 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 42.5 m95 -136.42 134.27 37.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.781 0.324 . . . . 74.41 110.896 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 307' ' ' TRP . . . . . 0.444 ' CZ3' HD12 ' A' ' 325' ' ' LEU . 22.0 m0 -129.2 156.96 43.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.112 -0.495 . . . . 75.32 110.932 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -101.33 113.41 26.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.283 -0.417 . . . . 62.15 110.869 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -124.7 -173.93 13.89 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.802 -0.713 . . . . 54.24 112.493 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 72.8 tt0 -137.74 136.22 37.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.897 0.379 . . . . 73.41 110.91 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.852 HD13 HG22 ' A' ' 294' ' ' VAL . 3.1 tp -149.2 134.4 18.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.454 . . . . 63.35 111.003 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 2.9 m120 58.86 29.94 19.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 64.35 110.901 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 81.2 -0.91 86.81 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.733 -0.746 . . . . 34.52 112.457 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 314' ' ' ARG . . . . . 0.435 ' HG2' HD13 ' A' ' 286' ' ' LEU . 9.5 ttp85 -103.5 111.46 23.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.869 0.366 . . . . 74.34 110.893 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 9.5 ttp180 -96.66 117.03 30.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 75.22 110.861 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -146.89 -155.23 6.45 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.793 -0.717 . . . . 72.52 112.539 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 23.1 m -118.48 155.41 20.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.817 0.342 . . . . 73.54 111.159 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 318' ' ' PHE . . . . . 0.745 ' CE2' HG11 ' A' ' 294' ' ' VAL . 6.7 p90 -163.72 156.11 15.23 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.569 0.7 . . . . 62.45 110.92 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.82 119.24 6.21 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.682 2.255 . . . . 62.42 112.337 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 320' ' ' ASP . . . . . 0.584 ' HA ' HG22 ' A' ' 323' ' ' VAL . 2.7 t70 -60.42 -18.97 54.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.191 -0.459 . . . . 74.14 110.841 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -68.24 -12.51 61.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 74.45 110.884 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -108.29 14.47 24.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 62.54 110.872 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 323' ' ' VAL . . . . . 0.584 HG22 ' HA ' ' A' ' 320' ' ' ASP . 18.0 m -148.86 149.54 14.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 74.0 111.085 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 10.2 ttmm -121.49 134.17 55.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 64.1 110.876 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.444 HD12 ' CZ3' ' A' ' 307' ' ' TRP . 0.0 OUTLIER -64.95 126.42 27.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 64.32 110.91 179.965 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.592 HD12 ' HB3' ' A' ' 271' ' ' TYR . 20.4 mt . . . . . 0 C--N 1.329 -0.314 0 CA-C-O 121.611 0.72 . . . . 72.42 110.909 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 4.1 p . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.821 0.343 . . . . 34.22 110.813 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.33 112.33 3.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 74.42 110.816 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -135.58 168.19 19.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 71.41 110.822 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 6.1 p -110.18 131.66 54.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.473 . . . . 73.53 110.873 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 4.1 tpm_? -131.55 67.11 1.53 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.064 -0.516 . . . . 75.31 110.81 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 7.1 t -148.25 156.05 42.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 73.23 111.097 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -90.74 -42.03 10.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 70.41 110.878 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 2.1 m -77.76 78.73 4.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.128 -0.487 . . . . 74.02 110.913 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -116.17 -176.06 2.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 65.34 110.854 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -155.15 141.59 18.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 54.34 110.838 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' TYR . . . . . 0.542 ' HB3' HD12 ' A' ' 326' ' ' LEU . 8.6 m-85 -128.11 149.39 50.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 73.51 110.863 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 25.7 m -138.55 148.19 43.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.098 -0.501 . . . . 73.33 110.843 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -102.95 123.05 45.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 71.51 110.912 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 274' ' ' VAL . . . . . 0.655 HG13 HD12 ' A' ' 288' ' ' ILE . 22.4 t -61.0 109.02 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 61.21 111.131 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 36.0 pt -83.64 -28.22 7.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 60.52 111.133 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -145.41 159.3 48.89 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.624 0.726 . . . . 75.32 110.851 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 159.78 52.15 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.651 2.234 . . . . 60.44 112.364 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -176.1 110.39 0.1 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.435 . . . . 74.24 110.929 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 279' ' ' GLU . . . . . 0.716 ' HA ' HG23 ' A' ' 287' ' ' THR . 21.7 tp10 -89.46 135.04 33.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.089 -0.505 . . . . 70.32 110.945 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -65.82 113.26 4.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 61.44 111.038 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -58.06 -26.44 62.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.436 . . . . 73.4 110.986 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -154.95 170.77 20.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 65.51 110.885 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -56.22 -25.99 49.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 60.24 110.882 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -70.05 -26.55 64.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.155 -0.475 . . . . 73.3 110.929 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -94.99 169.56 10.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 64.15 110.89 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.598 HD23 ' CD2' ' A' ' 318' ' ' PHE . 14.0 tp -120.57 137.24 54.5 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.16 -0.473 . . . . 71.55 110.931 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.716 HG23 ' HA ' ' A' ' 279' ' ' GLU . 91.5 m -90.9 145.25 24.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 72.11 111.109 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 288' ' ' ILE . . . . . 0.655 HD12 HG13 ' A' ' 274' ' ' VAL . 48.1 pt -150.26 142.95 17.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 72.14 111.094 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 44.4 mttm -114.36 139.8 49.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 63.3 110.894 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -51.94 129.84 27.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.15 -0.477 . . . . 62.05 110.919 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 102.27 -25.59 27.18 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.744 -0.741 . . . . 51.02 112.534 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.496 ' O ' HD13 ' A' ' 293' ' ' ILE . 6.6 m-20 -76.49 174.53 10.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.752 0.31 . . . . 60.41 110.856 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.496 HD13 ' O ' ' A' ' 292' ' ' ASP . 31.4 mm -124.94 125.99 70.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 74.12 111.139 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 294' ' ' VAL . . . . . 0.682 HG11 ' CE2' ' A' ' 318' ' ' PHE . 78.5 t -107.82 135.1 47.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 71.23 111.114 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 88.8 m -88.17 111.52 21.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.209 -0.45 . . . . 75.33 111.176 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.559 HD11 ' HB3' ' A' ' 307' ' ' TRP . 7.6 tp -69.97 118.96 13.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 71.5 110.899 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 61.7 mt -104.73 -47.6 9.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.142 -0.481 . . . . 45.12 111.167 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -135.21 178.13 7.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 74.21 110.896 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 66.1 mttt -141.41 112.82 7.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.104 -0.498 . . . . 72.43 110.955 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -50.53 165.18 0.1 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 74.23 110.961 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 3.2 t -115.14 -69.2 0.87 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.21 -0.45 . . . . 73.32 110.887 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 1.9 mp -67.92 -12.4 15.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 75.52 111.159 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -95.86 68.18 2.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.18 -0.463 . . . . 72.04 110.878 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 6.6 p -51.51 122.76 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 71.33 111.135 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.69 21.92 38.44 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.679 -0.772 . . . . 55.41 112.459 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 56.5 m95 -140.0 138.07 35.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.761 0.315 . . . . 73.12 110.833 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 307' ' ' TRP . . . . . 0.76 ' CZ3' HD12 ' A' ' 325' ' ' LEU . 20.6 m0 -133.18 155.91 48.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.167 -0.47 . . . . 73.05 110.893 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -99.38 121.95 41.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.277 -0.42 . . . . 72.41 110.9 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -140.69 -174.41 13.98 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.77 -0.729 . . . . 15.42 112.51 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -134.41 145.76 49.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.956 0.407 . . . . 72.14 110.846 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.414 HD13 HG22 ' A' ' 294' ' ' VAL . 5.1 tp -155.73 131.81 10.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.073 -0.512 . . . . 75.34 110.922 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 2.9 m120 56.96 29.96 17.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 73.32 110.918 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 79.14 19.14 72.96 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.717 -0.754 . . . . 64.41 112.539 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -120.71 114.26 21.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.859 0.361 . . . . 74.45 110.86 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 42.0 ttt180 -96.97 132.13 43.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.113 -0.494 . . . . 72.44 110.878 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -170.72 -159.94 17.96 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.741 -0.742 . . . . 72.22 112.476 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 27.7 m -116.76 147.64 20.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.781 0.324 . . . . 54.14 111.163 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 318' ' ' PHE . . . . . 0.682 ' CE2' HG11 ' A' ' 294' ' ' VAL . 7.1 p90 -149.74 156.77 38.69 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.701 0.762 . . . . 72.55 110.82 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.8 121.76 8.44 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.651 2.234 . . . . 71.01 112.332 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 320' ' ' ASP . . . . . 0.531 ' HA ' HG22 ' A' ' 323' ' ' VAL . 1.7 p-10 -61.04 -19.01 60.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 75.05 110.921 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -73.85 -9.74 58.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.491 . . . . 63.5 110.883 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -113.64 22.03 14.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 73.54 110.828 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 323' ' ' VAL . . . . . 0.531 HG22 ' HA ' ' A' ' 320' ' ' ASP . 18.7 m -148.94 156.38 7.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 74.02 111.098 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 20.4 tttt -121.87 114.81 21.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.473 . . . . 74.14 110.854 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.76 HD12 ' CZ3' ' A' ' 307' ' ' TRP . 0.8 OUTLIER -64.98 125.9 26.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 72.21 110.89 179.922 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.737 HD13 ' CD1' ' A' ' 330' ' ' PHE . 20.4 mt -68.9 159.13 84.01 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.559 0.695 . . . . 63.14 110.916 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.66 167.75 23.4 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.694 2.263 . . . . 63.35 112.353 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -16.71 37.41 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.71 2.273 . . . . 72.15 112.302 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -84.45 -42.94 15.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 64.31 110.906 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 330' ' ' PHE . . . . . 0.737 ' CD1' HD13 ' A' ' 326' ' ' LEU . 11.3 t80 -65.69 112.81 3.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 72.42 110.803 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -139.27 107.62 5.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.122 -0.49 . . . . 75.43 110.812 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 21.2 ttmm -61.28 -58.83 6.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.098 -0.501 . . . . 62.41 110.894 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.225 -0.443 . . . . 74.53 110.839 179.997 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 6.4 t . . . . . 0 CA--C 1.526 0.043 0 CA-C-O 120.936 0.398 . . . . 73.41 110.77 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 4.6 ptt? -153.63 170.79 20.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.056 -0.52 . . . . 74.34 110.889 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -105.49 -65.16 1.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 75.52 110.863 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 66.7 p -86.73 115.47 24.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 73.41 110.886 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 15.1 mmt85 -55.85 157.52 4.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 75.25 110.867 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 17.5 m -54.51 146.26 16.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.093 -0.503 . . . . 55.33 111.118 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -113.95 49.09 1.02 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 72.14 110.897 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 46.5 m 55.13 42.42 30.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 70.3 110.9 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -70.55 177.93 3.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.152 -0.476 . . . . 75.54 110.925 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -143.44 132.17 22.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 74.2 110.913 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 271' ' ' TYR . . . . . 0.492 ' HB3' HD12 ' A' ' 326' ' ' LEU . 16.7 m-85 -129.62 152.86 48.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 63.44 110.9 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 272' ' ' CYS . . . . . 0.447 ' SG ' HD13 ' A' ' 296' ' ' LEU . 31.8 m -139.17 153.2 47.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 71.55 110.87 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 38.8 tttt -110.57 119.18 38.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 52.41 110.913 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 274' ' ' VAL . . . . . 0.819 HG13 HD12 ' A' ' 288' ' ' ILE . 26.2 t -56.0 111.32 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 75.11 111.128 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 34.5 pt -87.43 -27.31 5.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 74.43 111.103 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -144.44 160.09 49.4 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.64 0.733 . . . . 71.11 110.856 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 158.57 56.52 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.676 2.251 . . . . 75.1 112.327 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -173.95 107.42 0.13 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.455 . . . . 74.31 110.868 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 279' ' ' GLU . . . . . 0.613 ' HA ' HG23 ' A' ' 287' ' ' THR . 30.0 tt0 -91.94 118.06 30.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.14 -0.482 . . . . 64.52 110.866 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -51.74 119.86 4.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 45.53 111.087 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -66.44 -26.19 67.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.439 . . . . 73.42 110.916 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -150.46 168.79 23.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.209 -0.45 . . . . 75.34 110.914 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -56.62 -25.9 54.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 64.11 110.875 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -70.05 -25.81 63.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 54.32 110.854 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -95.03 166.32 12.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.243 -0.435 . . . . 73.43 110.887 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.641 HD23 ' CD2' ' A' ' 318' ' ' PHE . 14.1 tp -115.97 137.1 52.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.157 -0.474 . . . . 71.24 110.944 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.613 HG23 ' HA ' ' A' ' 279' ' ' GLU . 91.4 m -91.15 144.48 25.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 64.15 111.139 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 288' ' ' ILE . . . . . 0.819 HD12 HG13 ' A' ' 274' ' ' VAL . 34.0 pt -150.47 146.77 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 61.42 111.092 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 289' ' ' LYS . . . . . 0.401 ' C ' HG11 ' A' ' 274' ' ' VAL . 25.7 mtpt -122.27 143.6 49.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 51.44 110.85 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 66.5 tt0 -52.0 130.08 28.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 73.02 110.871 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 100.79 -25.53 28.01 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.738 -0.744 . . . . 74.21 112.503 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.69 170.91 15.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.78 0.324 . . . . 73.51 110.861 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 48.5 mm -123.4 128.49 74.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 54.03 111.187 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 294' ' ' VAL . . . . . 0.704 HG11 ' CE2' ' A' ' 318' ' ' PHE . 94.1 t -108.62 138.06 37.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.234 -0.439 . . . . 62.53 111.162 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 47.1 m -94.07 113.35 25.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.208 -0.451 . . . . 73.24 111.116 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.447 HD13 ' SG ' ' A' ' 272' ' ' CYS . 4.1 tp -69.95 117.6 11.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.214 -0.448 . . . . 72.3 110.948 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 69.2 mt -107.06 -28.32 2.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.439 . . . . 63.12 111.127 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -155.05 178.11 10.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 73.13 110.861 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 8.7 mttm -141.53 112.94 7.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 75.45 110.915 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -49.92 162.31 0.2 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.284 -0.417 . . . . 73.2 110.833 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.8 t -113.58 -68.97 0.89 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 74.21 110.888 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 38.9 mt -67.17 -12.99 16.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 73.41 111.149 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -96.7 70.36 2.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.485 . . . . 54.11 110.873 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.404 ' O ' HG13 ' A' ' 304' ' ' VAL . 6.5 p -51.48 122.17 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 71.5 111.232 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.09 19.51 50.27 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.812 -0.709 . . . . 73.32 112.497 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -135.47 137.79 42.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.772 0.32 . . . . 74.22 110.917 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 307' ' ' TRP . . . . . 0.789 ' CZ3' HD12 ' A' ' 325' ' ' LEU . 22.5 m0 -131.76 158.78 40.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.25 -0.432 . . . . 75.31 110.943 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -103.5 120.38 40.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.307 -0.406 . . . . 42.22 110.841 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -136.53 -169.74 11.79 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.789 -0.719 . . . . 64.34 112.458 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -137.89 147.87 44.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.826 0.346 . . . . 72.43 110.9 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.595 HD13 HG22 ' A' ' 294' ' ' VAL . 9.9 tp -150.22 123.19 8.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 63.52 110.913 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 3.3 m120 55.55 30.61 15.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.256 -0.429 . . . . 75.11 110.895 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 92.13 -16.58 59.31 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.758 -0.734 . . . . 74.53 112.441 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -85.52 112.53 21.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.87 0.367 . . . . 73.51 110.872 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 42.3 mtp180 -99.83 135.45 41.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.101 -0.5 . . . . 61.24 110.869 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -172.61 -163.33 26.24 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.733 -0.746 . . . . 74.35 112.488 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 27.7 m -109.59 160.55 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.866 0.365 . . . . 71.44 111.116 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 318' ' ' PHE . . . . . 0.704 ' CE2' HG11 ' A' ' 294' ' ' VAL . 4.6 p90 -165.2 156.21 12.57 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.621 0.724 . . . . 74.44 110.885 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 118.77 5.88 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.685 2.256 . . . . 70.12 112.268 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 320' ' ' ASP . . . . . 0.535 ' HA ' HG22 ' A' ' 323' ' ' VAL . 2.9 t70 -60.13 -19.74 55.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 72.34 110.874 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -73.26 -8.48 55.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 61.14 110.863 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -114.78 21.38 14.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 75.12 110.888 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 323' ' ' VAL . . . . . 0.535 HG22 ' HA ' ' A' ' 320' ' ' ASP . 18.5 m -148.74 146.34 17.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.113 -0.494 . . . . 71.41 111.056 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 15.2 ttmm -106.83 109.77 21.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.114 -0.493 . . . . 62.22 110.95 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.789 HD12 ' CZ3' ' A' ' 307' ' ' TRP . 2.6 tt -64.93 119.03 9.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 73.02 110.954 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.492 HD12 ' HB3' ' A' ' 271' ' ' TYR . 20.3 mt -61.45 159.25 33.18 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.549 0.69 . . . . 74.45 110.9 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 167.81 23.46 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.579 2.186 . . . . 74.21 112.336 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -17.24 37.56 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.696 2.264 . . . . 52.12 112.324 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -77.69 -41.47 37.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.216 -0.447 . . . . 70.35 110.869 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 330' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -64.64 114.24 4.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 63.42 110.865 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 -147.71 107.58 4.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 73.14 110.909 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -95.23 -66.14 0.93 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.164 -0.471 . . . . 65.24 110.886 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.245 -0.434 . . . . 65.25 110.905 179.957 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 9.5 m . . . . . 0 CA--C 1.526 0.034 0 CA-C-O 120.885 0.374 . . . . 51.11 110.825 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -102.04 112.21 24.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.101 -0.5 . . . . 74.33 110.916 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -170.21 135.44 1.31 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 73.13 110.889 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.13 156.93 3.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 74.31 110.926 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.48 122.76 26.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.46 . . . . 65.42 110.862 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 266' ' ' THR . . . . . 0.595 HG23 ' H ' ' A' ' 268' ' ' SER . 8.9 t -67.3 -31.63 72.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 75.1 111.192 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 19.5 ttpt 52.15 31.06 8.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 74.44 110.969 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.595 ' H ' HG23 ' A' ' 266' ' ' THR . 8.2 t -141.13 29.67 1.82 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.146 -0.479 . . . . 70.45 110.795 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 7.5 tttp -56.52 176.29 0.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 72.01 110.877 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -139.97 117.79 11.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 61.44 110.813 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 271' ' ' TYR . . . . . 0.567 ' HB3' HD12 ' A' ' 326' ' ' LEU . 14.8 m-85 -116.43 148.06 41.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 71.14 110.951 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 24.8 m -133.42 146.69 51.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.076 -0.511 . . . . 45.44 110.915 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 49.9 tttt -106.06 122.12 45.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 72.54 110.885 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 274' ' ' VAL . . . . . 0.467 HG13 HD12 ' A' ' 288' ' ' ILE . 23.0 t -61.66 113.21 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 73.14 111.121 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 28.3 pt -88.21 -29.97 5.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.138 -0.483 . . . . 72.43 111.068 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -140.1 158.76 66.39 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.622 0.725 . . . . 72.32 110.855 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 156.04 64.42 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.636 2.224 . . . . 41.23 112.375 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -173.68 107.96 0.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 75.15 110.883 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 279' ' ' GLU . . . . . 0.682 ' HA ' HG23 ' A' ' 287' ' ' THR . 13.9 tt0 -87.99 142.4 27.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.109 -0.496 . . . . 75.42 110.894 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -70.52 113.02 7.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.126 -0.488 . . . . 54.24 111.091 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -58.01 -25.84 61.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 74.13 110.929 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -155.72 170.25 22.46 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.195 -0.457 . . . . 74.55 110.898 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -56.51 -25.21 50.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 63.3 110.818 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -72.13 -25.02 61.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 61.42 110.843 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -95.02 167.1 11.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 73.03 110.871 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.644 HD23 ' CD2' ' A' ' 318' ' ' PHE . 14.3 tp -115.01 136.82 52.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 71.22 110.958 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.682 HG23 ' HA ' ' A' ' 279' ' ' GLU . 86.6 m -92.12 142.07 27.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 72.12 111.115 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 288' ' ' ILE . . . . . 0.531 HG21 HG21 ' A' ' 294' ' ' VAL . 31.9 pt -148.78 146.48 17.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 73.31 111.143 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -119.33 140.72 49.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 62.3 110.828 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -51.97 128.67 24.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 71.2 110.916 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 104.14 -23.97 30.52 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.691 -0.766 . . . . 42.52 112.426 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.16 175.3 10.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.744 0.306 . . . . 52.13 110.913 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 39.9 mm -125.34 128.81 72.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.199 -0.455 . . . . 72.4 111.117 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 294' ' ' VAL . . . . . 0.692 HG11 ' CE2' ' A' ' 318' ' ' PHE . 98.3 t -109.77 137.99 39.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.49 . . . . 74.5 111.172 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 40.5 m -91.16 111.68 23.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 64.41 111.186 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.44 HD11 ' HB3' ' A' ' 307' ' ' TRP . 5.9 tp -70.07 117.56 11.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.238 -0.437 . . . . 52.53 110.858 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 64.4 mt -106.97 -34.67 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 71.24 111.186 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -147.45 178.18 8.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.134 -0.484 . . . . 60.1 110.84 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 35.8 mttp -141.45 112.95 7.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 74.02 110.893 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -49.74 165.79 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 63.44 110.899 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.5 t -118.15 -69.38 0.85 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.214 -0.448 . . . . 53.13 110.872 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 47.2 mt -65.27 -14.36 16.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 72.14 111.165 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -98.32 71.7 2.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 44.34 110.9 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 59.3 t -51.52 122.31 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 72.34 111.138 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.61 20.45 44.25 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.731 -0.747 . . . . 42.13 112.488 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 50.8 m95 -135.23 134.27 39.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.713 0.292 . . . . 70.33 110.952 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 307' ' ' TRP . . . . . 0.44 ' HB3' HD11 ' A' ' 296' ' ' LEU . 24.4 m0 -129.66 156.64 43.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.25 -0.432 . . . . 64.44 110.955 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -101.98 126.28 48.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.277 -0.42 . . . . 75.33 110.868 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -143.77 -167.84 11.98 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.705 -0.759 . . . . 73.33 112.454 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -138.32 147.53 43.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.875 0.369 . . . . 75.41 110.936 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 4.8 tp -157.95 132.05 8.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 70.24 110.932 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 2.9 m120 56.35 29.99 16.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 74.44 110.911 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 79.79 18.44 72.83 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.723 -0.751 . . . . 63.24 112.579 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 16.0 mmt180 -121.58 113.53 19.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.767 0.318 . . . . 70.4 110.878 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -97.22 132.05 43.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.244 -0.434 . . . . 74.3 110.895 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -170.07 -163.67 24.49 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.827 -0.702 . . . . 63.23 112.54 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 8.3 m -108.12 157.27 8.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.86 0.362 . . . . 65.42 111.113 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 318' ' ' PHE . . . . . 0.692 ' CE2' HG11 ' A' ' 294' ' ' VAL . 5.9 p90 -163.17 156.08 16.26 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.714 0.769 . . . . 74.41 110.83 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.69 117.47 5.1 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.691 2.261 . . . . 51.21 112.398 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 320' ' ' ASP . . . . . 0.577 ' HA ' HG22 ' A' ' 323' ' ' VAL . 2.9 t70 -57.77 -22.56 47.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.252 -0.431 . . . . 65.5 110.92 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -68.85 -12.26 61.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 70.12 110.861 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -108.46 14.72 24.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 72.52 110.857 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 323' ' ' VAL . . . . . 0.577 HG22 ' HA ' ' A' ' 320' ' ' ASP . 17.9 m -148.69 138.11 15.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.475 . . . . 72.53 111.11 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.74 123.06 48.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 72.31 110.905 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 2.5 mt -64.93 122.67 17.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.439 . . . . 70.31 110.918 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.762 HD13 ' CD1' ' A' ' 330' ' ' PHE . 20.2 mt -55.66 159.21 5.25 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.533 0.682 . . . . 60.44 110.922 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.74 167.76 23.47 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.654 2.236 . . . . 73.33 112.422 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -20.49 34.74 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.695 2.264 . . . . 61.51 112.342 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -79.54 -32.83 42.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 75.13 110.871 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 330' ' ' PHE . . . . . 0.762 ' CD1' HD13 ' A' ' 326' ' ' LEU . 10.6 t80 -78.38 115.28 17.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 72.01 110.825 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -141.56 107.05 5.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 52.44 110.92 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 15.9 ttmt -76.75 -52.95 8.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 45.35 110.903 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.236 -0.438 . . . . 63.02 110.861 -179.997 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 3.1 p . . . . . 0 N--CA 1.458 -0.062 0 CA-C-O 120.859 0.362 . . . . 62.44 110.882 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 1.7 ptp -110.39 138.15 47.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.1 -0.5 . . . . 73.2 110.897 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -120.2 109.19 15.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 74.21 110.866 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 58.6 m -99.67 57.43 1.01 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 71.24 110.853 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 14.1 tpp180 -118.01 48.8 1.33 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.058 -0.519 . . . . 63.55 110.86 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 15.3 t -61.27 138.47 58.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 73.04 111.11 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 46.5 tttm -74.16 -47.0 38.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 71.42 110.881 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 9.4 t -81.39 84.33 6.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 65.24 110.879 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 28.6 mtpt -101.53 -178.36 3.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.463 . . . . 75.23 110.936 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -140.31 128.21 21.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.269 -0.423 . . . . 74.34 110.853 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 271' ' ' TYR . . . . . 0.532 ' HB3' HD12 ' A' ' 326' ' ' LEU . 11.5 m-85 -128.23 152.88 47.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.453 . . . . 72.2 110.948 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 26.2 m -138.78 146.48 41.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.118 -0.492 . . . . 73.44 110.888 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 14.3 tttp -103.0 117.35 34.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 74.43 110.823 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 274' ' ' VAL . . . . . 0.713 HG13 HD12 ' A' ' 288' ' ' ILE . 26.2 t -55.91 112.32 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 70.13 111.132 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 37.9 pt -88.33 -28.08 5.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.175 -0.466 . . . . 54.2 111.134 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -142.6 159.71 56.43 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.61 0.719 . . . . 53.42 110.884 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 160.05 51.15 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.738 2.292 . . . . 74.33 112.263 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -173.29 109.78 0.18 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 74.41 110.91 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 279' ' ' GLU . . . . . 0.656 ' HA ' HG23 ' A' ' 287' ' ' THR . 42.9 tt0 -91.08 127.0 36.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.115 -0.493 . . . . 51.52 110.887 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -58.82 117.63 4.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 63.22 111.074 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -65.84 -25.8 67.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 74.12 110.871 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 -153.0 168.41 25.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 73.41 110.923 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -56.14 -26.3 49.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 44.34 110.886 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -71.02 -25.22 62.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 63.31 110.88 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 285' ' ' GLU . . . . . 0.504 ' OE1' HG23 ' A' ' 317' ' ' VAL . 6.2 mm-40 -94.86 164.79 12.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 71.24 110.95 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.594 HD12 ' H ' ' A' ' 287' ' ' THR . 14.1 tp -115.21 137.12 52.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.46 . . . . 60.32 110.962 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.656 HG23 ' HA ' ' A' ' 279' ' ' GLU . 85.0 m -91.81 144.74 25.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.221 -0.445 . . . . 75.35 111.143 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 288' ' ' ILE . . . . . 0.713 HD12 HG13 ' A' ' 274' ' ' VAL . 44.4 pt -150.34 144.7 17.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 52.12 111.13 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 18.2 mtmm -116.14 140.05 49.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 70.12 110.87 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -51.89 128.56 24.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 72.24 110.895 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 104.02 -21.3 38.38 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.679 -0.772 . . . . 62.34 112.382 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -81.58 172.52 13.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.795 0.331 . . . . 54.4 110.846 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.523 ' O ' HD13 ' A' ' 311' ' ' LEU . 76.2 mt -123.61 126.51 73.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.488 . . . . 75.25 111.127 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 294' ' ' VAL . . . . . 0.72 HG11 ' CE2' ' A' ' 318' ' ' PHE . 93.1 t -109.63 136.05 46.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 74.31 111.116 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 95.4 m -87.72 113.02 23.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.21 -0.45 . . . . 73.3 111.138 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.578 HD11 ' HB3' ' A' ' 307' ' ' TRP . 8.0 tp -70.01 112.65 6.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.277 -0.42 . . . . 72.23 110.943 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 297' ' ' ILE . . . . . 0.406 HD11 ' HB2' ' A' ' 310' ' ' GLU . 50.5 mt -98.29 -49.19 11.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 71.43 111.217 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -132.71 178.43 6.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 74.22 110.805 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 17.6 mttp -141.82 112.96 7.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 73.31 110.936 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -50.15 162.15 0.23 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.27 -0.423 . . . . 74.22 110.857 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 3.0 t -113.87 -68.92 0.89 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 73.43 110.907 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 302' ' ' ILE . . . . . 0.406 HG22 ' O ' ' A' ' 302' ' ' ILE . 34.1 mt -68.54 -12.01 15.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 74.44 111.075 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -97.96 69.72 2.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 61.44 110.935 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 6.6 p -51.47 122.6 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 51.21 111.129 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 91.04 17.28 51.81 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.692 -0.766 . . . . 31.13 112.413 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 34.7 m95 -133.98 135.89 43.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.743 0.306 . . . . 75.33 110.949 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 307' ' ' TRP . . . . . 0.798 ' CZ3' HD12 ' A' ' 325' ' ' LEU . 22.4 m0 -132.84 155.26 49.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.431 . . . . 74.32 110.883 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -97.04 121.31 38.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 75.31 110.836 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 309' ' ' GLY . . . . . 0.45 ' O ' HD22 ' A' ' 286' ' ' LEU . . . -138.68 179.82 18.07 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.735 -0.745 . . . . 74.24 112.437 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 310' ' ' GLU . . . . . 0.406 ' HB2' HD11 ' A' ' 297' ' ' ILE . 34.1 tt0 -133.72 141.67 47.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.918 0.389 . . . . 70.54 110.841 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.523 HD13 ' O ' ' A' ' 293' ' ' ILE . 24.8 tp -155.39 136.8 14.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.11 -0.496 . . . . 63.24 110.86 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 3.0 m120 56.92 30.55 18.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 61.41 110.9 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 75.82 19.46 78.91 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.788 -0.72 . . . . 71.2 112.464 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -118.61 117.82 29.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.726 0.298 . . . . 64.13 110.82 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 60.6 ttt180 -99.89 129.63 45.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 74.44 110.866 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -170.7 -162.76 23.58 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.792 -0.718 . . . . 54.22 112.512 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.504 HG23 ' OE1' ' A' ' 285' ' ' GLU . 12.4 m -115.48 150.2 17.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.919 0.39 . . . . 54.42 111.068 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 318' ' ' PHE . . . . . 0.72 ' CE2' HG11 ' A' ' 294' ' ' VAL . 8.5 p90 -155.16 155.89 30.54 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.63 0.728 . . . . 74.54 110.952 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 117.94 5.38 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.698 2.266 . . . . 71.41 112.313 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 320' ' ' ASP . . . . . 0.565 ' HA ' HG22 ' A' ' 323' ' ' VAL . 3.1 t70 -59.41 -20.7 56.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 74.34 110.885 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -68.97 -12.08 61.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 72.03 110.881 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -108.84 16.64 22.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 62.2 110.913 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 323' ' ' VAL . . . . . 0.565 HG22 ' HA ' ' A' ' 320' ' ' ASP . 18.6 m -148.81 150.87 13.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.104 -0.498 . . . . 32.51 111.09 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 47.8 tttp -109.18 115.3 29.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 73.23 110.855 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.798 HD12 ' CZ3' ' A' ' 307' ' ' TRP . 2.8 tt -65.19 116.03 6.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 75.34 110.964 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.532 HD12 ' HB3' ' A' ' 271' ' ' TYR . 20.4 mt -55.81 159.26 5.51 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.634 0.73 . . . . 71.3 110.885 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.77 167.74 23.59 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.686 2.257 . . . . 74.13 112.332 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.75 -18.25 37.14 Favored 'Trans proline' 0 N--CA 1.466 -0.117 0 C-N-CA 122.708 2.272 . . . . 74.42 112.319 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -79.79 -40.6 28.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 63.01 110.906 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 330' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -64.16 114.12 3.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 70.13 110.863 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -149.17 107.2 3.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 73.44 110.964 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? -88.25 -52.08 5.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 73.01 110.946 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 71.21 110.905 179.979 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 16.1 t . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.9 0.381 . . . . 40.1 110.808 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 4.8 ptp -110.59 37.81 2.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.087 -0.506 . . . . 64.45 110.93 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -104.41 136.05 44.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.466 . . . . 73.33 110.827 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 79.4 p -84.28 152.02 24.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 75.55 110.891 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 62.8 mmt-85 -86.12 176.35 8.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.098 -0.501 . . . . 71.41 110.804 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 266' ' ' THR . . . . . 0.634 HG22 ' CE ' ' A' ' 269' ' ' LYS . 0.8 OUTLIER -81.41 95.18 6.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.103 -0.499 . . . . 41.44 111.167 -179.979 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 22.5 ttmt -58.4 -67.39 0.36 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 53.22 110.945 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 6.5 t -163.75 109.2 1.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.438 . . . . 63.51 110.839 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.634 ' CE ' HG22 ' A' ' 266' ' ' THR . 0.9 OUTLIER -102.08 179.25 4.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.14 -0.482 . . . . 65.34 110.922 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -144.49 118.84 9.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 63.31 110.818 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 271' ' ' TYR . . . . . 0.58 ' CE1' HG23 ' A' ' 295' ' ' THR . 10.0 m-85 -111.27 153.77 25.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 74.55 110.937 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 272' ' ' CYS . . . . . 0.432 ' SG ' HD13 ' A' ' 296' ' ' LEU . 26.7 m -136.0 145.63 46.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.105 -0.498 . . . . 73.13 110.821 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 3.0 ttpp -103.34 126.47 50.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 72.32 110.886 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 274' ' ' VAL . . . . . 0.517 HG13 HD12 ' A' ' 288' ' ' ILE . 22.0 t -61.1 114.46 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 72.13 111.106 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 0.414 HD11 ' O ' ' A' ' 321' ' ' ASN . 29.8 pt -89.16 -25.67 5.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 43.12 111.097 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -147.71 159.24 41.47 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.671 0.748 . . . . 75.43 110.897 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 155.48 65.75 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.624 2.216 . . . . 74.41 112.336 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -170.8 112.22 0.39 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 71.33 110.964 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 279' ' ' GLU . . . . . 0.605 ' HA ' HG23 ' A' ' 287' ' ' THR . 11.9 tt0 -93.81 130.39 39.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.445 . . . . 74.41 110.868 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -64.08 117.32 6.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.148 -0.478 . . . . 44.45 111.167 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 78.4 mm-40 -60.33 -25.57 65.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.238 -0.437 . . . . 73.34 110.924 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -155.91 176.26 12.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 75.15 110.865 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -58.48 -25.9 62.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.144 -0.48 . . . . 70.31 110.869 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -70.43 -26.38 63.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.172 -0.467 . . . . 74.12 110.849 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 285' ' ' GLU . . . . . 0.497 ' OE1' HG23 ' A' ' 317' ' ' VAL . 28.1 mm-40 -96.55 161.79 13.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 63.1 110.884 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.6 HD12 ' H ' ' A' ' 287' ' ' THR . 14.0 tp -115.25 136.65 52.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 75.44 110.94 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.605 HG23 ' HA ' ' A' ' 279' ' ' GLU . 90.5 m -90.57 144.85 25.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 61.2 111.086 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 288' ' ' ILE . . . . . 0.517 HD12 HG13 ' A' ' 274' ' ' VAL . 44.8 pt -150.32 141.82 16.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 74.43 111.145 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.28 145.16 42.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 72.2 110.892 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -51.86 131.85 31.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 44.43 110.879 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.98 -26.23 24.29 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.759 -0.734 . . . . 72.52 112.454 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.405 ' HB2' HG21 ' A' ' 274' ' ' VAL . 14.4 m-20 -69.55 176.07 3.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.793 0.33 . . . . 74.32 110.843 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 68.8 mt -134.19 125.45 47.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 65.44 111.173 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 294' ' ' VAL . . . . . 0.748 HG11 ' CE2' ' A' ' 318' ' ' PHE . 98.3 t -111.28 138.08 41.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.159 -0.473 . . . . 65.22 111.107 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 295' ' ' THR . . . . . 0.58 HG23 ' CE1' ' A' ' 271' ' ' TYR . 6.3 m -87.39 118.51 26.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.188 -0.46 . . . . 74.23 111.131 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.432 HD13 ' SG ' ' A' ' 272' ' ' CYS . 6.1 tp -69.87 111.02 5.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 75.22 110.939 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 23.9 mm -100.49 -29.95 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 54.13 111.139 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -157.36 178.12 10.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 64.04 110.884 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 21.8 mttt -141.4 112.98 7.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.207 -0.451 . . . . 73.31 110.876 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -49.77 162.01 0.2 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 61.34 110.847 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.9 t -113.79 -68.98 0.89 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 62.03 110.882 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 30.3 mm -67.49 -12.44 15.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.441 . . . . 72.25 111.108 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -97.49 70.46 2.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 61.41 110.871 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.406 ' O ' HG13 ' A' ' 304' ' ' VAL . 6.0 p -51.4 121.24 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 62.2 111.107 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.39 24.8 30.14 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.697 -0.763 . . . . 70.2 112.475 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 57.5 m95 -140.23 133.43 29.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.751 0.31 . . . . 73.33 110.877 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 307' ' ' TRP . . . . . 0.713 ' CZ3' HD12 ' A' ' 325' ' ' LEU . 22.6 m0 -129.25 154.55 46.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.25 -0.432 . . . . 72.34 110.95 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -99.04 116.33 31.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.239 -0.437 . . . . 62.41 110.944 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -127.99 -173.72 13.55 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.724 -0.751 . . . . 65.33 112.529 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -135.97 134.95 39.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.836 0.351 . . . . 74.51 110.888 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.509 HD13 HG22 ' A' ' 294' ' ' VAL . 10.1 tp -143.99 130.75 20.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 53.11 110.95 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 2.9 m120 59.04 29.95 19.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.151 -0.477 . . . . 73.04 110.84 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 83.33 -1.48 88.64 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.692 -0.766 . . . . 74.43 112.451 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 314' ' ' ARG . . . . . 0.423 ' HG2' HD13 ' A' ' 286' ' ' LEU . 0.0 OUTLIER -103.01 119.33 38.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.829 0.347 . . . . 75.13 110.876 -179.873 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 70.1 mtt180 -98.82 131.0 45.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 71.23 110.906 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -162.09 -162.77 13.69 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.784 -0.722 . . . . 72.43 112.515 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.497 HG23 ' OE1' ' A' ' 285' ' ' GLU . 25.1 m -115.22 153.13 16.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.884 0.373 . . . . 51.34 111.111 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 318' ' ' PHE . . . . . 0.748 ' CE2' HG11 ' A' ' 294' ' ' VAL . 5.1 p90 -157.36 157.42 30.22 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.657 0.741 . . . . 60.43 110.815 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 119.96 6.82 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.679 2.253 . . . . 73.14 112.302 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 320' ' ' ASP . . . . . 0.57 ' HA ' HG22 ' A' ' 323' ' ' VAL . 1.5 p-10 -57.42 -23.36 49.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 64.43 110.878 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 321' ' ' ASN . . . . . 0.414 ' O ' HD11 ' A' ' 275' ' ' ILE . 10.8 m-20 -69.53 -11.58 60.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 73.13 110.922 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -109.45 15.48 22.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 72.41 110.85 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 323' ' ' VAL . . . . . 0.57 HG22 ' HA ' ' A' ' 320' ' ' ASP . 18.0 m -148.7 149.56 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 62.11 111.217 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -117.02 117.6 30.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 71.1 110.862 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.713 HD12 ' CZ3' ' A' ' 307' ' ' TRP . 1.1 tt -65.03 125.01 23.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 64.04 110.893 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.767 HD13 ' CD1' ' A' ' 330' ' ' PHE . 20.7 mt -61.21 159.23 30.92 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.582 0.706 . . . . 71.54 110.992 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 167.83 23.34 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.638 2.226 . . . . 72.12 112.327 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -25.31 28.64 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.711 2.274 . . . . 72.25 112.341 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -76.21 -37.87 57.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 70.33 110.942 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 330' ' ' PHE . . . . . 0.767 ' CD1' HD13 ' A' ' 326' ' ' LEU . 15.4 t80 -73.07 110.47 7.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 52.02 110.849 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -137.9 107.49 6.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.083 -0.508 . . . . 72.24 110.883 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -67.11 -35.46 79.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 74.42 110.933 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 333' ' ' GLU . . . . . 0.473 ' HB2' HG21 ' A' ' 266' ' ' THR . 3.4 pt-20 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 73.31 110.929 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 34.6 m . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.862 0.363 . . . . 42.3 110.833 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.39 48.95 1.66 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.124 -0.489 . . . . 62.54 110.878 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -146.33 125.69 13.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.297 -0.41 . . . . 73.31 110.853 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 41.6 t -78.82 -40.34 33.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.177 -0.465 . . . . 61.43 110.881 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -131.68 103.54 6.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 74.24 110.96 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 15.1 t -81.06 168.73 18.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 74.22 111.143 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 31.4 tttp -52.69 154.56 2.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.429 . . . . 71.43 110.893 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 5.5 m -64.71 102.98 0.63 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 74.41 110.834 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 33.7 mmtt -103.9 169.1 8.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 74.33 110.875 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -151.69 138.39 18.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.444 . . . . 73.2 110.889 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 271' ' ' TYR . . . . . 0.563 ' CZ ' HG23 ' A' ' 295' ' ' THR . 22.8 m-85 -138.71 154.15 48.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.46 . . . . 70.13 110.931 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 56.5 m -135.67 152.99 51.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.121 -0.491 . . . . 64.25 110.838 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 18.5 tptm -102.78 129.75 49.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 74.32 110.883 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 274' ' ' VAL . . . . . 0.906 HG13 HD12 ' A' ' 288' ' ' ILE . 25.7 t -73.05 108.35 4.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.282 -0.417 . . . . 60.04 111.116 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 21.7 pt -86.96 -30.3 5.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 74.11 111.178 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -138.83 158.79 69.33 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.663 0.744 . . . . 64.02 110.875 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.84 165.85 29.68 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.659 2.239 . . . . 61.45 112.354 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -174.43 107.32 0.11 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.245 -0.434 . . . . 64.32 110.886 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 279' ' ' GLU . . . . . 0.526 ' HA ' HG23 ' A' ' 287' ' ' THR . 73.6 tt0 -92.66 111.65 23.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.106 -0.497 . . . . 62.12 110.885 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -51.69 117.22 2.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 74.44 111.103 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 52.0 mm-40 -63.23 -25.43 68.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.274 -0.421 . . . . 74.44 110.912 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 24.9 m-20 -150.7 167.77 26.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.441 . . . . 74.55 110.909 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -58.07 -24.16 57.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 74.55 110.866 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -70.06 -24.91 63.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.247 -0.433 . . . . 64.42 110.808 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -95.01 169.51 10.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 75.13 110.895 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.774 HD23 ' CD2' ' A' ' 318' ' ' PHE . 22.3 tp -114.95 131.21 56.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.137 -0.483 . . . . 73.4 110.9 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.526 HG23 ' HA ' ' A' ' 279' ' ' GLU . 97.6 m -92.08 139.09 30.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 62.33 111.158 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 288' ' ' ILE . . . . . 0.906 HD12 HG13 ' A' ' 274' ' ' VAL . 26.0 pt -147.0 157.33 10.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 43.03 111.122 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 289' ' ' LYS . . . . . 0.408 ' C ' HG11 ' A' ' 274' ' ' VAL . 23.3 mtpp -133.56 142.67 48.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 71.4 110.91 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -50.84 133.12 26.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 73.32 110.93 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 100.65 -22.13 41.02 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.864 -0.684 . . . . 73.52 112.564 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -85.23 173.48 10.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.824 0.345 . . . . 73.32 110.824 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 41.6 mm -123.55 133.91 67.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 74.3 111.08 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 294' ' ' VAL . . . . . 0.645 HG11 ' CE2' ' A' ' 318' ' ' PHE . 93.3 t -108.11 127.63 64.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 63.21 111.179 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 295' ' ' THR . . . . . 0.563 HG23 ' CZ ' ' A' ' 271' ' ' TYR . 29.1 m -82.98 107.8 15.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 64.05 111.162 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.511 HD11 ' HB3' ' A' ' 307' ' ' TRP . 7.5 tp -69.84 117.54 11.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 73.22 110.911 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 63.8 mt -109.73 -36.55 2.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.209 -0.451 . . . . 63.34 111.14 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -144.03 177.47 8.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.131 -0.486 . . . . 75.4 110.878 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 31.9 mttp -141.75 113.01 7.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 62.01 110.881 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -49.6 160.15 0.3 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 74.42 110.791 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.6 t -113.68 -69.01 0.89 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 52.42 110.892 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 41.8 mt -66.35 -13.54 16.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.19 -0.459 . . . . 75.31 111.114 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.53 71.63 2.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 75.34 110.84 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.416 ' O ' HG13 ' A' ' 304' ' ' VAL . 5.9 p -51.23 120.7 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.474 . . . . 65.22 111.117 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.37 25.79 27.4 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.726 -0.75 . . . . 72.42 112.523 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 57.8 m95 -140.38 135.27 31.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.727 0.299 . . . . 72.45 110.963 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 307' ' ' TRP . . . . . 0.778 ' CZ3' HD12 ' A' ' 325' ' ' LEU . 22.6 m0 -130.26 156.75 44.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 72.32 110.956 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -103.8 126.3 50.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 73.33 110.851 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -140.25 -163.76 9.64 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.672 -0.775 . . . . 71.54 112.439 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -142.79 146.28 34.08 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.844 0.354 . . . . 63.2 110.837 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.401 HD22 HG22 ' A' ' 288' ' ' ILE . 3.5 tp -160.05 129.05 5.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.12 -0.491 . . . . 72.22 110.924 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 3.0 m120 55.46 38.25 30.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 53.52 110.92 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 72.3 18.73 78.34 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.78 -0.724 . . . . 64.34 112.434 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -128.47 115.0 17.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.792 0.329 . . . . 75.41 110.881 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 2.9 ptt85 -116.9 139.45 50.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 74.22 110.865 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -162.6 -112.78 0.29 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.757 -0.735 . . . . 74.31 112.517 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 24.2 m -151.25 143.88 16.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.847 0.356 . . . . 74.21 111.178 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 318' ' ' PHE . . . . . 0.774 ' CD2' HD23 ' A' ' 286' ' ' LEU . 31.1 p90 -150.54 155.76 36.37 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.679 0.752 . . . . 74.15 110.841 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 120.69 7.44 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.674 2.249 . . . . 53.13 112.315 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 320' ' ' ASP . . . . . 0.513 ' HA ' HG22 ' A' ' 323' ' ' VAL . 1.5 p-10 -60.31 -19.81 56.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 72.14 110.832 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -73.54 -8.21 54.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 71.42 110.866 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -114.47 16.99 17.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 72.43 110.876 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 323' ' ' VAL . . . . . 0.515 HG21 ' HE1' ' A' ' 318' ' ' PHE . 23.4 m -150.21 141.42 16.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 65.42 111.152 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -105.27 118.01 35.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 62.12 110.93 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.778 HD12 ' CZ3' ' A' ' 307' ' ' TRP . 1.7 tt -64.82 132.3 49.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 72.3 110.894 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 20.3 mt -73.33 159.18 85.49 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.578 0.704 . . . . 70.31 110.943 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.75 167.82 23.34 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.652 2.235 . . . . 54.54 112.386 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 -18.65 36.65 Favored 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.67 2.247 . . . . 51.11 112.373 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -77.99 -42.95 31.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.203 -0.453 . . . . 61.35 110.854 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 330' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -68.45 115.82 8.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.18 -0.464 . . . . 63.42 110.814 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -152.34 107.16 3.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 52.04 110.848 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -83.76 -59.5 2.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 72.43 110.891 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 64.35 110.858 179.941 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 96.1 p . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.805 0.336 . . . . 42.43 110.826 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 8.7 ptp -150.8 -178.31 6.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 44.54 110.876 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -136.39 121.91 19.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 54.44 110.803 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 48.6 m -154.12 152.06 29.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 64.1 110.853 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 6.6 tpp85 -64.09 120.69 12.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.204 -0.453 . . . . 64.12 110.883 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 266' ' ' THR . . . . . 0.629 HG23 ' C ' ' A' ' 333' ' ' GLU . 88.4 m -111.36 117.05 32.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 64.42 111.199 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 4.9 ttmm -52.47 167.72 0.13 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.439 . . . . 73.53 110.898 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 18.1 t -74.15 77.84 1.76 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.252 -0.431 . . . . 42.34 110.933 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 3.9 mtpm? -102.91 -175.69 2.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.48 . . . . 73.1 110.92 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -149.37 144.45 26.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 71.11 110.856 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -142.68 148.31 37.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.192 -0.458 . . . . 71.35 110.907 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 33.7 m -137.0 147.66 46.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.05 -0.523 . . . . 63.21 110.902 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 31.8 tttt -103.07 117.61 34.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 73.45 110.918 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 274' ' ' VAL . . . . . 0.684 HG13 HD12 ' A' ' 288' ' ' ILE . 24.5 t -55.78 115.9 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 74.42 111.177 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 0.425 HD11 ' O ' ' A' ' 321' ' ' ASN . 33.6 pt -90.04 -27.74 5.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 71.43 111.148 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -144.45 159.28 52.18 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.662 0.744 . . . . 73.21 110.893 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.78 158.75 55.87 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.718 2.279 . . . . 64.23 112.3 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -173.43 108.32 0.15 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.142 -0.481 . . . . 73.24 110.958 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 279' ' ' GLU . . . . . 0.678 ' HA ' HG23 ' A' ' 287' ' ' THR . 10.5 tt0 -90.74 129.37 36.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 71.44 110.915 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -64.4 133.95 53.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 71.14 111.099 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -76.16 -12.65 60.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.43 . . . . 63.4 110.866 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 282' ' ' ASN . . . . . 0.56 HD22 ' N ' ' A' ' 282' ' ' ASN . 0.0 OUTLIER -175.54 -178.47 1.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 75.11 110.963 -179.964 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -58.66 -26.24 63.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.258 -0.428 . . . . 72.31 110.874 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 284' ' ' ASP . . . . . 0.463 ' O ' HG22 ' A' ' 317' ' ' VAL . 22.5 t0 -70.26 -25.84 63.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 73.52 110.927 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 285' ' ' GLU . . . . . 0.473 ' OE1' HG23 ' A' ' 317' ' ' VAL . 68.6 mm-40 -100.04 167.28 10.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 73.44 110.851 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.627 HD23 ' CD2' ' A' ' 318' ' ' PHE . 28.2 tp -121.04 131.49 54.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.133 -0.485 . . . . 75.34 110.965 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.678 HG23 ' HA ' ' A' ' 279' ' ' GLU . 87.6 m -88.45 143.08 27.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 72.22 111.161 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 288' ' ' ILE . . . . . 0.684 HD12 HG13 ' A' ' 274' ' ' VAL . 51.0 pt -150.34 143.49 17.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.295 -0.412 . . . . 71.43 111.071 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 37.4 mtpt -112.31 140.4 47.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 50.0 110.897 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -52.01 133.32 32.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.197 -0.456 . . . . 71.21 110.915 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.59 -19.68 53.65 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.747 -0.74 . . . . 43.21 112.458 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -79.31 173.23 12.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.745 0.307 . . . . 61.03 110.867 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 66.8 mt -124.17 125.15 70.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 64.45 111.212 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 294' ' ' VAL . . . . . 0.677 HG11 ' CE2' ' A' ' 318' ' ' PHE . 84.2 t -107.99 134.02 51.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.179 -0.464 . . . . 62.43 111.084 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 39.0 m -84.76 111.14 19.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 54.34 111.103 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.56 HD11 ' HB3' ' A' ' 307' ' ' TRP . 8.7 tp -69.96 118.56 12.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 45.22 110.952 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 76.2 mt -106.46 -47.69 8.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 74.11 111.123 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -134.85 178.17 7.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.44 . . . . 50.12 110.842 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 25.0 mttp -141.36 112.95 7.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 74.54 110.957 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.94 165.25 0.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.441 . . . . 62.42 110.914 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.6 t -118.3 -69.34 0.86 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 54.5 110.804 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 2.0 mp -65.89 -13.89 16.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.184 -0.462 . . . . 75.32 111.088 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -98.8 70.31 1.86 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 73.42 110.79 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 7.3 p -51.35 123.96 3.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 71.21 111.129 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.39 23.31 34.55 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.707 -0.759 . . . . 71.22 112.466 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 56.5 m95 -140.09 135.49 32.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.797 0.332 . . . . 72.24 110.919 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 307' ' ' TRP . . . . . 0.76 ' CZ3' HD12 ' A' ' 325' ' ' LEU . 22.5 m0 -131.23 154.87 47.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.22 -0.446 . . . . 74.13 110.876 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -99.99 124.65 45.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 63.41 110.947 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -141.87 -167.09 11.14 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.66 -0.781 . . . . 64.43 112.478 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -140.43 147.4 39.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.897 0.379 . . . . 72.13 110.909 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.409 HD22 HG22 ' A' ' 288' ' ' ILE . 6.7 tp -157.65 132.18 8.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 74.33 110.839 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 2.9 m120 57.36 30.2 18.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 61.21 110.877 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 79.15 18.64 74.03 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.749 -0.739 . . . . 70.23 112.482 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 25.5 mmm180 -122.69 115.1 21.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.745 0.307 . . . . 73.14 110.869 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 33.3 mtm180 -96.99 141.02 30.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 73.14 110.883 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -178.32 -162.54 28.23 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.772 -0.728 . . . . 72.34 112.48 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.473 HG23 ' OE1' ' A' ' 285' ' ' GLU . 27.5 m -111.64 155.68 12.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.873 0.368 . . . . 74.3 111.182 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 318' ' ' PHE . . . . . 0.677 ' CE2' HG11 ' A' ' 294' ' ' VAL . 5.4 p90 -159.13 156.53 26.37 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.684 0.754 . . . . 74.11 110.828 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 120.23 7.05 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.634 2.223 . . . . 73.23 112.385 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 320' ' ' ASP . . . . . 0.559 ' HA ' HG22 ' A' ' 323' ' ' VAL . 1.6 p-10 -59.12 -21.16 58.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.265 -0.425 . . . . 73.24 110.861 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 321' ' ' ASN . . . . . 0.425 ' O ' HD11 ' A' ' 275' ' ' ILE . 2.8 t-20 -71.53 -11.23 60.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 73.01 110.837 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -110.62 18.35 19.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 70.44 110.846 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 323' ' ' VAL . . . . . 0.559 HG22 ' HA ' ' A' ' 320' ' ' ASP . 18.9 m -149.3 149.52 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 64.14 111.148 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -115.49 116.86 28.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 75.24 110.899 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.76 HD12 ' CZ3' ' A' ' 307' ' ' TRP . 0.9 OUTLIER -64.94 128.17 34.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.252 -0.431 . . . . 73.31 110.99 179.848 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.4 HD13 ' CD1' ' A' ' 330' ' ' PHE . 20.2 mt -68.85 159.18 83.64 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.595 0.712 . . . . 74.51 110.904 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.61 167.7 23.49 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.8 2.333 . . . . 70.41 112.344 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 -16.93 37.47 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.63 2.22 . . . . 74.04 112.358 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.57 -34.56 30.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 71.12 110.84 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 330' ' ' PHE . . . . . 0.4 ' CD1' HD13 ' A' ' 326' ' ' LEU . 2.1 t80 -66.06 115.06 5.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.191 -0.459 . . . . 65.32 110.891 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -136.29 106.99 6.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 63.43 110.919 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 10.6 ttmm -83.14 -69.03 0.66 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 74.11 110.931 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 333' ' ' GLU . . . . . 0.629 ' C ' HG23 ' A' ' 266' ' ' THR . 18.0 tt0 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 64.2 110.914 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 14.4 m . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.899 0.381 . . . . 72.21 110.907 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -60.29 167.89 2.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 65.4 110.822 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -67.64 121.17 15.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.441 . . . . 73.34 110.917 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 6.6 t -110.61 98.49 7.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 73.12 110.871 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -118.5 153.25 34.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 72.41 110.94 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 6.9 m -55.41 121.93 10.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.279 -0.419 . . . . 72.41 111.099 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 10.9 ptpp? -88.52 -34.49 17.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 74.44 110.876 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 3.0 t -95.61 55.45 1.67 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 52.43 110.862 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 19.2 tttt -53.78 167.04 0.27 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.231 -0.44 . . . . 75.12 110.914 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -145.38 121.53 10.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.455 . . . . 54.32 110.856 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 271' ' ' TYR . . . . . 0.665 ' CB ' HD12 ' A' ' 326' ' ' LEU . 8.5 m-85 -111.15 143.85 41.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 65.11 110.896 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 22.6 m -128.29 149.36 50.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.107 -0.497 . . . . 72.11 110.86 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 7.9 tttm -108.03 117.42 34.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 75.24 110.92 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 274' ' ' VAL . . . . . 0.599 HG13 HD12 ' A' ' 288' ' ' ILE . 27.7 t -58.41 113.49 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 72.52 111.15 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 26.6 pt -87.09 -30.49 5.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 73.53 111.123 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -142.46 158.39 60.64 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.657 0.741 . . . . 75.14 110.88 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.68 158.69 56.19 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.642 2.228 . . . . 63.44 112.364 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -174.38 113.51 0.17 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.237 -0.438 . . . . 75.2 110.912 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 279' ' ' GLU . . . . . 0.689 ' HA ' HG23 ' A' ' 287' ' ' THR . 11.8 tt0 -93.61 120.54 34.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.09 -0.505 . . . . 73.5 110.891 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 280' ' ' ALA . . . . . 0.412 ' HB2' ' C ' ' A' ' 286' ' ' LEU . . . -51.83 113.49 1.01 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 60.22 111.078 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -54.58 -29.76 52.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 74.11 110.905 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -155.47 172.25 18.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 71.11 110.891 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -58.2 -22.77 53.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.154 -0.476 . . . . 73.44 110.86 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -70.0 -21.01 63.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 65.24 110.833 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -105.28 177.24 4.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 72.44 110.935 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.648 HD23 ' CD2' ' A' ' 318' ' ' PHE . 13.1 tp -122.61 135.95 54.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.466 . . . . 50.15 110.902 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.689 HG23 ' HA ' ' A' ' 279' ' ' GLU . 77.9 m -88.28 146.32 25.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.121 -0.49 . . . . 71.43 111.114 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 288' ' ' ILE . . . . . 0.599 HD12 HG13 ' A' ' 274' ' ' VAL . 47.6 pt -150.28 143.89 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 74.01 111.189 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 33.8 mtmt -117.53 140.9 49.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 63.14 110.906 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 -51.92 135.03 31.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.232 -0.44 . . . . 45.35 110.857 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 93.82 -23.64 29.94 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.721 -0.752 . . . . 63.54 112.469 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -76.55 171.3 14.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.832 0.348 . . . . 65.4 110.902 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 37.4 mm -122.67 125.78 73.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 33.43 111.137 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 294' ' ' VAL . . . . . 0.678 HG11 ' CE2' ' A' ' 318' ' ' PHE . 97.8 t -103.27 138.11 28.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 61.32 111.092 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 59.4 m -93.56 109.06 20.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 75.54 111.151 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.694 HD11 ' HB3' ' A' ' 307' ' ' TRP . 7.0 tp -69.89 124.84 25.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.271 -0.422 . . . . 72.42 110.894 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 297' ' ' ILE . . . . . 0.405 HD11 ' HB2' ' A' ' 310' ' ' GLU . 40.5 mt -111.1 -47.37 6.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.449 . . . . 73.03 111.119 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -137.74 169.99 16.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 71.43 110.898 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 19.1 mttt -137.35 112.37 9.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.218 -0.446 . . . . 62.04 110.963 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -56.04 179.78 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.187 -0.46 . . . . 71.5 110.862 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 1.7 t -129.05 -69.53 0.7 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 64.15 110.876 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 60.1 mt -59.4 -18.43 14.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 73.02 111.146 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -99.02 62.11 1.28 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.463 . . . . 65.05 110.899 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 71.6 t -51.51 136.36 11.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.244 -0.435 . . . . 51.35 111.154 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 88.69 14.27 61.57 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.76 -0.733 . . . . 63.33 112.543 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 51.1 m95 -139.27 148.15 42.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.758 0.313 . . . . 74.11 110.925 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 307' ' ' TRP . . . . . 0.757 ' CZ3' HD12 ' A' ' 325' ' ' LEU . 10.2 m0 -139.36 148.23 42.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.294 -0.412 . . . . 73.13 110.947 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -94.29 119.08 32.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.283 -0.417 . . . . 73.33 110.849 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -139.22 -163.41 9.49 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.736 -0.745 . . . . 51.12 112.456 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 310' ' ' GLU . . . . . 0.405 ' HB2' HD11 ' A' ' 297' ' ' ILE . 61.6 tt0 -143.79 149.1 36.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.885 0.374 . . . . 73.43 110.916 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 4.9 tp -159.98 133.29 6.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.201 -0.454 . . . . 64.24 110.94 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 2.8 m120 58.14 29.94 18.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 63.4 110.856 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 78.93 17.38 77.22 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.783 -0.722 . . . . 75.54 112.494 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 23.6 mmt85 -122.33 117.47 26.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.843 0.354 . . . . 74.25 110.874 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 27.3 mtm-85 -98.21 136.22 38.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 72.03 110.859 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -172.06 -158.42 16.15 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.737 -0.745 . . . . 43.3 112.504 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 24.3 m -117.72 148.02 20.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.881 0.372 . . . . 71.31 111.126 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 318' ' ' PHE . . . . . 0.678 ' CE2' HG11 ' A' ' 294' ' ' VAL . 9.8 p90 -149.49 156.97 39.34 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.689 0.757 . . . . 73.11 110.824 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 121.5 8.19 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.655 2.237 . . . . 72.1 112.314 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 320' ' ' ASP . . . . . 0.542 ' HA ' HG22 ' A' ' 323' ' ' VAL . 1.7 p-10 -61.75 -17.74 57.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 71.55 110.862 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -75.95 -5.82 48.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 64.23 110.88 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -119.76 23.61 11.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.12 -0.491 . . . . 65.24 110.879 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 323' ' ' VAL . . . . . 0.542 HG22 ' HA ' ' A' ' 320' ' ' ASP . 18.2 m -149.04 144.14 18.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.154 -0.475 . . . . 75.12 111.065 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 55.2 tttt -110.45 111.17 22.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 74.11 110.926 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.757 HD12 ' CZ3' ' A' ' 307' ' ' TRP . 1.0 OUTLIER -64.92 126.61 28.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 55.1 110.837 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.665 HD12 ' CB ' ' A' ' 271' ' ' TYR . 20.4 mt -60.79 159.26 27.18 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.541 0.686 . . . . 73.14 110.958 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.83 167.78 23.56 Favored 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 122.706 2.27 . . . . 74.33 112.323 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -18.6 36.81 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.689 2.259 . . . . 74.42 112.325 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.32 -42.75 20.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 74.54 110.929 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 330' ' ' PHE . . . . . 0.481 ' CD1' HD13 ' A' ' 326' ' ' LEU . 3.8 t80 -64.92 115.77 5.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.262 -0.426 . . . . 72.42 110.935 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -149.33 107.01 3.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.079 -0.51 . . . . 62.55 110.868 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 1.6 ttmm -64.88 -57.87 7.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.116 -0.493 . . . . 71.43 110.877 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 57.7 tt0 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 73.32 110.903 179.981 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 28.5 p . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.879 0.371 . . . . 75.11 110.913 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 7.4 ptm 39.44 41.71 0.75 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 73.34 110.851 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -80.08 145.9 32.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.27 -0.423 . . . . 75.12 110.913 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 5.6 t -113.69 -62.15 1.64 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 74.31 110.799 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 78.8 mmt-85 54.29 44.84 28.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.158 -0.474 . . . . 73.23 110.889 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 15.3 t -92.15 166.98 12.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 71.54 111.112 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 7.8 mptt -107.52 -27.91 10.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 73.23 110.852 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 13.7 p -88.1 80.85 7.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 74.03 110.865 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 22.7 mttm -107.85 179.33 4.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.127 -0.488 . . . . 73.43 110.887 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -142.4 131.61 23.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 74.04 110.884 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 271' ' ' TYR . . . . . 0.431 ' HB3' HD12 ' A' ' 326' ' ' LEU . 15.5 m-85 -130.85 154.1 48.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.211 -0.45 . . . . 73.3 110.955 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 272' ' ' CYS . . . . . 0.423 ' SG ' HD13 ' A' ' 296' ' ' LEU . 22.8 m -139.0 147.36 42.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.113 -0.494 . . . . 74.01 110.866 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 14.3 tttp -103.66 119.08 38.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.204 -0.453 . . . . 62.51 110.862 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 274' ' ' VAL . . . . . 0.552 HG13 HD12 ' A' ' 288' ' ' ILE . 53.1 t -60.3 109.13 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 64.24 111.076 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 26.5 pt -85.98 -30.63 6.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.12 -0.491 . . . . 72.01 111.095 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -138.33 159.97 65.78 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.659 0.742 . . . . 74.44 110.915 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 158.93 55.26 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.736 2.291 . . . . 73.15 112.352 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -172.81 106.02 0.16 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 71.31 111.018 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 279' ' ' GLU . . . . . 0.607 ' HA ' HG23 ' A' ' 287' ' ' THR . 19.5 tt0 -91.23 127.54 36.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 74.02 110.869 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 280' ' ' ALA . . . . . 0.502 ' HB1' ' HB2' ' A' ' 285' ' ' GLU . . . -63.86 113.04 3.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.476 . . . . 44.55 111.126 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -59.26 -26.07 64.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.264 -0.425 . . . . 65.42 110.95 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -149.48 168.7 22.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 71.3 110.875 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -57.02 -24.91 57.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.483 . . . . 45.42 110.859 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -70.01 -25.68 63.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.217 -0.447 . . . . 61.3 110.877 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 285' ' ' GLU . . . . . 0.502 ' HB2' ' HB1' ' A' ' 280' ' ' ALA . 70.1 mm-40 -95.02 166.47 11.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.171 -0.468 . . . . 72.44 110.903 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.646 HD23 ' CD2' ' A' ' 318' ' ' PHE . 21.5 tp -114.89 133.6 55.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 74.02 110.932 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.607 HG23 ' HA ' ' A' ' 279' ' ' GLU . 95.5 m -91.61 140.69 29.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 74.42 111.129 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 288' ' ' ILE . . . . . 0.654 HG21 HG21 ' A' ' 294' ' ' VAL . 50.4 pt -150.14 143.25 17.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 54.35 111.136 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 16.5 mmtm -114.53 141.03 48.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 74.24 110.877 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -52.02 122.54 8.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.446 . . . . 61.54 110.866 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 113.31 -22.82 14.81 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.8 -0.714 . . . . 31.11 112.448 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -86.46 160.4 19.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.708 0.289 . . . . 72.5 110.925 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 80.7 mt -110.94 129.4 66.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 62.5 111.087 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 294' ' ' VAL . . . . . 0.721 HG11 ' CE2' ' A' ' 318' ' ' PHE . 100.0 t -107.15 138.07 34.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.106 -0.497 . . . . 72.21 111.138 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 56.1 m -89.31 111.47 22.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.126 -0.488 . . . . 72.04 111.116 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.472 HD11 ' HB3' ' A' ' 307' ' ' TRP . 7.5 tp -69.98 118.54 12.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.276 -0.42 . . . . 72.13 110.91 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 297' ' ' ILE . . . . . 0.67 HG21 HH21 ' A' ' 315' ' ' ARG . 64.4 mt -105.79 -48.62 8.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 71.24 111.092 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -133.53 178.17 7.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 61.45 110.892 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 24.2 mttt -141.32 113.02 7.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 71.43 110.885 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -49.9 161.77 0.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.457 . . . . 72.41 110.92 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.9 t -113.37 -69.02 0.89 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.222 -0.444 . . . . 51.24 110.869 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 302' ' ' ILE . . . . . 0.4 HG22 ' O ' ' A' ' 302' ' ' ILE . 35.1 mt -67.77 -12.51 15.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 73.35 111.166 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -97.52 69.31 2.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 55.11 110.879 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 6.9 p -51.17 123.21 2.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.244 -0.435 . . . . 55.11 111.18 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.5 19.43 48.98 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.755 -0.736 . . . . 65.32 112.549 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 49.2 m95 -136.29 136.39 39.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.742 0.306 . . . . 72.43 110.902 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 307' ' ' TRP . . . . . 0.757 ' CZ3' HD12 ' A' ' 325' ' ' LEU . 22.6 m0 -132.1 156.09 46.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 65.44 110.936 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -100.63 120.78 40.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.228 -0.442 . . . . 73.31 110.802 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -134.67 -168.71 11.76 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.782 -0.723 . . . . 71.42 112.509 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -141.74 141.4 33.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.868 0.366 . . . . 74.21 110.873 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.711 HD13 HG22 ' A' ' 294' ' ' VAL . 5.4 tp -140.81 118.52 11.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.133 -0.485 . . . . 74.01 110.879 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 3.2 m120 58.55 32.74 22.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 71.32 110.85 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 91.88 -16.96 58.19 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.785 -0.721 . . . . 72.33 112.532 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.33 110.1 17.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.786 0.326 . . . . 72.35 110.898 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.67 HH21 HG21 ' A' ' 297' ' ' ILE . 48.3 mtp180 -98.66 133.73 42.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 73.35 110.911 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -169.16 -155.67 10.02 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.716 -0.754 . . . . 45.23 112.396 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.465 HG23 ' OE1' ' A' ' 285' ' ' GLU . 12.8 m -120.25 155.88 23.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.826 0.346 . . . . 73.53 111.206 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 318' ' ' PHE . . . . . 0.721 ' CE2' HG11 ' A' ' 294' ' ' VAL . 6.4 p90 -161.29 155.94 19.82 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.64 0.733 . . . . 74.24 110.853 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 117.85 5.33 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.676 2.251 . . . . 65.12 112.395 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 320' ' ' ASP . . . . . 0.541 ' HA ' HG22 ' A' ' 323' ' ' VAL . 3.2 t70 -59.19 -21.21 59.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.269 -0.423 . . . . 64.42 110.871 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -70.79 -10.76 60.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 71.42 110.819 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -111.14 19.27 18.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 65.2 110.856 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 323' ' ' VAL . . . . . 0.541 HG22 ' HA ' ' A' ' 320' ' ' ASP . 18.5 m -148.77 150.7 13.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 53.34 111.114 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 4.4 ttmt -110.9 115.09 28.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 54.22 110.903 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.757 HD12 ' CZ3' ' A' ' 307' ' ' TRP . 1.1 tt -64.91 120.32 12.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.228 -0.442 . . . . 65.33 110.91 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.711 HD13 ' CD1' ' A' ' 330' ' ' PHE . 20.3 mt -64.14 159.2 58.79 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.606 0.717 . . . . 72.22 110.899 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.7 167.74 23.49 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.623 2.215 . . . . 71.21 112.377 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 -16.6 37.74 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.694 2.263 . . . . 71.5 112.38 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -82.84 -30.5 28.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 64.11 110.884 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 330' ' ' PHE . . . . . 0.711 ' CD1' HD13 ' A' ' 326' ' ' LEU . 6.8 t80 -65.96 114.46 5.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 62.41 110.889 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -130.31 107.19 9.08 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.068 -0.515 . . . . 60.3 110.843 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 4.0 tmtt? -84.19 -45.84 12.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 72.25 110.902 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 15.5 pm0 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 71.13 110.867 179.966 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 45.7 m . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.814 0.34 . . . . 53.43 110.912 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 14.3 mmt -103.31 150.48 23.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 73.41 110.905 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -73.87 146.54 44.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.121 -0.491 . . . . 70.44 110.913 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 6.0 p -96.65 -47.66 5.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.293 -0.412 . . . . 74.42 110.872 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 27.2 mtm180 -121.41 168.31 11.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.13 -0.486 . . . . 72.41 110.825 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 15.0 t -111.98 170.01 8.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 74.42 111.114 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 33.8 mtpt -56.65 178.2 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.467 . . . . 75.24 110.87 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 69.3 m -60.84 101.09 0.13 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.234 -0.439 . . . . 44.12 110.815 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 14.6 pttm -110.26 -177.88 3.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 74.12 110.93 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -164.39 132.33 3.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.218 -0.446 . . . . 75.2 110.878 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 271' ' ' TYR . . . . . 0.445 ' CE1' HG23 ' A' ' 295' ' ' THR . 8.1 m-85 -124.63 156.23 37.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.147 -0.479 . . . . 65.24 110.89 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 272' ' ' CYS . . . . . 0.444 ' SG ' HD13 ' A' ' 296' ' ' LEU . 30.1 m -139.74 153.01 47.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 65.44 110.898 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -111.0 121.47 45.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 75.34 110.843 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 21.7 t -58.89 114.14 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.48 . . . . 41.12 111.118 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 25.7 pt -88.71 -30.47 5.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 73.34 111.095 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -139.72 158.85 67.17 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.679 0.752 . . . . 74.24 110.881 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 155.21 66.55 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.681 2.254 . . . . 75.24 112.339 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -174.59 108.63 0.12 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.212 -0.449 . . . . 65.45 110.935 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 279' ' ' GLU . . . . . 0.581 ' HA ' HG23 ' A' ' 287' ' ' THR . 50.5 tt0 -88.1 150.07 23.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.5 . . . . 65.13 110.837 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -80.36 114.27 19.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 74.01 111.164 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -63.68 -25.67 68.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 73.1 110.874 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -150.66 168.6 23.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 71.23 110.888 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -58.75 -25.58 63.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 62.22 110.897 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -69.95 -25.4 63.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.47 . . . . 74.52 110.89 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -94.93 167.41 11.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.447 . . . . 71.31 110.866 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.666 HD23 ' CD2' ' A' ' 318' ' ' PHE . 13.7 tp -115.27 136.52 53.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.464 . . . . 75.35 110.952 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.591 ' N ' HD12 ' A' ' 286' ' ' LEU . 95.7 m -90.71 138.36 31.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 73.5 111.11 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 288' ' ' ILE . . . . . 0.618 HG21 HG21 ' A' ' 294' ' ' VAL . 0.1 OUTLIER -147.29 145.55 19.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 63.54 111.129 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -119.53 139.33 52.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.108 -0.496 . . . . 74.13 110.829 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 69.7 tt0 -52.02 123.98 11.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 72.41 110.876 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 110.32 -20.54 25.54 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.756 -0.735 . . . . 64.14 112.55 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -85.13 175.57 8.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.801 0.334 . . . . 73.13 110.888 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.404 HG23 ' O ' ' A' ' 272' ' ' CYS . 41.0 mm -123.81 138.37 53.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 74.01 111.157 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 294' ' ' VAL . . . . . 0.725 HG11 ' CE2' ' A' ' 318' ' ' PHE . 66.3 t -120.57 138.0 52.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.172 -0.467 . . . . 71.14 111.122 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 295' ' ' THR . . . . . 0.445 HG23 ' CE1' ' A' ' 271' ' ' TYR . 91.0 m -92.05 116.01 28.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 70.42 111.206 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.444 HD13 ' SG ' ' A' ' 272' ' ' CYS . 4.5 tp -69.82 112.79 6.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.302 -0.408 . . . . 54.0 110.893 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 62.3 mt -102.0 -28.26 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.439 . . . . 45.34 111.086 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -156.42 178.05 10.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.214 -0.448 . . . . 65.33 110.901 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 29.6 mttp -141.33 112.92 7.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 62.33 110.904 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -50.21 163.54 0.15 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 70.51 110.847 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.7 t -114.52 -69.24 0.87 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.461 . . . . 71.45 110.855 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 2.0 mp -66.57 -13.31 16.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.494 . . . . 71.0 111.151 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -96.42 70.66 2.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.139 -0.482 . . . . 62.21 110.842 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 60.4 t -51.38 120.85 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 73.12 111.183 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.65 20.53 43.74 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.74 -0.743 . . . . 70.34 112.497 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 39.1 m95 -135.4 135.84 40.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.772 0.32 . . . . 63.41 110.898 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 307' ' ' TRP . . . . . 0.755 ' CZ3' HD12 ' A' ' 325' ' ' LEU . 23.5 m0 -130.85 157.32 43.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 74.34 110.871 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -101.43 116.13 32.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 44.41 110.888 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -130.08 -173.1 13.29 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.734 -0.746 . . . . 63.34 112.485 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -136.57 141.29 43.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.86 0.362 . . . . 74.43 110.848 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 293' ' ' ILE . 5.5 tp -141.97 121.26 13.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.127 -0.488 . . . . 72.23 110.901 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 3.0 m120 55.06 33.11 19.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 74.21 110.866 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 92.09 -16.59 59.26 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.714 -0.755 . . . . 65.11 112.487 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -82.99 109.23 16.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.857 0.36 . . . . 73.03 110.845 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.33 125.85 46.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.484 . . . . 71.15 110.904 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -163.43 -158.99 10.23 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.76 -0.734 . . . . 72.35 112.521 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 6.6 m -114.19 156.7 15.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.86 0.362 . . . . 62.31 111.137 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 318' ' ' PHE . . . . . 0.725 ' CE2' HG11 ' A' ' 294' ' ' VAL . 6.1 p90 -163.67 156.05 15.3 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.645 0.736 . . . . 64.13 110.869 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 117.71 5.25 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.659 2.239 . . . . 73.02 112.326 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 320' ' ' ASP . . . . . 0.556 ' HA ' HG22 ' A' ' 323' ' ' VAL . 2.9 t70 -58.34 -22.04 51.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.259 -0.428 . . . . 63.11 110.843 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -69.27 -11.78 61.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 73.13 110.987 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -109.18 17.04 22.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.472 . . . . 63.22 110.874 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 323' ' ' VAL . . . . . 0.556 HG22 ' HA ' ' A' ' 320' ' ' ASP . 18.4 m -148.81 150.58 13.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.144 -0.48 . . . . 64.43 111.173 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -112.09 119.28 37.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.223 -0.444 . . . . 65.1 110.872 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.755 HD12 ' CZ3' ' A' ' 307' ' ' TRP . 0.6 OUTLIER -64.89 116.29 6.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.226 -0.443 . . . . 71.44 110.857 179.938 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 21.2 mt -65.01 159.06 67.59 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.608 0.718 . . . . 75.23 110.916 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 167.74 23.64 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.645 2.23 . . . . 75.12 112.334 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -28.0 25.69 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.651 2.234 . . . . 63.23 112.325 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -66.56 -27.26 67.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.247 -0.433 . . . . 75.23 110.886 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 330' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -66.81 115.47 6.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 74.24 110.856 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -134.6 106.96 7.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 64.35 110.899 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -108.02 -48.78 3.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 73.12 110.916 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 70.33 110.898 179.981 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 23.8 p . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.843 0.354 . . . . 45.53 110.866 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 3.9 mmt -125.58 69.55 1.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 71.24 110.889 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -116.95 63.52 0.72 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.274 -0.421 . . . . 55.24 110.897 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 4.8 t -117.8 157.48 26.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 71.31 110.856 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 76.5 mtt-85 -87.38 173.54 9.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.095 -0.502 . . . . 73.24 110.836 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 14.0 m -81.3 136.75 35.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 73.1 111.087 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.62 -178.48 5.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 54.42 110.873 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 22.6 t 55.12 26.88 8.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 72.31 110.848 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 6.2 ptpp? -94.34 -169.93 2.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 63.44 110.903 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -154.24 143.7 21.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.184 -0.462 . . . . 73.21 110.882 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 271' ' ' TYR . . . . . 0.663 ' CE1' HG23 ' A' ' 295' ' ' THR . 8.9 m-85 -133.5 152.94 51.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.207 -0.452 . . . . 74.4 110.932 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 34.4 m -139.98 147.93 41.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.093 -0.503 . . . . 44.11 110.941 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 33.3 tttt -102.99 121.98 43.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 71.41 110.908 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 274' ' ' VAL . . . . . 0.42 HG21 ' HB ' ' A' ' 288' ' ' ILE . 46.9 t -62.22 110.99 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 54.05 111.123 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 26.8 pt -85.52 -32.82 7.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 72.42 111.139 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -135.95 158.0 74.78 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.629 0.728 . . . . 61.14 110.918 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 150.17 68.13 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.715 2.277 . . . . 72.31 112.327 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -171.17 106.06 0.24 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.235 -0.439 . . . . 70.03 110.963 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 279' ' ' GLU . . . . . 0.772 ' HA ' HG23 ' A' ' 287' ' ' THR . 0.3 OUTLIER -93.03 147.01 23.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.073 -0.512 . . . . 75.53 110.851 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 280' ' ' ALA . . . . . 0.545 ' HB1' ' HB2' ' A' ' 285' ' ' GLU . . . -82.04 124.56 29.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 71.44 111.091 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -72.31 -32.1 66.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 73.23 110.899 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -137.36 172.35 13.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 64.23 110.929 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -62.22 -17.91 59.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 71.3 110.824 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 284' ' ' ASP . . . . . 0.563 ' O ' HG22 ' A' ' 317' ' ' VAL . 13.9 t0 -75.57 -19.39 59.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.241 -0.436 . . . . 72.45 110.838 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 285' ' ' GLU . . . . . 0.545 ' HB2' ' HB1' ' A' ' 280' ' ' ALA . 2.0 mp0 -105.62 164.1 12.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.224 -0.444 . . . . 70.05 110.868 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.577 HD23 ' CD2' ' A' ' 318' ' ' PHE . 14.6 tp -115.47 135.61 53.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.158 -0.473 . . . . 64.54 110.899 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.772 HG23 ' HA ' ' A' ' 279' ' ' GLU . 46.2 m -88.31 141.42 28.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 55.03 111.12 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 288' ' ' ILE . . . . . 0.561 HG21 HG21 ' A' ' 294' ' ' VAL . 33.6 pt -150.09 139.66 15.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 60.41 111.104 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 29.2 mttm -109.99 138.31 46.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 73.34 110.867 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -51.65 126.85 18.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 75.11 110.922 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 107.15 -23.51 27.05 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.657 -0.782 . . . . 72.45 112.476 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -84.99 160.44 20.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.763 0.316 . . . . 74.32 110.873 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 35.1 mm -110.82 128.92 66.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.16 -0.473 . . . . 73.32 111.07 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 294' ' ' VAL . . . . . 0.732 HG11 ' CE2' ' A' ' 318' ' ' PHE . 94.5 t -103.51 138.02 29.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.103 -0.499 . . . . 61.52 111.131 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 295' ' ' THR . . . . . 0.663 HG23 ' CE1' ' A' ' 271' ' ' TYR . 59.8 m -87.48 110.57 20.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 74.11 111.212 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.524 HD11 ' HB3' ' A' ' 307' ' ' TRP . 7.6 tp -70.01 116.07 9.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 63.43 110.904 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 54.4 mt -102.46 -47.59 11.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 72.32 111.177 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -135.29 178.21 7.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 61.42 110.966 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 23.3 mttt -141.15 112.88 7.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 64.12 110.859 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -49.98 160.49 0.33 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 72.3 110.849 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.7 t -113.09 -69.01 0.89 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.237 -0.438 . . . . 54.03 110.858 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 1.9 mp -66.72 -13.24 16.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.475 . . . . 75.42 111.103 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.66 69.78 1.88 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.192 -0.458 . . . . 74.54 110.85 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 88.0 t -51.43 124.24 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.443 . . . . 63.22 111.095 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.41 19.12 50.73 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.703 -0.761 . . . . 72.31 112.539 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 46.4 m95 -136.02 135.21 39.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.781 0.325 . . . . 73.33 110.881 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 307' ' ' TRP . . . . . 0.758 ' CZ3' HD12 ' A' ' 325' ' ' LEU . 23.4 m0 -131.19 154.94 47.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 64.21 110.967 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -99.13 118.31 35.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.291 -0.413 . . . . 61.44 110.877 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -130.08 -171.83 13.01 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.824 -0.703 . . . . 72.3 112.556 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -140.71 144.24 35.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.895 0.379 . . . . 74.25 110.851 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.422 HD13 HG22 ' A' ' 294' ' ' VAL . 2.3 tp -160.04 135.45 8.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 72.34 110.886 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 2.7 m120 59.52 29.99 19.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.13 -0.486 . . . . 53.23 110.951 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 77.87 10.05 86.5 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.7 -0.762 . . . . 70.15 112.536 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -115.41 111.82 21.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.818 0.342 . . . . 72.12 110.861 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 10.3 ttp85 -96.63 124.32 40.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 72.4 110.832 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -154.9 -157.09 8.03 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.779 -0.724 . . . . 62.34 112.511 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.563 HG22 ' O ' ' A' ' 284' ' ' ASP . 20.2 m -118.87 154.02 21.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.833 0.349 . . . . 63.24 111.185 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 318' ' ' PHE . . . . . 0.732 ' CE2' HG11 ' A' ' 294' ' ' VAL . 7.2 p90 -160.52 155.82 21.43 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.629 0.728 . . . . 73.42 110.899 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 117.91 5.36 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.724 2.283 . . . . 71.22 112.339 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 320' ' ' ASP . . . . . 0.557 ' HA ' HG22 ' A' ' 323' ' ' VAL . 3.1 t70 -59.12 -21.21 58.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 72.04 110.871 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -68.92 -12.11 61.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 63.52 110.885 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -108.81 16.56 22.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 74.42 110.816 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 323' ' ' VAL . . . . . 0.557 HG22 ' HA ' ' A' ' 320' ' ' ASP . 18.0 m -148.66 150.82 13.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.442 . . . . 74.2 111.134 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -109.75 118.6 36.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 73.14 110.936 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.758 HD12 ' CZ3' ' A' ' 307' ' ' TRP . 1.2 tt -64.97 121.13 13.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.441 . . . . 63.53 110.96 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.736 HD13 ' CD1' ' A' ' 330' ' ' PHE . 20.3 mt -66.57 159.32 74.61 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.631 0.729 . . . . 63.42 110.896 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.83 167.72 23.73 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.634 2.223 . . . . 72.54 112.358 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.67 -16.6 38.01 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.757 2.305 . . . . 64.43 112.342 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -82.65 -29.4 30.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 72.44 110.832 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 330' ' ' PHE . . . . . 0.736 ' CD1' HD13 ' A' ' 326' ' ' LEU . 3.3 t80 -66.19 115.49 6.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.46 . . . . 55.13 110.899 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -139.67 107.02 5.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.133 -0.485 . . . . 72.1 110.866 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 14.2 mtpp -91.7 -74.39 0.51 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.123 -0.49 . . . . 74.52 110.91 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 64.41 110.88 179.938 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 55.2 m . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.853 0.359 . . . . 73.33 110.849 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.41 -22.34 53.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 44.2 110.869 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 58.7 58.94 3.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.218 -0.446 . . . . 73.02 110.829 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 4.2 m -106.63 -30.67 8.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 64.11 110.892 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 58.5 mtm180 -70.17 110.65 5.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 75.42 110.86 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -139.62 141.21 37.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.129 -0.487 . . . . 62.14 111.185 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.48 133.68 55.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 71.23 110.936 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 6.3 t 60.0 33.25 21.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 74.14 110.793 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 2.4 tttm -58.13 176.85 0.14 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.122 -0.49 . . . . 71.43 110.957 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -139.04 120.93 15.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.269 -0.423 . . . . 74.04 110.859 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 271' ' ' TYR . . . . . 0.65 ' HB3' HD12 ' A' ' 326' ' ' LEU . 12.2 m-85 -117.16 153.08 33.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.248 -0.433 . . . . 73.5 110.884 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 272' ' ' CYS . . . . . 0.45 ' O ' HG23 ' A' ' 293' ' ' ILE . 22.9 m -136.66 148.43 47.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.084 -0.507 . . . . 52.13 110.883 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 39.1 tttt -106.47 123.41 48.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.172 -0.467 . . . . 75.12 110.964 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 21.4 t -61.57 114.12 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 62.34 111.1 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 28.1 pt -85.88 -30.02 6.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 74.23 111.101 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -144.03 157.98 56.43 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.578 0.704 . . . . 74.11 110.905 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 154.03 67.99 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.624 2.216 . . . . 65.01 112.349 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -172.92 111.74 0.22 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 74.3 110.921 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 279' ' ' GLU . . . . . 0.784 ' HA ' HG23 ' A' ' 287' ' ' THR . 7.2 tm-20 -92.36 131.02 37.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.118 -0.492 . . . . 73.51 110.933 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -57.54 119.32 6.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 51.42 111.148 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.46 -25.79 68.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 71.1 110.861 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -154.63 172.77 17.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.25 -0.432 . . . . 51.23 110.94 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -58.48 -25.65 62.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 75.41 110.855 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.35 -25.73 62.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.213 -0.449 . . . . 72.23 110.799 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -94.88 166.97 11.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 71.14 110.941 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.681 HD23 ' CD2' ' A' ' 318' ' ' PHE . 12.9 tp -116.94 135.64 53.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.448 . . . . 64.01 110.967 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.784 HG23 ' HA ' ' A' ' 279' ' ' GLU . 60.1 m -86.92 146.69 26.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 72.34 111.172 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 31.1 pt -150.35 137.89 13.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 65.54 111.13 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -111.28 139.24 46.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 63.44 110.896 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -51.94 135.87 29.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 75.04 110.878 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 92.9 -22.37 34.44 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.766 -0.73 . . . . 44.22 112.527 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -77.08 178.32 7.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.783 0.325 . . . . 71.21 110.858 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.45 HG23 ' O ' ' A' ' 272' ' ' CYS . 51.2 mt -130.09 125.81 60.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.151 -0.477 . . . . 73.53 111.161 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 294' ' ' VAL . . . . . 0.652 HG11 ' CE2' ' A' ' 318' ' ' PHE . 21.5 t -101.4 138.08 26.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.154 -0.476 . . . . 61.45 111.153 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 37.9 m -92.49 110.68 22.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 65.24 111.102 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.428 HD11 ' HB3' ' A' ' 307' ' ' TRP . 4.7 tp -69.89 121.48 17.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 63.42 110.936 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 297' ' ' ILE . . . . . 0.423 HG22 ' OD1' ' A' ' 298' ' ' ASN . 62.7 mt -110.13 -37.3 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 62.5 111.162 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 298' ' ' ASN . . . . . 0.423 ' OD1' HG22 ' A' ' 297' ' ' ILE . 7.5 m120 -150.08 170.53 18.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.484 . . . . 75.1 110.928 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 15.8 mttt -137.3 112.34 9.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 73.14 110.923 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -56.0 179.76 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.239 -0.437 . . . . 60.2 110.887 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 1.7 t -128.99 -69.41 0.71 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 72.2 110.861 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 42.0 mm -59.83 -18.0 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 73.3 111.153 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -99.44 61.77 1.2 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 53.31 110.845 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 62.5 t -51.35 136.53 10.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.464 . . . . 62.21 111.197 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 88.62 14.46 61.44 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.793 -0.718 . . . . 74.41 112.477 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 52.4 m95 -139.7 148.67 42.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.785 0.326 . . . . 74.24 110.869 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 307' ' ' TRP . . . . . 0.6 ' CZ3' HD12 ' A' ' 325' ' ' LEU . 10.3 m0 -139.12 148.66 43.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.47 . . . . 71.54 110.919 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -94.62 122.27 37.05 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.217 -0.447 . . . . 73.41 110.887 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -144.55 -164.43 10.53 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.781 -0.723 . . . . 61.21 112.49 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -142.37 148.2 37.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.87 0.366 . . . . 55.51 110.884 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 3.9 tp -159.02 130.15 6.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.474 . . . . 74.41 110.946 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 2.9 m120 58.97 30.01 19.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.277 -0.42 . . . . 61.04 110.911 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 82.8 2.51 90.66 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.774 -0.727 . . . . 53.23 112.427 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -105.61 121.31 43.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.825 0.345 . . . . 73.44 110.897 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 55.1 mtm180 -105.65 133.74 49.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 74.33 110.806 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -171.93 -151.15 7.61 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.712 -0.756 . . . . 71.13 112.446 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 33.7 m -124.25 145.79 30.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.868 0.366 . . . . 72.13 111.14 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 318' ' ' PHE . . . . . 0.681 ' CD2' HD23 ' A' ' 286' ' ' LEU . 18.2 p90 -144.56 157.01 56.41 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.644 0.735 . . . . 74.35 110.877 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 121.73 8.41 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.678 2.252 . . . . 74.45 112.375 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 320' ' ' ASP . . . . . 0.526 ' HA ' HG22 ' A' ' 323' ' ' VAL . 1.6 p-10 -62.2 -17.32 57.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 61.22 110.888 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -76.61 -5.23 46.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.115 -0.493 . . . . 72.43 110.813 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -121.01 24.5 10.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 74.41 110.849 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 323' ' ' VAL . . . . . 0.526 HG22 ' HA ' ' A' ' 320' ' ' ASP . 17.5 m -148.61 147.39 16.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.175 -0.466 . . . . 71.3 111.105 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -114.07 114.35 26.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.474 . . . . 73.43 110.95 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.6 HD12 ' CZ3' ' A' ' 307' ' ' TRP . 0.8 OUTLIER -64.99 125.65 25.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.187 -0.461 . . . . 74.52 110.915 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.65 HD12 ' HB3' ' A' ' 271' ' ' TYR . 21.5 mt -67.94 159.02 81.66 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.58 0.705 . . . . 72.45 110.901 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.84 167.79 23.52 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.607 2.204 . . . . 73.43 112.33 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.9 -16.93 37.18 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.684 2.256 . . . . 62.05 112.255 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -85.17 -43.03 14.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.281 -0.418 . . . . 50.3 110.879 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 330' ' ' PHE . . . . . 0.43 ' CD1' HD13 ' A' ' 326' ' ' LEU . 4.5 t80 -69.16 116.06 9.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 73.22 110.876 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -147.21 106.99 3.95 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.117 -0.492 . . . . 72.21 110.884 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -59.87 -54.81 41.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 52.41 110.919 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 61.31 110.854 179.969 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 3.3 m . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.849 0.357 . . . . 71.41 110.884 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 14.5 mmt 53.94 36.37 24.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.47 . . . . 51.44 110.887 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -77.96 -27.75 49.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 52.24 110.895 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 62.5 m -82.17 93.2 7.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 64.43 110.842 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.26 -26.14 13.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.472 . . . . 70.24 110.882 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 28.8 m -62.13 114.3 3.35 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.198 -0.456 . . . . 75.52 111.085 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.04 -28.21 8.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 65.13 110.895 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 15.2 p -90.62 49.83 1.73 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 73.32 110.857 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.57 178.96 7.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 74.45 110.851 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -165.56 123.07 1.51 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 70.13 110.851 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 271' ' ' TYR . . . . . 0.555 ' HB3' HD12 ' A' ' 326' ' ' LEU . 12.5 m-85 -110.65 137.8 47.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.173 -0.467 . . . . 73.4 110.962 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 25.3 m -126.92 145.61 50.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.148 -0.478 . . . . 64.14 110.923 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 17.6 ttpt -103.65 127.78 51.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 51.42 110.892 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 274' ' ' VAL . . . . . 0.631 HG13 HD12 ' A' ' 288' ' ' ILE . 21.5 t -61.58 114.42 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.29 -0.414 . . . . 61.21 111.076 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 0.538 HD11 ' O ' ' A' ' 321' ' ' ASN . 34.4 pt -88.97 -27.06 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 45.0 111.128 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -145.94 159.25 47.22 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.635 0.731 . . . . 74.45 110.853 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 151.94 68.89 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.706 2.27 . . . . 63.43 112.276 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -166.41 111.47 0.8 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 75.34 110.916 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 279' ' ' GLU . . . . . 0.639 ' HA ' HG23 ' A' ' 287' ' ' THR . 42.3 tt0 -94.88 129.01 42.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 73.24 110.887 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -63.41 113.82 3.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 71.32 111.104 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -59.58 -26.44 65.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 74.13 110.899 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -150.7 170.25 19.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.221 -0.445 . . . . 51.01 110.842 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -56.57 -25.95 53.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 74.33 110.829 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -70.08 -25.86 63.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 72.31 110.851 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 285' ' ' GLU . . . . . 0.426 ' OE1' HG23 ' A' ' 317' ' ' VAL . 46.5 mm-40 -94.96 164.66 12.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 73.21 110.9 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.665 HD13 ' HG3' ' A' ' 314' ' ' ARG . 14.4 tp -116.41 136.71 52.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.09 -0.505 . . . . 75.45 110.893 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.639 HG23 ' HA ' ' A' ' 279' ' ' GLU . 85.1 m -92.59 144.86 24.91 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.151 -0.477 . . . . 54.35 111.132 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 288' ' ' ILE . . . . . 0.631 HD12 HG13 ' A' ' 274' ' ' VAL . 48.4 pt -150.37 142.9 17.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 54.43 111.143 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 31.8 mtpt -112.38 141.04 46.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.153 -0.476 . . . . 72.32 110.931 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -51.95 131.56 31.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 74.3 110.851 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 99.96 -22.22 41.22 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.702 -0.761 . . . . 63.33 112.438 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -76.12 178.12 6.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.757 0.313 . . . . 60.12 110.874 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 81.2 mt -133.02 122.1 45.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 72.24 111.179 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 294' ' ' VAL . . . . . 0.745 HG11 ' CE2' ' A' ' 318' ' ' PHE . 90.1 t -105.66 138.1 32.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 63.13 111.149 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 52.3 m -87.77 114.34 24.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 63.4 111.136 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.404 HD11 ' HB3' ' A' ' 307' ' ' TRP . 5.5 tp -70.01 112.43 6.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.258 -0.428 . . . . 65.35 110.909 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 61.2 mt -101.43 -29.03 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.107 -0.497 . . . . 62.14 111.128 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -155.69 178.08 10.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.444 . . . . 41.43 110.9 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 27.7 mttp -141.33 112.97 7.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 71.04 110.938 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -49.68 160.78 0.26 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.213 -0.449 . . . . 52.33 110.888 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.8 t -113.29 -68.97 0.89 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 50.12 110.897 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 31.0 mm -66.97 -12.86 15.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 60.22 111.109 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -97.17 70.81 2.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 70.13 110.947 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.412 HG13 ' O ' ' A' ' 304' ' ' VAL . 5.9 p -51.31 120.75 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 73.13 111.145 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.54 24.47 30.74 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.758 -0.734 . . . . 63.15 112.461 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 56.3 m95 -139.72 135.94 33.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.809 0.337 . . . . 72.23 110.913 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 307' ' ' TRP . . . . . 0.404 ' HB3' HD11 ' A' ' 296' ' ' LEU . 22.3 m0 -130.69 156.66 44.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 64.31 110.867 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -101.38 115.51 30.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.194 -0.457 . . . . 75.23 110.925 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -128.66 -172.64 13.23 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.755 -0.736 . . . . 51.53 112.503 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -141.32 140.43 33.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.861 0.362 . . . . 71.41 110.931 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.456 HD13 HG22 ' A' ' 294' ' ' VAL . 4.5 tp -145.69 128.94 16.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 73.14 110.838 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 3.0 m120 56.8 29.88 16.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 61.4 110.816 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 87.52 -8.62 76.64 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.716 -0.754 . . . . 73.13 112.527 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 314' ' ' ARG . . . . . 0.665 ' HG3' HD13 ' A' ' 286' ' ' LEU . 4.3 tpt180 -93.08 109.01 20.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.722 0.296 . . . . 74.04 110.887 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 10.4 ttp85 -96.69 133.35 41.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 74.23 110.904 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -166.43 -158.87 11.47 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.669 -0.777 . . . . 70.11 112.41 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.426 HG23 ' OE1' ' A' ' 285' ' ' GLU . 19.2 m -116.76 154.47 18.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.883 0.373 . . . . 73.3 111.129 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 318' ' ' PHE . . . . . 0.745 ' CE2' HG11 ' A' ' 294' ' ' VAL . 5.5 p90 -159.79 157.07 25.57 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.621 0.724 . . . . 71.3 110.865 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 121.65 8.33 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.705 2.27 . . . . 62.02 112.348 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 320' ' ' ASP . . . . . 0.545 ' HA ' HG22 ' A' ' 323' ' ' VAL . 1.6 p-10 -58.35 -22.31 53.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 64.4 110.937 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 321' ' ' ASN . . . . . 0.538 ' O ' HD11 ' A' ' 275' ' ' ILE . 19.7 m120 -69.85 -15.78 63.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 75.43 110.863 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -104.36 15.62 27.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 70.4 110.859 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 323' ' ' VAL . . . . . 0.545 HG22 ' HA ' ' A' ' 320' ' ' ASP . 18.9 m -149.16 150.59 13.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 75.33 111.12 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 24.8 ttpt -125.35 125.75 43.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 74.23 110.895 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 2.5 mt -64.95 130.78 44.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 71.23 110.98 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.555 HD12 ' HB3' ' A' ' 271' ' ' TYR . 20.2 mt -56.51 159.24 6.87 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.592 0.711 . . . . 70.15 110.871 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 167.73 23.49 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.676 2.251 . . . . 74.32 112.35 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -17.1 37.79 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.657 2.238 . . . . 75.13 112.386 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -81.75 -33.9 30.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.197 -0.456 . . . . 65.25 110.893 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 330' ' ' PHE . . . . . 0.442 ' CD1' HD13 ' A' ' 326' ' ' LEU . 2.3 t80 -69.99 114.88 8.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 65.42 110.899 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -138.62 107.06 5.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 43.24 110.839 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 15.0 tptm -70.87 -74.0 0.16 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 70.34 110.83 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.261 -0.427 . . . . 71.12 110.891 -179.967 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 12.6 t . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.896 0.379 . . . . 65.34 110.834 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 3.5 mmm -133.84 151.8 51.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.12 -0.491 . . . . 75.15 110.913 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -85.28 -43.31 13.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 74.24 110.86 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 55.56 53.14 10.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.458 . . . . 72.52 110.842 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -124.39 133.09 53.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.106 -0.497 . . . . 73.35 110.837 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 96.1 m -96.23 -72.99 0.61 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.197 -0.456 . . . . 70.12 111.117 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 6.0 mmtm -164.93 -177.72 4.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 50.35 110.877 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 6.5 p -78.23 60.36 2.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 43.31 110.866 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 5.5 mmtp -126.23 161.78 26.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 75.23 110.9 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -142.5 134.91 27.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 54.0 110.833 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 271' ' ' TYR . . . . . 0.589 ' HB3' HD12 ' A' ' 326' ' ' LEU . 14.4 m-85 -130.46 143.09 50.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.211 -0.45 . . . . 73.55 110.922 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 22.1 m -133.04 149.37 52.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.116 -0.493 . . . . 74.33 110.887 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 15.5 tttp -103.89 121.75 43.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 74.11 110.935 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 274' ' ' VAL . . . . . 0.54 ' CG2' HG23 ' A' ' 294' ' ' VAL . 57.8 t -61.65 111.71 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 62.33 111.141 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 28.5 pt -84.1 -32.12 8.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 71.22 111.098 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -140.39 157.78 67.76 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.661 0.743 . . . . 73.1 110.927 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.81 159.23 54.13 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.695 2.264 . . . . 73.41 112.25 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -174.16 109.64 0.14 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 54.14 110.915 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 279' ' ' GLU . . . . . 0.624 ' HA ' HG23 ' A' ' 287' ' ' THR . 9.2 tt0 -89.33 139.47 30.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 70.32 110.829 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 280' ' ' ALA . . . . . 0.429 ' HB2' ' C ' ' A' ' 286' ' ' LEU . . . -87.5 121.42 29.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 63.42 111.042 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -60.22 -42.46 95.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 63.42 110.933 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -148.64 -174.66 4.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 44.45 110.89 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -57.98 -19.75 32.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 73.15 110.909 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 284' ' ' ASP . . . . . 0.455 ' O ' HG22 ' A' ' 317' ' ' VAL . 2.2 t70 -72.07 -8.39 54.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 53.51 110.882 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 285' ' ' GLU . . . . . 0.421 ' HB2' ' HB1' ' A' ' 280' ' ' ALA . 9.3 mp0 -132.61 158.91 41.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 74.01 110.855 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.648 HD23 ' CD2' ' A' ' 318' ' ' PHE . 17.0 tp -114.89 133.44 55.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 74.22 110.979 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.624 HG23 ' HA ' ' A' ' 279' ' ' GLU . 86.7 m -84.32 145.04 28.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 64.21 111.144 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 288' ' ' ILE . . . . . 0.419 HG22 HD22 ' A' ' 311' ' ' LEU . 38.6 pt -150.88 138.83 14.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 55.34 111.064 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 31.2 mttm -110.43 136.1 50.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.131 -0.486 . . . . 75.43 110.962 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 290' ' ' GLU . . . . . 0.402 ' HA ' HG12 ' A' ' 274' ' ' VAL . 34.0 tt0 -51.68 128.7 24.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.45 . . . . 71.31 110.877 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 105.26 -26.21 22.57 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.699 -0.762 . . . . 54.21 112.483 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -83.28 156.16 23.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.694 0.283 . . . . 64.54 110.934 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 56.6 mt -106.64 126.26 62.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.194 -0.457 . . . . 52.33 111.107 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 294' ' ' VAL . . . . . 0.714 HG11 ' CE2' ' A' ' 318' ' ' PHE . 62.1 t -96.11 138.13 22.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 70.44 111.077 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 56.2 m -91.1 109.43 20.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.16 -0.473 . . . . 72.24 111.145 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.469 HD11 ' HB3' ' A' ' 307' ' ' TRP . 4.2 tp -69.85 121.2 16.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.187 -0.46 . . . . 64.5 110.892 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 297' ' ' ILE . . . . . 0.486 HD11 ' HB2' ' A' ' 310' ' ' GLU . 38.9 mt -107.93 -36.69 3.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.233 -0.44 . . . . 64.45 111.171 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -151.02 170.69 18.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.128 -0.487 . . . . 74.0 110.907 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 21.7 mttt -137.28 112.28 9.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 74.22 110.858 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -55.49 178.61 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.436 . . . . 75.32 110.891 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 1.7 t -128.04 -69.36 0.73 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.207 -0.452 . . . . 64.44 110.936 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 60.8 mt -59.71 -18.26 14.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 70.51 111.137 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.35 61.67 1.21 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.462 . . . . 63.53 110.919 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 54.9 t -51.44 136.8 10.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 74.02 111.119 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 88.75 14.17 61.61 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.721 -0.752 . . . . 72.43 112.533 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 52.2 m95 -139.68 149.04 43.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.729 0.3 . . . . 75.15 110.871 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 307' ' ' TRP . . . . . 0.61 ' CZ3' HD12 ' A' ' 325' ' ' LEU . 10.4 m0 -139.22 148.78 43.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 73.53 110.89 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -94.47 117.56 30.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 65.03 110.969 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -138.4 -168.87 11.42 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.711 -0.757 . . . . 54.1 112.509 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 310' ' ' GLU . . . . . 0.486 ' HB2' HD11 ' A' ' 297' ' ' ILE . 71.1 tt0 -138.49 148.1 43.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.834 0.35 . . . . 71.4 110.95 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.609 HD13 HG22 ' A' ' 294' ' ' VAL . 6.3 tp -158.6 129.55 6.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.19 -0.459 . . . . 64.55 110.953 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 2.9 m120 58.94 30.0 19.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 60.41 110.864 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 84.47 -5.13 82.35 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.72 -0.752 . . . . 74.41 112.46 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -98.3 122.35 41.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.757 0.313 . . . . 73.1 110.915 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 63.0 mtm180 -106.97 132.03 53.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 73.22 110.835 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -168.04 -149.5 6.14 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.7 -0.762 . . . . 24.31 112.468 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.455 HG22 ' O ' ' A' ' 284' ' ' ASP . 18.7 m -127.17 146.45 33.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.896 0.379 . . . . 71.33 111.119 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 318' ' ' PHE . . . . . 0.714 ' CE2' HG11 ' A' ' 294' ' ' VAL . 14.3 p90 -144.95 157.37 54.43 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.656 0.741 . . . . 72.33 110.841 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.66 121.24 7.95 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.727 2.285 . . . . 71.11 112.344 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 320' ' ' ASP . . . . . 0.552 ' HA ' HG22 ' A' ' 323' ' ' VAL . 1.6 p-10 -60.66 -18.73 55.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 73.11 110.831 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -74.85 -6.7 50.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.481 . . . . 74.11 110.921 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -118.06 22.12 12.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 73.12 110.83 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 323' ' ' VAL . . . . . 0.552 HG22 ' HA ' ' A' ' 320' ' ' ASP . 17.5 m -149.02 145.12 18.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 74.42 111.15 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -111.19 117.38 33.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 64.33 110.919 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.61 HD12 ' CZ3' ' A' ' 307' ' ' TRP . 0.8 OUTLIER -64.87 125.47 24.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 51.23 110.932 179.943 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.589 HD12 ' HB3' ' A' ' 271' ' ' TYR . 20.3 mt -64.13 159.21 58.62 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.59 0.71 . . . . 52.14 110.936 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 167.7 23.63 Favored 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 122.741 2.294 . . . . 63.34 112.382 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 -15.99 37.56 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.693 2.262 . . . . 72.12 112.377 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -84.08 -42.9 15.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.457 . . . . 71.11 110.887 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 330' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -72.22 108.05 5.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 74.14 110.947 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -146.11 107.24 4.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 72.34 110.891 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 32.3 mttm -86.48 -74.47 0.42 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 63.33 110.843 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 72.12 110.869 -179.995 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.892 0.377 . . . . 54.12 110.86 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 10.6 mmt -113.79 176.55 4.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 65.42 110.908 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -116.8 26.69 9.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 72.35 110.832 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 53.9 p -139.69 -179.87 6.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 54.34 110.872 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 14.9 mmp_? -55.84 105.33 0.18 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.156 -0.474 . . . . 73.35 110.857 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 2.1 t -117.76 -40.53 3.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 63.32 111.163 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 30.6 mttp 52.38 33.1 12.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.454 . . . . 74.31 110.815 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 1.3 t -144.88 28.18 1.27 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.242 -0.435 . . . . 65.13 110.893 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -56.51 168.19 0.61 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.088 -0.506 . . . . 73.33 110.905 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -119.82 118.14 30.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.208 -0.451 . . . . 73.11 110.876 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 271' ' ' TYR . . . . . 0.703 ' CE1' HG23 ' A' ' 295' ' ' THR . 6.7 m-85 -124.1 156.61 36.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 50.34 110.917 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 272' ' ' CYS . . . . . 0.407 ' SG ' HD13 ' A' ' 296' ' ' LEU . 23.5 m -138.92 152.44 47.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.123 -0.489 . . . . 65.21 110.886 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt -108.21 126.67 53.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.141 -0.481 . . . . 74.22 110.916 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 38.9 t -63.21 109.32 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 72.15 111.107 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 30.0 pt -83.25 -31.53 8.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 75.4 111.14 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -140.84 159.2 63.22 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.654 0.74 . . . . 73.14 110.86 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 152.08 69.02 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.675 2.25 . . . . 54.53 112.318 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -174.38 105.96 0.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 65.12 110.839 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 279' ' ' GLU . . . . . 0.576 ' HA ' HG23 ' A' ' 287' ' ' THR . 1.4 mp0 -89.2 141.06 28.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.108 -0.496 . . . . 64.5 110.915 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -54.54 113.03 1.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 60.05 111.176 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -69.05 -26.45 64.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.303 -0.408 . . . . 75.44 110.945 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 18.9 m-80 -144.03 174.74 10.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.134 -0.485 . . . . 74.04 110.91 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -63.53 -26.13 68.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 75.31 110.854 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 284' ' ' ASP . . . . . 0.593 ' O ' HG22 ' A' ' 317' ' ' VAL . 14.6 m-20 -88.06 6.14 37.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 74.04 110.838 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -105.65 164.64 11.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.253 -0.43 . . . . 73.13 110.889 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.777 HD23 ' CD2' ' A' ' 318' ' ' PHE . 21.3 tp -115.75 131.23 57.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.491 . . . . 70.33 110.903 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.576 HG23 ' HA ' ' A' ' 279' ' ' GLU . 91.5 m -87.43 136.14 33.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 53.23 111.078 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 288' ' ' ILE . . . . . 0.478 HG21 HG21 ' A' ' 294' ' ' VAL . 0.1 OUTLIER -147.49 146.15 18.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 72.44 111.149 179.871 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 27.4 mtmm -120.64 145.98 46.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 72.14 110.945 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -52.0 131.82 31.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.27 -0.423 . . . . 73.14 110.847 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.03 -27.1 19.81 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.804 -0.712 . . . . 35.42 112.52 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -71.71 173.34 8.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.778 0.323 . . . . 73.02 110.839 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 28.5 mm -124.24 135.9 62.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 64.15 111.156 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 294' ' ' VAL . . . . . 0.634 HG11 ' CE2' ' A' ' 318' ' ' PHE . 19.5 t -111.69 132.43 60.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.247 -0.433 . . . . 62.24 111.067 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 295' ' ' THR . . . . . 0.703 HG23 ' CE1' ' A' ' 271' ' ' TYR . 17.4 m -87.89 112.09 22.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.089 -0.505 . . . . 72.34 111.136 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.407 HD13 ' SG ' ' A' ' 272' ' ' CYS . 6.0 tp -69.59 119.69 14.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 74.4 110.977 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 58.9 mt -115.72 -25.18 3.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.283 -0.417 . . . . 53.43 111.095 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -158.29 176.84 11.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.014 0.435 . . . . 74.1 110.779 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 48.7 mttt -141.18 113.03 7.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.048 -0.524 . . . . 65.12 110.897 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.01 166.75 0.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 75.44 110.903 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.2 t -119.6 -69.35 0.85 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.241 -0.436 . . . . 64.3 110.919 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 36.0 mm -64.26 -14.72 16.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 71.11 111.133 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -96.51 74.47 2.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 72.34 110.848 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 58.9 t -51.37 117.36 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 71.01 111.129 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 88.89 29.68 17.32 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.793 -0.718 . . . . 45.24 112.477 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 58.8 m95 -140.67 135.05 31.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.68 0.276 . . . . 63.44 110.977 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 307' ' ' TRP . . . . . 0.726 ' CZ3' HD12 ' A' ' 325' ' ' LEU . 24.2 m0 -129.26 157.55 41.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.254 -0.43 . . . . 72.25 110.934 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -104.78 124.77 49.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.305 -0.407 . . . . 54.21 110.887 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -140.24 -164.82 10.05 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.706 -0.759 . . . . 51.54 112.451 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -142.94 143.68 32.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.915 0.388 . . . . 55.21 110.865 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.432 HD22 ' O ' ' A' ' 287' ' ' THR . 2.0 tp -146.56 122.77 10.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 61.23 110.959 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 3.1 m120 58.55 29.94 19.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 73.15 110.892 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 89.61 -8.63 79.43 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.715 -0.755 . . . . 72.02 112.459 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 17.2 tpp180 -94.14 114.24 26.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.703 0.287 . . . . 75.53 110.913 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 36.7 mtm180 -98.86 138.19 36.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.202 -0.454 . . . . 73.44 110.828 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -171.93 -160.61 20.86 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.797 -0.716 . . . . 63.14 112.475 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 284' ' ' ASP . 32.6 m -118.36 154.0 20.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.857 0.36 . . . . 62.2 111.145 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 318' ' ' PHE . . . . . 0.777 ' CD2' HD23 ' A' ' 286' ' ' LEU . 26.0 p90 -156.04 156.34 30.31 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.639 0.733 . . . . 73.2 110.882 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 119.5 6.44 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.701 2.267 . . . . 63.23 112.351 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 320' ' ' ASP . . . . . 0.536 ' HA ' HG22 ' A' ' 323' ' ' VAL . 1.5 p-10 -60.89 -18.86 58.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.431 . . . . 73.33 110.888 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -74.55 -7.15 52.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.157 -0.474 . . . . 54.53 110.82 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -117.63 24.19 11.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 74.45 110.776 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 323' ' ' VAL . . . . . 0.536 HG22 ' HA ' ' A' ' 320' ' ' ASP . 18.1 m -148.89 153.13 11.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 44.43 111.122 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -116.8 113.39 22.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 64.12 110.957 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.726 HD12 ' CZ3' ' A' ' 307' ' ' TRP . 1.2 tt -65.1 126.48 28.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 72.33 110.906 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.459 HD13 ' CD1' ' A' ' 330' ' ' PHE . 20.3 mt -68.57 159.2 82.71 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.642 0.734 . . . . 72.24 110.855 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 167.73 23.52 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.701 2.267 . . . . 73.34 112.375 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 -16.6 37.34 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.694 2.263 . . . . 74.4 112.282 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -82.63 -28.35 30.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.219 -0.446 . . . . 64.34 110.861 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 330' ' ' PHE . . . . . 0.459 ' CD1' HD13 ' A' ' 326' ' ' LEU . 2.4 t80 -78.67 115.43 18.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.142 -0.481 . . . . 74.34 110.883 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -137.17 106.97 6.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.087 -0.506 . . . . 74.31 110.861 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.92 -73.73 0.09 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 70.51 110.864 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.284 -0.416 . . . . 75.4 110.877 179.969 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 3.0 p . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.91 0.386 . . . . 75.33 110.9 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 58.7 mtt -112.22 147.89 35.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 72.42 110.897 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -78.81 148.08 33.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 72.23 110.888 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 1.2 m -152.79 141.06 20.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 71.24 110.778 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -116.37 92.78 3.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.085 -0.507 . . . . 74.13 110.89 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 266' ' ' THR . . . . . 0.617 HG22 ' H ' ' A' ' 268' ' ' SER . 95.2 m -60.62 -73.52 0.09 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.175 -0.466 . . . . 63.33 111.168 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 23.0 ttpt 54.3 38.98 30.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 71.31 110.889 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.617 ' H ' HG22 ' A' ' 266' ' ' THR . 58.7 m -135.73 31.05 3.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.265 -0.425 . . . . 44.12 110.801 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -124.47 -178.2 4.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.159 -0.473 . . . . 72.21 110.863 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -123.82 124.39 42.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 74.23 110.839 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 271' ' ' TYR . . . . . 0.485 ' CE1' HG23 ' A' ' 295' ' ' THR . 8.8 m-85 -129.26 150.99 50.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 74.22 110.857 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 26.4 m -139.19 150.7 45.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.058 -0.519 . . . . 64.43 110.911 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -107.77 122.92 47.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.447 . . . . 73.53 110.896 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 274' ' ' VAL . . . . . 0.458 HG11 ' C ' ' A' ' 289' ' ' LYS . 24.1 t -56.01 116.18 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.292 -0.413 . . . . 74.35 111.193 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 0.418 HG21 ' HB2' ' A' ' 324' ' ' LYS . 29.7 pt -97.95 -17.55 6.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 71.41 111.127 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -145.52 151.98 48.31 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.627 0.727 . . . . 71.53 110.903 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.67 151.52 69.62 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.655 2.237 . . . . 54.31 112.363 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -174.45 140.43 0.63 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.451 . . . . 73.14 110.932 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 279' ' ' GLU . . . . . 0.531 ' HA ' HG23 ' A' ' 287' ' ' THR . 49.5 tt0 -121.17 143.18 49.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.054 -0.521 . . . . 75.25 110.882 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -76.61 127.79 33.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 72.41 111.116 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -71.48 -25.82 62.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.242 -0.435 . . . . 74.13 110.878 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -155.75 177.54 11.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 51.1 110.887 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -56.94 -25.75 58.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.177 -0.465 . . . . 61.14 110.878 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 284' ' ' ASP . . . . . 0.449 ' O ' HG22 ' A' ' 317' ' ' VAL . 18.9 t0 -72.29 -24.85 61.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.474 . . . . 72.41 110.864 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 285' ' ' GLU . . . . . 0.482 ' OE2' HG23 ' A' ' 317' ' ' VAL . 19.8 mm-40 -94.97 163.5 13.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.172 -0.467 . . . . 62.52 110.895 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.616 HD23 ' CD2' ' A' ' 318' ' ' PHE . 20.3 tp -119.78 131.24 55.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.13 -0.486 . . . . 71.44 110.923 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.531 HG23 ' HA ' ' A' ' 279' ' ' GLU . 96.7 m -85.97 143.3 28.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.154 -0.475 . . . . 75.01 111.139 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 288' ' ' ILE . . . . . 0.461 HG21 HG21 ' A' ' 294' ' ' VAL . 47.9 pt -150.26 142.36 17.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 71.31 111.115 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 289' ' ' LYS . . . . . 0.458 ' C ' HG11 ' A' ' 274' ' ' VAL . 17.3 mmtp -122.07 144.73 48.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 64.54 110.897 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -51.5 128.81 23.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 74.31 110.863 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 101.43 -30.89 9.41 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.753 -0.737 . . . . 75.22 112.493 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -69.77 171.83 8.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.736 0.303 . . . . 73.53 110.917 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 67.4 mt -126.71 126.16 68.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 71.15 111.087 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 294' ' ' VAL . . . . . 0.71 HG11 ' CE2' ' A' ' 318' ' ' PHE . 64.6 t -104.37 138.21 30.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 74.02 111.135 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 295' ' ' THR . . . . . 0.485 HG23 ' CE1' ' A' ' 271' ' ' TYR . 49.2 m -92.63 111.4 22.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.154 -0.475 . . . . 64.05 111.129 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.41 HD11 ' HB3' ' A' ' 307' ' ' TRP . 5.3 tp -69.82 122.28 18.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 71.42 110.937 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 67.6 mt -110.53 -39.8 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 73.01 111.124 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -145.71 171.67 14.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 65.55 110.872 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -136.09 111.87 9.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 72.1 110.899 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.08 177.5 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 71.42 110.938 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 1.9 t -126.46 -69.33 0.77 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 64.23 110.91 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 38.6 mm -62.64 -15.89 15.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 63.04 111.185 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.26 61.35 2.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 73.54 110.9 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 56.6 t -51.12 130.97 11.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 71.2 111.118 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.91 14.71 58.97 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.779 -0.724 . . . . 73.5 112.484 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 44.0 m95 -137.01 162.86 32.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.816 0.341 . . . . 73.21 110.872 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 307' ' ' TRP . . . . . 0.44 ' CZ3' HD12 ' A' ' 325' ' ' LEU . 5.0 m0 -151.0 156.44 41.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 70.31 110.866 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -102.66 119.06 38.17 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.246 -0.434 . . . . 73.33 110.903 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -140.55 -162.92 9.31 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.75 -0.738 . . . . 61.13 112.51 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -145.65 148.64 33.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.934 0.397 . . . . 65.03 110.834 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.438 HD23 ' O ' ' A' ' 287' ' ' THR . 14.5 tp -157.98 134.95 9.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.074 -0.512 . . . . 71.02 110.894 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 2.9 m120 57.23 30.44 18.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 74.45 110.926 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 77.95 18.88 76.19 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.784 -0.722 . . . . 62.43 112.416 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 31.5 mmm-85 -124.99 121.01 33.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.867 0.365 . . . . 74.43 110.849 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 39.8 mtp180 -99.55 142.54 30.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 73.45 110.876 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -176.52 -160.06 23.09 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.793 -0.718 . . . . 71.54 112.523 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.482 HG23 ' OE2' ' A' ' 285' ' ' GLU . 29.5 m -115.51 151.07 17.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.923 0.392 . . . . 70.44 111.17 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 318' ' ' PHE . . . . . 0.71 ' CE2' HG11 ' A' ' 294' ' ' VAL . 10.5 p90 -154.69 155.77 30.83 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.64 0.733 . . . . 72.01 110.916 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 119.8 6.69 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.744 2.296 . . . . 64.11 112.31 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 320' ' ' ASP . . . . . 0.528 ' HA ' HG22 ' A' ' 323' ' ' VAL . 1.7 p-10 -61.06 -18.61 58.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.242 -0.435 . . . . 73.34 110.855 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 75.1 m-80 -74.88 -6.98 52.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 71.42 110.887 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -117.54 22.77 12.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 74.21 110.892 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 323' ' ' VAL . . . . . 0.528 HG22 ' HA ' ' A' ' 320' ' ' ASP . 18.3 m -148.82 144.28 18.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.464 . . . . 73.53 111.17 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 324' ' ' LYS . . . . . 0.418 ' HB2' HG21 ' A' ' 275' ' ' ILE . 52.6 tttt -109.45 116.95 32.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.464 . . . . 70.1 110.891 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.44 HD12 ' CZ3' ' A' ' 307' ' ' TRP . 0.6 OUTLIER -65.02 119.36 10.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 53.4 110.952 179.89 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.437 HD13 ' CG ' ' A' ' 330' ' ' PHE . 20.2 mt -66.61 159.22 75.46 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.615 0.722 . . . . 71.12 110.896 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 167.79 23.43 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.638 2.225 . . . . 64.13 112.408 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 -19.84 35.43 Favored 'Trans proline' 0 C--O 1.23 0.113 0 C-N-CA 122.707 2.271 . . . . 73.41 112.349 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.28 -33.19 49.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 74.41 110.93 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 330' ' ' PHE . . . . . 0.437 ' CG ' HD13 ' A' ' 326' ' ' LEU . 2.8 t80 -64.03 115.46 4.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 73.25 110.842 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -133.36 106.93 7.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 71.22 110.934 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.16 -46.83 8.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.183 -0.462 . . . . 71.32 110.907 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 21.5 pm0 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.253 -0.431 . . . . 72.14 110.871 179.985 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 1.3 t . . . . . 0 N--CA 1.458 -0.059 0 CA-C-O 120.892 0.377 . . . . 61.45 110.874 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 36.7 mtt -97.17 174.07 6.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.084 -0.507 . . . . 71.2 110.879 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -67.66 145.17 55.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 71.01 110.878 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 7.1 m -90.97 -58.96 2.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 70.22 110.81 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 47.6 ttp180 -94.51 123.48 37.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.108 -0.496 . . . . 72.23 110.866 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 3.7 m -113.97 141.15 47.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 72.32 111.154 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 36.0 mttt -76.25 -176.16 3.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 74.0 110.861 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 8.7 m -81.19 68.46 7.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 75.01 110.858 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 24.8 mtpt -102.58 -176.5 3.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.472 . . . . 72.0 110.905 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -163.18 154.11 16.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 72.14 110.845 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 271' ' ' TYR . . . . . 0.426 ' CZ ' HG23 ' A' ' 295' ' ' THR . 33.9 m-85 -142.85 147.19 35.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.452 . . . . 75.25 110.942 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 272' ' ' CYS . . . . . 0.446 ' SG ' HD22 ' A' ' 296' ' ' LEU . 23.7 m -135.26 149.22 49.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 73.23 110.85 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 47.4 tttt -103.49 115.17 30.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.181 -0.463 . . . . 75.31 110.886 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 274' ' ' VAL . . . . . 0.55 HG21 ' HB ' ' A' ' 288' ' ' ILE . 58.9 t -57.47 118.26 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.262 -0.426 . . . . 53.42 111.08 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 26.2 pt -93.42 -30.98 4.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.489 . . . . 62.15 111.13 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -136.56 159.4 70.63 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.642 0.734 . . . . 52.21 110.929 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 159.63 52.69 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.648 2.232 . . . . 62.31 112.367 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -172.76 110.02 0.21 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.27 -0.423 . . . . 72.33 110.948 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 279' ' ' GLU . . . . . 0.682 ' HA ' HG23 ' A' ' 287' ' ' THR . 34.0 tt0 -93.23 128.02 39.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 71.13 110.868 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -61.82 116.27 4.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 72.51 111.109 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -57.9 -26.73 62.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 74.31 110.99 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -152.43 173.87 14.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 61.23 110.949 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -58.78 -26.28 63.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 61.35 110.945 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -70.11 -24.92 63.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.1 -0.5 . . . . 65.13 110.856 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -95.07 167.32 11.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 75.01 110.865 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.636 HD23 ' CD2' ' A' ' 318' ' ' PHE . 15.1 tp -116.78 137.43 52.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 42.01 110.921 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.682 HG23 ' HA ' ' A' ' 279' ' ' GLU . 85.4 m -95.18 144.35 25.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 53.24 111.128 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 288' ' ' ILE . . . . . 0.651 HG21 HG21 ' A' ' 294' ' ' VAL . 41.8 pt -150.34 149.72 14.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 42.4 111.128 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -121.93 140.79 52.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 73.32 110.909 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 8.1 tm-20 -51.83 122.95 9.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 64.44 110.861 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 113.26 -23.16 14.33 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.726 -0.749 . . . . 15.41 112.466 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -88.42 152.14 22.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.817 0.341 . . . . 71.32 110.867 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 62.7 mt -104.55 123.65 58.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 71.34 111.147 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 294' ' ' VAL . . . . . 0.74 HG11 ' CE2' ' A' ' 318' ' ' PHE . 90.9 t -100.17 138.04 25.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 73.02 111.114 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 295' ' ' THR . . . . . 0.426 HG23 ' CZ ' ' A' ' 271' ' ' TYR . 33.9 m -86.5 109.35 19.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.166 -0.47 . . . . 74.03 111.154 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.474 HD11 ' HB3' ' A' ' 307' ' ' TRP . 7.4 tp -69.86 117.76 11.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 70.01 110.904 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 69.0 mt -104.45 -48.41 9.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 73.21 111.086 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -134.38 178.13 7.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 41.23 110.895 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -141.46 112.77 7.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.157 -0.474 . . . . 73.31 110.91 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -50.56 165.77 0.09 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.229 -0.441 . . . . 72.41 110.805 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.8 t -115.69 -69.14 0.87 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.479 . . . . 74.04 110.864 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 2.0 mp -67.57 -12.61 15.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.434 . . . . 71.43 111.194 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.84 69.3 3.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 63.33 110.894 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 76.7 t -51.43 121.41 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 62.21 111.136 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.33 20.34 45.73 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.733 -0.746 . . . . 73.22 112.551 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 42.0 m95 -136.27 138.7 42.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.708 0.289 . . . . 75.13 110.909 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 307' ' ' TRP . . . . . 0.76 ' CZ3' HD12 ' A' ' 325' ' ' LEU . 19.5 m0 -134.3 157.19 46.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.454 . . . . 73.32 110.918 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -100.52 117.25 34.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.288 -0.415 . . . . 73.11 110.888 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -129.77 -170.13 12.67 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.768 -0.73 . . . . 62.24 112.505 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -143.83 146.82 33.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.864 0.364 . . . . 74.3 110.947 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.652 HD13 HG22 ' A' ' 294' ' ' VAL . 2.6 tp -155.77 132.27 10.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.181 -0.463 . . . . 73.22 110.92 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 2.9 m120 56.81 29.86 16.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 72.32 110.854 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 84.76 -6.8 76.73 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.747 -0.74 . . . . 73.1 112.485 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 314' ' ' ARG . . . . . 0.543 ' HG3' HD13 ' A' ' 286' ' ' LEU . 14.1 tpp180 -96.09 108.6 21.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.773 0.321 . . . . 62.12 110.857 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 8.9 ttp180 -96.61 129.75 43.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 73.33 110.952 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -161.34 -157.96 9.11 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.78 -0.724 . . . . 70.53 112.507 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 15.8 m -117.25 154.59 18.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.843 0.354 . . . . 74.52 111.119 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 318' ' ' PHE . . . . . 0.74 ' CE2' HG11 ' A' ' 294' ' ' VAL . 7.6 p90 -162.19 155.83 17.9 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.648 0.737 . . . . 72.23 110.904 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.85 118.5 5.72 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.699 2.266 . . . . 72.14 112.293 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 320' ' ' ASP . . . . . 0.579 ' HA ' HG22 ' A' ' 323' ' ' VAL . 3.0 t70 -59.67 -20.32 55.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 71.41 110.83 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -68.4 -12.65 61.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 44.35 110.887 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -107.96 14.15 25.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 71.25 110.856 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 323' ' ' VAL . . . . . 0.579 HG22 ' HA ' ' A' ' 320' ' ' ASP . 17.7 m -148.56 145.21 18.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.487 . . . . 71.41 111.09 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 21.6 ttpp -106.52 118.77 37.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 65.34 110.958 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.76 HD12 ' CZ3' ' A' ' 307' ' ' TRP . 1.9 tt -64.98 132.0 48.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 63.4 110.934 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.566 HD13 ' CD1' ' A' ' 330' ' ' PHE . 20.4 mt -68.92 159.23 83.6 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.572 0.701 . . . . 73.11 110.936 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 167.67 23.84 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.715 2.276 . . . . 74.41 112.37 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.7 -17.29 37.95 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.709 2.272 . . . . 60.44 112.298 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -81.07 -30.19 34.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.303 -0.408 . . . . 70.21 110.888 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 330' ' ' PHE . . . . . 0.566 ' CD1' HD13 ' A' ' 326' ' ' LEU . 4.0 t80 -72.57 109.38 6.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 75.54 110.888 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -135.92 107.45 6.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 74.32 110.929 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.37 -60.96 2.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 73.13 110.844 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.213 -0.449 . . . . 74.43 110.909 179.975 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 93.2 p . . . . . 0 C--O 1.23 0.059 0 CA-C-O 120.88 0.371 . . . . 72.14 110.888 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 24.3 mmm -118.49 65.38 0.76 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 61.41 110.869 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -58.34 135.27 57.14 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.236 -0.438 . . . . 61.53 110.868 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 7.6 t -144.74 122.78 12.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 54.52 110.865 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 14.6 mmp_? -98.57 163.25 12.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.128 -0.487 . . . . 73.13 110.843 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 266' ' ' THR . . . . . 0.407 HG23 ' HG3' ' A' ' 269' ' ' LYS . 14.7 t -106.09 143.24 34.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 62.11 111.122 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -97.17 -26.35 14.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 65.34 110.903 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 11.4 p -79.3 62.95 3.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 74.55 110.832 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.407 ' HG3' HG23 ' A' ' 266' ' ' THR . 73.8 mttt -101.47 -177.79 3.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.111 -0.495 . . . . 74.41 110.93 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -137.15 134.3 36.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 75.1 110.862 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 271' ' ' TYR . . . . . 0.536 ' CB ' HD12 ' A' ' 326' ' ' LEU . 10.3 m-85 -132.33 139.61 48.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 74.43 110.903 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 272' ' ' CYS . . . . . 0.508 ' SG ' HD13 ' A' ' 296' ' ' LEU . 36.0 m -127.76 148.61 50.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.479 . . . . 63.24 110.887 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 38.6 tttt -102.9 118.04 35.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 71.52 110.878 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 274' ' ' VAL . . . . . 0.652 HG13 HD12 ' A' ' 288' ' ' ILE . 61.6 t -58.82 112.99 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.252 -0.431 . . . . 61.2 111.15 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 0.422 HG21 ' HG2' ' A' ' 324' ' ' LYS . 30.9 pt -86.5 -31.47 6.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 74.45 111.099 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -139.71 158.14 68.56 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.603 0.716 . . . . 71.32 110.867 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 153.94 68.43 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.702 2.268 . . . . 60.22 112.361 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -171.48 105.95 0.22 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 71.44 110.927 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 279' ' ' GLU . . . . . 0.732 ' HA ' HG23 ' A' ' 287' ' ' THR . 9.7 tt0 -88.57 143.84 26.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 74.15 110.837 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -78.09 123.39 26.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.096 -0.502 . . . . 41.44 111.095 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -74.85 -26.13 59.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 74.13 110.943 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -144.49 170.07 16.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 74.03 110.883 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -57.35 -26.18 60.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.139 -0.482 . . . . 61.33 110.928 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 284' ' ' ASP . . . . . 0.559 ' O ' HG22 ' A' ' 317' ' ' VAL . 3.4 t70 -70.95 -25.56 62.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 52.24 110.922 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -95.16 161.28 14.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 64.43 110.928 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.599 HD12 ' N ' ' A' ' 287' ' ' THR . 13.4 tp -120.1 136.54 54.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.235 -0.439 . . . . 74.1 110.941 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.732 HG23 ' HA ' ' A' ' 279' ' ' GLU . 73.2 m -86.2 146.1 26.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 64.42 111.087 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 288' ' ' ILE . . . . . 0.652 HD12 HG13 ' A' ' 274' ' ' VAL . 44.3 pt -150.41 145.04 17.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.439 . . . . 73.22 111.106 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -117.64 136.98 52.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 62.01 110.873 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -51.76 126.15 17.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 62.24 110.88 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 108.51 -26.02 17.7 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.713 -0.756 . . . . 75.13 112.476 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -85.38 153.95 22.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.766 0.317 . . . . 73.24 110.917 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 29.2 mm -105.08 123.14 59.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.298 -0.41 . . . . 74.44 111.104 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 294' ' ' VAL . . . . . 0.722 HG11 ' CE2' ' A' ' 318' ' ' PHE . 87.8 t -93.25 138.04 21.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 72.01 111.123 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 89.4 m -86.46 108.55 18.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 51.14 111.156 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.508 HD13 ' SG ' ' A' ' 272' ' ' CYS . 3.3 tp -69.91 115.1 8.74 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.256 -0.429 . . . . 71.2 110.924 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 79.2 mt -103.71 -26.91 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 74.42 111.091 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -157.39 178.0 10.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 63.25 110.85 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 24.9 mttt -141.34 113.01 7.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.126 -0.488 . . . . 71.54 110.9 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -49.77 162.43 0.18 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.215 -0.448 . . . . 71.55 110.91 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.8 t -114.51 -68.99 0.88 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.261 -0.427 . . . . 61.12 110.931 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 40.2 mt -67.0 -13.12 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 73.53 111.063 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -95.77 71.04 3.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 74.35 110.876 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 42.1 t -51.28 119.99 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 74.0 111.178 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.32 24.79 30.31 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.715 -0.755 . . . . 51.12 112.463 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 55.6 m95 -139.67 138.26 35.9 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.743 0.306 . . . . 72.1 110.986 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 307' ' ' TRP . . . . . 0.762 ' CH2' HD12 ' A' ' 325' ' ' LEU . 20.8 m0 -132.53 158.45 42.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.278 -0.419 . . . . 71.22 110.857 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -103.03 115.18 30.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 73.1 110.949 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -130.34 -171.76 12.99 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.677 -0.773 . . . . 63.55 112.462 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -141.85 143.64 33.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.906 0.384 . . . . 74.12 110.878 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.6 HD13 HG22 ' A' ' 294' ' ' VAL . 1.8 tp -160.03 147.05 16.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 64.34 110.937 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 2.8 m120 56.6 29.94 16.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 62.23 110.862 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 76.24 7.83 84.99 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.696 -0.764 . . . . 71.23 112.431 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.9 126.29 52.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.835 0.35 . . . . 71.13 110.877 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 7.8 ttp180 -100.9 141.21 34.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 74.11 110.928 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -172.78 -158.84 18.09 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.741 -0.742 . . . . 53.44 112.493 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 284' ' ' ASP . 35.4 m -117.86 162.99 15.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.932 0.396 . . . . 71.52 111.087 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 318' ' ' PHE . . . . . 0.722 ' CE2' HG11 ' A' ' 294' ' ' VAL . 7.1 p90 -166.71 157.04 10.54 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.66 0.743 . . . . 75.51 110.866 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.83 122.31 8.97 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.63 2.22 . . . . 71.44 112.365 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 320' ' ' ASP . . . . . 0.541 ' HA ' HG22 ' A' ' 323' ' ' VAL . 1.6 p-10 -59.2 -21.31 59.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.238 -0.437 . . . . 74.34 110.876 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -69.93 -16.99 63.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 71.22 110.898 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -102.95 15.13 30.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 64.41 110.863 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 323' ' ' VAL . . . . . 0.541 HG22 ' HA ' ' A' ' 320' ' ' ASP . 18.2 m -148.99 150.45 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 72.34 111.217 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 324' ' ' LYS . . . . . 0.422 ' HG2' HG21 ' A' ' 275' ' ' ILE . 17.2 mmtm -114.8 117.32 30.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 72.1 110.894 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.762 HD12 ' CH2' ' A' ' 307' ' ' TRP . 1.9 tt -64.92 127.38 31.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.246 -0.434 . . . . 72.22 110.908 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.536 HD12 ' CB ' ' A' ' 271' ' ' TYR . 20.4 mt -59.38 159.27 16.87 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.575 0.702 . . . . 63.41 110.932 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.84 167.76 23.6 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.656 2.238 . . . . 73.43 112.336 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.68 -16.76 38.05 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.728 2.285 . . . . 53.11 112.365 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -82.64 -40.87 20.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.182 -0.463 . . . . 74.21 110.911 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 330' ' ' PHE . . . . . 0.491 ' CD1' HD13 ' A' ' 326' ' ' LEU . 3.4 t80 -66.6 115.69 6.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 74.51 110.873 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -141.61 106.92 5.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.155 -0.475 . . . . 71.1 110.907 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.21 -65.34 0.97 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.097 -0.501 . . . . 54.33 110.965 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 72.43 110.879 179.961 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 31.0 t . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.898 0.38 . . . . 62.32 110.835 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 6.0 mmm -79.63 98.44 6.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 70.52 110.88 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.55 104.8 13.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 64.31 110.915 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 70.2 m -75.94 159.01 31.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.255 -0.429 . . . . 51.34 110.788 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.52 -28.54 8.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.092 -0.504 . . . . 74.24 110.858 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 3.0 m -71.88 117.17 13.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.199 -0.455 . . . . 70.54 111.165 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 23.8 mtpp -89.61 -53.99 4.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.226 -0.443 . . . . 75.21 110.857 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 1.2 p -122.04 129.08 52.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 64.21 110.812 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 3.0 mtpm? -112.23 -178.21 3.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.095 -0.502 . . . . 71.54 110.861 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -127.48 125.0 39.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 73.44 110.897 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 271' ' ' TYR . . . . . 0.484 ' CB ' HD12 ' A' ' 326' ' ' LEU . 7.5 m-85 -127.64 146.78 50.43 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.213 -0.449 . . . . 71.51 110.926 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 272' ' ' CYS . . . . . 0.524 ' SG ' HD22 ' A' ' 296' ' ' LEU . 45.5 m -133.64 147.9 51.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 40.41 110.863 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 28.9 tttt -102.9 119.23 38.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 74.15 110.928 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 274' ' ' VAL . . . . . 0.473 ' CG2' HG23 ' A' ' 294' ' ' VAL . 58.8 t -59.37 112.6 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.31 -0.405 . . . . 73.44 111.075 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 0.57 HG21 ' HG3' ' A' ' 324' ' ' LYS . 29.2 pt -86.59 -31.89 6.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 64.34 111.092 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -138.71 158.73 69.62 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.669 0.747 . . . . 74.35 110.91 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 161.49 45.72 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.679 2.253 . . . . 71.24 112.338 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -174.87 111.92 0.14 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.274 -0.421 . . . . 74.3 110.934 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 279' ' ' GLU . . . . . 0.727 ' HA ' HG23 ' A' ' 287' ' ' THR . 24.4 tt0 -92.17 131.97 36.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.101 -0.5 . . . . 75.43 110.872 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 280' ' ' ALA . . . . . 0.472 ' HB1' ' HB2' ' A' ' 285' ' ' GLU . . . -68.26 115.67 7.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 72.03 111.077 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -58.08 -30.35 66.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 72.34 110.936 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -149.72 175.18 11.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 73.14 110.9 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -58.65 -25.64 62.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 72.54 110.891 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -69.93 -25.88 63.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 75.2 110.897 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 285' ' ' GLU . . . . . 0.529 ' OE1' HG23 ' A' ' 317' ' ' VAL . 63.7 mm-40 -94.93 163.41 13.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 72.11 110.916 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.613 HD23 ' CD2' ' A' ' 318' ' ' PHE . 23.2 tp -116.08 131.54 56.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 62.42 110.949 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.727 HG23 ' HA ' ' A' ' 279' ' ' GLU . 60.4 m -88.24 144.61 26.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 73.54 111.141 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 288' ' ' ILE . . . . . 0.54 HG21 HG21 ' A' ' 294' ' ' VAL . 43.9 pt -150.34 146.87 16.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 70.21 111.12 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -119.11 139.57 51.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.478 . . . . 52.5 110.871 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -51.91 124.01 11.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.475 . . . . 71.55 110.878 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 111.65 -24.97 14.09 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.768 -0.73 . . . . 73.34 112.46 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -85.98 156.16 20.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.789 0.328 . . . . 73.43 110.893 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 36.7 mm -108.63 127.14 65.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.288 -0.415 . . . . 61.35 111.18 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 294' ' ' VAL . . . . . 0.708 HG11 ' CE2' ' A' ' 318' ' ' PHE . 61.1 t -102.59 138.1 28.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 74.14 111.121 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 97.8 m -82.38 103.8 12.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 74.33 111.139 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.648 HD11 ' HB3' ' A' ' 307' ' ' TRP . 9.0 tp -69.89 113.15 6.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.144 -0.48 . . . . 75.44 110.897 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 19.7 mt -92.8 -49.17 13.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 62.04 111.155 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -149.88 178.62 8.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 63.21 110.863 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -129.17 112.3 13.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 63.2 110.85 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -49.8 166.6 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 72.34 110.878 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.0 t -111.02 -69.11 0.89 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.203 -0.453 . . . . 43.35 110.894 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 51.4 mt -63.62 -15.3 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 72.01 111.192 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -93.31 65.26 3.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.112 -0.494 . . . . 64.32 110.897 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 57.7 t -51.19 118.69 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 74.23 111.119 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.54 23.07 34.84 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.788 -0.72 . . . . 50.42 112.496 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 52.8 m95 -139.06 133.01 31.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.735 0.303 . . . . 74.32 110.925 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 307' ' ' TRP . . . . . 0.758 ' CZ3' HD12 ' A' ' 325' ' ' LEU . 28.6 m0 -124.34 149.62 46.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.257 -0.429 . . . . 74.44 110.882 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -97.62 119.78 36.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.435 . . . . 73.11 110.944 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -136.74 -167.24 11.08 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.668 -0.777 . . . . 74.54 112.408 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -139.34 138.48 36.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.926 0.394 . . . . 74.31 110.844 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.657 HD13 HG22 ' A' ' 294' ' ' VAL . 13.2 tp -145.78 129.98 17.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.489 . . . . 64.41 110.895 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 2.9 m120 58.89 29.95 19.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 71.23 110.805 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 84.03 -4.72 82.3 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.753 -0.737 . . . . 73.42 112.458 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 9.5 ttp85 -100.44 120.15 39.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.842 0.353 . . . . 50.43 110.842 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 32.4 mtm180 -99.9 140.54 33.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.469 . . . . 73.2 110.847 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -173.29 -159.85 20.66 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.689 -0.767 . . . . 72.24 112.479 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.529 HG23 ' OE1' ' A' ' 285' ' ' GLU . 17.0 m -117.02 148.63 19.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.859 0.362 . . . . 65.34 111.098 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 318' ' ' PHE . . . . . 0.708 ' CE2' HG11 ' A' ' 294' ' ' VAL . 8.8 p90 -151.01 156.76 35.52 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.722 0.772 . . . . 54.34 110.847 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 120.01 6.87 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.71 2.273 . . . . 70.42 112.332 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 320' ' ' ASP . . . . . 0.567 ' HA ' HG22 ' A' ' 323' ' ' VAL . 1.6 p-10 -58.58 -21.91 54.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.276 -0.42 . . . . 71.44 110.844 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -71.14 -10.2 59.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.471 . . . . 74.3 110.877 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -111.88 17.68 19.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 73.13 110.905 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 323' ' ' VAL . . . . . 0.567 HG22 ' HA ' ' A' ' 320' ' ' ASP . 18.0 m -149.07 151.89 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.11 -0.496 . . . . 62.13 111.125 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 324' ' ' LYS . . . . . 0.57 ' HG3' HG21 ' A' ' 275' ' ' ILE . 8.9 mtpp -118.94 118.63 32.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 75.33 110.934 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.758 HD12 ' CZ3' ' A' ' 307' ' ' TRP . 0.7 OUTLIER -65.02 130.56 43.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.208 -0.451 . . . . 75.43 110.855 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.484 HD12 ' CB ' ' A' ' 271' ' ' TYR . 20.2 mt -63.96 159.21 57.05 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 121.631 0.729 . . . . 63.4 110.855 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 167.71 23.63 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.729 2.286 . . . . 40.22 112.38 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -21.35 33.72 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.657 2.238 . . . . 64.32 112.391 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -77.1 -37.73 53.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.46 . . . . 73.34 110.877 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 330' ' ' PHE . . . . . 0.419 ' CD1' HD13 ' A' ' 326' ' ' LEU . 4.5 t80 -75.37 114.37 13.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 50.24 110.873 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -151.2 107.38 3.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.169 -0.469 . . . . 61.44 110.868 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 19.2 mtpp -82.87 -72.12 0.46 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.11 -0.495 . . . . 73.21 110.886 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 63.02 110.861 -179.97 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 34.1 m . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.832 0.348 . . . . 61.15 110.847 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 2.6 mpp? -135.71 113.99 11.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 71.34 110.894 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -115.44 110.78 19.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.283 -0.417 . . . . 71.23 110.821 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 3.8 m -69.37 147.71 50.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 72.14 110.809 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 6.2 tpt85 -99.3 -26.62 14.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.113 -0.494 . . . . 72.12 110.852 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 7.5 t -105.18 143.64 33.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 71.31 111.107 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 17.9 tttt -88.48 -37.29 15.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 75.14 110.915 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 13.4 t -74.28 81.43 1.85 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.256 -0.429 . . . . 71.35 110.891 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 4.2 pttm -129.67 -174.27 3.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 65.31 110.869 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -152.77 130.13 11.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 70.33 110.844 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 271' ' ' TYR . . . . . 0.592 ' HB3' HD12 ' A' ' 326' ' ' LEU . 7.6 m-85 -115.94 142.78 46.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.243 -0.435 . . . . 75.13 110.943 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 272' ' ' CYS . . . . . 0.476 ' SG ' HD13 ' A' ' 296' ' ' LEU . 22.7 m -127.29 146.32 50.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.113 -0.494 . . . . 73.12 110.919 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -102.9 126.11 49.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 64.3 110.912 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 274' ' ' VAL . . . . . 0.43 HG21 ' HB ' ' A' ' 288' ' ' ILE . 47.8 t -64.84 112.23 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.309 -0.405 . . . . 72.42 111.136 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 27.0 pt -85.74 -32.09 6.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.269 -0.423 . . . . 54.41 111.127 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -138.53 157.96 71.28 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.624 0.726 . . . . 75.11 110.878 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 156.66 62.77 Favored 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 122.674 2.249 . . . . 62.33 112.345 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -172.41 108.21 0.2 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 63.34 110.924 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 279' ' ' GLU . . . . . 0.712 ' HA ' HG23 ' A' ' 287' ' ' THR . 25.2 tt0 -88.15 138.97 30.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 70.11 110.866 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -68.45 116.52 9.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 74.43 111.099 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -56.47 -28.08 58.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 73.23 110.907 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -153.73 175.93 12.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 70.22 110.885 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -58.8 -25.81 63.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.145 -0.48 . . . . 74.52 110.855 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.16 -23.57 61.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 65.32 110.86 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -94.96 167.96 11.08 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.179 -0.464 . . . . 73.41 110.909 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.626 HD23 ' CD2' ' A' ' 318' ' ' PHE . 14.6 tp -119.01 136.67 54.0 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.163 -0.471 . . . . 61.43 110.9 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.712 HG23 ' HA ' ' A' ' 279' ' ' GLU . 85.6 m -91.89 146.08 24.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.159 -0.473 . . . . 74.34 111.144 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 288' ' ' ILE . . . . . 0.43 ' HB ' HG21 ' A' ' 274' ' ' VAL . 33.7 pt -149.49 143.3 18.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.281 -0.418 . . . . 63.2 111.183 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 20.2 mtpp -117.26 140.05 50.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.148 -0.478 . . . . 70.04 110.919 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -51.43 121.84 6.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 71.4 110.924 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 115.2 -31.03 6.42 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.727 -0.749 . . . . 70.21 112.48 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -79.4 160.39 26.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.725 0.298 . . . . 74.23 110.889 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.463 HG23 ' O ' ' A' ' 272' ' ' CYS . 3.2 mp -115.95 128.05 73.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 63.53 111.115 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 294' ' ' VAL . . . . . 0.852 HG22 HD13 ' A' ' 311' ' ' LEU . 99.8 t -105.03 138.15 31.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 70.35 111.127 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 295' ' ' THR . . . . . 0.569 HG23 ' CE1' ' A' ' 271' ' ' TYR . 3.3 m -85.98 117.7 25.0 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.174 -0.466 . . . . 61.34 111.151 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.476 HD13 ' SG ' ' A' ' 272' ' ' CYS . 5.2 tp -69.88 110.66 5.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.243 -0.435 . . . . 61.44 110.865 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 27.5 mm -100.12 -26.12 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 63.53 111.079 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -162.11 178.31 8.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 74.34 110.862 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 40.9 mttt -141.38 112.95 7.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 75.24 110.885 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -49.66 161.74 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 74.23 110.902 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.8 t -113.53 -69.05 0.89 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 74.44 110.86 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 38.6 mt -66.97 -12.98 15.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.432 . . . . 74.52 111.172 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -97.36 70.46 2.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.135 -0.484 . . . . 74.33 110.843 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.405 ' O ' HG13 ' A' ' 304' ' ' VAL . 6.3 p -51.35 121.89 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 73.54 111.176 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.24 21.0 43.14 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.695 -0.764 . . . . 54.24 112.461 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 42.5 m95 -136.42 134.27 37.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.781 0.324 . . . . 74.41 110.896 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 307' ' ' TRP . . . . . 0.444 ' CZ3' HD12 ' A' ' 325' ' ' LEU . 22.0 m0 -129.2 156.96 43.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.112 -0.495 . . . . 75.32 110.932 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -101.33 113.41 26.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.283 -0.417 . . . . 62.15 110.869 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -124.7 -173.93 13.89 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.802 -0.713 . . . . 54.24 112.493 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 72.8 tt0 -137.74 136.22 37.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.897 0.379 . . . . 73.41 110.91 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.852 HD13 HG22 ' A' ' 294' ' ' VAL . 3.1 tp -149.2 134.4 18.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.454 . . . . 63.35 111.003 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 2.9 m120 58.86 29.94 19.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 64.35 110.901 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 81.2 -0.91 86.81 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.733 -0.746 . . . . 34.52 112.457 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 314' ' ' ARG . . . . . 0.435 ' HG2' HD13 ' A' ' 286' ' ' LEU . 9.5 ttp85 -103.5 111.46 23.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.869 0.366 . . . . 74.34 110.893 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 9.5 ttp180 -96.66 117.03 30.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 75.22 110.861 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -146.89 -155.23 6.45 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.793 -0.717 . . . . 72.52 112.539 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 23.1 m -118.48 155.41 20.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.817 0.342 . . . . 73.54 111.159 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 318' ' ' PHE . . . . . 0.745 ' CE2' HG11 ' A' ' 294' ' ' VAL . 6.7 p90 -163.72 156.11 15.23 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.569 0.7 . . . . 62.45 110.92 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.82 119.24 6.21 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.682 2.255 . . . . 62.42 112.337 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 320' ' ' ASP . . . . . 0.584 ' HA ' HG22 ' A' ' 323' ' ' VAL . 2.7 t70 -60.42 -18.97 54.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.191 -0.459 . . . . 74.14 110.841 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -68.24 -12.51 61.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 74.45 110.884 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -108.29 14.47 24.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 62.54 110.872 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 323' ' ' VAL . . . . . 0.584 HG22 ' HA ' ' A' ' 320' ' ' ASP . 18.0 m -148.86 149.54 14.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 74.0 111.085 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 10.2 ttmm -121.49 134.17 55.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 64.1 110.876 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.444 HD12 ' CZ3' ' A' ' 307' ' ' TRP . 0.0 OUTLIER -64.95 126.42 27.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 64.32 110.91 179.965 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.751 HD13 ' CD1' ' A' ' 330' ' ' PHE . 20.4 mt -63.53 159.16 53.66 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.611 0.72 . . . . 72.42 110.909 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 167.6 23.96 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.742 2.295 . . . . 74.14 112.373 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.73 -16.15 37.53 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.632 2.221 . . . . 72.43 112.306 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -84.95 -42.07 15.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 75.34 110.868 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 330' ' ' PHE . . . . . 0.751 ' CD1' HD13 ' A' ' 326' ' ' LEU . 8.9 t80 -63.93 118.57 8.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 72.3 110.889 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -136.89 106.78 6.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.081 -0.509 . . . . 75.43 110.836 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 18.3 tttm -60.57 -45.56 93.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.08 -0.509 . . . . 71.41 110.94 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 63.2 110.904 179.914 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.838 0.351 . . . . 54.34 110.838 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' TYR . . . . . 0.542 ' HB3' HD12 ' A' ' 326' ' ' LEU . 8.6 m-85 -128.11 149.39 50.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 73.51 110.863 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 25.7 m -138.55 148.19 43.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.098 -0.501 . . . . 73.33 110.843 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -102.95 123.05 45.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 71.51 110.912 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . 0.655 HG13 HD12 ' A' ' 288' ' ' ILE . 22.4 t -61.0 109.02 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 61.21 111.131 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 36.0 pt -83.64 -28.22 7.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 60.52 111.133 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -145.41 159.3 48.89 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.624 0.726 . . . . 75.32 110.851 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 159.78 52.15 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.651 2.234 . . . . 60.44 112.364 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -176.1 110.39 0.1 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.435 . . . . 74.24 110.929 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . 0.716 ' HA ' HG23 ' A' ' 287' ' ' THR . 21.7 tp10 -89.46 135.04 33.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.089 -0.505 . . . . 70.32 110.945 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -65.82 113.26 4.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 61.44 111.038 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -58.06 -26.44 62.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.436 . . . . 73.4 110.986 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -154.95 170.77 20.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 65.51 110.885 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -56.22 -25.99 49.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 60.24 110.882 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -70.05 -26.55 64.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.155 -0.475 . . . . 73.3 110.929 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -94.99 169.56 10.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 64.15 110.89 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.598 HD23 ' CD2' ' A' ' 318' ' ' PHE . 14.0 tp -120.57 137.24 54.5 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.16 -0.473 . . . . 71.55 110.931 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.716 HG23 ' HA ' ' A' ' 279' ' ' GLU . 91.5 m -90.9 145.25 24.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 72.11 111.109 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' ILE . . . . . 0.655 HD12 HG13 ' A' ' 274' ' ' VAL . 48.1 pt -150.26 142.95 17.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 72.14 111.094 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 44.4 mttm -114.36 139.8 49.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 63.3 110.894 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -51.94 129.84 27.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.15 -0.477 . . . . 62.05 110.919 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 102.27 -25.59 27.18 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.744 -0.741 . . . . 51.02 112.534 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.496 ' O ' HD13 ' A' ' 293' ' ' ILE . 6.6 m-20 -76.49 174.53 10.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.752 0.31 . . . . 60.41 110.856 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.496 HD13 ' O ' ' A' ' 292' ' ' ASP . 31.4 mm -124.94 125.99 70.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 74.12 111.139 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . 0.682 HG11 ' CE2' ' A' ' 318' ' ' PHE . 78.5 t -107.82 135.1 47.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 71.23 111.114 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 88.8 m -88.17 111.52 21.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.209 -0.45 . . . . 75.33 111.176 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.559 HD11 ' HB3' ' A' ' 307' ' ' TRP . 7.6 tp -69.97 118.96 13.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 71.5 110.899 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' ILE . . . . . 0.402 HG22 HD22 ' A' ' 298' ' ' ASN . 61.7 mt -104.73 -47.6 9.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.142 -0.481 . . . . 45.12 111.167 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . 0.402 HD22 HG22 ' A' ' 297' ' ' ILE . 9.5 m-80 -135.21 178.13 7.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 74.21 110.896 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 66.1 mttt -141.41 112.82 7.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.104 -0.498 . . . . 72.43 110.955 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -50.53 165.18 0.1 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 74.23 110.961 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 3.2 t -115.14 -69.2 0.87 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.21 -0.45 . . . . 73.32 110.887 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 1.9 mp -67.92 -12.4 15.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 75.52 111.159 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -95.86 68.18 2.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.18 -0.463 . . . . 72.04 110.878 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 6.6 p -51.51 122.76 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 71.33 111.135 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.69 21.92 38.44 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.679 -0.772 . . . . 55.41 112.459 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 56.5 m95 -140.0 138.07 35.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.761 0.315 . . . . 73.12 110.833 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' TRP . . . . . 0.76 ' CZ3' HD12 ' A' ' 325' ' ' LEU . 20.6 m0 -133.18 155.91 48.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.167 -0.47 . . . . 73.05 110.893 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -99.38 121.95 41.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.277 -0.42 . . . . 72.41 110.9 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -140.69 -174.41 13.98 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.77 -0.729 . . . . 15.42 112.51 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -134.41 145.76 49.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.956 0.407 . . . . 72.14 110.846 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.414 HD13 HG22 ' A' ' 294' ' ' VAL . 5.1 tp -155.73 131.81 10.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.073 -0.512 . . . . 75.34 110.922 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 56.96 29.96 17.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 73.32 110.918 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 79.14 19.14 72.96 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.717 -0.754 . . . . 64.41 112.539 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -120.71 114.26 21.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.859 0.361 . . . . 74.45 110.86 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 42.0 ttt180 -96.97 132.13 43.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.113 -0.494 . . . . 72.44 110.878 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -170.72 -159.94 17.96 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.741 -0.742 . . . . 72.22 112.476 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 27.7 m -116.76 147.64 20.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.781 0.324 . . . . 54.14 111.163 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' PHE . . . . . 0.682 ' CE2' HG11 ' A' ' 294' ' ' VAL . 7.1 p90 -149.74 156.77 38.69 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.701 0.762 . . . . 72.55 110.82 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.8 121.76 8.44 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.651 2.234 . . . . 71.01 112.332 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . 0.531 ' HA ' HG22 ' A' ' 323' ' ' VAL . 1.7 p-10 -61.04 -19.01 60.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 75.05 110.921 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -73.85 -9.74 58.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.491 . . . . 63.5 110.883 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -113.64 22.03 14.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 73.54 110.828 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . 0.531 HG22 ' HA ' ' A' ' 320' ' ' ASP . 18.7 m -148.94 156.38 7.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 74.02 111.098 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 20.4 tttt -121.87 114.81 21.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.473 . . . . 74.14 110.854 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.76 HD12 ' CZ3' ' A' ' 307' ' ' TRP . 0.8 OUTLIER -64.98 125.9 26.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 72.21 110.89 179.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.542 HD12 ' HB3' ' A' ' 271' ' ' TYR . 20.4 mt . . . . . 0 C--N 1.328 -0.345 0 CA-C-O 121.559 0.695 . . . . 63.14 110.916 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.771 0.32 . . . . 74.2 110.913 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' TYR . . . . . 0.492 ' HB3' HD12 ' A' ' 326' ' ' LEU . 16.7 m-85 -129.62 152.86 48.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 63.44 110.9 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' CYS . . . . . 0.447 ' SG ' HD13 ' A' ' 296' ' ' LEU . 31.8 m -139.17 153.2 47.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 71.55 110.87 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 38.8 tttt -110.57 119.18 38.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 52.41 110.913 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . 0.819 HG13 HD12 ' A' ' 288' ' ' ILE . 26.2 t -56.0 111.32 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 75.11 111.128 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 34.5 pt -87.43 -27.31 5.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 74.43 111.103 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -144.44 160.09 49.4 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.64 0.733 . . . . 71.11 110.856 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 158.57 56.52 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.676 2.251 . . . . 75.1 112.327 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -173.95 107.42 0.13 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.455 . . . . 74.31 110.868 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . 0.613 ' HA ' HG23 ' A' ' 287' ' ' THR . 30.0 tt0 -91.94 118.06 30.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.14 -0.482 . . . . 64.52 110.866 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -51.74 119.86 4.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 45.53 111.087 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -66.44 -26.19 67.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.439 . . . . 73.42 110.916 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -150.46 168.79 23.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.209 -0.45 . . . . 75.34 110.914 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -56.62 -25.9 54.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 64.11 110.875 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -70.05 -25.81 63.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 54.32 110.854 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -95.03 166.32 12.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.243 -0.435 . . . . 73.43 110.887 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.641 HD23 ' CD2' ' A' ' 318' ' ' PHE . 14.1 tp -115.97 137.1 52.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.157 -0.474 . . . . 71.24 110.944 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.613 HG23 ' HA ' ' A' ' 279' ' ' GLU . 91.4 m -91.15 144.48 25.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 64.15 111.139 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' ILE . . . . . 0.819 HD12 HG13 ' A' ' 274' ' ' VAL . 34.0 pt -150.47 146.77 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 61.42 111.092 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . 0.401 ' C ' HG11 ' A' ' 274' ' ' VAL . 25.7 mtpt -122.27 143.6 49.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 51.44 110.85 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 66.5 tt0 -52.0 130.08 28.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 73.02 110.871 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 100.79 -25.53 28.01 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.738 -0.744 . . . . 74.21 112.503 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.69 170.91 15.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.78 0.324 . . . . 73.51 110.861 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 48.5 mm -123.4 128.49 74.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 54.03 111.187 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . 0.704 HG11 ' CE2' ' A' ' 318' ' ' PHE . 94.1 t -108.62 138.06 37.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.234 -0.439 . . . . 62.53 111.162 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 47.1 m -94.07 113.35 25.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.208 -0.451 . . . . 73.24 111.116 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.447 HD13 ' SG ' ' A' ' 272' ' ' CYS . 4.1 tp -69.95 117.6 11.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.214 -0.448 . . . . 72.3 110.948 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 69.2 mt -107.06 -28.32 2.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.439 . . . . 63.12 111.127 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -155.05 178.11 10.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 73.13 110.861 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 8.7 mttm -141.53 112.94 7.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 75.45 110.915 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -49.92 162.31 0.2 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.284 -0.417 . . . . 73.2 110.833 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.8 t -113.58 -68.97 0.89 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 74.21 110.888 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 38.9 mt -67.17 -12.99 16.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 73.41 111.149 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -96.7 70.36 2.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.485 . . . . 54.11 110.873 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.404 ' O ' HG13 ' A' ' 304' ' ' VAL . 6.5 p -51.48 122.17 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 71.5 111.232 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.09 19.51 50.27 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.812 -0.709 . . . . 73.32 112.497 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -135.47 137.79 42.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.772 0.32 . . . . 74.22 110.917 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' TRP . . . . . 0.789 ' CZ3' HD12 ' A' ' 325' ' ' LEU . 22.5 m0 -131.76 158.78 40.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.25 -0.432 . . . . 75.31 110.943 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -103.5 120.38 40.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.307 -0.406 . . . . 42.22 110.841 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -136.53 -169.74 11.79 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.789 -0.719 . . . . 64.34 112.458 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -137.89 147.87 44.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.826 0.346 . . . . 72.43 110.9 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.595 HD13 HG22 ' A' ' 294' ' ' VAL . 9.9 tp -150.22 123.19 8.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 63.52 110.913 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 55.55 30.61 15.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.256 -0.429 . . . . 75.11 110.895 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 92.13 -16.58 59.31 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.758 -0.734 . . . . 74.53 112.441 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -85.52 112.53 21.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.87 0.367 . . . . 73.51 110.872 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 42.3 mtp180 -99.83 135.45 41.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.101 -0.5 . . . . 61.24 110.869 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -172.61 -163.33 26.24 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.733 -0.746 . . . . 74.35 112.488 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 27.7 m -109.59 160.55 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.866 0.365 . . . . 71.44 111.116 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' PHE . . . . . 0.704 ' CE2' HG11 ' A' ' 294' ' ' VAL . 4.6 p90 -165.2 156.21 12.57 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.621 0.724 . . . . 74.44 110.885 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 118.77 5.88 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.685 2.256 . . . . 70.12 112.268 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . 0.535 ' HA ' HG22 ' A' ' 323' ' ' VAL . 2.9 t70 -60.13 -19.74 55.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 72.34 110.874 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -73.26 -8.48 55.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 61.14 110.863 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -114.78 21.38 14.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 75.12 110.888 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . 0.535 HG22 ' HA ' ' A' ' 320' ' ' ASP . 18.5 m -148.74 146.34 17.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.113 -0.494 . . . . 71.41 111.056 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 15.2 ttmm -106.83 109.77 21.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.114 -0.493 . . . . 62.22 110.95 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.789 HD12 ' CZ3' ' A' ' 307' ' ' TRP . 2.6 tt -64.93 119.03 9.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 73.02 110.954 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.492 HD12 ' HB3' ' A' ' 271' ' ' TYR . 20.3 mt . . . . . 0 C--N 1.328 -0.346 0 CA-C-O 121.549 0.69 . . . . 74.45 110.9 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.847 0.356 . . . . 61.44 110.813 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' TYR . . . . . 0.567 ' HB3' HD12 ' A' ' 326' ' ' LEU . 14.8 m-85 -116.43 148.06 41.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 71.14 110.951 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 24.8 m -133.42 146.69 51.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.076 -0.511 . . . . 45.44 110.915 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 49.9 tttt -106.06 122.12 45.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 72.54 110.885 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . 0.467 HG13 HD12 ' A' ' 288' ' ' ILE . 23.0 t -61.66 113.21 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 73.14 111.121 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 28.3 pt -88.21 -29.97 5.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.138 -0.483 . . . . 72.43 111.068 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -140.1 158.76 66.39 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.622 0.725 . . . . 72.32 110.855 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 156.04 64.42 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.636 2.224 . . . . 41.23 112.375 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -173.68 107.96 0.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 75.15 110.883 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . 0.682 ' HA ' HG23 ' A' ' 287' ' ' THR . 13.9 tt0 -87.99 142.4 27.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.109 -0.496 . . . . 75.42 110.894 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -70.52 113.02 7.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.126 -0.488 . . . . 54.24 111.091 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -58.01 -25.84 61.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 74.13 110.929 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -155.72 170.25 22.46 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.195 -0.457 . . . . 74.55 110.898 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -56.51 -25.21 50.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 63.3 110.818 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -72.13 -25.02 61.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 61.42 110.843 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -95.02 167.1 11.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 73.03 110.871 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.644 HD23 ' CD2' ' A' ' 318' ' ' PHE . 14.3 tp -115.01 136.82 52.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 71.22 110.958 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.682 HG23 ' HA ' ' A' ' 279' ' ' GLU . 86.6 m -92.12 142.07 27.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 72.12 111.115 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' ILE . . . . . 0.531 HG21 HG21 ' A' ' 294' ' ' VAL . 31.9 pt -148.78 146.48 17.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 73.31 111.143 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -119.33 140.72 49.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 62.3 110.828 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -51.97 128.67 24.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 71.2 110.916 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 104.14 -23.97 30.52 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.691 -0.766 . . . . 42.52 112.426 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.16 175.3 10.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.744 0.306 . . . . 52.13 110.913 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 39.9 mm -125.34 128.81 72.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.199 -0.455 . . . . 72.4 111.117 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . 0.692 HG11 ' CE2' ' A' ' 318' ' ' PHE . 98.3 t -109.77 137.99 39.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.49 . . . . 74.5 111.172 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 40.5 m -91.16 111.68 23.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 64.41 111.186 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.44 HD11 ' HB3' ' A' ' 307' ' ' TRP . 5.9 tp -70.07 117.56 11.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.238 -0.437 . . . . 52.53 110.858 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 64.4 mt -106.97 -34.67 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 71.24 111.186 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -147.45 178.18 8.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.134 -0.484 . . . . 60.1 110.84 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 35.8 mttp -141.45 112.95 7.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 74.02 110.893 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -49.74 165.79 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 63.44 110.899 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.5 t -118.15 -69.38 0.85 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.214 -0.448 . . . . 53.13 110.872 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 47.2 mt -65.27 -14.36 16.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 72.14 111.165 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -98.32 71.7 2.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 44.34 110.9 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 59.3 t -51.52 122.31 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 72.34 111.138 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.61 20.45 44.25 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.731 -0.747 . . . . 42.13 112.488 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 50.8 m95 -135.23 134.27 39.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.713 0.292 . . . . 70.33 110.952 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' TRP . . . . . 0.44 ' HB3' HD11 ' A' ' 296' ' ' LEU . 24.4 m0 -129.66 156.64 43.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.25 -0.432 . . . . 64.44 110.955 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -101.98 126.28 48.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.277 -0.42 . . . . 75.33 110.868 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -143.77 -167.84 11.98 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.705 -0.759 . . . . 73.33 112.454 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -138.32 147.53 43.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.875 0.369 . . . . 75.41 110.936 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 4.8 tp -157.95 132.05 8.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 70.24 110.932 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 56.35 29.99 16.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 74.44 110.911 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 79.79 18.44 72.83 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.723 -0.751 . . . . 63.24 112.579 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 16.0 mmt180 -121.58 113.53 19.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.767 0.318 . . . . 70.4 110.878 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -97.22 132.05 43.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.244 -0.434 . . . . 74.3 110.895 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -170.07 -163.67 24.49 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.827 -0.702 . . . . 63.23 112.54 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 8.3 m -108.12 157.27 8.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.86 0.362 . . . . 65.42 111.113 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' PHE . . . . . 0.692 ' CE2' HG11 ' A' ' 294' ' ' VAL . 5.9 p90 -163.17 156.08 16.26 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.714 0.769 . . . . 74.41 110.83 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.69 117.47 5.1 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.691 2.261 . . . . 51.21 112.398 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . 0.577 ' HA ' HG22 ' A' ' 323' ' ' VAL . 2.9 t70 -57.77 -22.56 47.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.252 -0.431 . . . . 65.5 110.92 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -68.85 -12.26 61.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 70.12 110.861 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -108.46 14.72 24.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 72.52 110.857 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . 0.577 HG22 ' HA ' ' A' ' 320' ' ' ASP . 17.9 m -148.69 138.11 15.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.475 . . . . 72.53 111.11 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.74 123.06 48.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 72.31 110.905 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 2.5 mt -64.93 122.67 17.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.439 . . . . 70.31 110.918 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.567 HD12 ' HB3' ' A' ' 271' ' ' TYR . 20.2 mt . . . . . 0 C--N 1.328 -0.343 0 CA-C-O 121.533 0.682 . . . . 60.44 110.922 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.838 0.351 . . . . 74.34 110.853 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' TYR . . . . . 0.532 ' HB3' HD12 ' A' ' 326' ' ' LEU . 11.5 m-85 -128.23 152.88 47.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.453 . . . . 72.2 110.948 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 26.2 m -138.78 146.48 41.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.118 -0.492 . . . . 73.44 110.888 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 14.3 tttp -103.0 117.35 34.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 74.43 110.823 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . 0.713 HG13 HD12 ' A' ' 288' ' ' ILE . 26.2 t -55.91 112.32 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 70.13 111.132 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 37.9 pt -88.33 -28.08 5.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.175 -0.466 . . . . 54.2 111.134 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -142.6 159.71 56.43 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.61 0.719 . . . . 53.42 110.884 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 160.05 51.15 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.738 2.292 . . . . 74.33 112.263 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -173.29 109.78 0.18 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 74.41 110.91 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . 0.656 ' HA ' HG23 ' A' ' 287' ' ' THR . 42.9 tt0 -91.08 127.0 36.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.115 -0.493 . . . . 51.52 110.887 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -58.82 117.63 4.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 63.22 111.074 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -65.84 -25.8 67.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 74.12 110.871 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 -153.0 168.41 25.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 73.41 110.923 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -56.14 -26.3 49.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 44.34 110.886 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -71.02 -25.22 62.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 63.31 110.88 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . 0.504 ' OE1' HG23 ' A' ' 317' ' ' VAL . 6.2 mm-40 -94.86 164.79 12.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 71.24 110.95 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.594 HD12 ' H ' ' A' ' 287' ' ' THR . 14.1 tp -115.21 137.12 52.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.46 . . . . 60.32 110.962 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.656 HG23 ' HA ' ' A' ' 279' ' ' GLU . 85.0 m -91.81 144.74 25.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.221 -0.445 . . . . 75.35 111.143 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' ILE . . . . . 0.713 HD12 HG13 ' A' ' 274' ' ' VAL . 44.4 pt -150.34 144.7 17.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 52.12 111.13 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 18.2 mtmm -116.14 140.05 49.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 70.12 110.87 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -51.89 128.56 24.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 72.24 110.895 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 104.02 -21.3 38.38 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.679 -0.772 . . . . 62.34 112.382 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -81.58 172.52 13.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.795 0.331 . . . . 54.4 110.846 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.523 ' O ' HD13 ' A' ' 311' ' ' LEU . 76.2 mt -123.61 126.51 73.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.488 . . . . 75.25 111.127 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . 0.72 HG11 ' CE2' ' A' ' 318' ' ' PHE . 93.1 t -109.63 136.05 46.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 74.31 111.116 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 95.4 m -87.72 113.02 23.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.21 -0.45 . . . . 73.3 111.138 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.578 HD11 ' HB3' ' A' ' 307' ' ' TRP . 8.0 tp -70.01 112.65 6.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.277 -0.42 . . . . 72.23 110.943 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' ILE . . . . . 0.406 HD11 ' HB2' ' A' ' 310' ' ' GLU . 50.5 mt -98.29 -49.19 11.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 71.43 111.217 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -132.71 178.43 6.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 74.22 110.805 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 17.6 mttp -141.82 112.96 7.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 73.31 110.936 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -50.15 162.15 0.23 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.27 -0.423 . . . . 74.22 110.857 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 3.0 t -113.87 -68.92 0.89 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 73.43 110.907 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' ILE . . . . . 0.406 HG22 ' O ' ' A' ' 302' ' ' ILE . 34.1 mt -68.54 -12.01 15.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 74.44 111.075 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -97.96 69.72 2.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 61.44 110.935 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 6.6 p -51.47 122.6 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 51.21 111.129 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 91.04 17.28 51.81 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.692 -0.766 . . . . 31.13 112.413 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 34.7 m95 -133.98 135.89 43.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.743 0.306 . . . . 75.33 110.949 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' TRP . . . . . 0.798 ' CZ3' HD12 ' A' ' 325' ' ' LEU . 22.4 m0 -132.84 155.26 49.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.431 . . . . 74.32 110.883 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -97.04 121.31 38.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 75.31 110.836 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . 0.45 ' O ' HD22 ' A' ' 286' ' ' LEU . . . -138.68 179.82 18.07 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.735 -0.745 . . . . 74.24 112.437 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . 0.406 ' HB2' HD11 ' A' ' 297' ' ' ILE . 34.1 tt0 -133.72 141.67 47.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.918 0.389 . . . . 70.54 110.841 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.523 HD13 ' O ' ' A' ' 293' ' ' ILE . 24.8 tp -155.39 136.8 14.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.11 -0.496 . . . . 63.24 110.86 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 56.92 30.55 18.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 61.41 110.9 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 75.82 19.46 78.91 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.788 -0.72 . . . . 71.2 112.464 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -118.61 117.82 29.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.726 0.298 . . . . 64.13 110.82 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 60.6 ttt180 -99.89 129.63 45.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 74.44 110.866 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -170.7 -162.76 23.58 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.792 -0.718 . . . . 54.22 112.512 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.504 HG23 ' OE1' ' A' ' 285' ' ' GLU . 12.4 m -115.48 150.2 17.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.919 0.39 . . . . 54.42 111.068 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' PHE . . . . . 0.72 ' CE2' HG11 ' A' ' 294' ' ' VAL . 8.5 p90 -155.16 155.89 30.54 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.63 0.728 . . . . 74.54 110.952 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 117.94 5.38 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.698 2.266 . . . . 71.41 112.313 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . 0.565 ' HA ' HG22 ' A' ' 323' ' ' VAL . 3.1 t70 -59.41 -20.7 56.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 74.34 110.885 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -68.97 -12.08 61.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 72.03 110.881 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -108.84 16.64 22.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 62.2 110.913 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . 0.565 HG22 ' HA ' ' A' ' 320' ' ' ASP . 18.6 m -148.81 150.87 13.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.104 -0.498 . . . . 32.51 111.09 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 47.8 tttp -109.18 115.3 29.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 73.23 110.855 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.798 HD12 ' CZ3' ' A' ' 307' ' ' TRP . 2.8 tt -65.19 116.03 6.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 75.34 110.964 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.532 HD12 ' HB3' ' A' ' 271' ' ' TYR . 20.4 mt . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 121.634 0.73 . . . . 71.3 110.885 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.824 0.345 . . . . 63.31 110.818 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' TYR . . . . . 0.58 ' CE1' HG23 ' A' ' 295' ' ' THR . 10.0 m-85 -111.27 153.77 25.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 74.55 110.937 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' CYS . . . . . 0.432 ' SG ' HD13 ' A' ' 296' ' ' LEU . 26.7 m -136.0 145.63 46.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.105 -0.498 . . . . 73.13 110.821 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 3.0 ttpp -103.34 126.47 50.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 72.32 110.886 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . 0.517 HG13 HD12 ' A' ' 288' ' ' ILE . 22.0 t -61.1 114.46 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 72.13 111.106 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 0.414 HD11 ' O ' ' A' ' 321' ' ' ASN . 29.8 pt -89.16 -25.67 5.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 43.12 111.097 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -147.71 159.24 41.47 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.671 0.748 . . . . 75.43 110.897 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 155.48 65.75 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.624 2.216 . . . . 74.41 112.336 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -170.8 112.22 0.39 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 71.33 110.964 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . 0.605 ' HA ' HG23 ' A' ' 287' ' ' THR . 11.9 tt0 -93.81 130.39 39.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.445 . . . . 74.41 110.868 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -64.08 117.32 6.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.148 -0.478 . . . . 44.45 111.167 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 78.4 mm-40 -60.33 -25.57 65.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.238 -0.437 . . . . 73.34 110.924 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -155.91 176.26 12.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 75.15 110.865 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -58.48 -25.9 62.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.144 -0.48 . . . . 70.31 110.869 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -70.43 -26.38 63.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.172 -0.467 . . . . 74.12 110.849 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . 0.497 ' OE1' HG23 ' A' ' 317' ' ' VAL . 28.1 mm-40 -96.55 161.79 13.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 63.1 110.884 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.6 HD12 ' H ' ' A' ' 287' ' ' THR . 14.0 tp -115.25 136.65 52.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 75.44 110.94 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.605 HG23 ' HA ' ' A' ' 279' ' ' GLU . 90.5 m -90.57 144.85 25.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 61.2 111.086 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' ILE . . . . . 0.517 HD12 HG13 ' A' ' 274' ' ' VAL . 44.8 pt -150.32 141.82 16.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 74.43 111.145 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.28 145.16 42.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 72.2 110.892 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -51.86 131.85 31.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 44.43 110.879 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.98 -26.23 24.29 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.759 -0.734 . . . . 72.52 112.454 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.405 ' HB2' HG21 ' A' ' 274' ' ' VAL . 14.4 m-20 -69.55 176.07 3.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.793 0.33 . . . . 74.32 110.843 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 68.8 mt -134.19 125.45 47.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 65.44 111.173 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . 0.748 HG11 ' CE2' ' A' ' 318' ' ' PHE . 98.3 t -111.28 138.08 41.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.159 -0.473 . . . . 65.22 111.107 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . 0.58 HG23 ' CE1' ' A' ' 271' ' ' TYR . 6.3 m -87.39 118.51 26.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.188 -0.46 . . . . 74.23 111.131 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.432 HD13 ' SG ' ' A' ' 272' ' ' CYS . 6.1 tp -69.87 111.02 5.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 75.22 110.939 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 23.9 mm -100.49 -29.95 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 54.13 111.139 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -157.36 178.12 10.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 64.04 110.884 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 21.8 mttt -141.4 112.98 7.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.207 -0.451 . . . . 73.31 110.876 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -49.77 162.01 0.2 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 61.34 110.847 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.9 t -113.79 -68.98 0.89 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 62.03 110.882 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 30.3 mm -67.49 -12.44 15.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.441 . . . . 72.25 111.108 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -97.49 70.46 2.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 61.41 110.871 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.406 ' O ' HG13 ' A' ' 304' ' ' VAL . 6.0 p -51.4 121.24 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 62.2 111.107 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.39 24.8 30.14 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.697 -0.763 . . . . 70.2 112.475 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 57.5 m95 -140.23 133.43 29.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.751 0.31 . . . . 73.33 110.877 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' TRP . . . . . 0.713 ' CZ3' HD12 ' A' ' 325' ' ' LEU . 22.6 m0 -129.25 154.55 46.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.25 -0.432 . . . . 72.34 110.95 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -99.04 116.33 31.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.239 -0.437 . . . . 62.41 110.944 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -127.99 -173.72 13.55 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.724 -0.751 . . . . 65.33 112.529 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -135.97 134.95 39.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.836 0.351 . . . . 74.51 110.888 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.509 HD13 HG22 ' A' ' 294' ' ' VAL . 10.1 tp -143.99 130.75 20.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 53.11 110.95 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 59.04 29.95 19.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.151 -0.477 . . . . 73.04 110.84 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 83.33 -1.48 88.64 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.692 -0.766 . . . . 74.43 112.451 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' ARG . . . . . 0.423 ' HG2' HD13 ' A' ' 286' ' ' LEU . 0.0 OUTLIER -103.01 119.33 38.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.829 0.347 . . . . 75.13 110.876 -179.873 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 70.1 mtt180 -98.82 131.0 45.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 71.23 110.906 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -162.09 -162.77 13.69 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.784 -0.722 . . . . 72.43 112.515 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.497 HG23 ' OE1' ' A' ' 285' ' ' GLU . 25.1 m -115.22 153.13 16.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.884 0.373 . . . . 51.34 111.111 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' PHE . . . . . 0.748 ' CE2' HG11 ' A' ' 294' ' ' VAL . 5.1 p90 -157.36 157.42 30.22 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.657 0.741 . . . . 60.43 110.815 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 119.96 6.82 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.679 2.253 . . . . 73.14 112.302 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . 0.57 ' HA ' HG22 ' A' ' 323' ' ' VAL . 1.5 p-10 -57.42 -23.36 49.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 64.43 110.878 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' ASN . . . . . 0.414 ' O ' HD11 ' A' ' 275' ' ' ILE . 10.8 m-20 -69.53 -11.58 60.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 73.13 110.922 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -109.45 15.48 22.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 72.41 110.85 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . 0.57 HG22 ' HA ' ' A' ' 320' ' ' ASP . 18.0 m -148.7 149.56 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 62.11 111.217 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -117.02 117.6 30.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 71.1 110.862 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.713 HD12 ' CZ3' ' A' ' 307' ' ' TRP . 1.1 tt -65.03 125.01 23.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 64.04 110.893 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.409 HD12 ' CB ' ' A' ' 271' ' ' TYR . 20.7 mt . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 121.582 0.706 . . . . 71.54 110.992 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.777 0.322 . . . . 73.2 110.889 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' TYR . . . . . 0.563 ' CZ ' HG23 ' A' ' 295' ' ' THR . 22.8 m-85 -138.71 154.15 48.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.46 . . . . 70.13 110.931 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 56.5 m -135.67 152.99 51.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.121 -0.491 . . . . 64.25 110.838 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 18.5 tptm -102.78 129.75 49.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 74.32 110.883 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . 0.906 HG13 HD12 ' A' ' 288' ' ' ILE . 25.7 t -73.05 108.35 4.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.282 -0.417 . . . . 60.04 111.116 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 21.7 pt -86.96 -30.3 5.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 74.11 111.178 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -138.83 158.79 69.33 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.663 0.744 . . . . 64.02 110.875 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.84 165.85 29.68 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.659 2.239 . . . . 61.45 112.354 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -174.43 107.32 0.11 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.245 -0.434 . . . . 64.32 110.886 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . 0.526 ' HA ' HG23 ' A' ' 287' ' ' THR . 73.6 tt0 -92.66 111.65 23.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.106 -0.497 . . . . 62.12 110.885 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -51.69 117.22 2.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 74.44 111.103 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 52.0 mm-40 -63.23 -25.43 68.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.274 -0.421 . . . . 74.44 110.912 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 24.9 m-20 -150.7 167.77 26.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.441 . . . . 74.55 110.909 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -58.07 -24.16 57.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 74.55 110.866 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -70.06 -24.91 63.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.247 -0.433 . . . . 64.42 110.808 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -95.01 169.51 10.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 75.13 110.895 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.774 HD23 ' CD2' ' A' ' 318' ' ' PHE . 22.3 tp -114.95 131.21 56.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.137 -0.483 . . . . 73.4 110.9 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.526 HG23 ' HA ' ' A' ' 279' ' ' GLU . 97.6 m -92.08 139.09 30.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 62.33 111.158 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' ILE . . . . . 0.906 HD12 HG13 ' A' ' 274' ' ' VAL . 26.0 pt -147.0 157.33 10.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 43.03 111.122 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . 0.408 ' C ' HG11 ' A' ' 274' ' ' VAL . 23.3 mtpp -133.56 142.67 48.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 71.4 110.91 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -50.84 133.12 26.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 73.32 110.93 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 100.65 -22.13 41.02 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.864 -0.684 . . . . 73.52 112.564 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -85.23 173.48 10.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.824 0.345 . . . . 73.32 110.824 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 41.6 mm -123.55 133.91 67.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 74.3 111.08 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . 0.645 HG11 ' CE2' ' A' ' 318' ' ' PHE . 93.3 t -108.11 127.63 64.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 63.21 111.179 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . 0.563 HG23 ' CZ ' ' A' ' 271' ' ' TYR . 29.1 m -82.98 107.8 15.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 64.05 111.162 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.511 HD11 ' HB3' ' A' ' 307' ' ' TRP . 7.5 tp -69.84 117.54 11.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 73.22 110.911 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 63.8 mt -109.73 -36.55 2.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.209 -0.451 . . . . 63.34 111.14 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -144.03 177.47 8.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.131 -0.486 . . . . 75.4 110.878 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 31.9 mttp -141.75 113.01 7.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 62.01 110.881 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -49.6 160.15 0.3 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 74.42 110.791 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.6 t -113.68 -69.01 0.89 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 52.42 110.892 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 41.8 mt -66.35 -13.54 16.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.19 -0.459 . . . . 75.31 111.114 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.53 71.63 2.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 75.34 110.84 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.416 ' O ' HG13 ' A' ' 304' ' ' VAL . 5.9 p -51.23 120.7 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.474 . . . . 65.22 111.117 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.37 25.79 27.4 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.726 -0.75 . . . . 72.42 112.523 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 57.8 m95 -140.38 135.27 31.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.727 0.299 . . . . 72.45 110.963 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' TRP . . . . . 0.778 ' CZ3' HD12 ' A' ' 325' ' ' LEU . 22.6 m0 -130.26 156.75 44.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 72.32 110.956 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -103.8 126.3 50.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 73.33 110.851 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -140.25 -163.76 9.64 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.672 -0.775 . . . . 71.54 112.439 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -142.79 146.28 34.08 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.844 0.354 . . . . 63.2 110.837 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.401 HD22 HG22 ' A' ' 288' ' ' ILE . 3.5 tp -160.05 129.05 5.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.12 -0.491 . . . . 72.22 110.924 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 55.46 38.25 30.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 53.52 110.92 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 72.3 18.73 78.34 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.78 -0.724 . . . . 64.34 112.434 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -128.47 115.0 17.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.792 0.329 . . . . 75.41 110.881 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 2.9 ptt85 -116.9 139.45 50.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 74.22 110.865 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -162.6 -112.78 0.29 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.757 -0.735 . . . . 74.31 112.517 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 24.2 m -151.25 143.88 16.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.847 0.356 . . . . 74.21 111.178 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 318' ' ' PHE . . . . . 0.774 ' CD2' HD23 ' A' ' 286' ' ' LEU . 31.1 p90 -150.54 155.76 36.37 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.679 0.752 . . . . 74.15 110.841 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 120.69 7.44 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.674 2.249 . . . . 53.13 112.315 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . 0.513 ' HA ' HG22 ' A' ' 323' ' ' VAL . 1.5 p-10 -60.31 -19.81 56.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 72.14 110.832 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -73.54 -8.21 54.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 71.42 110.866 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -114.47 16.99 17.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 72.43 110.876 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . 0.515 HG21 ' HE1' ' A' ' 318' ' ' PHE . 23.4 m -150.21 141.42 16.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 65.42 111.152 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -105.27 118.01 35.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 62.12 110.93 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.778 HD12 ' CZ3' ' A' ' 307' ' ' TRP . 1.7 tt -64.82 132.3 49.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 72.3 110.894 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 20.3 mt . . . . . 0 C--N 1.328 -0.339 0 CA-C-O 121.578 0.704 . . . . 70.31 110.943 179.831 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.797 0.332 . . . . 71.11 110.856 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -142.68 148.31 37.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.192 -0.458 . . . . 71.35 110.907 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 33.7 m -137.0 147.66 46.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.05 -0.523 . . . . 63.21 110.902 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 31.8 tttt -103.07 117.61 34.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 73.45 110.918 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . 0.684 HG13 HD12 ' A' ' 288' ' ' ILE . 24.5 t -55.78 115.9 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 74.42 111.177 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 0.425 HD11 ' O ' ' A' ' 321' ' ' ASN . 33.6 pt -90.04 -27.74 5.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 71.43 111.148 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -144.45 159.28 52.18 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.662 0.744 . . . . 73.21 110.893 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.78 158.75 55.87 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.718 2.279 . . . . 64.23 112.3 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -173.43 108.32 0.15 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.142 -0.481 . . . . 73.24 110.958 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . 0.678 ' HA ' HG23 ' A' ' 287' ' ' THR . 10.5 tt0 -90.74 129.37 36.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 71.44 110.915 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -64.4 133.95 53.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 71.14 111.099 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -76.16 -12.65 60.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.43 . . . . 63.4 110.866 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . 0.56 HD22 ' N ' ' A' ' 282' ' ' ASN . 0.0 OUTLIER -175.54 -178.47 1.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 75.11 110.963 -179.964 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -58.66 -26.24 63.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.258 -0.428 . . . . 72.31 110.874 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' ASP . . . . . 0.463 ' O ' HG22 ' A' ' 317' ' ' VAL . 22.5 t0 -70.26 -25.84 63.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 73.52 110.927 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . 0.473 ' OE1' HG23 ' A' ' 317' ' ' VAL . 68.6 mm-40 -100.04 167.28 10.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 73.44 110.851 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.627 HD23 ' CD2' ' A' ' 318' ' ' PHE . 28.2 tp -121.04 131.49 54.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.133 -0.485 . . . . 75.34 110.965 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.678 HG23 ' HA ' ' A' ' 279' ' ' GLU . 87.6 m -88.45 143.08 27.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 72.22 111.161 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' ILE . . . . . 0.684 HD12 HG13 ' A' ' 274' ' ' VAL . 51.0 pt -150.34 143.49 17.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.295 -0.412 . . . . 71.43 111.071 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 37.4 mtpt -112.31 140.4 47.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 50.0 110.897 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -52.01 133.32 32.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.197 -0.456 . . . . 71.21 110.915 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.59 -19.68 53.65 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.747 -0.74 . . . . 43.21 112.458 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -79.31 173.23 12.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.745 0.307 . . . . 61.03 110.867 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 66.8 mt -124.17 125.15 70.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 64.45 111.212 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . 0.677 HG11 ' CE2' ' A' ' 318' ' ' PHE . 84.2 t -107.99 134.02 51.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.179 -0.464 . . . . 62.43 111.084 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 39.0 m -84.76 111.14 19.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 54.34 111.103 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.56 HD11 ' HB3' ' A' ' 307' ' ' TRP . 8.7 tp -69.96 118.56 12.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 45.22 110.952 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 76.2 mt -106.46 -47.69 8.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 74.11 111.123 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -134.85 178.17 7.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.44 . . . . 50.12 110.842 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 25.0 mttp -141.36 112.95 7.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 74.54 110.957 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.94 165.25 0.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.441 . . . . 62.42 110.914 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.6 t -118.3 -69.34 0.86 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 54.5 110.804 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 2.0 mp -65.89 -13.89 16.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.184 -0.462 . . . . 75.32 111.088 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -98.8 70.31 1.86 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 73.42 110.79 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 7.3 p -51.35 123.96 3.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 71.21 111.129 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.39 23.31 34.55 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.707 -0.759 . . . . 71.22 112.466 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 56.5 m95 -140.09 135.49 32.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.797 0.332 . . . . 72.24 110.919 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' TRP . . . . . 0.76 ' CZ3' HD12 ' A' ' 325' ' ' LEU . 22.5 m0 -131.23 154.87 47.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.22 -0.446 . . . . 74.13 110.876 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -99.99 124.65 45.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 63.41 110.947 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -141.87 -167.09 11.14 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.66 -0.781 . . . . 64.43 112.478 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -140.43 147.4 39.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.897 0.379 . . . . 72.13 110.909 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.409 HD22 HG22 ' A' ' 288' ' ' ILE . 6.7 tp -157.65 132.18 8.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 74.33 110.839 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 57.36 30.2 18.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 61.21 110.877 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 79.15 18.64 74.03 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.749 -0.739 . . . . 70.23 112.482 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 25.5 mmm180 -122.69 115.1 21.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.745 0.307 . . . . 73.14 110.869 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 33.3 mtm180 -96.99 141.02 30.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 73.14 110.883 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -178.32 -162.54 28.23 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.772 -0.728 . . . . 72.34 112.48 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.473 HG23 ' OE1' ' A' ' 285' ' ' GLU . 27.5 m -111.64 155.68 12.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.873 0.368 . . . . 74.3 111.182 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 318' ' ' PHE . . . . . 0.677 ' CE2' HG11 ' A' ' 294' ' ' VAL . 5.4 p90 -159.13 156.53 26.37 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.684 0.754 . . . . 74.11 110.828 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 120.23 7.05 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.634 2.223 . . . . 73.23 112.385 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . 0.559 ' HA ' HG22 ' A' ' 323' ' ' VAL . 1.6 p-10 -59.12 -21.16 58.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.265 -0.425 . . . . 73.24 110.861 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 321' ' ' ASN . . . . . 0.425 ' O ' HD11 ' A' ' 275' ' ' ILE . 2.8 t-20 -71.53 -11.23 60.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 73.01 110.837 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -110.62 18.35 19.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 70.44 110.846 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . 0.559 HG22 ' HA ' ' A' ' 320' ' ' ASP . 18.9 m -149.3 149.52 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 64.14 111.148 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -115.49 116.86 28.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 75.24 110.899 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.76 HD12 ' CZ3' ' A' ' 307' ' ' TRP . 0.9 OUTLIER -64.94 128.17 34.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.252 -0.431 . . . . 73.31 110.99 179.848 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 20.2 mt . . . . . 0 C--N 1.329 -0.319 0 CA-C-O 121.595 0.712 . . . . 74.51 110.904 179.949 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.801 0.334 . . . . 54.32 110.856 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' TYR . . . . . 0.665 ' CB ' HD12 ' A' ' 326' ' ' LEU . 8.5 m-85 -111.15 143.85 41.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 65.11 110.896 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 22.6 m -128.29 149.36 50.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.107 -0.497 . . . . 72.11 110.86 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 7.9 tttm -108.03 117.42 34.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 75.24 110.92 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . 0.599 HG13 HD12 ' A' ' 288' ' ' ILE . 27.7 t -58.41 113.49 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 72.52 111.15 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 26.6 pt -87.09 -30.49 5.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 73.53 111.123 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -142.46 158.39 60.64 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.657 0.741 . . . . 75.14 110.88 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.68 158.69 56.19 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.642 2.228 . . . . 63.44 112.364 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -174.38 113.51 0.17 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.237 -0.438 . . . . 75.2 110.912 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . 0.689 ' HA ' HG23 ' A' ' 287' ' ' THR . 11.8 tt0 -93.61 120.54 34.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.09 -0.505 . . . . 73.5 110.891 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . 0.412 ' HB2' ' C ' ' A' ' 286' ' ' LEU . . . -51.83 113.49 1.01 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 60.22 111.078 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -54.58 -29.76 52.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 74.11 110.905 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -155.47 172.25 18.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 71.11 110.891 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -58.2 -22.77 53.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.154 -0.476 . . . . 73.44 110.86 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -70.0 -21.01 63.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 65.24 110.833 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -105.28 177.24 4.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 72.44 110.935 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.648 HD23 ' CD2' ' A' ' 318' ' ' PHE . 13.1 tp -122.61 135.95 54.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.466 . . . . 50.15 110.902 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.689 HG23 ' HA ' ' A' ' 279' ' ' GLU . 77.9 m -88.28 146.32 25.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.121 -0.49 . . . . 71.43 111.114 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' ILE . . . . . 0.599 HD12 HG13 ' A' ' 274' ' ' VAL . 47.6 pt -150.28 143.89 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 74.01 111.189 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 33.8 mtmt -117.53 140.9 49.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 63.14 110.906 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 -51.92 135.03 31.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.232 -0.44 . . . . 45.35 110.857 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 93.82 -23.64 29.94 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.721 -0.752 . . . . 63.54 112.469 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -76.55 171.3 14.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.832 0.348 . . . . 65.4 110.902 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 37.4 mm -122.67 125.78 73.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 33.43 111.137 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . 0.678 HG11 ' CE2' ' A' ' 318' ' ' PHE . 97.8 t -103.27 138.11 28.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 61.32 111.092 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 59.4 m -93.56 109.06 20.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 75.54 111.151 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.694 HD11 ' HB3' ' A' ' 307' ' ' TRP . 7.0 tp -69.89 124.84 25.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.271 -0.422 . . . . 72.42 110.894 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' ILE . . . . . 0.532 HG22 ' ND2' ' A' ' 298' ' ' ASN . 40.5 mt -111.1 -47.37 6.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.449 . . . . 73.03 111.119 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . 0.532 ' ND2' HG22 ' A' ' 297' ' ' ILE . 11.6 m-80 -137.74 169.99 16.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 71.43 110.898 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 19.1 mttt -137.35 112.37 9.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.218 -0.446 . . . . 62.04 110.963 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -56.04 179.78 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.187 -0.46 . . . . 71.5 110.862 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 1.7 t -129.05 -69.53 0.7 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 64.15 110.876 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 60.1 mt -59.4 -18.43 14.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 73.02 111.146 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -99.02 62.11 1.28 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.463 . . . . 65.05 110.899 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 71.6 t -51.51 136.36 11.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.244 -0.435 . . . . 51.35 111.154 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 88.69 14.27 61.57 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.76 -0.733 . . . . 63.33 112.543 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 51.1 m95 -139.27 148.15 42.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.758 0.313 . . . . 74.11 110.925 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' TRP . . . . . 0.757 ' CZ3' HD12 ' A' ' 325' ' ' LEU . 10.2 m0 -139.36 148.23 42.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.294 -0.412 . . . . 73.13 110.947 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -94.29 119.08 32.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.283 -0.417 . . . . 73.33 110.849 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -139.22 -163.41 9.49 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.736 -0.745 . . . . 51.12 112.456 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . 0.405 ' HB2' HD11 ' A' ' 297' ' ' ILE . 61.6 tt0 -143.79 149.1 36.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.885 0.374 . . . . 73.43 110.916 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 4.9 tp -159.98 133.29 6.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.201 -0.454 . . . . 64.24 110.94 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 58.14 29.94 18.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 63.4 110.856 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 78.93 17.38 77.22 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.783 -0.722 . . . . 75.54 112.494 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 23.6 mmt85 -122.33 117.47 26.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.843 0.354 . . . . 74.25 110.874 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 27.3 mtm-85 -98.21 136.22 38.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 72.03 110.859 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -172.06 -158.42 16.15 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.737 -0.745 . . . . 43.3 112.504 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 24.3 m -117.72 148.02 20.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.881 0.372 . . . . 71.31 111.126 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 318' ' ' PHE . . . . . 0.678 ' CE2' HG11 ' A' ' 294' ' ' VAL . 9.8 p90 -149.49 156.97 39.34 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.689 0.757 . . . . 73.11 110.824 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 121.5 8.19 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.655 2.237 . . . . 72.1 112.314 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . 0.542 ' HA ' HG22 ' A' ' 323' ' ' VAL . 1.7 p-10 -61.75 -17.74 57.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 71.55 110.862 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -75.95 -5.82 48.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 64.23 110.88 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -119.76 23.61 11.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.12 -0.491 . . . . 65.24 110.879 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . 0.542 HG22 ' HA ' ' A' ' 320' ' ' ASP . 18.2 m -149.04 144.14 18.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.154 -0.475 . . . . 75.12 111.065 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 55.2 tttt -110.45 111.17 22.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 74.11 110.926 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.757 HD12 ' CZ3' ' A' ' 307' ' ' TRP . 1.0 OUTLIER -64.92 126.61 28.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 55.1 110.837 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.665 HD12 ' CB ' ' A' ' 271' ' ' TYR . 20.4 mt . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 121.541 0.686 . . . . 73.14 110.958 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.794 0.331 . . . . 74.04 110.884 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' TYR . . . . . 0.431 ' HB3' HD12 ' A' ' 326' ' ' LEU . 15.5 m-85 -130.85 154.1 48.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.211 -0.45 . . . . 73.3 110.955 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' CYS . . . . . 0.423 ' SG ' HD13 ' A' ' 296' ' ' LEU . 22.8 m -139.0 147.36 42.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.113 -0.494 . . . . 74.01 110.866 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 14.3 tttp -103.66 119.08 38.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.204 -0.453 . . . . 62.51 110.862 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . 0.552 HG13 HD12 ' A' ' 288' ' ' ILE . 53.1 t -60.3 109.13 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 64.24 111.076 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 26.5 pt -85.98 -30.63 6.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.12 -0.491 . . . . 72.01 111.095 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -138.33 159.97 65.78 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.659 0.742 . . . . 74.44 110.915 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 158.93 55.26 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.736 2.291 . . . . 73.15 112.352 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -172.81 106.02 0.16 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 71.31 111.018 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . 0.607 ' HA ' HG23 ' A' ' 287' ' ' THR . 19.5 tt0 -91.23 127.54 36.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 74.02 110.869 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . 0.502 ' HB1' ' HB2' ' A' ' 285' ' ' GLU . . . -63.86 113.04 3.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.476 . . . . 44.55 111.126 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -59.26 -26.07 64.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.264 -0.425 . . . . 65.42 110.95 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -149.48 168.7 22.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 71.3 110.875 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -57.02 -24.91 57.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.483 . . . . 45.42 110.859 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -70.01 -25.68 63.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.217 -0.447 . . . . 61.3 110.877 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . 0.502 ' HB2' ' HB1' ' A' ' 280' ' ' ALA . 70.1 mm-40 -95.02 166.47 11.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.171 -0.468 . . . . 72.44 110.903 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.646 HD23 ' CD2' ' A' ' 318' ' ' PHE . 21.5 tp -114.89 133.6 55.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 74.02 110.932 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.607 HG23 ' HA ' ' A' ' 279' ' ' GLU . 95.5 m -91.61 140.69 29.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 74.42 111.129 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' ILE . . . . . 0.654 HG21 HG21 ' A' ' 294' ' ' VAL . 50.4 pt -150.14 143.25 17.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 54.35 111.136 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 16.5 mmtm -114.53 141.03 48.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 74.24 110.877 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -52.02 122.54 8.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.446 . . . . 61.54 110.866 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 113.31 -22.82 14.81 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.8 -0.714 . . . . 31.11 112.448 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -86.46 160.4 19.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.708 0.289 . . . . 72.5 110.925 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 80.7 mt -110.94 129.4 66.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 62.5 111.087 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . 0.721 HG11 ' CE2' ' A' ' 318' ' ' PHE . 100.0 t -107.15 138.07 34.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.106 -0.497 . . . . 72.21 111.138 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 56.1 m -89.31 111.47 22.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.126 -0.488 . . . . 72.04 111.116 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.472 HD11 ' HB3' ' A' ' 307' ' ' TRP . 7.5 tp -69.98 118.54 12.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.276 -0.42 . . . . 72.13 110.91 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' ILE . . . . . 0.67 HG21 HH21 ' A' ' 315' ' ' ARG . 64.4 mt -105.79 -48.62 8.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 71.24 111.092 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -133.53 178.17 7.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 61.45 110.892 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 24.2 mttt -141.32 113.02 7.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 71.43 110.885 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -49.9 161.77 0.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.457 . . . . 72.41 110.92 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.9 t -113.37 -69.02 0.89 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.222 -0.444 . . . . 51.24 110.869 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 302' ' ' ILE . . . . . 0.4 HG22 ' O ' ' A' ' 302' ' ' ILE . 35.1 mt -67.77 -12.51 15.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 73.35 111.166 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -97.52 69.31 2.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 55.11 110.879 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 6.9 p -51.17 123.21 2.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.244 -0.435 . . . . 55.11 111.18 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.5 19.43 48.98 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.755 -0.736 . . . . 65.32 112.549 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 49.2 m95 -136.29 136.39 39.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.742 0.306 . . . . 72.43 110.902 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' TRP . . . . . 0.757 ' CZ3' HD12 ' A' ' 325' ' ' LEU . 22.6 m0 -132.1 156.09 46.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 65.44 110.936 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -100.63 120.78 40.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.228 -0.442 . . . . 73.31 110.802 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -134.67 -168.71 11.76 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.782 -0.723 . . . . 71.42 112.509 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -141.74 141.4 33.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.868 0.366 . . . . 74.21 110.873 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.711 HD13 HG22 ' A' ' 294' ' ' VAL . 5.4 tp -140.81 118.52 11.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.133 -0.485 . . . . 74.01 110.879 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 58.55 32.74 22.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 71.32 110.85 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 91.88 -16.96 58.19 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.785 -0.721 . . . . 72.33 112.532 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.33 110.1 17.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.786 0.326 . . . . 72.35 110.898 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.67 HH21 HG21 ' A' ' 297' ' ' ILE . 48.3 mtp180 -98.66 133.73 42.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 73.35 110.911 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -169.16 -155.67 10.02 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.716 -0.754 . . . . 45.23 112.396 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.465 HG23 ' OE1' ' A' ' 285' ' ' GLU . 12.8 m -120.25 155.88 23.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.826 0.346 . . . . 73.53 111.206 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 318' ' ' PHE . . . . . 0.721 ' CE2' HG11 ' A' ' 294' ' ' VAL . 6.4 p90 -161.29 155.94 19.82 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.64 0.733 . . . . 74.24 110.853 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 117.85 5.33 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.676 2.251 . . . . 65.12 112.395 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . 0.541 ' HA ' HG22 ' A' ' 323' ' ' VAL . 3.2 t70 -59.19 -21.21 59.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.269 -0.423 . . . . 64.42 110.871 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -70.79 -10.76 60.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 71.42 110.819 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -111.14 19.27 18.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 65.2 110.856 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . 0.541 HG22 ' HA ' ' A' ' 320' ' ' ASP . 18.5 m -148.77 150.7 13.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 53.34 111.114 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 4.4 ttmt -110.9 115.09 28.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 54.22 110.903 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.757 HD12 ' CZ3' ' A' ' 307' ' ' TRP . 1.1 tt -64.91 120.32 12.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.228 -0.442 . . . . 65.33 110.91 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.431 HD12 ' HB3' ' A' ' 271' ' ' TYR . 20.3 mt . . . . . 0 C--N 1.328 -0.368 0 CA-C-O 121.606 0.717 . . . . 72.22 110.899 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.813 0.339 . . . . 75.2 110.878 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' TYR . . . . . 0.445 ' CE1' HG23 ' A' ' 295' ' ' THR . 8.1 m-85 -124.63 156.23 37.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.147 -0.479 . . . . 65.24 110.89 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' CYS . . . . . 0.444 ' SG ' HD13 ' A' ' 296' ' ' LEU . 30.1 m -139.74 153.01 47.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 65.44 110.898 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -111.0 121.47 45.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 75.34 110.843 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 21.7 t -58.89 114.14 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.48 . . . . 41.12 111.118 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 25.7 pt -88.71 -30.47 5.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 73.34 111.095 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -139.72 158.85 67.17 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.679 0.752 . . . . 74.24 110.881 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 155.21 66.55 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.681 2.254 . . . . 75.24 112.339 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -174.59 108.63 0.12 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.212 -0.449 . . . . 65.45 110.935 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . 0.581 ' HA ' HG23 ' A' ' 287' ' ' THR . 50.5 tt0 -88.1 150.07 23.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.5 . . . . 65.13 110.837 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -80.36 114.27 19.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 74.01 111.164 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -63.68 -25.67 68.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 73.1 110.874 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -150.66 168.6 23.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 71.23 110.888 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -58.75 -25.58 63.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 62.22 110.897 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -69.95 -25.4 63.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.47 . . . . 74.52 110.89 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -94.93 167.41 11.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.447 . . . . 71.31 110.866 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.666 HD23 ' CD2' ' A' ' 318' ' ' PHE . 13.7 tp -115.27 136.52 53.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.464 . . . . 75.35 110.952 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.591 ' N ' HD12 ' A' ' 286' ' ' LEU . 95.7 m -90.71 138.36 31.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 73.5 111.11 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' ILE . . . . . 0.618 HG21 HG21 ' A' ' 294' ' ' VAL . 0.1 OUTLIER -147.29 145.55 19.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 63.54 111.129 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -119.53 139.33 52.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.108 -0.496 . . . . 74.13 110.829 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 69.7 tt0 -52.02 123.98 11.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 72.41 110.876 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 110.32 -20.54 25.54 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.756 -0.735 . . . . 64.14 112.55 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -85.13 175.57 8.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.801 0.334 . . . . 73.13 110.888 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.404 HG23 ' O ' ' A' ' 272' ' ' CYS . 41.0 mm -123.81 138.37 53.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 74.01 111.157 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . 0.725 HG11 ' CE2' ' A' ' 318' ' ' PHE . 66.3 t -120.57 138.0 52.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.172 -0.467 . . . . 71.14 111.122 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . 0.445 HG23 ' CE1' ' A' ' 271' ' ' TYR . 91.0 m -92.05 116.01 28.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 70.42 111.206 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.444 HD13 ' SG ' ' A' ' 272' ' ' CYS . 4.5 tp -69.82 112.79 6.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.302 -0.408 . . . . 54.0 110.893 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 62.3 mt -102.0 -28.26 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.439 . . . . 45.34 111.086 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -156.42 178.05 10.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.214 -0.448 . . . . 65.33 110.901 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 29.6 mttp -141.33 112.92 7.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 62.33 110.904 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -50.21 163.54 0.15 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 70.51 110.847 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.7 t -114.52 -69.24 0.87 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.461 . . . . 71.45 110.855 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 2.0 mp -66.57 -13.31 16.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.494 . . . . 71.0 111.151 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -96.42 70.66 2.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.139 -0.482 . . . . 62.21 110.842 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 60.4 t -51.38 120.85 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 73.12 111.183 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.65 20.53 43.74 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.74 -0.743 . . . . 70.34 112.497 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 39.1 m95 -135.4 135.84 40.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.772 0.32 . . . . 63.41 110.898 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' TRP . . . . . 0.755 ' CZ3' HD12 ' A' ' 325' ' ' LEU . 23.5 m0 -130.85 157.32 43.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 74.34 110.871 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -101.43 116.13 32.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 44.41 110.888 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -130.08 -173.1 13.29 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.734 -0.746 . . . . 63.34 112.485 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -136.57 141.29 43.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.86 0.362 . . . . 74.43 110.848 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 293' ' ' ILE . 5.5 tp -141.97 121.26 13.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.127 -0.488 . . . . 72.23 110.901 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 55.06 33.11 19.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 74.21 110.866 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 92.09 -16.59 59.26 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.714 -0.755 . . . . 65.11 112.487 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -82.99 109.23 16.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.857 0.36 . . . . 73.03 110.845 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.33 125.85 46.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.484 . . . . 71.15 110.904 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -163.43 -158.99 10.23 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.76 -0.734 . . . . 72.35 112.521 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 6.6 m -114.19 156.7 15.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.86 0.362 . . . . 62.31 111.137 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 318' ' ' PHE . . . . . 0.725 ' CE2' HG11 ' A' ' 294' ' ' VAL . 6.1 p90 -163.67 156.05 15.3 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.645 0.736 . . . . 64.13 110.869 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 117.71 5.25 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.659 2.239 . . . . 73.02 112.326 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . 0.556 ' HA ' HG22 ' A' ' 323' ' ' VAL . 2.9 t70 -58.34 -22.04 51.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.259 -0.428 . . . . 63.11 110.843 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -69.27 -11.78 61.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 73.13 110.987 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -109.18 17.04 22.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.472 . . . . 63.22 110.874 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . 0.556 HG22 ' HA ' ' A' ' 320' ' ' ASP . 18.4 m -148.81 150.58 13.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.144 -0.48 . . . . 64.43 111.173 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -112.09 119.28 37.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.223 -0.444 . . . . 65.1 110.872 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.755 HD12 ' CZ3' ' A' ' 307' ' ' TRP . 0.6 OUTLIER -64.89 116.29 6.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.226 -0.443 . . . . 71.44 110.857 179.938 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 21.2 mt . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 121.608 0.718 . . . . 75.23 110.916 179.836 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.799 0.333 . . . . 73.21 110.882 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 271' ' ' TYR . . . . . 0.663 ' CE1' HG23 ' A' ' 295' ' ' THR . 8.9 m-85 -133.5 152.94 51.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.207 -0.452 . . . . 74.4 110.932 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 34.4 m -139.98 147.93 41.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.093 -0.503 . . . . 44.11 110.941 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 33.3 tttt -102.99 121.98 43.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 71.41 110.908 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . 0.42 HG21 ' HB ' ' A' ' 288' ' ' ILE . 46.9 t -62.22 110.99 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 54.05 111.123 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 26.8 pt -85.52 -32.82 7.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 72.42 111.139 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -135.95 158.0 74.78 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.629 0.728 . . . . 61.14 110.918 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 150.17 68.13 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.715 2.277 . . . . 72.31 112.327 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -171.17 106.06 0.24 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.235 -0.439 . . . . 70.03 110.963 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . 0.772 ' HA ' HG23 ' A' ' 287' ' ' THR . 0.3 OUTLIER -93.03 147.01 23.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.073 -0.512 . . . . 75.53 110.851 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . 0.545 ' HB1' ' HB2' ' A' ' 285' ' ' GLU . . . -82.04 124.56 29.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 71.44 111.091 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -72.31 -32.1 66.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 73.23 110.899 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -137.36 172.35 13.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 64.23 110.929 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -62.22 -17.91 59.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 71.3 110.824 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 284' ' ' ASP . . . . . 0.563 ' O ' HG22 ' A' ' 317' ' ' VAL . 13.9 t0 -75.57 -19.39 59.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.241 -0.436 . . . . 72.45 110.838 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . 0.545 ' HB2' ' HB1' ' A' ' 280' ' ' ALA . 2.0 mp0 -105.62 164.1 12.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.224 -0.444 . . . . 70.05 110.868 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.577 HD23 ' CD2' ' A' ' 318' ' ' PHE . 14.6 tp -115.47 135.61 53.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.158 -0.473 . . . . 64.54 110.899 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.772 HG23 ' HA ' ' A' ' 279' ' ' GLU . 46.2 m -88.31 141.42 28.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 55.03 111.12 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 288' ' ' ILE . . . . . 0.561 HG21 HG21 ' A' ' 294' ' ' VAL . 33.6 pt -150.09 139.66 15.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 60.41 111.104 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 29.2 mttm -109.99 138.31 46.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 73.34 110.867 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -51.65 126.85 18.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 75.11 110.922 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 107.15 -23.51 27.05 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.657 -0.782 . . . . 72.45 112.476 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -84.99 160.44 20.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.763 0.316 . . . . 74.32 110.873 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 35.1 mm -110.82 128.92 66.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.16 -0.473 . . . . 73.32 111.07 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . 0.732 HG11 ' CE2' ' A' ' 318' ' ' PHE . 94.5 t -103.51 138.02 29.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.103 -0.499 . . . . 61.52 111.131 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . 0.663 HG23 ' CE1' ' A' ' 271' ' ' TYR . 59.8 m -87.48 110.57 20.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 74.11 111.212 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.524 HD11 ' HB3' ' A' ' 307' ' ' TRP . 7.6 tp -70.01 116.07 9.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 63.43 110.904 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 54.4 mt -102.46 -47.59 11.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 72.32 111.177 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -135.29 178.21 7.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 61.42 110.966 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 23.3 mttt -141.15 112.88 7.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 64.12 110.859 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -49.98 160.49 0.33 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 72.3 110.849 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.7 t -113.09 -69.01 0.89 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.237 -0.438 . . . . 54.03 110.858 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 1.9 mp -66.72 -13.24 16.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.475 . . . . 75.42 111.103 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.66 69.78 1.88 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.192 -0.458 . . . . 74.54 110.85 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 88.0 t -51.43 124.24 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.443 . . . . 63.22 111.095 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.41 19.12 50.73 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.703 -0.761 . . . . 72.31 112.539 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 46.4 m95 -136.02 135.21 39.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.781 0.325 . . . . 73.33 110.881 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 307' ' ' TRP . . . . . 0.758 ' CZ3' HD12 ' A' ' 325' ' ' LEU . 23.4 m0 -131.19 154.94 47.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 64.21 110.967 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -99.13 118.31 35.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.291 -0.413 . . . . 61.44 110.877 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -130.08 -171.83 13.01 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.824 -0.703 . . . . 72.3 112.556 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -140.71 144.24 35.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.895 0.379 . . . . 74.25 110.851 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.422 HD13 HG22 ' A' ' 294' ' ' VAL . 2.3 tp -160.04 135.45 8.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 72.34 110.886 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 59.52 29.99 19.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.13 -0.486 . . . . 53.23 110.951 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 77.87 10.05 86.5 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.7 -0.762 . . . . 70.15 112.536 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -115.41 111.82 21.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.818 0.342 . . . . 72.12 110.861 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 10.3 ttp85 -96.63 124.32 40.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 72.4 110.832 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -154.9 -157.09 8.03 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.779 -0.724 . . . . 62.34 112.511 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.563 HG22 ' O ' ' A' ' 284' ' ' ASP . 20.2 m -118.87 154.02 21.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.833 0.349 . . . . 63.24 111.185 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 318' ' ' PHE . . . . . 0.732 ' CE2' HG11 ' A' ' 294' ' ' VAL . 7.2 p90 -160.52 155.82 21.43 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.629 0.728 . . . . 73.42 110.899 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 117.91 5.36 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.724 2.283 . . . . 71.22 112.339 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . 0.557 ' HA ' HG22 ' A' ' 323' ' ' VAL . 3.1 t70 -59.12 -21.21 58.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 72.04 110.871 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -68.92 -12.11 61.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 63.52 110.885 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -108.81 16.56 22.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 74.42 110.816 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . 0.557 HG22 ' HA ' ' A' ' 320' ' ' ASP . 18.0 m -148.66 150.82 13.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.442 . . . . 74.2 111.134 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -109.75 118.6 36.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 73.14 110.936 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.758 HD12 ' CZ3' ' A' ' 307' ' ' TRP . 1.2 tt -64.97 121.13 13.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.441 . . . . 63.53 110.96 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.405 HD12 ' HB3' ' A' ' 271' ' ' TYR . 20.3 mt . . . . . 0 C--N 1.329 -0.322 0 CA-C-O 121.631 0.729 . . . . 63.42 110.896 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.753 0.311 . . . . 74.04 110.859 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 271' ' ' TYR . . . . . 0.65 ' HB3' HD12 ' A' ' 326' ' ' LEU . 12.2 m-85 -117.16 153.08 33.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.248 -0.433 . . . . 73.5 110.884 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 272' ' ' CYS . . . . . 0.45 ' O ' HG23 ' A' ' 293' ' ' ILE . 22.9 m -136.66 148.43 47.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.084 -0.507 . . . . 52.13 110.883 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 39.1 tttt -106.47 123.41 48.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.172 -0.467 . . . . 75.12 110.964 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 21.4 t -61.57 114.12 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 62.34 111.1 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 28.1 pt -85.88 -30.02 6.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 74.23 111.101 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -144.03 157.98 56.43 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.578 0.704 . . . . 74.11 110.905 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 154.03 67.99 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.624 2.216 . . . . 65.01 112.349 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -172.92 111.74 0.22 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 74.3 110.921 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . 0.784 ' HA ' HG23 ' A' ' 287' ' ' THR . 7.2 tm-20 -92.36 131.02 37.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.118 -0.492 . . . . 73.51 110.933 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -57.54 119.32 6.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 51.42 111.148 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.46 -25.79 68.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 71.1 110.861 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -154.63 172.77 17.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.25 -0.432 . . . . 51.23 110.94 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -58.48 -25.65 62.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 75.41 110.855 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.35 -25.73 62.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.213 -0.449 . . . . 72.23 110.799 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -94.88 166.97 11.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 71.14 110.941 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.681 HD23 ' CD2' ' A' ' 318' ' ' PHE . 12.9 tp -116.94 135.64 53.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.448 . . . . 64.01 110.967 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.784 HG23 ' HA ' ' A' ' 279' ' ' GLU . 60.1 m -86.92 146.69 26.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 72.34 111.172 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 31.1 pt -150.35 137.89 13.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 65.54 111.13 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -111.28 139.24 46.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 63.44 110.896 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -51.94 135.87 29.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 75.04 110.878 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 92.9 -22.37 34.44 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.766 -0.73 . . . . 44.22 112.527 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -77.08 178.32 7.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.783 0.325 . . . . 71.21 110.858 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.45 HG23 ' O ' ' A' ' 272' ' ' CYS . 51.2 mt -130.09 125.81 60.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.151 -0.477 . . . . 73.53 111.161 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . 0.652 HG11 ' CE2' ' A' ' 318' ' ' PHE . 21.5 t -101.4 138.08 26.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.154 -0.476 . . . . 61.45 111.153 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 37.9 m -92.49 110.68 22.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 65.24 111.102 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.428 HD11 ' HB3' ' A' ' 307' ' ' TRP . 4.7 tp -69.89 121.48 17.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 63.42 110.936 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 297' ' ' ILE . . . . . 0.573 HG22 ' ND2' ' A' ' 298' ' ' ASN . 62.7 mt -110.13 -37.3 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 62.5 111.162 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . 0.573 ' ND2' HG22 ' A' ' 297' ' ' ILE . 16.6 m-80 -150.08 170.53 18.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.484 . . . . 75.1 110.928 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 15.8 mttt -137.3 112.34 9.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 73.14 110.923 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -56.0 179.76 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.239 -0.437 . . . . 60.2 110.887 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 1.7 t -128.99 -69.41 0.71 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 72.2 110.861 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 42.0 mm -59.83 -18.0 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 73.3 111.153 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -99.44 61.77 1.2 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 53.31 110.845 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 62.5 t -51.35 136.53 10.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.464 . . . . 62.21 111.197 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 88.62 14.46 61.44 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.793 -0.718 . . . . 74.41 112.477 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 52.4 m95 -139.7 148.67 42.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.785 0.326 . . . . 74.24 110.869 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 307' ' ' TRP . . . . . 0.6 ' CZ3' HD12 ' A' ' 325' ' ' LEU . 10.3 m0 -139.12 148.66 43.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.47 . . . . 71.54 110.919 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -94.62 122.27 37.05 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.217 -0.447 . . . . 73.41 110.887 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -144.55 -164.43 10.53 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.781 -0.723 . . . . 61.21 112.49 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -142.37 148.2 37.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.87 0.366 . . . . 55.51 110.884 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 3.9 tp -159.02 130.15 6.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.474 . . . . 74.41 110.946 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 58.97 30.01 19.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.277 -0.42 . . . . 61.04 110.911 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 82.8 2.51 90.66 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.774 -0.727 . . . . 53.23 112.427 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -105.61 121.31 43.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.825 0.345 . . . . 73.44 110.897 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 55.1 mtm180 -105.65 133.74 49.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 74.33 110.806 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -171.93 -151.15 7.61 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.712 -0.756 . . . . 71.13 112.446 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 33.7 m -124.25 145.79 30.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.868 0.366 . . . . 72.13 111.14 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 318' ' ' PHE . . . . . 0.681 ' CD2' HD23 ' A' ' 286' ' ' LEU . 18.2 p90 -144.56 157.01 56.41 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.644 0.735 . . . . 74.35 110.877 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 121.73 8.41 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.678 2.252 . . . . 74.45 112.375 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . 0.526 ' HA ' HG22 ' A' ' 323' ' ' VAL . 1.6 p-10 -62.2 -17.32 57.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 61.22 110.888 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -76.61 -5.23 46.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.115 -0.493 . . . . 72.43 110.813 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -121.01 24.5 10.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 74.41 110.849 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . 0.526 HG22 ' HA ' ' A' ' 320' ' ' ASP . 17.5 m -148.61 147.39 16.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.175 -0.466 . . . . 71.3 111.105 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -114.07 114.35 26.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.474 . . . . 73.43 110.95 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.6 HD12 ' CZ3' ' A' ' 307' ' ' TRP . 0.8 OUTLIER -64.99 125.65 25.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.187 -0.461 . . . . 74.52 110.915 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.65 HD12 ' HB3' ' A' ' 271' ' ' TYR . 21.5 mt . . . . . 0 C--N 1.328 -0.326 0 CA-C-O 121.58 0.705 . . . . 72.45 110.901 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.766 0.317 . . . . 70.13 110.851 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 271' ' ' TYR . . . . . 0.555 ' HB3' HD12 ' A' ' 326' ' ' LEU . 12.5 m-85 -110.65 137.8 47.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.173 -0.467 . . . . 73.4 110.962 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 25.3 m -126.92 145.61 50.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.148 -0.478 . . . . 64.14 110.923 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 17.6 ttpt -103.65 127.78 51.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 51.42 110.892 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . 0.631 HG13 HD12 ' A' ' 288' ' ' ILE . 21.5 t -61.58 114.42 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.29 -0.414 . . . . 61.21 111.076 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 0.538 HD11 ' O ' ' A' ' 321' ' ' ASN . 34.4 pt -88.97 -27.06 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 45.0 111.128 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -145.94 159.25 47.22 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.635 0.731 . . . . 74.45 110.853 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 151.94 68.89 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.706 2.27 . . . . 63.43 112.276 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -166.41 111.47 0.8 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 75.34 110.916 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . 0.639 ' HA ' HG23 ' A' ' 287' ' ' THR . 42.3 tt0 -94.88 129.01 42.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 73.24 110.887 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -63.41 113.82 3.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 71.32 111.104 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -59.58 -26.44 65.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 74.13 110.899 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -150.7 170.25 19.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.221 -0.445 . . . . 51.01 110.842 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -56.57 -25.95 53.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 74.33 110.829 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -70.08 -25.86 63.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 72.31 110.851 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . 0.426 ' OE1' HG23 ' A' ' 317' ' ' VAL . 46.5 mm-40 -94.96 164.66 12.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 73.21 110.9 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.665 HD13 ' HG3' ' A' ' 314' ' ' ARG . 14.4 tp -116.41 136.71 52.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.09 -0.505 . . . . 75.45 110.893 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.639 HG23 ' HA ' ' A' ' 279' ' ' GLU . 85.1 m -92.59 144.86 24.91 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.151 -0.477 . . . . 54.35 111.132 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 288' ' ' ILE . . . . . 0.631 HD12 HG13 ' A' ' 274' ' ' VAL . 48.4 pt -150.37 142.9 17.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 54.43 111.143 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 31.8 mtpt -112.38 141.04 46.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.153 -0.476 . . . . 72.32 110.931 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -51.95 131.56 31.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 74.3 110.851 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 99.96 -22.22 41.22 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.702 -0.761 . . . . 63.33 112.438 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -76.12 178.12 6.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.757 0.313 . . . . 60.12 110.874 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 81.2 mt -133.02 122.1 45.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 72.24 111.179 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . 0.745 HG11 ' CE2' ' A' ' 318' ' ' PHE . 90.1 t -105.66 138.1 32.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 63.13 111.149 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 52.3 m -87.77 114.34 24.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 63.4 111.136 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.404 HD11 ' HB3' ' A' ' 307' ' ' TRP . 5.5 tp -70.01 112.43 6.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.258 -0.428 . . . . 65.35 110.909 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 61.2 mt -101.43 -29.03 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.107 -0.497 . . . . 62.14 111.128 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -155.69 178.08 10.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.444 . . . . 41.43 110.9 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 27.7 mttp -141.33 112.97 7.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 71.04 110.938 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -49.68 160.78 0.26 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.213 -0.449 . . . . 52.33 110.888 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.8 t -113.29 -68.97 0.89 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 50.12 110.897 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 31.0 mm -66.97 -12.86 15.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 60.22 111.109 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -97.17 70.81 2.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 70.13 110.947 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.412 HG13 ' O ' ' A' ' 304' ' ' VAL . 5.9 p -51.31 120.75 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 73.13 111.145 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.54 24.47 30.74 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.758 -0.734 . . . . 63.15 112.461 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 56.3 m95 -139.72 135.94 33.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.809 0.337 . . . . 72.23 110.913 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 307' ' ' TRP . . . . . 0.404 ' HB3' HD11 ' A' ' 296' ' ' LEU . 22.3 m0 -130.69 156.66 44.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 64.31 110.867 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -101.38 115.51 30.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.194 -0.457 . . . . 75.23 110.925 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -128.66 -172.64 13.23 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.755 -0.736 . . . . 51.53 112.503 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -141.32 140.43 33.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.861 0.362 . . . . 71.41 110.931 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.456 HD13 HG22 ' A' ' 294' ' ' VAL . 4.5 tp -145.69 128.94 16.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 73.14 110.838 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 56.8 29.88 16.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 61.4 110.816 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 87.52 -8.62 76.64 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.716 -0.754 . . . . 73.13 112.527 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 314' ' ' ARG . . . . . 0.665 ' HG3' HD13 ' A' ' 286' ' ' LEU . 4.3 tpt180 -93.08 109.01 20.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.722 0.296 . . . . 74.04 110.887 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 10.4 ttp85 -96.69 133.35 41.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 74.23 110.904 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -166.43 -158.87 11.47 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.669 -0.777 . . . . 70.11 112.41 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.426 HG23 ' OE1' ' A' ' 285' ' ' GLU . 19.2 m -116.76 154.47 18.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.883 0.373 . . . . 73.3 111.129 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 318' ' ' PHE . . . . . 0.745 ' CE2' HG11 ' A' ' 294' ' ' VAL . 5.5 p90 -159.79 157.07 25.57 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.621 0.724 . . . . 71.3 110.865 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 121.65 8.33 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.705 2.27 . . . . 62.02 112.348 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . 0.545 ' HA ' HG22 ' A' ' 323' ' ' VAL . 1.6 p-10 -58.35 -22.31 53.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 64.4 110.937 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 321' ' ' ASN . . . . . 0.538 ' O ' HD11 ' A' ' 275' ' ' ILE . 19.7 m120 -69.85 -15.78 63.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 75.43 110.863 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -104.36 15.62 27.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 70.4 110.859 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . 0.545 HG22 ' HA ' ' A' ' 320' ' ' ASP . 18.9 m -149.16 150.59 13.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 75.33 111.12 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 24.8 ttpt -125.35 125.75 43.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 74.23 110.895 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 2.5 mt -64.95 130.78 44.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 71.23 110.98 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.555 HD12 ' HB3' ' A' ' 271' ' ' TYR . 20.2 mt . . . . . 0 C--N 1.329 -0.322 0 CA-C-O 121.592 0.711 . . . . 70.15 110.871 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.87 0.367 . . . . 54.0 110.833 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 271' ' ' TYR . . . . . 0.589 ' HB3' HD12 ' A' ' 326' ' ' LEU . 14.4 m-85 -130.46 143.09 50.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.211 -0.45 . . . . 73.55 110.922 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 22.1 m -133.04 149.37 52.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.116 -0.493 . . . . 74.33 110.887 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 15.5 tttp -103.89 121.75 43.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 74.11 110.935 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . 0.54 ' CG2' HG23 ' A' ' 294' ' ' VAL . 57.8 t -61.65 111.71 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 62.33 111.141 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 28.5 pt -84.1 -32.12 8.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 71.22 111.098 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -140.39 157.78 67.76 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.661 0.743 . . . . 73.1 110.927 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.81 159.23 54.13 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.695 2.264 . . . . 73.41 112.25 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -174.16 109.64 0.14 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 54.14 110.915 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . 0.624 ' HA ' HG23 ' A' ' 287' ' ' THR . 9.2 tt0 -89.33 139.47 30.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 70.32 110.829 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . 0.429 ' HB2' ' C ' ' A' ' 286' ' ' LEU . . . -87.5 121.42 29.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 63.42 111.042 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -60.22 -42.46 95.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 63.42 110.933 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -148.64 -174.66 4.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 44.45 110.89 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -57.98 -19.75 32.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 73.15 110.909 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 284' ' ' ASP . . . . . 0.455 ' O ' HG22 ' A' ' 317' ' ' VAL . 2.2 t70 -72.07 -8.39 54.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 53.51 110.882 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . 0.421 ' HB2' ' HB1' ' A' ' 280' ' ' ALA . 9.3 mp0 -132.61 158.91 41.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 74.01 110.855 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.648 HD23 ' CD2' ' A' ' 318' ' ' PHE . 17.0 tp -114.89 133.44 55.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 74.22 110.979 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.624 HG23 ' HA ' ' A' ' 279' ' ' GLU . 86.7 m -84.32 145.04 28.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 64.21 111.144 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 288' ' ' ILE . . . . . 0.419 HG22 HD22 ' A' ' 311' ' ' LEU . 38.6 pt -150.88 138.83 14.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 55.34 111.064 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 31.2 mttm -110.43 136.1 50.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.131 -0.486 . . . . 75.43 110.962 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 290' ' ' GLU . . . . . 0.402 ' HA ' HG12 ' A' ' 274' ' ' VAL . 34.0 tt0 -51.68 128.7 24.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.45 . . . . 71.31 110.877 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 105.26 -26.21 22.57 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.699 -0.762 . . . . 54.21 112.483 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -83.28 156.16 23.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.694 0.283 . . . . 64.54 110.934 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 56.6 mt -106.64 126.26 62.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.194 -0.457 . . . . 52.33 111.107 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . 0.714 HG11 ' CE2' ' A' ' 318' ' ' PHE . 62.1 t -96.11 138.13 22.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 70.44 111.077 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 56.2 m -91.1 109.43 20.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.16 -0.473 . . . . 72.24 111.145 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.469 HD11 ' HB3' ' A' ' 307' ' ' TRP . 4.2 tp -69.85 121.2 16.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.187 -0.46 . . . . 64.5 110.892 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 297' ' ' ILE . . . . . 0.486 HD11 ' HB2' ' A' ' 310' ' ' GLU . 38.9 mt -107.93 -36.69 3.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.233 -0.44 . . . . 64.45 111.171 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . 0.421 ' ND2' HG22 ' A' ' 297' ' ' ILE . 18.3 m-80 -151.02 170.69 18.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.128 -0.487 . . . . 74.0 110.907 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 21.7 mttt -137.28 112.28 9.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 74.22 110.858 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -55.49 178.61 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.436 . . . . 75.32 110.891 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 1.7 t -128.04 -69.36 0.73 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.207 -0.452 . . . . 64.44 110.936 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 60.8 mt -59.71 -18.26 14.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 70.51 111.137 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.35 61.67 1.21 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.462 . . . . 63.53 110.919 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 54.9 t -51.44 136.8 10.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 74.02 111.119 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 88.75 14.17 61.61 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.721 -0.752 . . . . 72.43 112.533 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 52.2 m95 -139.68 149.04 43.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.729 0.3 . . . . 75.15 110.871 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 307' ' ' TRP . . . . . 0.61 ' CZ3' HD12 ' A' ' 325' ' ' LEU . 10.4 m0 -139.22 148.78 43.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 73.53 110.89 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -94.47 117.56 30.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 65.03 110.969 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -138.4 -168.87 11.42 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.711 -0.757 . . . . 54.1 112.509 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . 0.486 ' HB2' HD11 ' A' ' 297' ' ' ILE . 71.1 tt0 -138.49 148.1 43.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.834 0.35 . . . . 71.4 110.95 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.609 HD13 HG22 ' A' ' 294' ' ' VAL . 6.3 tp -158.6 129.55 6.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.19 -0.459 . . . . 64.55 110.953 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 58.94 30.0 19.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 60.41 110.864 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 84.47 -5.13 82.35 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.72 -0.752 . . . . 74.41 112.46 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -98.3 122.35 41.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.757 0.313 . . . . 73.1 110.915 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 63.0 mtm180 -106.97 132.03 53.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 73.22 110.835 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -168.04 -149.5 6.14 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.7 -0.762 . . . . 24.31 112.468 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.455 HG22 ' O ' ' A' ' 284' ' ' ASP . 18.7 m -127.17 146.45 33.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.896 0.379 . . . . 71.33 111.119 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 318' ' ' PHE . . . . . 0.714 ' CE2' HG11 ' A' ' 294' ' ' VAL . 14.3 p90 -144.95 157.37 54.43 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.656 0.741 . . . . 72.33 110.841 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.66 121.24 7.95 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.727 2.285 . . . . 71.11 112.344 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . 0.552 ' HA ' HG22 ' A' ' 323' ' ' VAL . 1.6 p-10 -60.66 -18.73 55.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 73.11 110.831 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -74.85 -6.7 50.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.481 . . . . 74.11 110.921 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -118.06 22.12 12.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 73.12 110.83 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . 0.552 HG22 ' HA ' ' A' ' 320' ' ' ASP . 17.5 m -149.02 145.12 18.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 74.42 111.15 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -111.19 117.38 33.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 64.33 110.919 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.61 HD12 ' CZ3' ' A' ' 307' ' ' TRP . 0.8 OUTLIER -64.87 125.47 24.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 51.23 110.932 179.943 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.589 HD12 ' HB3' ' A' ' 271' ' ' TYR . 20.3 mt . . . . . 0 C--N 1.329 -0.322 0 CA-C-O 121.59 0.71 . . . . 52.14 110.936 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.859 0.361 . . . . 73.11 110.876 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 271' ' ' TYR . . . . . 0.703 ' CE1' HG23 ' A' ' 295' ' ' THR . 6.7 m-85 -124.1 156.61 36.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 50.34 110.917 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 272' ' ' CYS . . . . . 0.407 ' SG ' HD13 ' A' ' 296' ' ' LEU . 23.5 m -138.92 152.44 47.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.123 -0.489 . . . . 65.21 110.886 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt -108.21 126.67 53.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.141 -0.481 . . . . 74.22 110.916 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 38.9 t -63.21 109.32 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 72.15 111.107 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 30.0 pt -83.25 -31.53 8.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 75.4 111.14 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -140.84 159.2 63.22 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.654 0.74 . . . . 73.14 110.86 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 152.08 69.02 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.675 2.25 . . . . 54.53 112.318 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -174.38 105.96 0.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 65.12 110.839 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . 0.576 ' HA ' HG23 ' A' ' 287' ' ' THR . 1.4 mp0 -89.2 141.06 28.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.108 -0.496 . . . . 64.5 110.915 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -54.54 113.03 1.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 60.05 111.176 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -69.05 -26.45 64.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.303 -0.408 . . . . 75.44 110.945 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 18.9 m-80 -144.03 174.74 10.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.134 -0.485 . . . . 74.04 110.91 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -63.53 -26.13 68.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 75.31 110.854 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 284' ' ' ASP . . . . . 0.593 ' O ' HG22 ' A' ' 317' ' ' VAL . 14.6 m-20 -88.06 6.14 37.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 74.04 110.838 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -105.65 164.64 11.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.253 -0.43 . . . . 73.13 110.889 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.777 HD23 ' CD2' ' A' ' 318' ' ' PHE . 21.3 tp -115.75 131.23 57.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.491 . . . . 70.33 110.903 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.576 HG23 ' HA ' ' A' ' 279' ' ' GLU . 91.5 m -87.43 136.14 33.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 53.23 111.078 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 288' ' ' ILE . . . . . 0.478 HG21 HG21 ' A' ' 294' ' ' VAL . 0.1 OUTLIER -147.49 146.15 18.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 72.44 111.149 179.871 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 27.4 mtmm -120.64 145.98 46.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 72.14 110.945 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -52.0 131.82 31.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.27 -0.423 . . . . 73.14 110.847 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.03 -27.1 19.81 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.804 -0.712 . . . . 35.42 112.52 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -71.71 173.34 8.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.778 0.323 . . . . 73.02 110.839 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 28.5 mm -124.24 135.9 62.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 64.15 111.156 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . 0.634 HG11 ' CE2' ' A' ' 318' ' ' PHE . 19.5 t -111.69 132.43 60.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.247 -0.433 . . . . 62.24 111.067 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . 0.703 HG23 ' CE1' ' A' ' 271' ' ' TYR . 17.4 m -87.89 112.09 22.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.089 -0.505 . . . . 72.34 111.136 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.407 HD13 ' SG ' ' A' ' 272' ' ' CYS . 6.0 tp -69.59 119.69 14.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 74.4 110.977 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 58.9 mt -115.72 -25.18 3.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.283 -0.417 . . . . 53.43 111.095 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -158.29 176.84 11.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.014 0.435 . . . . 74.1 110.779 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 48.7 mttt -141.18 113.03 7.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.048 -0.524 . . . . 65.12 110.897 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.01 166.75 0.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 75.44 110.903 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.2 t -119.6 -69.35 0.85 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.241 -0.436 . . . . 64.3 110.919 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 36.0 mm -64.26 -14.72 16.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 71.11 111.133 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -96.51 74.47 2.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 72.34 110.848 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 58.9 t -51.37 117.36 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 71.01 111.129 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 88.89 29.68 17.32 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.793 -0.718 . . . . 45.24 112.477 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 58.8 m95 -140.67 135.05 31.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.68 0.276 . . . . 63.44 110.977 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 307' ' ' TRP . . . . . 0.726 ' CZ3' HD12 ' A' ' 325' ' ' LEU . 24.2 m0 -129.26 157.55 41.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.254 -0.43 . . . . 72.25 110.934 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -104.78 124.77 49.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.305 -0.407 . . . . 54.21 110.887 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -140.24 -164.82 10.05 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.706 -0.759 . . . . 51.54 112.451 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -142.94 143.68 32.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.915 0.388 . . . . 55.21 110.865 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.432 HD22 ' O ' ' A' ' 287' ' ' THR . 2.0 tp -146.56 122.77 10.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 61.23 110.959 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 58.55 29.94 19.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 73.15 110.892 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 89.61 -8.63 79.43 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.715 -0.755 . . . . 72.02 112.459 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 17.2 tpp180 -94.14 114.24 26.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.703 0.287 . . . . 75.53 110.913 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 36.7 mtm180 -98.86 138.19 36.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.202 -0.454 . . . . 73.44 110.828 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -171.93 -160.61 20.86 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.797 -0.716 . . . . 63.14 112.475 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 284' ' ' ASP . 32.6 m -118.36 154.0 20.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.857 0.36 . . . . 62.2 111.145 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 318' ' ' PHE . . . . . 0.777 ' CD2' HD23 ' A' ' 286' ' ' LEU . 26.0 p90 -156.04 156.34 30.31 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.639 0.733 . . . . 73.2 110.882 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 119.5 6.44 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.701 2.267 . . . . 63.23 112.351 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . 0.536 ' HA ' HG22 ' A' ' 323' ' ' VAL . 1.5 p-10 -60.89 -18.86 58.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.431 . . . . 73.33 110.888 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -74.55 -7.15 52.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.157 -0.474 . . . . 54.53 110.82 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -117.63 24.19 11.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 74.45 110.776 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . 0.536 HG22 ' HA ' ' A' ' 320' ' ' ASP . 18.1 m -148.89 153.13 11.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 44.43 111.122 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -116.8 113.39 22.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 64.12 110.957 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.726 HD12 ' CZ3' ' A' ' 307' ' ' TRP . 1.2 tt -65.1 126.48 28.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 72.33 110.906 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 20.3 mt . . . . . 0 C--N 1.328 -0.363 0 CA-C-O 121.642 0.734 . . . . 72.24 110.855 179.896 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.794 0.331 . . . . 74.23 110.839 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 271' ' ' TYR . . . . . 0.485 ' CE1' HG23 ' A' ' 295' ' ' THR . 8.8 m-85 -129.26 150.99 50.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 74.22 110.857 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 26.4 m -139.19 150.7 45.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.058 -0.519 . . . . 64.43 110.911 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -107.77 122.92 47.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.447 . . . . 73.53 110.896 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . 0.458 HG11 ' C ' ' A' ' 289' ' ' LYS . 24.1 t -56.01 116.18 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.292 -0.413 . . . . 74.35 111.193 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 0.418 HG21 ' HB2' ' A' ' 324' ' ' LYS . 29.7 pt -97.95 -17.55 6.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 71.41 111.127 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -145.52 151.98 48.31 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.627 0.727 . . . . 71.53 110.903 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.67 151.52 69.62 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.655 2.237 . . . . 54.31 112.363 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -174.45 140.43 0.63 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.451 . . . . 73.14 110.932 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . 0.531 ' HA ' HG23 ' A' ' 287' ' ' THR . 49.5 tt0 -121.17 143.18 49.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.054 -0.521 . . . . 75.25 110.882 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -76.61 127.79 33.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 72.41 111.116 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -71.48 -25.82 62.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.242 -0.435 . . . . 74.13 110.878 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -155.75 177.54 11.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 51.1 110.887 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -56.94 -25.75 58.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.177 -0.465 . . . . 61.14 110.878 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 284' ' ' ASP . . . . . 0.449 ' O ' HG22 ' A' ' 317' ' ' VAL . 18.9 t0 -72.29 -24.85 61.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.474 . . . . 72.41 110.864 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . 0.482 ' OE2' HG23 ' A' ' 317' ' ' VAL . 19.8 mm-40 -94.97 163.5 13.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.172 -0.467 . . . . 62.52 110.895 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.616 HD23 ' CD2' ' A' ' 318' ' ' PHE . 20.3 tp -119.78 131.24 55.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.13 -0.486 . . . . 71.44 110.923 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.531 HG23 ' HA ' ' A' ' 279' ' ' GLU . 96.7 m -85.97 143.3 28.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.154 -0.475 . . . . 75.01 111.139 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 288' ' ' ILE . . . . . 0.461 HG21 HG21 ' A' ' 294' ' ' VAL . 47.9 pt -150.26 142.36 17.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 71.31 111.115 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . 0.458 ' C ' HG11 ' A' ' 274' ' ' VAL . 17.3 mmtp -122.07 144.73 48.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 64.54 110.897 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -51.5 128.81 23.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 74.31 110.863 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 101.43 -30.89 9.41 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.753 -0.737 . . . . 75.22 112.493 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -69.77 171.83 8.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.736 0.303 . . . . 73.53 110.917 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 67.4 mt -126.71 126.16 68.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 71.15 111.087 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . 0.71 HG11 ' CE2' ' A' ' 318' ' ' PHE . 64.6 t -104.37 138.21 30.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 74.02 111.135 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . 0.485 HG23 ' CE1' ' A' ' 271' ' ' TYR . 49.2 m -92.63 111.4 22.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.154 -0.475 . . . . 64.05 111.129 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.41 HD11 ' HB3' ' A' ' 307' ' ' TRP . 5.3 tp -69.82 122.28 18.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 71.42 110.937 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 297' ' ' ILE . . . . . 0.55 HG22 HD22 ' A' ' 298' ' ' ASN . 67.6 mt -110.53 -39.8 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 73.01 111.124 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . 0.55 HD22 HG22 ' A' ' 297' ' ' ILE . 17.2 m-80 -145.71 171.67 14.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 65.55 110.872 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -136.09 111.87 9.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 72.1 110.899 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.08 177.5 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 71.42 110.938 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 1.9 t -126.46 -69.33 0.77 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 64.23 110.91 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 38.6 mm -62.64 -15.89 15.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 63.04 111.185 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.26 61.35 2.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 73.54 110.9 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 56.6 t -51.12 130.97 11.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 71.2 111.118 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.91 14.71 58.97 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.779 -0.724 . . . . 73.5 112.484 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 44.0 m95 -137.01 162.86 32.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.816 0.341 . . . . 73.21 110.872 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 307' ' ' TRP . . . . . 0.44 ' CZ3' HD12 ' A' ' 325' ' ' LEU . 5.0 m0 -151.0 156.44 41.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 70.31 110.866 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -102.66 119.06 38.17 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.246 -0.434 . . . . 73.33 110.903 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -140.55 -162.92 9.31 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.75 -0.738 . . . . 61.13 112.51 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -145.65 148.64 33.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.934 0.397 . . . . 65.03 110.834 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.438 HD23 ' O ' ' A' ' 287' ' ' THR . 14.5 tp -157.98 134.95 9.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.074 -0.512 . . . . 71.02 110.894 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 57.23 30.44 18.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 74.45 110.926 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 77.95 18.88 76.19 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.784 -0.722 . . . . 62.43 112.416 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 31.5 mmm-85 -124.99 121.01 33.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.867 0.365 . . . . 74.43 110.849 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 39.8 mtp180 -99.55 142.54 30.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 73.45 110.876 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -176.52 -160.06 23.09 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.793 -0.718 . . . . 71.54 112.523 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.482 HG23 ' OE2' ' A' ' 285' ' ' GLU . 29.5 m -115.51 151.07 17.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.923 0.392 . . . . 70.44 111.17 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 318' ' ' PHE . . . . . 0.71 ' CE2' HG11 ' A' ' 294' ' ' VAL . 10.5 p90 -154.69 155.77 30.83 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.64 0.733 . . . . 72.01 110.916 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 119.8 6.69 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.744 2.296 . . . . 64.11 112.31 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . 0.528 ' HA ' HG22 ' A' ' 323' ' ' VAL . 1.7 p-10 -61.06 -18.61 58.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.242 -0.435 . . . . 73.34 110.855 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 75.1 m-80 -74.88 -6.98 52.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 71.42 110.887 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -117.54 22.77 12.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 74.21 110.892 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . 0.528 HG22 ' HA ' ' A' ' 320' ' ' ASP . 18.3 m -148.82 144.28 18.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.464 . . . . 73.53 111.17 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . 0.418 ' HB2' HG21 ' A' ' 275' ' ' ILE . 52.6 tttt -109.45 116.95 32.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.464 . . . . 70.1 110.891 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.44 HD12 ' CZ3' ' A' ' 307' ' ' TRP . 0.6 OUTLIER -65.02 119.36 10.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 53.4 110.952 179.89 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.425 HD12 ' HB3' ' A' ' 271' ' ' TYR . 20.2 mt . . . . . 0 C--N 1.328 -0.348 0 CA-C-O 121.615 0.722 . . . . 71.12 110.896 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.81 0.338 . . . . 72.14 110.845 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 271' ' ' TYR . . . . . 0.426 ' CZ ' HG23 ' A' ' 295' ' ' THR . 33.9 m-85 -142.85 147.19 35.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.452 . . . . 75.25 110.942 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 272' ' ' CYS . . . . . 0.446 ' SG ' HD22 ' A' ' 296' ' ' LEU . 23.7 m -135.26 149.22 49.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 73.23 110.85 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 47.4 tttt -103.49 115.17 30.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.181 -0.463 . . . . 75.31 110.886 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . 0.55 HG21 ' HB ' ' A' ' 288' ' ' ILE . 58.9 t -57.47 118.26 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.262 -0.426 . . . . 53.42 111.08 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 26.2 pt -93.42 -30.98 4.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.489 . . . . 62.15 111.13 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -136.56 159.4 70.63 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.642 0.734 . . . . 52.21 110.929 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 159.63 52.69 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.648 2.232 . . . . 62.31 112.367 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -172.76 110.02 0.21 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.27 -0.423 . . . . 72.33 110.948 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . 0.682 ' HA ' HG23 ' A' ' 287' ' ' THR . 34.0 tt0 -93.23 128.02 39.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 71.13 110.868 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -61.82 116.27 4.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 72.51 111.109 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -57.9 -26.73 62.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 74.31 110.99 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -152.43 173.87 14.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 61.23 110.949 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -58.78 -26.28 63.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 61.35 110.945 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -70.11 -24.92 63.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.1 -0.5 . . . . 65.13 110.856 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -95.07 167.32 11.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 75.01 110.865 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.636 HD23 ' CD2' ' A' ' 318' ' ' PHE . 15.1 tp -116.78 137.43 52.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 42.01 110.921 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.682 HG23 ' HA ' ' A' ' 279' ' ' GLU . 85.4 m -95.18 144.35 25.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 53.24 111.128 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 288' ' ' ILE . . . . . 0.651 HG21 HG21 ' A' ' 294' ' ' VAL . 41.8 pt -150.34 149.72 14.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 42.4 111.128 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -121.93 140.79 52.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 73.32 110.909 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 8.1 tm-20 -51.83 122.95 9.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 64.44 110.861 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 113.26 -23.16 14.33 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.726 -0.749 . . . . 15.41 112.466 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -88.42 152.14 22.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.817 0.341 . . . . 71.32 110.867 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 62.7 mt -104.55 123.65 58.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 71.34 111.147 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . 0.74 HG11 ' CE2' ' A' ' 318' ' ' PHE . 90.9 t -100.17 138.04 25.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 73.02 111.114 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . 0.426 HG23 ' CZ ' ' A' ' 271' ' ' TYR . 33.9 m -86.5 109.35 19.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.166 -0.47 . . . . 74.03 111.154 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.474 HD11 ' HB3' ' A' ' 307' ' ' TRP . 7.4 tp -69.86 117.76 11.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 70.01 110.904 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 69.0 mt -104.45 -48.41 9.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 73.21 111.086 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -134.38 178.13 7.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 41.23 110.895 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -141.46 112.77 7.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.157 -0.474 . . . . 73.31 110.91 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -50.56 165.77 0.09 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.229 -0.441 . . . . 72.41 110.805 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.8 t -115.69 -69.14 0.87 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.479 . . . . 74.04 110.864 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 2.0 mp -67.57 -12.61 15.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.434 . . . . 71.43 111.194 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.84 69.3 3.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 63.33 110.894 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 76.7 t -51.43 121.41 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 62.21 111.136 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.33 20.34 45.73 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.733 -0.746 . . . . 73.22 112.551 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 42.0 m95 -136.27 138.7 42.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.708 0.289 . . . . 75.13 110.909 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 307' ' ' TRP . . . . . 0.76 ' CZ3' HD12 ' A' ' 325' ' ' LEU . 19.5 m0 -134.3 157.19 46.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.454 . . . . 73.32 110.918 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -100.52 117.25 34.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.288 -0.415 . . . . 73.11 110.888 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -129.77 -170.13 12.67 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.768 -0.73 . . . . 62.24 112.505 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -143.83 146.82 33.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.864 0.364 . . . . 74.3 110.947 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.652 HD13 HG22 ' A' ' 294' ' ' VAL . 2.6 tp -155.77 132.27 10.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.181 -0.463 . . . . 73.22 110.92 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 56.81 29.86 16.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 72.32 110.854 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 84.76 -6.8 76.73 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.747 -0.74 . . . . 73.1 112.485 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 314' ' ' ARG . . . . . 0.543 ' HG3' HD13 ' A' ' 286' ' ' LEU . 14.1 tpp180 -96.09 108.6 21.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.773 0.321 . . . . 62.12 110.857 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 8.9 ttp180 -96.61 129.75 43.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 73.33 110.952 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -161.34 -157.96 9.11 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.78 -0.724 . . . . 70.53 112.507 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 15.8 m -117.25 154.59 18.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.843 0.354 . . . . 74.52 111.119 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 318' ' ' PHE . . . . . 0.74 ' CE2' HG11 ' A' ' 294' ' ' VAL . 7.6 p90 -162.19 155.83 17.9 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.648 0.737 . . . . 72.23 110.904 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.85 118.5 5.72 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.699 2.266 . . . . 72.14 112.293 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . 0.579 ' HA ' HG22 ' A' ' 323' ' ' VAL . 3.0 t70 -59.67 -20.32 55.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 71.41 110.83 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -68.4 -12.65 61.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 44.35 110.887 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -107.96 14.15 25.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 71.25 110.856 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . 0.579 HG22 ' HA ' ' A' ' 320' ' ' ASP . 17.7 m -148.56 145.21 18.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.487 . . . . 71.41 111.09 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 21.6 ttpp -106.52 118.77 37.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 65.34 110.958 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.76 HD12 ' CZ3' ' A' ' 307' ' ' TRP . 1.9 tt -64.98 132.0 48.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 63.4 110.934 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.434 ' O ' HD23 ' A' ' 325' ' ' LEU . 20.4 mt . . . . . 0 C--N 1.328 -0.365 0 CA-C-O 121.572 0.701 . . . . 73.11 110.936 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.89 0.376 . . . . 75.1 110.862 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 271' ' ' TYR . . . . . 0.536 ' CB ' HD12 ' A' ' 326' ' ' LEU . 10.3 m-85 -132.33 139.61 48.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 74.43 110.903 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 272' ' ' CYS . . . . . 0.508 ' SG ' HD13 ' A' ' 296' ' ' LEU . 36.0 m -127.76 148.61 50.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.479 . . . . 63.24 110.887 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 38.6 tttt -102.9 118.04 35.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 71.52 110.878 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . 0.652 HG13 HD12 ' A' ' 288' ' ' ILE . 61.6 t -58.82 112.99 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.252 -0.431 . . . . 61.2 111.15 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 0.422 HG21 ' HG2' ' A' ' 324' ' ' LYS . 30.9 pt -86.5 -31.47 6.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 74.45 111.099 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -139.71 158.14 68.56 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.603 0.716 . . . . 71.32 110.867 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 153.94 68.43 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.702 2.268 . . . . 60.22 112.361 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -171.48 105.95 0.22 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 71.44 110.927 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . 0.732 ' HA ' HG23 ' A' ' 287' ' ' THR . 9.7 tt0 -88.57 143.84 26.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 74.15 110.837 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -78.09 123.39 26.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.096 -0.502 . . . . 41.44 111.095 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -74.85 -26.13 59.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 74.13 110.943 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -144.49 170.07 16.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 74.03 110.883 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -57.35 -26.18 60.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.139 -0.482 . . . . 61.33 110.928 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 284' ' ' ASP . . . . . 0.559 ' O ' HG22 ' A' ' 317' ' ' VAL . 3.4 t70 -70.95 -25.56 62.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 52.24 110.922 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -95.16 161.28 14.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 64.43 110.928 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.599 HD12 ' N ' ' A' ' 287' ' ' THR . 13.4 tp -120.1 136.54 54.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.235 -0.439 . . . . 74.1 110.941 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.732 HG23 ' HA ' ' A' ' 279' ' ' GLU . 73.2 m -86.2 146.1 26.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 64.42 111.087 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 288' ' ' ILE . . . . . 0.652 HD12 HG13 ' A' ' 274' ' ' VAL . 44.3 pt -150.41 145.04 17.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.439 . . . . 73.22 111.106 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -117.64 136.98 52.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 62.01 110.873 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -51.76 126.15 17.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 62.24 110.88 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 108.51 -26.02 17.7 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.713 -0.756 . . . . 75.13 112.476 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -85.38 153.95 22.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.766 0.317 . . . . 73.24 110.917 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 29.2 mm -105.08 123.14 59.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.298 -0.41 . . . . 74.44 111.104 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . 0.722 HG11 ' CE2' ' A' ' 318' ' ' PHE . 87.8 t -93.25 138.04 21.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 72.01 111.123 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 89.4 m -86.46 108.55 18.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 51.14 111.156 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.508 HD13 ' SG ' ' A' ' 272' ' ' CYS . 3.3 tp -69.91 115.1 8.74 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.256 -0.429 . . . . 71.2 110.924 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 79.2 mt -103.71 -26.91 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 74.42 111.091 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -157.39 178.0 10.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 63.25 110.85 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 24.9 mttt -141.34 113.01 7.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.126 -0.488 . . . . 71.54 110.9 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -49.77 162.43 0.18 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.215 -0.448 . . . . 71.55 110.91 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.8 t -114.51 -68.99 0.88 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.261 -0.427 . . . . 61.12 110.931 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 40.2 mt -67.0 -13.12 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 73.53 111.063 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -95.77 71.04 3.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 74.35 110.876 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 42.1 t -51.28 119.99 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 74.0 111.178 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.32 24.79 30.31 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.715 -0.755 . . . . 51.12 112.463 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 55.6 m95 -139.67 138.26 35.9 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.743 0.306 . . . . 72.1 110.986 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 307' ' ' TRP . . . . . 0.762 ' CH2' HD12 ' A' ' 325' ' ' LEU . 20.8 m0 -132.53 158.45 42.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.278 -0.419 . . . . 71.22 110.857 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -103.03 115.18 30.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 73.1 110.949 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -130.34 -171.76 12.99 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.677 -0.773 . . . . 63.55 112.462 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -141.85 143.64 33.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.906 0.384 . . . . 74.12 110.878 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.6 HD13 HG22 ' A' ' 294' ' ' VAL . 1.8 tp -160.03 147.05 16.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 64.34 110.937 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 56.6 29.94 16.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 62.23 110.862 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 76.24 7.83 84.99 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.696 -0.764 . . . . 71.23 112.431 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.9 126.29 52.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.835 0.35 . . . . 71.13 110.877 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 7.8 ttp180 -100.9 141.21 34.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 74.11 110.928 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -172.78 -158.84 18.09 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.741 -0.742 . . . . 53.44 112.493 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 284' ' ' ASP . 35.4 m -117.86 162.99 15.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.932 0.396 . . . . 71.52 111.087 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 318' ' ' PHE . . . . . 0.722 ' CE2' HG11 ' A' ' 294' ' ' VAL . 7.1 p90 -166.71 157.04 10.54 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.66 0.743 . . . . 75.51 110.866 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.83 122.31 8.97 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.63 2.22 . . . . 71.44 112.365 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . 0.541 ' HA ' HG22 ' A' ' 323' ' ' VAL . 1.6 p-10 -59.2 -21.31 59.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.238 -0.437 . . . . 74.34 110.876 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -69.93 -16.99 63.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 71.22 110.898 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -102.95 15.13 30.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 64.41 110.863 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . 0.541 HG22 ' HA ' ' A' ' 320' ' ' ASP . 18.2 m -148.99 150.45 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 72.34 111.217 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . 0.422 ' HG2' HG21 ' A' ' 275' ' ' ILE . 17.2 mmtm -114.8 117.32 30.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 72.1 110.894 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.762 HD12 ' CH2' ' A' ' 307' ' ' TRP . 1.9 tt -64.92 127.38 31.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.246 -0.434 . . . . 72.22 110.908 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.536 HD12 ' CB ' ' A' ' 271' ' ' TYR . 20.4 mt . . . . . 0 C--N 1.329 -0.313 0 CA-C-O 121.575 0.702 . . . . 63.41 110.932 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.773 0.321 . . . . 73.44 110.897 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 271' ' ' TYR . . . . . 0.484 ' CB ' HD12 ' A' ' 326' ' ' LEU . 7.5 m-85 -127.64 146.78 50.43 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.213 -0.449 . . . . 71.51 110.926 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 272' ' ' CYS . . . . . 0.524 ' SG ' HD22 ' A' ' 296' ' ' LEU . 45.5 m -133.64 147.9 51.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 40.41 110.863 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 28.9 tttt -102.9 119.23 38.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 74.15 110.928 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . 0.473 ' CG2' HG23 ' A' ' 294' ' ' VAL . 58.8 t -59.37 112.6 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.31 -0.405 . . . . 73.44 111.075 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 0.57 HG21 ' HG3' ' A' ' 324' ' ' LYS . 29.2 pt -86.59 -31.89 6.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 64.34 111.092 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -138.71 158.73 69.62 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.669 0.747 . . . . 74.35 110.91 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 161.49 45.72 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.679 2.253 . . . . 71.24 112.338 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -174.87 111.92 0.14 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.274 -0.421 . . . . 74.3 110.934 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . 0.727 ' HA ' HG23 ' A' ' 287' ' ' THR . 24.4 tt0 -92.17 131.97 36.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.101 -0.5 . . . . 75.43 110.872 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . 0.472 ' HB1' ' HB2' ' A' ' 285' ' ' GLU . . . -68.26 115.67 7.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 72.03 111.077 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -58.08 -30.35 66.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 72.34 110.936 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -149.72 175.18 11.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 73.14 110.9 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -58.65 -25.64 62.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 72.54 110.891 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -69.93 -25.88 63.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 75.2 110.897 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . 0.529 ' OE1' HG23 ' A' ' 317' ' ' VAL . 63.7 mm-40 -94.93 163.41 13.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 72.11 110.916 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.613 HD23 ' CD2' ' A' ' 318' ' ' PHE . 23.2 tp -116.08 131.54 56.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 62.42 110.949 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.727 HG23 ' HA ' ' A' ' 279' ' ' GLU . 60.4 m -88.24 144.61 26.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 73.54 111.141 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 288' ' ' ILE . . . . . 0.54 HG21 HG21 ' A' ' 294' ' ' VAL . 43.9 pt -150.34 146.87 16.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 70.21 111.12 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -119.11 139.57 51.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.478 . . . . 52.5 110.871 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -51.91 124.01 11.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.475 . . . . 71.55 110.878 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 111.65 -24.97 14.09 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.768 -0.73 . . . . 73.34 112.46 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -85.98 156.16 20.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.789 0.328 . . . . 73.43 110.893 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 36.7 mm -108.63 127.14 65.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.288 -0.415 . . . . 61.35 111.18 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . 0.708 HG11 ' CE2' ' A' ' 318' ' ' PHE . 61.1 t -102.59 138.1 28.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 74.14 111.121 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 97.8 m -82.38 103.8 12.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 74.33 111.139 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.648 HD11 ' HB3' ' A' ' 307' ' ' TRP . 9.0 tp -69.89 113.15 6.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.144 -0.48 . . . . 75.44 110.897 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 19.7 mt -92.8 -49.17 13.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 62.04 111.155 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -149.88 178.62 8.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 63.21 110.863 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -129.17 112.3 13.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 63.2 110.85 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -49.8 166.6 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 72.34 110.878 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.0 t -111.02 -69.11 0.89 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.203 -0.453 . . . . 43.35 110.894 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 51.4 mt -63.62 -15.3 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 72.01 111.192 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -93.31 65.26 3.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.112 -0.494 . . . . 64.32 110.897 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 57.7 t -51.19 118.69 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 74.23 111.119 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.54 23.07 34.84 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.788 -0.72 . . . . 50.42 112.496 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 52.8 m95 -139.06 133.01 31.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.735 0.303 . . . . 74.32 110.925 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 307' ' ' TRP . . . . . 0.758 ' CZ3' HD12 ' A' ' 325' ' ' LEU . 28.6 m0 -124.34 149.62 46.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.257 -0.429 . . . . 74.44 110.882 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -97.62 119.78 36.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.435 . . . . 73.11 110.944 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -136.74 -167.24 11.08 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.668 -0.777 . . . . 74.54 112.408 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -139.34 138.48 36.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.926 0.394 . . . . 74.31 110.844 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.657 HD13 HG22 ' A' ' 294' ' ' VAL . 13.2 tp -145.78 129.98 17.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.489 . . . . 64.41 110.895 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 58.89 29.95 19.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 71.23 110.805 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 84.03 -4.72 82.3 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.753 -0.737 . . . . 73.42 112.458 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 9.5 ttp85 -100.44 120.15 39.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.842 0.353 . . . . 50.43 110.842 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 32.4 mtm180 -99.9 140.54 33.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.469 . . . . 73.2 110.847 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -173.29 -159.85 20.66 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.689 -0.767 . . . . 72.24 112.479 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.529 HG23 ' OE1' ' A' ' 285' ' ' GLU . 17.0 m -117.02 148.63 19.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.859 0.362 . . . . 65.34 111.098 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 318' ' ' PHE . . . . . 0.708 ' CE2' HG11 ' A' ' 294' ' ' VAL . 8.8 p90 -151.01 156.76 35.52 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.722 0.772 . . . . 54.34 110.847 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 120.01 6.87 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.71 2.273 . . . . 70.42 112.332 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . 0.567 ' HA ' HG22 ' A' ' 323' ' ' VAL . 1.6 p-10 -58.58 -21.91 54.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.276 -0.42 . . . . 71.44 110.844 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -71.14 -10.2 59.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.471 . . . . 74.3 110.877 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -111.88 17.68 19.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 73.13 110.905 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . 0.567 HG22 ' HA ' ' A' ' 320' ' ' ASP . 18.0 m -149.07 151.89 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.11 -0.496 . . . . 62.13 111.125 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . 0.57 ' HG3' HG21 ' A' ' 275' ' ' ILE . 8.9 mtpp -118.94 118.63 32.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 75.33 110.934 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.758 HD12 ' CZ3' ' A' ' 307' ' ' TRP . 0.7 OUTLIER -65.02 130.56 43.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.208 -0.451 . . . . 75.43 110.855 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.484 HD12 ' CB ' ' A' ' 271' ' ' TYR . 20.2 mt . . . . . 0 C--N 1.327 -0.384 0 CA-C-O 121.631 0.729 . . . . 63.4 110.855 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.805 0.336 . . . . 70.33 110.844 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 271' ' ' TYR . . . . . 0.592 ' HB3' HD12 ' A' ' 326' ' ' LEU . 7.6 m-85 -115.94 142.78 46.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.243 -0.435 . . . . 75.13 110.943 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 272' ' ' CYS . . . . . 0.476 ' SG ' HD13 ' A' ' 296' ' ' LEU . 22.7 m -127.29 146.32 50.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.113 -0.494 . . . . 73.12 110.919 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -102.9 126.11 49.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 64.3 110.912 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . 0.43 HG21 ' HB ' ' A' ' 288' ' ' ILE . 47.8 t -64.84 112.23 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.309 -0.405 . . . . 72.42 111.136 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 27.0 pt -85.74 -32.09 6.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.269 -0.423 . . . . 54.41 111.127 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -138.53 157.96 71.28 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.624 0.726 . . . . 75.11 110.878 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 156.66 62.77 Favored 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 122.674 2.249 . . . . 62.33 112.345 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -172.41 108.21 0.2 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 63.34 110.924 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . 0.712 ' HA ' HG23 ' A' ' 287' ' ' THR . 25.2 tt0 -88.15 138.97 30.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 70.11 110.866 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -68.45 116.52 9.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 74.43 111.099 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -56.47 -28.08 58.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 73.23 110.907 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -153.73 175.93 12.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 70.22 110.885 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -58.8 -25.81 63.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.145 -0.48 . . . . 74.52 110.855 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.16 -23.57 61.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 65.32 110.86 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -94.96 167.96 11.08 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.179 -0.464 . . . . 73.41 110.909 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.626 HD23 ' CD2' ' A' ' 318' ' ' PHE . 14.6 tp -119.01 136.67 54.0 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.163 -0.471 . . . . 61.43 110.9 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.712 HG23 ' HA ' ' A' ' 279' ' ' GLU . 85.6 m -91.89 146.08 24.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.159 -0.473 . . . . 74.34 111.144 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 288' ' ' ILE . . . . . 0.43 ' HB ' HG21 ' A' ' 274' ' ' VAL . 33.7 pt -149.49 143.3 18.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.281 -0.418 . . . . 63.2 111.183 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 20.2 mtpp -117.26 140.05 50.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.148 -0.478 . . . . 70.04 110.919 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -51.43 121.84 6.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 71.4 110.924 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 115.2 -31.03 6.42 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.727 -0.749 . . . . 70.21 112.48 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -79.4 160.39 26.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.725 0.298 . . . . 74.23 110.889 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.463 HG23 ' O ' ' A' ' 272' ' ' CYS . 3.2 mp -115.95 128.05 73.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 63.53 111.115 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . 0.852 HG22 HD13 ' A' ' 311' ' ' LEU . 99.8 t -105.03 138.15 31.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 70.35 111.127 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . 0.569 HG23 ' CE1' ' A' ' 271' ' ' TYR . 3.3 m -85.98 117.7 25.0 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.174 -0.466 . . . . 61.34 111.151 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.476 HD13 ' SG ' ' A' ' 272' ' ' CYS . 5.2 tp -69.88 110.66 5.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.243 -0.435 . . . . 61.44 110.865 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 27.5 mm -100.12 -26.12 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 63.53 111.079 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -162.11 178.31 8.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 74.34 110.862 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 40.9 mttt -141.38 112.95 7.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 75.24 110.885 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -49.66 161.74 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 74.23 110.902 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.8 t -113.53 -69.05 0.89 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 74.44 110.86 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 38.6 mt -66.97 -12.98 15.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.432 . . . . 74.52 111.172 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -97.36 70.46 2.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.135 -0.484 . . . . 74.33 110.843 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.405 ' O ' HG13 ' A' ' 304' ' ' VAL . 6.3 p -51.35 121.89 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 73.54 111.176 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.24 21.0 43.14 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.695 -0.764 . . . . 54.24 112.461 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 42.5 m95 -136.42 134.27 37.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.781 0.324 . . . . 74.41 110.896 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 307' ' ' TRP . . . . . 0.444 ' CZ3' HD12 ' A' ' 325' ' ' LEU . 22.0 m0 -129.2 156.96 43.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.112 -0.495 . . . . 75.32 110.932 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -101.33 113.41 26.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.283 -0.417 . . . . 62.15 110.869 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -124.7 -173.93 13.89 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.802 -0.713 . . . . 54.24 112.493 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 72.8 tt0 -137.74 136.22 37.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.897 0.379 . . . . 73.41 110.91 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.852 HD13 HG22 ' A' ' 294' ' ' VAL . 3.1 tp -149.2 134.4 18.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.454 . . . . 63.35 111.003 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 58.86 29.94 19.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 64.35 110.901 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 81.2 -0.91 86.81 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.733 -0.746 . . . . 34.52 112.457 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 314' ' ' ARG . . . . . 0.435 ' HG2' HD13 ' A' ' 286' ' ' LEU . 9.5 ttp85 -103.5 111.46 23.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.869 0.366 . . . . 74.34 110.893 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 9.5 ttp180 -96.66 117.03 30.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 75.22 110.861 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -146.89 -155.23 6.45 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.793 -0.717 . . . . 72.52 112.539 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 23.1 m -118.48 155.41 20.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.817 0.342 . . . . 73.54 111.159 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 318' ' ' PHE . . . . . 0.745 ' CE2' HG11 ' A' ' 294' ' ' VAL . 6.7 p90 -163.72 156.11 15.23 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.569 0.7 . . . . 62.45 110.92 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.82 119.24 6.21 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.682 2.255 . . . . 62.42 112.337 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . 0.584 ' HA ' HG22 ' A' ' 323' ' ' VAL . 2.7 t70 -60.42 -18.97 54.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.191 -0.459 . . . . 74.14 110.841 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -68.24 -12.51 61.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 74.45 110.884 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -108.29 14.47 24.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 62.54 110.872 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . 0.584 HG22 ' HA ' ' A' ' 320' ' ' ASP . 18.0 m -148.86 149.54 14.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 74.0 111.085 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 10.2 ttmm -121.49 134.17 55.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 64.1 110.876 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.444 HD12 ' CZ3' ' A' ' 307' ' ' TRP . 0.0 OUTLIER -64.95 126.42 27.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 64.32 110.91 179.965 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.592 HD12 ' HB3' ' A' ' 271' ' ' TYR . 20.4 mt . . . . . 0 C--N 1.329 -0.314 0 CA-C-O 121.611 0.72 . . . . 72.42 110.909 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 4.1 p . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.821 0.343 . . . . 34.22 110.813 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.33 112.33 3.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 74.42 110.816 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -135.58 168.19 19.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 71.41 110.822 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 6.1 p -110.18 131.66 54.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.473 . . . . 73.53 110.873 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 4.1 tpm_? -131.55 67.11 1.53 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.064 -0.516 . . . . 75.31 110.81 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 7.1 t -148.25 156.05 42.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 73.23 111.097 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -90.74 -42.03 10.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 70.41 110.878 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 2.1 m -77.76 78.73 4.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.128 -0.487 . . . . 74.02 110.913 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -116.17 -176.06 2.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 65.34 110.854 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -155.15 141.59 18.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 54.34 110.838 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' TYR . . . . . 0.542 ' HB3' HD12 ' A' ' 326' ' ' LEU . 8.6 m-85 -128.11 149.39 50.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 73.51 110.863 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 25.7 m -138.55 148.19 43.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.098 -0.501 . . . . 73.33 110.843 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -102.95 123.05 45.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 71.51 110.912 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . 0.655 HG13 HD12 ' A' ' 288' ' ' ILE . 22.4 t -61.0 109.02 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 61.21 111.131 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 36.0 pt -83.64 -28.22 7.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 60.52 111.133 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -145.41 159.3 48.89 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.624 0.726 . . . . 75.32 110.851 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 159.78 52.15 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.651 2.234 . . . . 60.44 112.364 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -176.1 110.39 0.1 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.435 . . . . 74.24 110.929 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . 0.716 ' HA ' HG23 ' A' ' 287' ' ' THR . 21.7 tp10 -89.46 135.04 33.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.089 -0.505 . . . . 70.32 110.945 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -65.82 113.26 4.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 61.44 111.038 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -58.06 -26.44 62.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.436 . . . . 73.4 110.986 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -154.95 170.77 20.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 65.51 110.885 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -56.22 -25.99 49.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 60.24 110.882 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -70.05 -26.55 64.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.155 -0.475 . . . . 73.3 110.929 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -94.99 169.56 10.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 64.15 110.89 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.598 HD23 ' CD2' ' A' ' 318' ' ' PHE . 14.0 tp -120.57 137.24 54.5 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.16 -0.473 . . . . 71.55 110.931 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.716 HG23 ' HA ' ' A' ' 279' ' ' GLU . 91.5 m -90.9 145.25 24.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 72.11 111.109 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' ILE . . . . . 0.655 HD12 HG13 ' A' ' 274' ' ' VAL . 48.1 pt -150.26 142.95 17.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 72.14 111.094 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 44.4 mttm -114.36 139.8 49.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 63.3 110.894 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -51.94 129.84 27.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.15 -0.477 . . . . 62.05 110.919 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 102.27 -25.59 27.18 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.744 -0.741 . . . . 51.02 112.534 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.496 ' O ' HD13 ' A' ' 293' ' ' ILE . 6.6 m-20 -76.49 174.53 10.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.752 0.31 . . . . 60.41 110.856 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.496 HD13 ' O ' ' A' ' 292' ' ' ASP . 31.4 mm -124.94 125.99 70.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 74.12 111.139 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . 0.682 HG11 ' CE2' ' A' ' 318' ' ' PHE . 78.5 t -107.82 135.1 47.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 71.23 111.114 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 88.8 m -88.17 111.52 21.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.209 -0.45 . . . . 75.33 111.176 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.559 HD11 ' HB3' ' A' ' 307' ' ' TRP . 7.6 tp -69.97 118.96 13.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 71.5 110.899 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.402 HG22 HD22 ' A' ' 298' ' ' ASN . 61.7 mt -104.73 -47.6 9.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.142 -0.481 . . . . 45.12 111.167 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . 0.402 HD22 HG22 ' A' ' 297' ' ' ILE . 9.5 m-80 -135.21 178.13 7.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 74.21 110.896 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 66.1 mttt -141.41 112.82 7.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.104 -0.498 . . . . 72.43 110.955 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -50.53 165.18 0.1 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 74.23 110.961 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 3.2 t -115.14 -69.2 0.87 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.21 -0.45 . . . . 73.32 110.887 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 1.9 mp -67.92 -12.4 15.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 75.52 111.159 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -95.86 68.18 2.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.18 -0.463 . . . . 72.04 110.878 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 6.6 p -51.51 122.76 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 71.33 111.135 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.69 21.92 38.44 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.679 -0.772 . . . . 55.41 112.459 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 56.5 m95 -140.0 138.07 35.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.761 0.315 . . . . 73.12 110.833 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' TRP . . . . . 0.76 ' CZ3' HD12 ' A' ' 325' ' ' LEU . 20.6 m0 -133.18 155.91 48.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.167 -0.47 . . . . 73.05 110.893 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -99.38 121.95 41.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.277 -0.42 . . . . 72.41 110.9 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -140.69 -174.41 13.98 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.77 -0.729 . . . . 15.42 112.51 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -134.41 145.76 49.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.956 0.407 . . . . 72.14 110.846 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.414 HD13 HG22 ' A' ' 294' ' ' VAL . 5.1 tp -155.73 131.81 10.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.073 -0.512 . . . . 75.34 110.922 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 56.96 29.96 17.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 73.32 110.918 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 79.14 19.14 72.96 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.717 -0.754 . . . . 64.41 112.539 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -120.71 114.26 21.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.859 0.361 . . . . 74.45 110.86 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 42.0 ttt180 -96.97 132.13 43.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.113 -0.494 . . . . 72.44 110.878 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -170.72 -159.94 17.96 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.741 -0.742 . . . . 72.22 112.476 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 27.7 m -116.76 147.64 20.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.781 0.324 . . . . 54.14 111.163 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' PHE . . . . . 0.682 ' CE2' HG11 ' A' ' 294' ' ' VAL . 7.1 p90 -149.74 156.77 38.69 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.701 0.762 . . . . 72.55 110.82 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.8 121.76 8.44 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.651 2.234 . . . . 71.01 112.332 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . 0.531 ' HA ' HG22 ' A' ' 323' ' ' VAL . 1.7 p-10 -61.04 -19.01 60.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 75.05 110.921 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -73.85 -9.74 58.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.491 . . . . 63.5 110.883 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -113.64 22.03 14.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 73.54 110.828 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . 0.531 HG22 ' HA ' ' A' ' 320' ' ' ASP . 18.7 m -148.94 156.38 7.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 74.02 111.098 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 20.4 tttt -121.87 114.81 21.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.473 . . . . 74.14 110.854 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.76 HD12 ' CZ3' ' A' ' 307' ' ' TRP . 0.8 OUTLIER -64.98 125.9 26.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 72.21 110.89 179.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.737 HD13 ' CD1' ' A' ' 330' ' ' PHE . 20.4 mt -68.9 159.13 84.01 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.559 0.695 . . . . 63.14 110.916 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.66 167.75 23.4 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.694 2.263 . . . . 63.35 112.353 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -16.71 37.41 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.71 2.273 . . . . 72.15 112.302 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -84.45 -42.94 15.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 64.31 110.906 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' PHE . . . . . 0.737 ' CD1' HD13 ' A' ' 326' ' ' LEU . 11.3 t80 -65.69 112.81 3.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 72.42 110.803 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -139.27 107.62 5.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.122 -0.49 . . . . 75.43 110.812 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 21.2 ttmm -61.28 -58.83 6.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.098 -0.501 . . . . 62.41 110.894 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.225 -0.443 . . . . 74.53 110.839 179.997 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 6.4 t . . . . . 0 CA--C 1.526 0.043 0 CA-C-O 120.936 0.398 . . . . 73.41 110.77 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 4.6 ptt? -153.63 170.79 20.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.056 -0.52 . . . . 74.34 110.889 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -105.49 -65.16 1.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 75.52 110.863 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 66.7 p -86.73 115.47 24.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 73.41 110.886 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 15.1 mmt85 -55.85 157.52 4.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 75.25 110.867 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 17.5 m -54.51 146.26 16.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.093 -0.503 . . . . 55.33 111.118 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -113.95 49.09 1.02 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 72.14 110.897 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 46.5 m 55.13 42.42 30.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 70.3 110.9 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -70.55 177.93 3.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.152 -0.476 . . . . 75.54 110.925 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -143.44 132.17 22.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 74.2 110.913 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' TYR . . . . . 0.492 ' HB3' HD12 ' A' ' 326' ' ' LEU . 16.7 m-85 -129.62 152.86 48.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 63.44 110.9 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' CYS . . . . . 0.447 ' SG ' HD13 ' A' ' 296' ' ' LEU . 31.8 m -139.17 153.2 47.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 71.55 110.87 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 38.8 tttt -110.57 119.18 38.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 52.41 110.913 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . 0.819 HG13 HD12 ' A' ' 288' ' ' ILE . 26.2 t -56.0 111.32 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 75.11 111.128 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 34.5 pt -87.43 -27.31 5.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 74.43 111.103 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -144.44 160.09 49.4 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.64 0.733 . . . . 71.11 110.856 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 158.57 56.52 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.676 2.251 . . . . 75.1 112.327 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -173.95 107.42 0.13 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.455 . . . . 74.31 110.868 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . 0.613 ' HA ' HG23 ' A' ' 287' ' ' THR . 30.0 tt0 -91.94 118.06 30.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.14 -0.482 . . . . 64.52 110.866 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -51.74 119.86 4.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 45.53 111.087 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -66.44 -26.19 67.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.439 . . . . 73.42 110.916 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -150.46 168.79 23.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.209 -0.45 . . . . 75.34 110.914 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -56.62 -25.9 54.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 64.11 110.875 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -70.05 -25.81 63.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 54.32 110.854 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -95.03 166.32 12.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.243 -0.435 . . . . 73.43 110.887 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.641 HD23 ' CD2' ' A' ' 318' ' ' PHE . 14.1 tp -115.97 137.1 52.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.157 -0.474 . . . . 71.24 110.944 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.613 HG23 ' HA ' ' A' ' 279' ' ' GLU . 91.4 m -91.15 144.48 25.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 64.15 111.139 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' ILE . . . . . 0.819 HD12 HG13 ' A' ' 274' ' ' VAL . 34.0 pt -150.47 146.77 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 61.42 111.092 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . 0.401 ' C ' HG11 ' A' ' 274' ' ' VAL . 25.7 mtpt -122.27 143.6 49.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 51.44 110.85 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 66.5 tt0 -52.0 130.08 28.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 73.02 110.871 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 100.79 -25.53 28.01 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.738 -0.744 . . . . 74.21 112.503 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.69 170.91 15.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.78 0.324 . . . . 73.51 110.861 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 48.5 mm -123.4 128.49 74.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 54.03 111.187 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . 0.704 HG11 ' CE2' ' A' ' 318' ' ' PHE . 94.1 t -108.62 138.06 37.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.234 -0.439 . . . . 62.53 111.162 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 47.1 m -94.07 113.35 25.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.208 -0.451 . . . . 73.24 111.116 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.447 HD13 ' SG ' ' A' ' 272' ' ' CYS . 4.1 tp -69.95 117.6 11.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.214 -0.448 . . . . 72.3 110.948 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 69.2 mt -107.06 -28.32 2.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.439 . . . . 63.12 111.127 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -155.05 178.11 10.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 73.13 110.861 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 8.7 mttm -141.53 112.94 7.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 75.45 110.915 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -49.92 162.31 0.2 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.284 -0.417 . . . . 73.2 110.833 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.8 t -113.58 -68.97 0.89 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 74.21 110.888 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 38.9 mt -67.17 -12.99 16.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 73.41 111.149 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -96.7 70.36 2.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.485 . . . . 54.11 110.873 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.404 ' O ' HG13 ' A' ' 304' ' ' VAL . 6.5 p -51.48 122.17 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 71.5 111.232 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.09 19.51 50.27 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.812 -0.709 . . . . 73.32 112.497 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -135.47 137.79 42.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.772 0.32 . . . . 74.22 110.917 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' TRP . . . . . 0.789 ' CZ3' HD12 ' A' ' 325' ' ' LEU . 22.5 m0 -131.76 158.78 40.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.25 -0.432 . . . . 75.31 110.943 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -103.5 120.38 40.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.307 -0.406 . . . . 42.22 110.841 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -136.53 -169.74 11.79 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.789 -0.719 . . . . 64.34 112.458 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -137.89 147.87 44.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.826 0.346 . . . . 72.43 110.9 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.595 HD13 HG22 ' A' ' 294' ' ' VAL . 9.9 tp -150.22 123.19 8.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 63.52 110.913 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 55.55 30.61 15.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.256 -0.429 . . . . 75.11 110.895 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 92.13 -16.58 59.31 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.758 -0.734 . . . . 74.53 112.441 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -85.52 112.53 21.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.87 0.367 . . . . 73.51 110.872 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 42.3 mtp180 -99.83 135.45 41.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.101 -0.5 . . . . 61.24 110.869 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -172.61 -163.33 26.24 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.733 -0.746 . . . . 74.35 112.488 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 27.7 m -109.59 160.55 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.866 0.365 . . . . 71.44 111.116 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' PHE . . . . . 0.704 ' CE2' HG11 ' A' ' 294' ' ' VAL . 4.6 p90 -165.2 156.21 12.57 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.621 0.724 . . . . 74.44 110.885 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 118.77 5.88 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.685 2.256 . . . . 70.12 112.268 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . 0.535 ' HA ' HG22 ' A' ' 323' ' ' VAL . 2.9 t70 -60.13 -19.74 55.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 72.34 110.874 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -73.26 -8.48 55.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 61.14 110.863 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -114.78 21.38 14.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 75.12 110.888 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . 0.535 HG22 ' HA ' ' A' ' 320' ' ' ASP . 18.5 m -148.74 146.34 17.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.113 -0.494 . . . . 71.41 111.056 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 15.2 ttmm -106.83 109.77 21.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.114 -0.493 . . . . 62.22 110.95 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.789 HD12 ' CZ3' ' A' ' 307' ' ' TRP . 2.6 tt -64.93 119.03 9.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 73.02 110.954 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.492 HD12 ' HB3' ' A' ' 271' ' ' TYR . 20.3 mt -61.45 159.25 33.18 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.549 0.69 . . . . 74.45 110.9 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 167.81 23.46 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.579 2.186 . . . . 74.21 112.336 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -17.24 37.56 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.696 2.264 . . . . 52.12 112.324 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -77.69 -41.47 37.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.216 -0.447 . . . . 70.35 110.869 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -64.64 114.24 4.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 63.42 110.865 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 -147.71 107.58 4.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 73.14 110.909 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -95.23 -66.14 0.93 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.164 -0.471 . . . . 65.24 110.886 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.245 -0.434 . . . . 65.25 110.905 179.957 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 9.5 m . . . . . 0 CA--C 1.526 0.034 0 CA-C-O 120.885 0.374 . . . . 51.11 110.825 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -102.04 112.21 24.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.101 -0.5 . . . . 74.33 110.916 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -170.21 135.44 1.31 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 73.13 110.889 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.13 156.93 3.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 74.31 110.926 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.48 122.76 26.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.46 . . . . 65.42 110.862 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . 0.595 HG23 ' H ' ' A' ' 268' ' ' SER . 8.9 t -67.3 -31.63 72.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 75.1 111.192 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 19.5 ttpt 52.15 31.06 8.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 74.44 110.969 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.595 ' H ' HG23 ' A' ' 266' ' ' THR . 8.2 t -141.13 29.67 1.82 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.146 -0.479 . . . . 70.45 110.795 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 7.5 tttp -56.52 176.29 0.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 72.01 110.877 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -139.97 117.79 11.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 61.44 110.813 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' TYR . . . . . 0.567 ' HB3' HD12 ' A' ' 326' ' ' LEU . 14.8 m-85 -116.43 148.06 41.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 71.14 110.951 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 24.8 m -133.42 146.69 51.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.076 -0.511 . . . . 45.44 110.915 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 49.9 tttt -106.06 122.12 45.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 72.54 110.885 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . 0.467 HG13 HD12 ' A' ' 288' ' ' ILE . 23.0 t -61.66 113.21 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 73.14 111.121 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 28.3 pt -88.21 -29.97 5.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.138 -0.483 . . . . 72.43 111.068 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -140.1 158.76 66.39 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.622 0.725 . . . . 72.32 110.855 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 156.04 64.42 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.636 2.224 . . . . 41.23 112.375 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -173.68 107.96 0.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 75.15 110.883 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . 0.682 ' HA ' HG23 ' A' ' 287' ' ' THR . 13.9 tt0 -87.99 142.4 27.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.109 -0.496 . . . . 75.42 110.894 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -70.52 113.02 7.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.126 -0.488 . . . . 54.24 111.091 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -58.01 -25.84 61.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 74.13 110.929 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -155.72 170.25 22.46 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.195 -0.457 . . . . 74.55 110.898 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -56.51 -25.21 50.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 63.3 110.818 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -72.13 -25.02 61.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 61.42 110.843 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -95.02 167.1 11.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 73.03 110.871 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.644 HD23 ' CD2' ' A' ' 318' ' ' PHE . 14.3 tp -115.01 136.82 52.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 71.22 110.958 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.682 HG23 ' HA ' ' A' ' 279' ' ' GLU . 86.6 m -92.12 142.07 27.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 72.12 111.115 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' ILE . . . . . 0.531 HG21 HG21 ' A' ' 294' ' ' VAL . 31.9 pt -148.78 146.48 17.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 73.31 111.143 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -119.33 140.72 49.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 62.3 110.828 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -51.97 128.67 24.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 71.2 110.916 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 104.14 -23.97 30.52 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.691 -0.766 . . . . 42.52 112.426 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.16 175.3 10.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.744 0.306 . . . . 52.13 110.913 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 39.9 mm -125.34 128.81 72.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.199 -0.455 . . . . 72.4 111.117 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . 0.692 HG11 ' CE2' ' A' ' 318' ' ' PHE . 98.3 t -109.77 137.99 39.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.49 . . . . 74.5 111.172 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 40.5 m -91.16 111.68 23.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 64.41 111.186 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.44 HD11 ' HB3' ' A' ' 307' ' ' TRP . 5.9 tp -70.07 117.56 11.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.238 -0.437 . . . . 52.53 110.858 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 64.4 mt -106.97 -34.67 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 71.24 111.186 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -147.45 178.18 8.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.134 -0.484 . . . . 60.1 110.84 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 35.8 mttp -141.45 112.95 7.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 74.02 110.893 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -49.74 165.79 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 63.44 110.899 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.5 t -118.15 -69.38 0.85 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.214 -0.448 . . . . 53.13 110.872 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 47.2 mt -65.27 -14.36 16.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 72.14 111.165 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -98.32 71.7 2.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 44.34 110.9 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 59.3 t -51.52 122.31 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 72.34 111.138 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.61 20.45 44.25 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.731 -0.747 . . . . 42.13 112.488 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 50.8 m95 -135.23 134.27 39.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.713 0.292 . . . . 70.33 110.952 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' TRP . . . . . 0.44 ' HB3' HD11 ' A' ' 296' ' ' LEU . 24.4 m0 -129.66 156.64 43.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.25 -0.432 . . . . 64.44 110.955 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -101.98 126.28 48.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.277 -0.42 . . . . 75.33 110.868 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -143.77 -167.84 11.98 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.705 -0.759 . . . . 73.33 112.454 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -138.32 147.53 43.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.875 0.369 . . . . 75.41 110.936 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 4.8 tp -157.95 132.05 8.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 70.24 110.932 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 56.35 29.99 16.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 74.44 110.911 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 79.79 18.44 72.83 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.723 -0.751 . . . . 63.24 112.579 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 16.0 mmt180 -121.58 113.53 19.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.767 0.318 . . . . 70.4 110.878 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -97.22 132.05 43.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.244 -0.434 . . . . 74.3 110.895 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -170.07 -163.67 24.49 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.827 -0.702 . . . . 63.23 112.54 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 8.3 m -108.12 157.27 8.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.86 0.362 . . . . 65.42 111.113 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' PHE . . . . . 0.692 ' CE2' HG11 ' A' ' 294' ' ' VAL . 5.9 p90 -163.17 156.08 16.26 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.714 0.769 . . . . 74.41 110.83 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.69 117.47 5.1 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.691 2.261 . . . . 51.21 112.398 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . 0.577 ' HA ' HG22 ' A' ' 323' ' ' VAL . 2.9 t70 -57.77 -22.56 47.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.252 -0.431 . . . . 65.5 110.92 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -68.85 -12.26 61.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 70.12 110.861 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -108.46 14.72 24.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 72.52 110.857 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . 0.577 HG22 ' HA ' ' A' ' 320' ' ' ASP . 17.9 m -148.69 138.11 15.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.475 . . . . 72.53 111.11 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.74 123.06 48.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 72.31 110.905 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 2.5 mt -64.93 122.67 17.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.439 . . . . 70.31 110.918 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.762 HD13 ' CD1' ' A' ' 330' ' ' PHE . 20.2 mt -55.66 159.21 5.25 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.533 0.682 . . . . 60.44 110.922 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.74 167.76 23.47 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.654 2.236 . . . . 73.33 112.422 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -20.49 34.74 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.695 2.264 . . . . 61.51 112.342 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -79.54 -32.83 42.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 75.13 110.871 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' PHE . . . . . 0.762 ' CD1' HD13 ' A' ' 326' ' ' LEU . 10.6 t80 -78.38 115.28 17.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 72.01 110.825 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -141.56 107.05 5.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 52.44 110.92 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 15.9 ttmt -76.75 -52.95 8.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 45.35 110.903 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.236 -0.438 . . . . 63.02 110.861 -179.997 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 3.1 p . . . . . 0 N--CA 1.458 -0.062 0 CA-C-O 120.859 0.362 . . . . 62.44 110.882 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 1.7 ptp -110.39 138.15 47.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.1 -0.5 . . . . 73.2 110.897 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -120.2 109.19 15.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 74.21 110.866 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 58.6 m -99.67 57.43 1.01 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 71.24 110.853 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 14.1 tpp180 -118.01 48.8 1.33 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.058 -0.519 . . . . 63.55 110.86 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 15.3 t -61.27 138.47 58.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 73.04 111.11 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 46.5 tttm -74.16 -47.0 38.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 71.42 110.881 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 9.4 t -81.39 84.33 6.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 65.24 110.879 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 28.6 mtpt -101.53 -178.36 3.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.463 . . . . 75.23 110.936 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -140.31 128.21 21.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.269 -0.423 . . . . 74.34 110.853 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' TYR . . . . . 0.532 ' HB3' HD12 ' A' ' 326' ' ' LEU . 11.5 m-85 -128.23 152.88 47.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.453 . . . . 72.2 110.948 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 26.2 m -138.78 146.48 41.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.118 -0.492 . . . . 73.44 110.888 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 14.3 tttp -103.0 117.35 34.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 74.43 110.823 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . 0.713 HG13 HD12 ' A' ' 288' ' ' ILE . 26.2 t -55.91 112.32 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 70.13 111.132 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 37.9 pt -88.33 -28.08 5.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.175 -0.466 . . . . 54.2 111.134 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -142.6 159.71 56.43 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.61 0.719 . . . . 53.42 110.884 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 160.05 51.15 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.738 2.292 . . . . 74.33 112.263 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -173.29 109.78 0.18 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 74.41 110.91 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . 0.656 ' HA ' HG23 ' A' ' 287' ' ' THR . 42.9 tt0 -91.08 127.0 36.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.115 -0.493 . . . . 51.52 110.887 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -58.82 117.63 4.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 63.22 111.074 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -65.84 -25.8 67.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 74.12 110.871 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 -153.0 168.41 25.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 73.41 110.923 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -56.14 -26.3 49.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 44.34 110.886 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -71.02 -25.22 62.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 63.31 110.88 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . 0.504 ' OE1' HG23 ' A' ' 317' ' ' VAL . 6.2 mm-40 -94.86 164.79 12.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 71.24 110.95 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.594 HD12 ' H ' ' A' ' 287' ' ' THR . 14.1 tp -115.21 137.12 52.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.46 . . . . 60.32 110.962 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.656 HG23 ' HA ' ' A' ' 279' ' ' GLU . 85.0 m -91.81 144.74 25.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.221 -0.445 . . . . 75.35 111.143 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' ILE . . . . . 0.713 HD12 HG13 ' A' ' 274' ' ' VAL . 44.4 pt -150.34 144.7 17.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 52.12 111.13 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 18.2 mtmm -116.14 140.05 49.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 70.12 110.87 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -51.89 128.56 24.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 72.24 110.895 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 104.02 -21.3 38.38 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.679 -0.772 . . . . 62.34 112.382 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -81.58 172.52 13.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.795 0.331 . . . . 54.4 110.846 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.523 ' O ' HD13 ' A' ' 311' ' ' LEU . 76.2 mt -123.61 126.51 73.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.488 . . . . 75.25 111.127 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . 0.72 HG11 ' CE2' ' A' ' 318' ' ' PHE . 93.1 t -109.63 136.05 46.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 74.31 111.116 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 95.4 m -87.72 113.02 23.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.21 -0.45 . . . . 73.3 111.138 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.578 HD11 ' HB3' ' A' ' 307' ' ' TRP . 8.0 tp -70.01 112.65 6.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.277 -0.42 . . . . 72.23 110.943 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.406 HD11 ' HB2' ' A' ' 310' ' ' GLU . 50.5 mt -98.29 -49.19 11.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 71.43 111.217 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -132.71 178.43 6.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 74.22 110.805 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 17.6 mttp -141.82 112.96 7.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 73.31 110.936 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -50.15 162.15 0.23 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.27 -0.423 . . . . 74.22 110.857 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 3.0 t -113.87 -68.92 0.89 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 73.43 110.907 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' ILE . . . . . 0.406 HG22 ' O ' ' A' ' 302' ' ' ILE . 34.1 mt -68.54 -12.01 15.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 74.44 111.075 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -97.96 69.72 2.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 61.44 110.935 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 6.6 p -51.47 122.6 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 51.21 111.129 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 91.04 17.28 51.81 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.692 -0.766 . . . . 31.13 112.413 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 34.7 m95 -133.98 135.89 43.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.743 0.306 . . . . 75.33 110.949 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' TRP . . . . . 0.798 ' CZ3' HD12 ' A' ' 325' ' ' LEU . 22.4 m0 -132.84 155.26 49.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.431 . . . . 74.32 110.883 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -97.04 121.31 38.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 75.31 110.836 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . 0.45 ' O ' HD22 ' A' ' 286' ' ' LEU . . . -138.68 179.82 18.07 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.735 -0.745 . . . . 74.24 112.437 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . 0.406 ' HB2' HD11 ' A' ' 297' ' ' ILE . 34.1 tt0 -133.72 141.67 47.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.918 0.389 . . . . 70.54 110.841 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.523 HD13 ' O ' ' A' ' 293' ' ' ILE . 24.8 tp -155.39 136.8 14.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.11 -0.496 . . . . 63.24 110.86 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 56.92 30.55 18.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 61.41 110.9 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 75.82 19.46 78.91 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.788 -0.72 . . . . 71.2 112.464 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -118.61 117.82 29.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.726 0.298 . . . . 64.13 110.82 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 60.6 ttt180 -99.89 129.63 45.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 74.44 110.866 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -170.7 -162.76 23.58 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.792 -0.718 . . . . 54.22 112.512 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.504 HG23 ' OE1' ' A' ' 285' ' ' GLU . 12.4 m -115.48 150.2 17.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.919 0.39 . . . . 54.42 111.068 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' PHE . . . . . 0.72 ' CE2' HG11 ' A' ' 294' ' ' VAL . 8.5 p90 -155.16 155.89 30.54 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.63 0.728 . . . . 74.54 110.952 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 117.94 5.38 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.698 2.266 . . . . 71.41 112.313 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . 0.565 ' HA ' HG22 ' A' ' 323' ' ' VAL . 3.1 t70 -59.41 -20.7 56.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 74.34 110.885 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -68.97 -12.08 61.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 72.03 110.881 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -108.84 16.64 22.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 62.2 110.913 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . 0.565 HG22 ' HA ' ' A' ' 320' ' ' ASP . 18.6 m -148.81 150.87 13.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.104 -0.498 . . . . 32.51 111.09 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 47.8 tttp -109.18 115.3 29.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 73.23 110.855 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.798 HD12 ' CZ3' ' A' ' 307' ' ' TRP . 2.8 tt -65.19 116.03 6.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 75.34 110.964 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.532 HD12 ' HB3' ' A' ' 271' ' ' TYR . 20.4 mt -55.81 159.26 5.51 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.634 0.73 . . . . 71.3 110.885 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.77 167.74 23.59 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.686 2.257 . . . . 74.13 112.332 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.75 -18.25 37.14 Favored 'Trans proline' 0 N--CA 1.466 -0.117 0 C-N-CA 122.708 2.272 . . . . 74.42 112.319 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -79.79 -40.6 28.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 63.01 110.906 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -64.16 114.12 3.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 70.13 110.863 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -149.17 107.2 3.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 73.44 110.964 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? -88.25 -52.08 5.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 73.01 110.946 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 71.21 110.905 179.979 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 16.1 t . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.9 0.381 . . . . 40.1 110.808 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 4.8 ptp -110.59 37.81 2.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.087 -0.506 . . . . 64.45 110.93 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -104.41 136.05 44.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.466 . . . . 73.33 110.827 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 79.4 p -84.28 152.02 24.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 75.55 110.891 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 62.8 mmt-85 -86.12 176.35 8.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.098 -0.501 . . . . 71.41 110.804 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . 0.634 HG22 ' CE ' ' A' ' 269' ' ' LYS . 0.8 OUTLIER -81.41 95.18 6.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.103 -0.499 . . . . 41.44 111.167 -179.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 22.5 ttmt -58.4 -67.39 0.36 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 53.22 110.945 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 6.5 t -163.75 109.2 1.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.438 . . . . 63.51 110.839 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.634 ' CE ' HG22 ' A' ' 266' ' ' THR . 0.9 OUTLIER -102.08 179.25 4.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.14 -0.482 . . . . 65.34 110.922 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -144.49 118.84 9.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 63.31 110.818 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' TYR . . . . . 0.58 ' CE1' HG23 ' A' ' 295' ' ' THR . 10.0 m-85 -111.27 153.77 25.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 74.55 110.937 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' CYS . . . . . 0.432 ' SG ' HD13 ' A' ' 296' ' ' LEU . 26.7 m -136.0 145.63 46.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.105 -0.498 . . . . 73.13 110.821 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 3.0 ttpp -103.34 126.47 50.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 72.32 110.886 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . 0.517 HG13 HD12 ' A' ' 288' ' ' ILE . 22.0 t -61.1 114.46 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 72.13 111.106 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 0.414 HD11 ' O ' ' A' ' 321' ' ' ASN . 29.8 pt -89.16 -25.67 5.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 43.12 111.097 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -147.71 159.24 41.47 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.671 0.748 . . . . 75.43 110.897 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 155.48 65.75 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.624 2.216 . . . . 74.41 112.336 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -170.8 112.22 0.39 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 71.33 110.964 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . 0.605 ' HA ' HG23 ' A' ' 287' ' ' THR . 11.9 tt0 -93.81 130.39 39.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.445 . . . . 74.41 110.868 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -64.08 117.32 6.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.148 -0.478 . . . . 44.45 111.167 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 78.4 mm-40 -60.33 -25.57 65.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.238 -0.437 . . . . 73.34 110.924 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -155.91 176.26 12.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 75.15 110.865 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -58.48 -25.9 62.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.144 -0.48 . . . . 70.31 110.869 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -70.43 -26.38 63.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.172 -0.467 . . . . 74.12 110.849 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . 0.497 ' OE1' HG23 ' A' ' 317' ' ' VAL . 28.1 mm-40 -96.55 161.79 13.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 63.1 110.884 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.6 HD12 ' H ' ' A' ' 287' ' ' THR . 14.0 tp -115.25 136.65 52.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 75.44 110.94 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.605 HG23 ' HA ' ' A' ' 279' ' ' GLU . 90.5 m -90.57 144.85 25.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 61.2 111.086 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' ILE . . . . . 0.517 HD12 HG13 ' A' ' 274' ' ' VAL . 44.8 pt -150.32 141.82 16.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 74.43 111.145 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.28 145.16 42.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 72.2 110.892 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -51.86 131.85 31.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 44.43 110.879 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.98 -26.23 24.29 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.759 -0.734 . . . . 72.52 112.454 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.405 ' HB2' HG21 ' A' ' 274' ' ' VAL . 14.4 m-20 -69.55 176.07 3.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.793 0.33 . . . . 74.32 110.843 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 68.8 mt -134.19 125.45 47.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 65.44 111.173 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . 0.748 HG11 ' CE2' ' A' ' 318' ' ' PHE . 98.3 t -111.28 138.08 41.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.159 -0.473 . . . . 65.22 111.107 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . 0.58 HG23 ' CE1' ' A' ' 271' ' ' TYR . 6.3 m -87.39 118.51 26.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.188 -0.46 . . . . 74.23 111.131 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.432 HD13 ' SG ' ' A' ' 272' ' ' CYS . 6.1 tp -69.87 111.02 5.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 75.22 110.939 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 23.9 mm -100.49 -29.95 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 54.13 111.139 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -157.36 178.12 10.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 64.04 110.884 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 21.8 mttt -141.4 112.98 7.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.207 -0.451 . . . . 73.31 110.876 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -49.77 162.01 0.2 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 61.34 110.847 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.9 t -113.79 -68.98 0.89 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 62.03 110.882 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 30.3 mm -67.49 -12.44 15.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.441 . . . . 72.25 111.108 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -97.49 70.46 2.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 61.41 110.871 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.406 ' O ' HG13 ' A' ' 304' ' ' VAL . 6.0 p -51.4 121.24 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 62.2 111.107 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.39 24.8 30.14 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.697 -0.763 . . . . 70.2 112.475 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 57.5 m95 -140.23 133.43 29.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.751 0.31 . . . . 73.33 110.877 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' TRP . . . . . 0.713 ' CZ3' HD12 ' A' ' 325' ' ' LEU . 22.6 m0 -129.25 154.55 46.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.25 -0.432 . . . . 72.34 110.95 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -99.04 116.33 31.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.239 -0.437 . . . . 62.41 110.944 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -127.99 -173.72 13.55 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.724 -0.751 . . . . 65.33 112.529 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -135.97 134.95 39.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.836 0.351 . . . . 74.51 110.888 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.509 HD13 HG22 ' A' ' 294' ' ' VAL . 10.1 tp -143.99 130.75 20.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 53.11 110.95 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 59.04 29.95 19.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.151 -0.477 . . . . 73.04 110.84 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 83.33 -1.48 88.64 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.692 -0.766 . . . . 74.43 112.451 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' ARG . . . . . 0.423 ' HG2' HD13 ' A' ' 286' ' ' LEU . 0.0 OUTLIER -103.01 119.33 38.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.829 0.347 . . . . 75.13 110.876 -179.873 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 70.1 mtt180 -98.82 131.0 45.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 71.23 110.906 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -162.09 -162.77 13.69 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.784 -0.722 . . . . 72.43 112.515 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.497 HG23 ' OE1' ' A' ' 285' ' ' GLU . 25.1 m -115.22 153.13 16.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.884 0.373 . . . . 51.34 111.111 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' PHE . . . . . 0.748 ' CE2' HG11 ' A' ' 294' ' ' VAL . 5.1 p90 -157.36 157.42 30.22 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.657 0.741 . . . . 60.43 110.815 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 119.96 6.82 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.679 2.253 . . . . 73.14 112.302 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . 0.57 ' HA ' HG22 ' A' ' 323' ' ' VAL . 1.5 p-10 -57.42 -23.36 49.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 64.43 110.878 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' ASN . . . . . 0.414 ' O ' HD11 ' A' ' 275' ' ' ILE . 10.8 m-20 -69.53 -11.58 60.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 73.13 110.922 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -109.45 15.48 22.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 72.41 110.85 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . 0.57 HG22 ' HA ' ' A' ' 320' ' ' ASP . 18.0 m -148.7 149.56 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 62.11 111.217 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -117.02 117.6 30.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 71.1 110.862 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.713 HD12 ' CZ3' ' A' ' 307' ' ' TRP . 1.1 tt -65.03 125.01 23.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 64.04 110.893 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.767 HD13 ' CD1' ' A' ' 330' ' ' PHE . 20.7 mt -61.21 159.23 30.92 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.582 0.706 . . . . 71.54 110.992 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 167.83 23.34 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.638 2.226 . . . . 72.12 112.327 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -25.31 28.64 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.711 2.274 . . . . 72.25 112.341 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -76.21 -37.87 57.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 70.33 110.942 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' PHE . . . . . 0.767 ' CD1' HD13 ' A' ' 326' ' ' LEU . 15.4 t80 -73.07 110.47 7.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 52.02 110.849 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -137.9 107.49 6.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.083 -0.508 . . . . 72.24 110.883 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -67.11 -35.46 79.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 74.42 110.933 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' GLU . . . . . 0.473 ' HB2' HG21 ' A' ' 266' ' ' THR . 3.4 pt-20 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 73.31 110.929 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 34.6 m . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.862 0.363 . . . . 42.3 110.833 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.39 48.95 1.66 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.124 -0.489 . . . . 62.54 110.878 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -146.33 125.69 13.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.297 -0.41 . . . . 73.31 110.853 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 41.6 t -78.82 -40.34 33.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.177 -0.465 . . . . 61.43 110.881 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -131.68 103.54 6.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 74.24 110.96 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 15.1 t -81.06 168.73 18.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 74.22 111.143 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 31.4 tttp -52.69 154.56 2.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.429 . . . . 71.43 110.893 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 5.5 m -64.71 102.98 0.63 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 74.41 110.834 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 33.7 mmtt -103.9 169.1 8.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 74.33 110.875 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -151.69 138.39 18.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.444 . . . . 73.2 110.889 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' TYR . . . . . 0.563 ' CZ ' HG23 ' A' ' 295' ' ' THR . 22.8 m-85 -138.71 154.15 48.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.46 . . . . 70.13 110.931 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 56.5 m -135.67 152.99 51.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.121 -0.491 . . . . 64.25 110.838 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 18.5 tptm -102.78 129.75 49.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 74.32 110.883 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . 0.906 HG13 HD12 ' A' ' 288' ' ' ILE . 25.7 t -73.05 108.35 4.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.282 -0.417 . . . . 60.04 111.116 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 21.7 pt -86.96 -30.3 5.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 74.11 111.178 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -138.83 158.79 69.33 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.663 0.744 . . . . 64.02 110.875 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.84 165.85 29.68 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.659 2.239 . . . . 61.45 112.354 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -174.43 107.32 0.11 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.245 -0.434 . . . . 64.32 110.886 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . 0.526 ' HA ' HG23 ' A' ' 287' ' ' THR . 73.6 tt0 -92.66 111.65 23.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.106 -0.497 . . . . 62.12 110.885 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -51.69 117.22 2.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 74.44 111.103 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 52.0 mm-40 -63.23 -25.43 68.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.274 -0.421 . . . . 74.44 110.912 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 24.9 m-20 -150.7 167.77 26.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.441 . . . . 74.55 110.909 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -58.07 -24.16 57.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 74.55 110.866 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -70.06 -24.91 63.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.247 -0.433 . . . . 64.42 110.808 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -95.01 169.51 10.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 75.13 110.895 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.774 HD23 ' CD2' ' A' ' 318' ' ' PHE . 22.3 tp -114.95 131.21 56.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.137 -0.483 . . . . 73.4 110.9 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.526 HG23 ' HA ' ' A' ' 279' ' ' GLU . 97.6 m -92.08 139.09 30.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 62.33 111.158 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' ILE . . . . . 0.906 HD12 HG13 ' A' ' 274' ' ' VAL . 26.0 pt -147.0 157.33 10.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 43.03 111.122 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . 0.408 ' C ' HG11 ' A' ' 274' ' ' VAL . 23.3 mtpp -133.56 142.67 48.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 71.4 110.91 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -50.84 133.12 26.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 73.32 110.93 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 100.65 -22.13 41.02 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.864 -0.684 . . . . 73.52 112.564 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -85.23 173.48 10.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.824 0.345 . . . . 73.32 110.824 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 41.6 mm -123.55 133.91 67.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 74.3 111.08 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . 0.645 HG11 ' CE2' ' A' ' 318' ' ' PHE . 93.3 t -108.11 127.63 64.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 63.21 111.179 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . 0.563 HG23 ' CZ ' ' A' ' 271' ' ' TYR . 29.1 m -82.98 107.8 15.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 64.05 111.162 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.511 HD11 ' HB3' ' A' ' 307' ' ' TRP . 7.5 tp -69.84 117.54 11.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 73.22 110.911 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 63.8 mt -109.73 -36.55 2.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.209 -0.451 . . . . 63.34 111.14 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -144.03 177.47 8.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.131 -0.486 . . . . 75.4 110.878 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 31.9 mttp -141.75 113.01 7.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 62.01 110.881 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -49.6 160.15 0.3 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 74.42 110.791 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.6 t -113.68 -69.01 0.89 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 52.42 110.892 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 41.8 mt -66.35 -13.54 16.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.19 -0.459 . . . . 75.31 111.114 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.53 71.63 2.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 75.34 110.84 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.416 ' O ' HG13 ' A' ' 304' ' ' VAL . 5.9 p -51.23 120.7 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.474 . . . . 65.22 111.117 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.37 25.79 27.4 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.726 -0.75 . . . . 72.42 112.523 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 57.8 m95 -140.38 135.27 31.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.727 0.299 . . . . 72.45 110.963 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' TRP . . . . . 0.778 ' CZ3' HD12 ' A' ' 325' ' ' LEU . 22.6 m0 -130.26 156.75 44.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 72.32 110.956 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -103.8 126.3 50.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 73.33 110.851 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -140.25 -163.76 9.64 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.672 -0.775 . . . . 71.54 112.439 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -142.79 146.28 34.08 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.844 0.354 . . . . 63.2 110.837 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.401 HD22 HG22 ' A' ' 288' ' ' ILE . 3.5 tp -160.05 129.05 5.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.12 -0.491 . . . . 72.22 110.924 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 55.46 38.25 30.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 53.52 110.92 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 72.3 18.73 78.34 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.78 -0.724 . . . . 64.34 112.434 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -128.47 115.0 17.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.792 0.329 . . . . 75.41 110.881 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 2.9 ptt85 -116.9 139.45 50.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 74.22 110.865 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -162.6 -112.78 0.29 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.757 -0.735 . . . . 74.31 112.517 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 24.2 m -151.25 143.88 16.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.847 0.356 . . . . 74.21 111.178 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' PHE . . . . . 0.774 ' CD2' HD23 ' A' ' 286' ' ' LEU . 31.1 p90 -150.54 155.76 36.37 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.679 0.752 . . . . 74.15 110.841 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 120.69 7.44 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.674 2.249 . . . . 53.13 112.315 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . 0.513 ' HA ' HG22 ' A' ' 323' ' ' VAL . 1.5 p-10 -60.31 -19.81 56.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 72.14 110.832 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -73.54 -8.21 54.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 71.42 110.866 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -114.47 16.99 17.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 72.43 110.876 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . 0.515 HG21 ' HE1' ' A' ' 318' ' ' PHE . 23.4 m -150.21 141.42 16.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 65.42 111.152 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -105.27 118.01 35.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 62.12 110.93 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.778 HD12 ' CZ3' ' A' ' 307' ' ' TRP . 1.7 tt -64.82 132.3 49.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 72.3 110.894 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 20.3 mt -73.33 159.18 85.49 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.578 0.704 . . . . 70.31 110.943 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.75 167.82 23.34 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.652 2.235 . . . . 54.54 112.386 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 -18.65 36.65 Favored 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.67 2.247 . . . . 51.11 112.373 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -77.99 -42.95 31.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.203 -0.453 . . . . 61.35 110.854 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -68.45 115.82 8.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.18 -0.464 . . . . 63.42 110.814 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -152.34 107.16 3.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 52.04 110.848 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -83.76 -59.5 2.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 72.43 110.891 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 64.35 110.858 179.941 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 96.1 p . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.805 0.336 . . . . 42.43 110.826 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 8.7 ptp -150.8 -178.31 6.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 44.54 110.876 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -136.39 121.91 19.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 54.44 110.803 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 48.6 m -154.12 152.06 29.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 64.1 110.853 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 6.6 tpp85 -64.09 120.69 12.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.204 -0.453 . . . . 64.12 110.883 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . 0.629 HG23 ' C ' ' A' ' 333' ' ' GLU . 88.4 m -111.36 117.05 32.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 64.42 111.199 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 4.9 ttmm -52.47 167.72 0.13 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.439 . . . . 73.53 110.898 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 18.1 t -74.15 77.84 1.76 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.252 -0.431 . . . . 42.34 110.933 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 3.9 mtpm? -102.91 -175.69 2.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.48 . . . . 73.1 110.92 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -149.37 144.45 26.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 71.11 110.856 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -142.68 148.31 37.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.192 -0.458 . . . . 71.35 110.907 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 33.7 m -137.0 147.66 46.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.05 -0.523 . . . . 63.21 110.902 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 31.8 tttt -103.07 117.61 34.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 73.45 110.918 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . 0.684 HG13 HD12 ' A' ' 288' ' ' ILE . 24.5 t -55.78 115.9 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 74.42 111.177 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 0.425 HD11 ' O ' ' A' ' 321' ' ' ASN . 33.6 pt -90.04 -27.74 5.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 71.43 111.148 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -144.45 159.28 52.18 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.662 0.744 . . . . 73.21 110.893 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.78 158.75 55.87 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.718 2.279 . . . . 64.23 112.3 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -173.43 108.32 0.15 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.142 -0.481 . . . . 73.24 110.958 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . 0.678 ' HA ' HG23 ' A' ' 287' ' ' THR . 10.5 tt0 -90.74 129.37 36.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 71.44 110.915 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -64.4 133.95 53.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 71.14 111.099 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -76.16 -12.65 60.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.43 . . . . 63.4 110.866 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . 0.56 HD22 ' N ' ' A' ' 282' ' ' ASN . 0.0 OUTLIER -175.54 -178.47 1.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 75.11 110.963 -179.964 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -58.66 -26.24 63.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.258 -0.428 . . . . 72.31 110.874 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' ASP . . . . . 0.463 ' O ' HG22 ' A' ' 317' ' ' VAL . 22.5 t0 -70.26 -25.84 63.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 73.52 110.927 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . 0.473 ' OE1' HG23 ' A' ' 317' ' ' VAL . 68.6 mm-40 -100.04 167.28 10.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 73.44 110.851 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.627 HD23 ' CD2' ' A' ' 318' ' ' PHE . 28.2 tp -121.04 131.49 54.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.133 -0.485 . . . . 75.34 110.965 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.678 HG23 ' HA ' ' A' ' 279' ' ' GLU . 87.6 m -88.45 143.08 27.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 72.22 111.161 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' ILE . . . . . 0.684 HD12 HG13 ' A' ' 274' ' ' VAL . 51.0 pt -150.34 143.49 17.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.295 -0.412 . . . . 71.43 111.071 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 37.4 mtpt -112.31 140.4 47.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 50.0 110.897 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -52.01 133.32 32.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.197 -0.456 . . . . 71.21 110.915 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.59 -19.68 53.65 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.747 -0.74 . . . . 43.21 112.458 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -79.31 173.23 12.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.745 0.307 . . . . 61.03 110.867 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 66.8 mt -124.17 125.15 70.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 64.45 111.212 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . 0.677 HG11 ' CE2' ' A' ' 318' ' ' PHE . 84.2 t -107.99 134.02 51.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.179 -0.464 . . . . 62.43 111.084 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 39.0 m -84.76 111.14 19.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 54.34 111.103 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.56 HD11 ' HB3' ' A' ' 307' ' ' TRP . 8.7 tp -69.96 118.56 12.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 45.22 110.952 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 76.2 mt -106.46 -47.69 8.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 74.11 111.123 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -134.85 178.17 7.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.44 . . . . 50.12 110.842 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 25.0 mttp -141.36 112.95 7.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 74.54 110.957 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.94 165.25 0.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.441 . . . . 62.42 110.914 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.6 t -118.3 -69.34 0.86 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 54.5 110.804 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 2.0 mp -65.89 -13.89 16.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.184 -0.462 . . . . 75.32 111.088 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -98.8 70.31 1.86 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 73.42 110.79 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 7.3 p -51.35 123.96 3.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 71.21 111.129 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.39 23.31 34.55 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.707 -0.759 . . . . 71.22 112.466 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 56.5 m95 -140.09 135.49 32.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.797 0.332 . . . . 72.24 110.919 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' TRP . . . . . 0.76 ' CZ3' HD12 ' A' ' 325' ' ' LEU . 22.5 m0 -131.23 154.87 47.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.22 -0.446 . . . . 74.13 110.876 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -99.99 124.65 45.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 63.41 110.947 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -141.87 -167.09 11.14 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.66 -0.781 . . . . 64.43 112.478 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -140.43 147.4 39.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.897 0.379 . . . . 72.13 110.909 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.409 HD22 HG22 ' A' ' 288' ' ' ILE . 6.7 tp -157.65 132.18 8.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 74.33 110.839 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 57.36 30.2 18.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 61.21 110.877 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 79.15 18.64 74.03 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.749 -0.739 . . . . 70.23 112.482 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 25.5 mmm180 -122.69 115.1 21.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.745 0.307 . . . . 73.14 110.869 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 33.3 mtm180 -96.99 141.02 30.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 73.14 110.883 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -178.32 -162.54 28.23 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.772 -0.728 . . . . 72.34 112.48 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.473 HG23 ' OE1' ' A' ' 285' ' ' GLU . 27.5 m -111.64 155.68 12.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.873 0.368 . . . . 74.3 111.182 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' PHE . . . . . 0.677 ' CE2' HG11 ' A' ' 294' ' ' VAL . 5.4 p90 -159.13 156.53 26.37 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.684 0.754 . . . . 74.11 110.828 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 120.23 7.05 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.634 2.223 . . . . 73.23 112.385 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . 0.559 ' HA ' HG22 ' A' ' 323' ' ' VAL . 1.6 p-10 -59.12 -21.16 58.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.265 -0.425 . . . . 73.24 110.861 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' ASN . . . . . 0.425 ' O ' HD11 ' A' ' 275' ' ' ILE . 2.8 t-20 -71.53 -11.23 60.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 73.01 110.837 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -110.62 18.35 19.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 70.44 110.846 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . 0.559 HG22 ' HA ' ' A' ' 320' ' ' ASP . 18.9 m -149.3 149.52 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 64.14 111.148 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -115.49 116.86 28.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 75.24 110.899 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.76 HD12 ' CZ3' ' A' ' 307' ' ' TRP . 0.9 OUTLIER -64.94 128.17 34.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.252 -0.431 . . . . 73.31 110.99 179.848 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.4 HD13 ' CD1' ' A' ' 330' ' ' PHE . 20.2 mt -68.85 159.18 83.64 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.595 0.712 . . . . 74.51 110.904 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.61 167.7 23.49 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.8 2.333 . . . . 70.41 112.344 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 -16.93 37.47 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.63 2.22 . . . . 74.04 112.358 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.57 -34.56 30.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 71.12 110.84 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' PHE . . . . . 0.4 ' CD1' HD13 ' A' ' 326' ' ' LEU . 2.1 t80 -66.06 115.06 5.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.191 -0.459 . . . . 65.32 110.891 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -136.29 106.99 6.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 63.43 110.919 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 10.6 ttmm -83.14 -69.03 0.66 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 74.11 110.931 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' GLU . . . . . 0.629 ' C ' HG23 ' A' ' 266' ' ' THR . 18.0 tt0 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 64.2 110.914 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 14.4 m . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.899 0.381 . . . . 72.21 110.907 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -60.29 167.89 2.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 65.4 110.822 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -67.64 121.17 15.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.441 . . . . 73.34 110.917 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 6.6 t -110.61 98.49 7.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 73.12 110.871 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -118.5 153.25 34.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 72.41 110.94 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 6.9 m -55.41 121.93 10.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.279 -0.419 . . . . 72.41 111.099 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 10.9 ptpp? -88.52 -34.49 17.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 74.44 110.876 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 3.0 t -95.61 55.45 1.67 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 52.43 110.862 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 19.2 tttt -53.78 167.04 0.27 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.231 -0.44 . . . . 75.12 110.914 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -145.38 121.53 10.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.455 . . . . 54.32 110.856 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' TYR . . . . . 0.665 ' CB ' HD12 ' A' ' 326' ' ' LEU . 8.5 m-85 -111.15 143.85 41.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 65.11 110.896 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 22.6 m -128.29 149.36 50.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.107 -0.497 . . . . 72.11 110.86 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 7.9 tttm -108.03 117.42 34.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 75.24 110.92 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . 0.599 HG13 HD12 ' A' ' 288' ' ' ILE . 27.7 t -58.41 113.49 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 72.52 111.15 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 26.6 pt -87.09 -30.49 5.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 73.53 111.123 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -142.46 158.39 60.64 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.657 0.741 . . . . 75.14 110.88 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.68 158.69 56.19 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.642 2.228 . . . . 63.44 112.364 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -174.38 113.51 0.17 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.237 -0.438 . . . . 75.2 110.912 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . 0.689 ' HA ' HG23 ' A' ' 287' ' ' THR . 11.8 tt0 -93.61 120.54 34.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.09 -0.505 . . . . 73.5 110.891 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . 0.412 ' HB2' ' C ' ' A' ' 286' ' ' LEU . . . -51.83 113.49 1.01 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 60.22 111.078 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -54.58 -29.76 52.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 74.11 110.905 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -155.47 172.25 18.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 71.11 110.891 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -58.2 -22.77 53.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.154 -0.476 . . . . 73.44 110.86 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -70.0 -21.01 63.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 65.24 110.833 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -105.28 177.24 4.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 72.44 110.935 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.648 HD23 ' CD2' ' A' ' 318' ' ' PHE . 13.1 tp -122.61 135.95 54.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.466 . . . . 50.15 110.902 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.689 HG23 ' HA ' ' A' ' 279' ' ' GLU . 77.9 m -88.28 146.32 25.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.121 -0.49 . . . . 71.43 111.114 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' ILE . . . . . 0.599 HD12 HG13 ' A' ' 274' ' ' VAL . 47.6 pt -150.28 143.89 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 74.01 111.189 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 33.8 mtmt -117.53 140.9 49.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 63.14 110.906 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 -51.92 135.03 31.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.232 -0.44 . . . . 45.35 110.857 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 93.82 -23.64 29.94 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.721 -0.752 . . . . 63.54 112.469 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -76.55 171.3 14.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.832 0.348 . . . . 65.4 110.902 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 37.4 mm -122.67 125.78 73.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 33.43 111.137 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . 0.678 HG11 ' CE2' ' A' ' 318' ' ' PHE . 97.8 t -103.27 138.11 28.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 61.32 111.092 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 59.4 m -93.56 109.06 20.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 75.54 111.151 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.694 HD11 ' HB3' ' A' ' 307' ' ' TRP . 7.0 tp -69.89 124.84 25.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.271 -0.422 . . . . 72.42 110.894 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.532 HG22 ' ND2' ' A' ' 298' ' ' ASN . 40.5 mt -111.1 -47.37 6.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.449 . . . . 73.03 111.119 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . 0.532 ' ND2' HG22 ' A' ' 297' ' ' ILE . 11.6 m-80 -137.74 169.99 16.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 71.43 110.898 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 19.1 mttt -137.35 112.37 9.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.218 -0.446 . . . . 62.04 110.963 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -56.04 179.78 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.187 -0.46 . . . . 71.5 110.862 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 1.7 t -129.05 -69.53 0.7 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 64.15 110.876 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 60.1 mt -59.4 -18.43 14.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 73.02 111.146 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -99.02 62.11 1.28 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.463 . . . . 65.05 110.899 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 71.6 t -51.51 136.36 11.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.244 -0.435 . . . . 51.35 111.154 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 88.69 14.27 61.57 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.76 -0.733 . . . . 63.33 112.543 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 51.1 m95 -139.27 148.15 42.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.758 0.313 . . . . 74.11 110.925 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' TRP . . . . . 0.757 ' CZ3' HD12 ' A' ' 325' ' ' LEU . 10.2 m0 -139.36 148.23 42.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.294 -0.412 . . . . 73.13 110.947 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -94.29 119.08 32.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.283 -0.417 . . . . 73.33 110.849 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -139.22 -163.41 9.49 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.736 -0.745 . . . . 51.12 112.456 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . 0.405 ' HB2' HD11 ' A' ' 297' ' ' ILE . 61.6 tt0 -143.79 149.1 36.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.885 0.374 . . . . 73.43 110.916 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 4.9 tp -159.98 133.29 6.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.201 -0.454 . . . . 64.24 110.94 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 58.14 29.94 18.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 63.4 110.856 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 78.93 17.38 77.22 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.783 -0.722 . . . . 75.54 112.494 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 23.6 mmt85 -122.33 117.47 26.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.843 0.354 . . . . 74.25 110.874 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 27.3 mtm-85 -98.21 136.22 38.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 72.03 110.859 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -172.06 -158.42 16.15 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.737 -0.745 . . . . 43.3 112.504 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 24.3 m -117.72 148.02 20.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.881 0.372 . . . . 71.31 111.126 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' PHE . . . . . 0.678 ' CE2' HG11 ' A' ' 294' ' ' VAL . 9.8 p90 -149.49 156.97 39.34 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.689 0.757 . . . . 73.11 110.824 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 121.5 8.19 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.655 2.237 . . . . 72.1 112.314 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . 0.542 ' HA ' HG22 ' A' ' 323' ' ' VAL . 1.7 p-10 -61.75 -17.74 57.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 71.55 110.862 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -75.95 -5.82 48.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 64.23 110.88 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -119.76 23.61 11.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.12 -0.491 . . . . 65.24 110.879 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . 0.542 HG22 ' HA ' ' A' ' 320' ' ' ASP . 18.2 m -149.04 144.14 18.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.154 -0.475 . . . . 75.12 111.065 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 55.2 tttt -110.45 111.17 22.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 74.11 110.926 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.757 HD12 ' CZ3' ' A' ' 307' ' ' TRP . 1.0 OUTLIER -64.92 126.61 28.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 55.1 110.837 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.665 HD12 ' CB ' ' A' ' 271' ' ' TYR . 20.4 mt -60.79 159.26 27.18 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.541 0.686 . . . . 73.14 110.958 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.83 167.78 23.56 Favored 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 122.706 2.27 . . . . 74.33 112.323 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -18.6 36.81 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.689 2.259 . . . . 74.42 112.325 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.32 -42.75 20.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 74.54 110.929 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' PHE . . . . . 0.481 ' CD1' HD13 ' A' ' 326' ' ' LEU . 3.8 t80 -64.92 115.77 5.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.262 -0.426 . . . . 72.42 110.935 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -149.33 107.01 3.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.079 -0.51 . . . . 62.55 110.868 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 1.6 ttmm -64.88 -57.87 7.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.116 -0.493 . . . . 71.43 110.877 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 57.7 tt0 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 73.32 110.903 179.981 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 28.5 p . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.879 0.371 . . . . 75.11 110.913 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 7.4 ptm 39.44 41.71 0.75 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 73.34 110.851 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -80.08 145.9 32.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.27 -0.423 . . . . 75.12 110.913 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 5.6 t -113.69 -62.15 1.64 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 74.31 110.799 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 78.8 mmt-85 54.29 44.84 28.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.158 -0.474 . . . . 73.23 110.889 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 15.3 t -92.15 166.98 12.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 71.54 111.112 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 7.8 mptt -107.52 -27.91 10.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 73.23 110.852 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 13.7 p -88.1 80.85 7.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 74.03 110.865 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 22.7 mttm -107.85 179.33 4.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.127 -0.488 . . . . 73.43 110.887 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -142.4 131.61 23.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 74.04 110.884 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' TYR . . . . . 0.431 ' HB3' HD12 ' A' ' 326' ' ' LEU . 15.5 m-85 -130.85 154.1 48.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.211 -0.45 . . . . 73.3 110.955 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' CYS . . . . . 0.423 ' SG ' HD13 ' A' ' 296' ' ' LEU . 22.8 m -139.0 147.36 42.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.113 -0.494 . . . . 74.01 110.866 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 14.3 tttp -103.66 119.08 38.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.204 -0.453 . . . . 62.51 110.862 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . 0.552 HG13 HD12 ' A' ' 288' ' ' ILE . 53.1 t -60.3 109.13 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 64.24 111.076 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 26.5 pt -85.98 -30.63 6.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.12 -0.491 . . . . 72.01 111.095 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -138.33 159.97 65.78 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.659 0.742 . . . . 74.44 110.915 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 158.93 55.26 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.736 2.291 . . . . 73.15 112.352 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -172.81 106.02 0.16 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 71.31 111.018 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . 0.607 ' HA ' HG23 ' A' ' 287' ' ' THR . 19.5 tt0 -91.23 127.54 36.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 74.02 110.869 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . 0.502 ' HB1' ' HB2' ' A' ' 285' ' ' GLU . . . -63.86 113.04 3.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.476 . . . . 44.55 111.126 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -59.26 -26.07 64.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.264 -0.425 . . . . 65.42 110.95 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -149.48 168.7 22.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 71.3 110.875 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -57.02 -24.91 57.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.483 . . . . 45.42 110.859 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -70.01 -25.68 63.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.217 -0.447 . . . . 61.3 110.877 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . 0.502 ' HB2' ' HB1' ' A' ' 280' ' ' ALA . 70.1 mm-40 -95.02 166.47 11.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.171 -0.468 . . . . 72.44 110.903 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.646 HD23 ' CD2' ' A' ' 318' ' ' PHE . 21.5 tp -114.89 133.6 55.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 74.02 110.932 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.607 HG23 ' HA ' ' A' ' 279' ' ' GLU . 95.5 m -91.61 140.69 29.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 74.42 111.129 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' ILE . . . . . 0.654 HG21 HG21 ' A' ' 294' ' ' VAL . 50.4 pt -150.14 143.25 17.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 54.35 111.136 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 16.5 mmtm -114.53 141.03 48.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 74.24 110.877 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -52.02 122.54 8.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.446 . . . . 61.54 110.866 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 113.31 -22.82 14.81 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.8 -0.714 . . . . 31.11 112.448 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -86.46 160.4 19.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.708 0.289 . . . . 72.5 110.925 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 80.7 mt -110.94 129.4 66.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 62.5 111.087 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . 0.721 HG11 ' CE2' ' A' ' 318' ' ' PHE . 100.0 t -107.15 138.07 34.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.106 -0.497 . . . . 72.21 111.138 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 56.1 m -89.31 111.47 22.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.126 -0.488 . . . . 72.04 111.116 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.472 HD11 ' HB3' ' A' ' 307' ' ' TRP . 7.5 tp -69.98 118.54 12.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.276 -0.42 . . . . 72.13 110.91 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.67 HG21 HH21 ' A' ' 315' ' ' ARG . 64.4 mt -105.79 -48.62 8.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 71.24 111.092 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -133.53 178.17 7.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 61.45 110.892 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 24.2 mttt -141.32 113.02 7.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 71.43 110.885 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -49.9 161.77 0.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.457 . . . . 72.41 110.92 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.9 t -113.37 -69.02 0.89 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.222 -0.444 . . . . 51.24 110.869 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' ILE . . . . . 0.4 HG22 ' O ' ' A' ' 302' ' ' ILE . 35.1 mt -67.77 -12.51 15.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 73.35 111.166 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -97.52 69.31 2.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 55.11 110.879 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 6.9 p -51.17 123.21 2.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.244 -0.435 . . . . 55.11 111.18 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.5 19.43 48.98 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.755 -0.736 . . . . 65.32 112.549 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 49.2 m95 -136.29 136.39 39.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.742 0.306 . . . . 72.43 110.902 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' TRP . . . . . 0.757 ' CZ3' HD12 ' A' ' 325' ' ' LEU . 22.6 m0 -132.1 156.09 46.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 65.44 110.936 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -100.63 120.78 40.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.228 -0.442 . . . . 73.31 110.802 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -134.67 -168.71 11.76 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.782 -0.723 . . . . 71.42 112.509 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -141.74 141.4 33.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.868 0.366 . . . . 74.21 110.873 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.711 HD13 HG22 ' A' ' 294' ' ' VAL . 5.4 tp -140.81 118.52 11.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.133 -0.485 . . . . 74.01 110.879 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 58.55 32.74 22.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 71.32 110.85 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 91.88 -16.96 58.19 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.785 -0.721 . . . . 72.33 112.532 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.33 110.1 17.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.786 0.326 . . . . 72.35 110.898 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.67 HH21 HG21 ' A' ' 297' ' ' ILE . 48.3 mtp180 -98.66 133.73 42.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 73.35 110.911 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -169.16 -155.67 10.02 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.716 -0.754 . . . . 45.23 112.396 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.465 HG23 ' OE1' ' A' ' 285' ' ' GLU . 12.8 m -120.25 155.88 23.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.826 0.346 . . . . 73.53 111.206 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' PHE . . . . . 0.721 ' CE2' HG11 ' A' ' 294' ' ' VAL . 6.4 p90 -161.29 155.94 19.82 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.64 0.733 . . . . 74.24 110.853 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 117.85 5.33 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.676 2.251 . . . . 65.12 112.395 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . 0.541 ' HA ' HG22 ' A' ' 323' ' ' VAL . 3.2 t70 -59.19 -21.21 59.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.269 -0.423 . . . . 64.42 110.871 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -70.79 -10.76 60.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 71.42 110.819 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -111.14 19.27 18.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 65.2 110.856 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . 0.541 HG22 ' HA ' ' A' ' 320' ' ' ASP . 18.5 m -148.77 150.7 13.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 53.34 111.114 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 4.4 ttmt -110.9 115.09 28.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 54.22 110.903 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.757 HD12 ' CZ3' ' A' ' 307' ' ' TRP . 1.1 tt -64.91 120.32 12.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.228 -0.442 . . . . 65.33 110.91 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.711 HD13 ' CD1' ' A' ' 330' ' ' PHE . 20.3 mt -64.14 159.2 58.79 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.606 0.717 . . . . 72.22 110.899 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.7 167.74 23.49 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.623 2.215 . . . . 71.21 112.377 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 -16.6 37.74 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.694 2.263 . . . . 71.5 112.38 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -82.84 -30.5 28.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 64.11 110.884 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' PHE . . . . . 0.711 ' CD1' HD13 ' A' ' 326' ' ' LEU . 6.8 t80 -65.96 114.46 5.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 62.41 110.889 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -130.31 107.19 9.08 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.068 -0.515 . . . . 60.3 110.843 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 4.0 tmtt? -84.19 -45.84 12.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 72.25 110.902 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 15.5 pm0 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 71.13 110.867 179.966 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 45.7 m . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.814 0.34 . . . . 53.43 110.912 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 14.3 mmt -103.31 150.48 23.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 73.41 110.905 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -73.87 146.54 44.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.121 -0.491 . . . . 70.44 110.913 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 6.0 p -96.65 -47.66 5.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.293 -0.412 . . . . 74.42 110.872 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 27.2 mtm180 -121.41 168.31 11.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.13 -0.486 . . . . 72.41 110.825 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 15.0 t -111.98 170.01 8.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 74.42 111.114 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 33.8 mtpt -56.65 178.2 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.467 . . . . 75.24 110.87 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 69.3 m -60.84 101.09 0.13 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.234 -0.439 . . . . 44.12 110.815 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 14.6 pttm -110.26 -177.88 3.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 74.12 110.93 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -164.39 132.33 3.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.218 -0.446 . . . . 75.2 110.878 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' TYR . . . . . 0.445 ' CE1' HG23 ' A' ' 295' ' ' THR . 8.1 m-85 -124.63 156.23 37.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.147 -0.479 . . . . 65.24 110.89 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' CYS . . . . . 0.444 ' SG ' HD13 ' A' ' 296' ' ' LEU . 30.1 m -139.74 153.01 47.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 65.44 110.898 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -111.0 121.47 45.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 75.34 110.843 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 21.7 t -58.89 114.14 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.48 . . . . 41.12 111.118 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 25.7 pt -88.71 -30.47 5.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 73.34 111.095 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -139.72 158.85 67.17 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.679 0.752 . . . . 74.24 110.881 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 155.21 66.55 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.681 2.254 . . . . 75.24 112.339 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -174.59 108.63 0.12 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.212 -0.449 . . . . 65.45 110.935 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . 0.581 ' HA ' HG23 ' A' ' 287' ' ' THR . 50.5 tt0 -88.1 150.07 23.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.5 . . . . 65.13 110.837 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -80.36 114.27 19.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 74.01 111.164 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -63.68 -25.67 68.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 73.1 110.874 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -150.66 168.6 23.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 71.23 110.888 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -58.75 -25.58 63.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 62.22 110.897 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -69.95 -25.4 63.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.47 . . . . 74.52 110.89 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -94.93 167.41 11.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.447 . . . . 71.31 110.866 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.666 HD23 ' CD2' ' A' ' 318' ' ' PHE . 13.7 tp -115.27 136.52 53.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.464 . . . . 75.35 110.952 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.591 ' N ' HD12 ' A' ' 286' ' ' LEU . 95.7 m -90.71 138.36 31.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 73.5 111.11 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' ILE . . . . . 0.618 HG21 HG21 ' A' ' 294' ' ' VAL . 0.1 OUTLIER -147.29 145.55 19.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 63.54 111.129 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -119.53 139.33 52.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.108 -0.496 . . . . 74.13 110.829 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 69.7 tt0 -52.02 123.98 11.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 72.41 110.876 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 110.32 -20.54 25.54 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.756 -0.735 . . . . 64.14 112.55 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -85.13 175.57 8.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.801 0.334 . . . . 73.13 110.888 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.404 HG23 ' O ' ' A' ' 272' ' ' CYS . 41.0 mm -123.81 138.37 53.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 74.01 111.157 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . 0.725 HG11 ' CE2' ' A' ' 318' ' ' PHE . 66.3 t -120.57 138.0 52.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.172 -0.467 . . . . 71.14 111.122 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . 0.445 HG23 ' CE1' ' A' ' 271' ' ' TYR . 91.0 m -92.05 116.01 28.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 70.42 111.206 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.444 HD13 ' SG ' ' A' ' 272' ' ' CYS . 4.5 tp -69.82 112.79 6.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.302 -0.408 . . . . 54.0 110.893 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 62.3 mt -102.0 -28.26 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.439 . . . . 45.34 111.086 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -156.42 178.05 10.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.214 -0.448 . . . . 65.33 110.901 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 29.6 mttp -141.33 112.92 7.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 62.33 110.904 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -50.21 163.54 0.15 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 70.51 110.847 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.7 t -114.52 -69.24 0.87 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.461 . . . . 71.45 110.855 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 2.0 mp -66.57 -13.31 16.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.494 . . . . 71.0 111.151 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -96.42 70.66 2.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.139 -0.482 . . . . 62.21 110.842 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 60.4 t -51.38 120.85 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 73.12 111.183 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.65 20.53 43.74 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.74 -0.743 . . . . 70.34 112.497 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 39.1 m95 -135.4 135.84 40.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.772 0.32 . . . . 63.41 110.898 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' TRP . . . . . 0.755 ' CZ3' HD12 ' A' ' 325' ' ' LEU . 23.5 m0 -130.85 157.32 43.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 74.34 110.871 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -101.43 116.13 32.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 44.41 110.888 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -130.08 -173.1 13.29 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.734 -0.746 . . . . 63.34 112.485 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -136.57 141.29 43.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.86 0.362 . . . . 74.43 110.848 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 293' ' ' ILE . 5.5 tp -141.97 121.26 13.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.127 -0.488 . . . . 72.23 110.901 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 55.06 33.11 19.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 74.21 110.866 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 92.09 -16.59 59.26 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.714 -0.755 . . . . 65.11 112.487 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -82.99 109.23 16.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.857 0.36 . . . . 73.03 110.845 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.33 125.85 46.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.484 . . . . 71.15 110.904 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -163.43 -158.99 10.23 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.76 -0.734 . . . . 72.35 112.521 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 6.6 m -114.19 156.7 15.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.86 0.362 . . . . 62.31 111.137 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' PHE . . . . . 0.725 ' CE2' HG11 ' A' ' 294' ' ' VAL . 6.1 p90 -163.67 156.05 15.3 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.645 0.736 . . . . 64.13 110.869 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 117.71 5.25 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.659 2.239 . . . . 73.02 112.326 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . 0.556 ' HA ' HG22 ' A' ' 323' ' ' VAL . 2.9 t70 -58.34 -22.04 51.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.259 -0.428 . . . . 63.11 110.843 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -69.27 -11.78 61.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 73.13 110.987 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -109.18 17.04 22.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.472 . . . . 63.22 110.874 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . 0.556 HG22 ' HA ' ' A' ' 320' ' ' ASP . 18.4 m -148.81 150.58 13.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.144 -0.48 . . . . 64.43 111.173 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -112.09 119.28 37.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.223 -0.444 . . . . 65.1 110.872 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.755 HD12 ' CZ3' ' A' ' 307' ' ' TRP . 0.6 OUTLIER -64.89 116.29 6.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.226 -0.443 . . . . 71.44 110.857 179.938 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 21.2 mt -65.01 159.06 67.59 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.608 0.718 . . . . 75.23 110.916 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 167.74 23.64 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.645 2.23 . . . . 75.12 112.334 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -28.0 25.69 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.651 2.234 . . . . 63.23 112.325 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -66.56 -27.26 67.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.247 -0.433 . . . . 75.23 110.886 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -66.81 115.47 6.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 74.24 110.856 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -134.6 106.96 7.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 64.35 110.899 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -108.02 -48.78 3.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 73.12 110.916 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 70.33 110.898 179.981 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 23.8 p . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.843 0.354 . . . . 45.53 110.866 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 3.9 mmt -125.58 69.55 1.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 71.24 110.889 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -116.95 63.52 0.72 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.274 -0.421 . . . . 55.24 110.897 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 4.8 t -117.8 157.48 26.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 71.31 110.856 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 76.5 mtt-85 -87.38 173.54 9.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.095 -0.502 . . . . 73.24 110.836 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 14.0 m -81.3 136.75 35.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 73.1 111.087 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.62 -178.48 5.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 54.42 110.873 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 22.6 t 55.12 26.88 8.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 72.31 110.848 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 6.2 ptpp? -94.34 -169.93 2.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 63.44 110.903 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -154.24 143.7 21.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.184 -0.462 . . . . 73.21 110.882 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' TYR . . . . . 0.663 ' CE1' HG23 ' A' ' 295' ' ' THR . 8.9 m-85 -133.5 152.94 51.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.207 -0.452 . . . . 74.4 110.932 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 34.4 m -139.98 147.93 41.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.093 -0.503 . . . . 44.11 110.941 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 33.3 tttt -102.99 121.98 43.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 71.41 110.908 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . 0.42 HG21 ' HB ' ' A' ' 288' ' ' ILE . 46.9 t -62.22 110.99 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 54.05 111.123 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 26.8 pt -85.52 -32.82 7.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 72.42 111.139 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -135.95 158.0 74.78 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.629 0.728 . . . . 61.14 110.918 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 150.17 68.13 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.715 2.277 . . . . 72.31 112.327 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -171.17 106.06 0.24 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.235 -0.439 . . . . 70.03 110.963 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . 0.772 ' HA ' HG23 ' A' ' 287' ' ' THR . 0.3 OUTLIER -93.03 147.01 23.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.073 -0.512 . . . . 75.53 110.851 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . 0.545 ' HB1' ' HB2' ' A' ' 285' ' ' GLU . . . -82.04 124.56 29.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 71.44 111.091 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -72.31 -32.1 66.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 73.23 110.899 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -137.36 172.35 13.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 64.23 110.929 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -62.22 -17.91 59.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 71.3 110.824 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' ASP . . . . . 0.563 ' O ' HG22 ' A' ' 317' ' ' VAL . 13.9 t0 -75.57 -19.39 59.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.241 -0.436 . . . . 72.45 110.838 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . 0.545 ' HB2' ' HB1' ' A' ' 280' ' ' ALA . 2.0 mp0 -105.62 164.1 12.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.224 -0.444 . . . . 70.05 110.868 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.577 HD23 ' CD2' ' A' ' 318' ' ' PHE . 14.6 tp -115.47 135.61 53.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.158 -0.473 . . . . 64.54 110.899 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.772 HG23 ' HA ' ' A' ' 279' ' ' GLU . 46.2 m -88.31 141.42 28.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 55.03 111.12 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' ILE . . . . . 0.561 HG21 HG21 ' A' ' 294' ' ' VAL . 33.6 pt -150.09 139.66 15.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 60.41 111.104 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 29.2 mttm -109.99 138.31 46.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 73.34 110.867 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -51.65 126.85 18.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 75.11 110.922 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 107.15 -23.51 27.05 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.657 -0.782 . . . . 72.45 112.476 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -84.99 160.44 20.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.763 0.316 . . . . 74.32 110.873 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 35.1 mm -110.82 128.92 66.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.16 -0.473 . . . . 73.32 111.07 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . 0.732 HG11 ' CE2' ' A' ' 318' ' ' PHE . 94.5 t -103.51 138.02 29.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.103 -0.499 . . . . 61.52 111.131 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . 0.663 HG23 ' CE1' ' A' ' 271' ' ' TYR . 59.8 m -87.48 110.57 20.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 74.11 111.212 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.524 HD11 ' HB3' ' A' ' 307' ' ' TRP . 7.6 tp -70.01 116.07 9.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 63.43 110.904 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 54.4 mt -102.46 -47.59 11.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 72.32 111.177 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -135.29 178.21 7.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 61.42 110.966 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 23.3 mttt -141.15 112.88 7.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 64.12 110.859 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -49.98 160.49 0.33 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 72.3 110.849 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.7 t -113.09 -69.01 0.89 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.237 -0.438 . . . . 54.03 110.858 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 1.9 mp -66.72 -13.24 16.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.475 . . . . 75.42 111.103 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.66 69.78 1.88 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.192 -0.458 . . . . 74.54 110.85 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 88.0 t -51.43 124.24 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.443 . . . . 63.22 111.095 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.41 19.12 50.73 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.703 -0.761 . . . . 72.31 112.539 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 46.4 m95 -136.02 135.21 39.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.781 0.325 . . . . 73.33 110.881 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 307' ' ' TRP . . . . . 0.758 ' CZ3' HD12 ' A' ' 325' ' ' LEU . 23.4 m0 -131.19 154.94 47.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 64.21 110.967 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -99.13 118.31 35.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.291 -0.413 . . . . 61.44 110.877 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -130.08 -171.83 13.01 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.824 -0.703 . . . . 72.3 112.556 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -140.71 144.24 35.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.895 0.379 . . . . 74.25 110.851 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.422 HD13 HG22 ' A' ' 294' ' ' VAL . 2.3 tp -160.04 135.45 8.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 72.34 110.886 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 59.52 29.99 19.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.13 -0.486 . . . . 53.23 110.951 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 77.87 10.05 86.5 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.7 -0.762 . . . . 70.15 112.536 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -115.41 111.82 21.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.818 0.342 . . . . 72.12 110.861 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 10.3 ttp85 -96.63 124.32 40.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 72.4 110.832 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -154.9 -157.09 8.03 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.779 -0.724 . . . . 62.34 112.511 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.563 HG22 ' O ' ' A' ' 284' ' ' ASP . 20.2 m -118.87 154.02 21.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.833 0.349 . . . . 63.24 111.185 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 318' ' ' PHE . . . . . 0.732 ' CE2' HG11 ' A' ' 294' ' ' VAL . 7.2 p90 -160.52 155.82 21.43 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.629 0.728 . . . . 73.42 110.899 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 117.91 5.36 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.724 2.283 . . . . 71.22 112.339 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . 0.557 ' HA ' HG22 ' A' ' 323' ' ' VAL . 3.1 t70 -59.12 -21.21 58.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 72.04 110.871 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -68.92 -12.11 61.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 63.52 110.885 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -108.81 16.56 22.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 74.42 110.816 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . 0.557 HG22 ' HA ' ' A' ' 320' ' ' ASP . 18.0 m -148.66 150.82 13.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.442 . . . . 74.2 111.134 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -109.75 118.6 36.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 73.14 110.936 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.758 HD12 ' CZ3' ' A' ' 307' ' ' TRP . 1.2 tt -64.97 121.13 13.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.441 . . . . 63.53 110.96 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.736 HD13 ' CD1' ' A' ' 330' ' ' PHE . 20.3 mt -66.57 159.32 74.61 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.631 0.729 . . . . 63.42 110.896 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.83 167.72 23.73 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.634 2.223 . . . . 72.54 112.358 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.67 -16.6 38.01 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.757 2.305 . . . . 64.43 112.342 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -82.65 -29.4 30.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 72.44 110.832 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 330' ' ' PHE . . . . . 0.736 ' CD1' HD13 ' A' ' 326' ' ' LEU . 3.3 t80 -66.19 115.49 6.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.46 . . . . 55.13 110.899 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -139.67 107.02 5.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.133 -0.485 . . . . 72.1 110.866 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 14.2 mtpp -91.7 -74.39 0.51 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.123 -0.49 . . . . 74.52 110.91 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 64.41 110.88 179.938 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 55.2 m . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.853 0.359 . . . . 73.33 110.849 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.41 -22.34 53.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 44.2 110.869 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 58.7 58.94 3.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.218 -0.446 . . . . 73.02 110.829 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 4.2 m -106.63 -30.67 8.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 64.11 110.892 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 58.5 mtm180 -70.17 110.65 5.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 75.42 110.86 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -139.62 141.21 37.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.129 -0.487 . . . . 62.14 111.185 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.48 133.68 55.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 71.23 110.936 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 6.3 t 60.0 33.25 21.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 74.14 110.793 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 2.4 tttm -58.13 176.85 0.14 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.122 -0.49 . . . . 71.43 110.957 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -139.04 120.93 15.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.269 -0.423 . . . . 74.04 110.859 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' TYR . . . . . 0.65 ' HB3' HD12 ' A' ' 326' ' ' LEU . 12.2 m-85 -117.16 153.08 33.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.248 -0.433 . . . . 73.5 110.884 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' CYS . . . . . 0.45 ' O ' HG23 ' A' ' 293' ' ' ILE . 22.9 m -136.66 148.43 47.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.084 -0.507 . . . . 52.13 110.883 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 39.1 tttt -106.47 123.41 48.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.172 -0.467 . . . . 75.12 110.964 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 21.4 t -61.57 114.12 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 62.34 111.1 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 28.1 pt -85.88 -30.02 6.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 74.23 111.101 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -144.03 157.98 56.43 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.578 0.704 . . . . 74.11 110.905 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 154.03 67.99 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.624 2.216 . . . . 65.01 112.349 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -172.92 111.74 0.22 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 74.3 110.921 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . 0.784 ' HA ' HG23 ' A' ' 287' ' ' THR . 7.2 tm-20 -92.36 131.02 37.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.118 -0.492 . . . . 73.51 110.933 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -57.54 119.32 6.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 51.42 111.148 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.46 -25.79 68.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 71.1 110.861 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -154.63 172.77 17.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.25 -0.432 . . . . 51.23 110.94 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -58.48 -25.65 62.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 75.41 110.855 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.35 -25.73 62.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.213 -0.449 . . . . 72.23 110.799 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -94.88 166.97 11.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 71.14 110.941 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.681 HD23 ' CD2' ' A' ' 318' ' ' PHE . 12.9 tp -116.94 135.64 53.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.448 . . . . 64.01 110.967 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.784 HG23 ' HA ' ' A' ' 279' ' ' GLU . 60.1 m -86.92 146.69 26.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 72.34 111.172 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 31.1 pt -150.35 137.89 13.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 65.54 111.13 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -111.28 139.24 46.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 63.44 110.896 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -51.94 135.87 29.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 75.04 110.878 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 92.9 -22.37 34.44 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.766 -0.73 . . . . 44.22 112.527 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -77.08 178.32 7.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.783 0.325 . . . . 71.21 110.858 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.45 HG23 ' O ' ' A' ' 272' ' ' CYS . 51.2 mt -130.09 125.81 60.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.151 -0.477 . . . . 73.53 111.161 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . 0.652 HG11 ' CE2' ' A' ' 318' ' ' PHE . 21.5 t -101.4 138.08 26.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.154 -0.476 . . . . 61.45 111.153 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 37.9 m -92.49 110.68 22.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 65.24 111.102 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.428 HD11 ' HB3' ' A' ' 307' ' ' TRP . 4.7 tp -69.89 121.48 17.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 63.42 110.936 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.573 HG22 ' ND2' ' A' ' 298' ' ' ASN . 62.7 mt -110.13 -37.3 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 62.5 111.162 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . 0.573 ' ND2' HG22 ' A' ' 297' ' ' ILE . 16.6 m-80 -150.08 170.53 18.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.484 . . . . 75.1 110.928 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 15.8 mttt -137.3 112.34 9.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 73.14 110.923 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -56.0 179.76 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.239 -0.437 . . . . 60.2 110.887 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 1.7 t -128.99 -69.41 0.71 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 72.2 110.861 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 42.0 mm -59.83 -18.0 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 73.3 111.153 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -99.44 61.77 1.2 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 53.31 110.845 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 62.5 t -51.35 136.53 10.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.464 . . . . 62.21 111.197 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 88.62 14.46 61.44 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.793 -0.718 . . . . 74.41 112.477 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 52.4 m95 -139.7 148.67 42.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.785 0.326 . . . . 74.24 110.869 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 307' ' ' TRP . . . . . 0.6 ' CZ3' HD12 ' A' ' 325' ' ' LEU . 10.3 m0 -139.12 148.66 43.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.47 . . . . 71.54 110.919 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -94.62 122.27 37.05 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.217 -0.447 . . . . 73.41 110.887 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -144.55 -164.43 10.53 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.781 -0.723 . . . . 61.21 112.49 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -142.37 148.2 37.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.87 0.366 . . . . 55.51 110.884 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 3.9 tp -159.02 130.15 6.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.474 . . . . 74.41 110.946 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 58.97 30.01 19.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.277 -0.42 . . . . 61.04 110.911 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 82.8 2.51 90.66 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.774 -0.727 . . . . 53.23 112.427 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -105.61 121.31 43.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.825 0.345 . . . . 73.44 110.897 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 55.1 mtm180 -105.65 133.74 49.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 74.33 110.806 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -171.93 -151.15 7.61 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.712 -0.756 . . . . 71.13 112.446 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 33.7 m -124.25 145.79 30.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.868 0.366 . . . . 72.13 111.14 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 318' ' ' PHE . . . . . 0.681 ' CD2' HD23 ' A' ' 286' ' ' LEU . 18.2 p90 -144.56 157.01 56.41 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.644 0.735 . . . . 74.35 110.877 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 121.73 8.41 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.678 2.252 . . . . 74.45 112.375 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . 0.526 ' HA ' HG22 ' A' ' 323' ' ' VAL . 1.6 p-10 -62.2 -17.32 57.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 61.22 110.888 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -76.61 -5.23 46.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.115 -0.493 . . . . 72.43 110.813 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -121.01 24.5 10.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 74.41 110.849 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . 0.526 HG22 ' HA ' ' A' ' 320' ' ' ASP . 17.5 m -148.61 147.39 16.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.175 -0.466 . . . . 71.3 111.105 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -114.07 114.35 26.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.474 . . . . 73.43 110.95 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.6 HD12 ' CZ3' ' A' ' 307' ' ' TRP . 0.8 OUTLIER -64.99 125.65 25.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.187 -0.461 . . . . 74.52 110.915 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.65 HD12 ' HB3' ' A' ' 271' ' ' TYR . 21.5 mt -67.94 159.02 81.66 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.58 0.705 . . . . 72.45 110.901 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.84 167.79 23.52 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.607 2.204 . . . . 73.43 112.33 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.9 -16.93 37.18 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.684 2.256 . . . . 62.05 112.255 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -85.17 -43.03 14.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.281 -0.418 . . . . 50.3 110.879 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 330' ' ' PHE . . . . . 0.43 ' CD1' HD13 ' A' ' 326' ' ' LEU . 4.5 t80 -69.16 116.06 9.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 73.22 110.876 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -147.21 106.99 3.95 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.117 -0.492 . . . . 72.21 110.884 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -59.87 -54.81 41.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 52.41 110.919 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 61.31 110.854 179.969 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 3.3 m . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.849 0.357 . . . . 71.41 110.884 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 14.5 mmt 53.94 36.37 24.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.47 . . . . 51.44 110.887 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -77.96 -27.75 49.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 52.24 110.895 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 62.5 m -82.17 93.2 7.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 64.43 110.842 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.26 -26.14 13.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.472 . . . . 70.24 110.882 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 28.8 m -62.13 114.3 3.35 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.198 -0.456 . . . . 75.52 111.085 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.04 -28.21 8.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 65.13 110.895 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 15.2 p -90.62 49.83 1.73 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 73.32 110.857 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.57 178.96 7.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 74.45 110.851 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -165.56 123.07 1.51 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 70.13 110.851 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' TYR . . . . . 0.555 ' HB3' HD12 ' A' ' 326' ' ' LEU . 12.5 m-85 -110.65 137.8 47.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.173 -0.467 . . . . 73.4 110.962 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 25.3 m -126.92 145.61 50.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.148 -0.478 . . . . 64.14 110.923 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 17.6 ttpt -103.65 127.78 51.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 51.42 110.892 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . 0.631 HG13 HD12 ' A' ' 288' ' ' ILE . 21.5 t -61.58 114.42 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.29 -0.414 . . . . 61.21 111.076 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 0.538 HD11 ' O ' ' A' ' 321' ' ' ASN . 34.4 pt -88.97 -27.06 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 45.0 111.128 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -145.94 159.25 47.22 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.635 0.731 . . . . 74.45 110.853 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 151.94 68.89 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.706 2.27 . . . . 63.43 112.276 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -166.41 111.47 0.8 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 75.34 110.916 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . 0.639 ' HA ' HG23 ' A' ' 287' ' ' THR . 42.3 tt0 -94.88 129.01 42.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 73.24 110.887 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -63.41 113.82 3.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 71.32 111.104 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -59.58 -26.44 65.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 74.13 110.899 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -150.7 170.25 19.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.221 -0.445 . . . . 51.01 110.842 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -56.57 -25.95 53.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 74.33 110.829 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -70.08 -25.86 63.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 72.31 110.851 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . 0.426 ' OE1' HG23 ' A' ' 317' ' ' VAL . 46.5 mm-40 -94.96 164.66 12.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 73.21 110.9 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.665 HD13 ' HG3' ' A' ' 314' ' ' ARG . 14.4 tp -116.41 136.71 52.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.09 -0.505 . . . . 75.45 110.893 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.639 HG23 ' HA ' ' A' ' 279' ' ' GLU . 85.1 m -92.59 144.86 24.91 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.151 -0.477 . . . . 54.35 111.132 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' ILE . . . . . 0.631 HD12 HG13 ' A' ' 274' ' ' VAL . 48.4 pt -150.37 142.9 17.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 54.43 111.143 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 31.8 mtpt -112.38 141.04 46.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.153 -0.476 . . . . 72.32 110.931 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -51.95 131.56 31.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 74.3 110.851 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 99.96 -22.22 41.22 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.702 -0.761 . . . . 63.33 112.438 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -76.12 178.12 6.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.757 0.313 . . . . 60.12 110.874 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 81.2 mt -133.02 122.1 45.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 72.24 111.179 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . 0.745 HG11 ' CE2' ' A' ' 318' ' ' PHE . 90.1 t -105.66 138.1 32.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 63.13 111.149 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 52.3 m -87.77 114.34 24.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 63.4 111.136 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.404 HD11 ' HB3' ' A' ' 307' ' ' TRP . 5.5 tp -70.01 112.43 6.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.258 -0.428 . . . . 65.35 110.909 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 61.2 mt -101.43 -29.03 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.107 -0.497 . . . . 62.14 111.128 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -155.69 178.08 10.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.444 . . . . 41.43 110.9 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 27.7 mttp -141.33 112.97 7.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 71.04 110.938 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -49.68 160.78 0.26 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.213 -0.449 . . . . 52.33 110.888 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.8 t -113.29 -68.97 0.89 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 50.12 110.897 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 31.0 mm -66.97 -12.86 15.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 60.22 111.109 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -97.17 70.81 2.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 70.13 110.947 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.412 HG13 ' O ' ' A' ' 304' ' ' VAL . 5.9 p -51.31 120.75 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 73.13 111.145 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.54 24.47 30.74 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.758 -0.734 . . . . 63.15 112.461 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 56.3 m95 -139.72 135.94 33.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.809 0.337 . . . . 72.23 110.913 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 307' ' ' TRP . . . . . 0.404 ' HB3' HD11 ' A' ' 296' ' ' LEU . 22.3 m0 -130.69 156.66 44.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 64.31 110.867 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -101.38 115.51 30.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.194 -0.457 . . . . 75.23 110.925 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -128.66 -172.64 13.23 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.755 -0.736 . . . . 51.53 112.503 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -141.32 140.43 33.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.861 0.362 . . . . 71.41 110.931 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.456 HD13 HG22 ' A' ' 294' ' ' VAL . 4.5 tp -145.69 128.94 16.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 73.14 110.838 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 56.8 29.88 16.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 61.4 110.816 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 87.52 -8.62 76.64 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.716 -0.754 . . . . 73.13 112.527 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 314' ' ' ARG . . . . . 0.665 ' HG3' HD13 ' A' ' 286' ' ' LEU . 4.3 tpt180 -93.08 109.01 20.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.722 0.296 . . . . 74.04 110.887 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 10.4 ttp85 -96.69 133.35 41.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 74.23 110.904 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -166.43 -158.87 11.47 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.669 -0.777 . . . . 70.11 112.41 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.426 HG23 ' OE1' ' A' ' 285' ' ' GLU . 19.2 m -116.76 154.47 18.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.883 0.373 . . . . 73.3 111.129 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 318' ' ' PHE . . . . . 0.745 ' CE2' HG11 ' A' ' 294' ' ' VAL . 5.5 p90 -159.79 157.07 25.57 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.621 0.724 . . . . 71.3 110.865 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 121.65 8.33 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.705 2.27 . . . . 62.02 112.348 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . 0.545 ' HA ' HG22 ' A' ' 323' ' ' VAL . 1.6 p-10 -58.35 -22.31 53.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 64.4 110.937 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 321' ' ' ASN . . . . . 0.538 ' O ' HD11 ' A' ' 275' ' ' ILE . 19.7 m120 -69.85 -15.78 63.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 75.43 110.863 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -104.36 15.62 27.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 70.4 110.859 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . 0.545 HG22 ' HA ' ' A' ' 320' ' ' ASP . 18.9 m -149.16 150.59 13.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 75.33 111.12 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 24.8 ttpt -125.35 125.75 43.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 74.23 110.895 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 2.5 mt -64.95 130.78 44.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 71.23 110.98 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.555 HD12 ' HB3' ' A' ' 271' ' ' TYR . 20.2 mt -56.51 159.24 6.87 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.592 0.711 . . . . 70.15 110.871 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 167.73 23.49 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.676 2.251 . . . . 74.32 112.35 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -17.1 37.79 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.657 2.238 . . . . 75.13 112.386 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -81.75 -33.9 30.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.197 -0.456 . . . . 65.25 110.893 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 330' ' ' PHE . . . . . 0.442 ' CD1' HD13 ' A' ' 326' ' ' LEU . 2.3 t80 -69.99 114.88 8.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 65.42 110.899 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -138.62 107.06 5.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 43.24 110.839 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 15.0 tptm -70.87 -74.0 0.16 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 70.34 110.83 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.261 -0.427 . . . . 71.12 110.891 -179.967 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 12.6 t . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.896 0.379 . . . . 65.34 110.834 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 3.5 mmm -133.84 151.8 51.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.12 -0.491 . . . . 75.15 110.913 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -85.28 -43.31 13.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 74.24 110.86 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 55.56 53.14 10.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.458 . . . . 72.52 110.842 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -124.39 133.09 53.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.106 -0.497 . . . . 73.35 110.837 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 96.1 m -96.23 -72.99 0.61 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.197 -0.456 . . . . 70.12 111.117 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 6.0 mmtm -164.93 -177.72 4.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 50.35 110.877 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 6.5 p -78.23 60.36 2.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 43.31 110.866 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 5.5 mmtp -126.23 161.78 26.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 75.23 110.9 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -142.5 134.91 27.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 54.0 110.833 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' TYR . . . . . 0.589 ' HB3' HD12 ' A' ' 326' ' ' LEU . 14.4 m-85 -130.46 143.09 50.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.211 -0.45 . . . . 73.55 110.922 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 22.1 m -133.04 149.37 52.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.116 -0.493 . . . . 74.33 110.887 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 15.5 tttp -103.89 121.75 43.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 74.11 110.935 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . 0.54 ' CG2' HG23 ' A' ' 294' ' ' VAL . 57.8 t -61.65 111.71 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 62.33 111.141 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 28.5 pt -84.1 -32.12 8.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 71.22 111.098 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -140.39 157.78 67.76 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.661 0.743 . . . . 73.1 110.927 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.81 159.23 54.13 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.695 2.264 . . . . 73.41 112.25 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -174.16 109.64 0.14 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 54.14 110.915 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . 0.624 ' HA ' HG23 ' A' ' 287' ' ' THR . 9.2 tt0 -89.33 139.47 30.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 70.32 110.829 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . 0.429 ' HB2' ' C ' ' A' ' 286' ' ' LEU . . . -87.5 121.42 29.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 63.42 111.042 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -60.22 -42.46 95.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 63.42 110.933 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -148.64 -174.66 4.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 44.45 110.89 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -57.98 -19.75 32.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 73.15 110.909 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' ASP . . . . . 0.455 ' O ' HG22 ' A' ' 317' ' ' VAL . 2.2 t70 -72.07 -8.39 54.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 53.51 110.882 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . 0.421 ' HB2' ' HB1' ' A' ' 280' ' ' ALA . 9.3 mp0 -132.61 158.91 41.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 74.01 110.855 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.648 HD23 ' CD2' ' A' ' 318' ' ' PHE . 17.0 tp -114.89 133.44 55.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 74.22 110.979 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.624 HG23 ' HA ' ' A' ' 279' ' ' GLU . 86.7 m -84.32 145.04 28.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 64.21 111.144 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' ILE . . . . . 0.419 HG22 HD22 ' A' ' 311' ' ' LEU . 38.6 pt -150.88 138.83 14.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 55.34 111.064 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 31.2 mttm -110.43 136.1 50.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.131 -0.486 . . . . 75.43 110.962 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' GLU . . . . . 0.402 ' HA ' HG12 ' A' ' 274' ' ' VAL . 34.0 tt0 -51.68 128.7 24.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.45 . . . . 71.31 110.877 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 105.26 -26.21 22.57 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.699 -0.762 . . . . 54.21 112.483 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -83.28 156.16 23.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.694 0.283 . . . . 64.54 110.934 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 56.6 mt -106.64 126.26 62.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.194 -0.457 . . . . 52.33 111.107 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . 0.714 HG11 ' CE2' ' A' ' 318' ' ' PHE . 62.1 t -96.11 138.13 22.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 70.44 111.077 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 56.2 m -91.1 109.43 20.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.16 -0.473 . . . . 72.24 111.145 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.469 HD11 ' HB3' ' A' ' 307' ' ' TRP . 4.2 tp -69.85 121.2 16.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.187 -0.46 . . . . 64.5 110.892 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.486 HD11 ' HB2' ' A' ' 310' ' ' GLU . 38.9 mt -107.93 -36.69 3.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.233 -0.44 . . . . 64.45 111.171 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . 0.421 ' ND2' HG22 ' A' ' 297' ' ' ILE . 18.3 m-80 -151.02 170.69 18.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.128 -0.487 . . . . 74.0 110.907 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 21.7 mttt -137.28 112.28 9.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 74.22 110.858 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -55.49 178.61 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.436 . . . . 75.32 110.891 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 1.7 t -128.04 -69.36 0.73 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.207 -0.452 . . . . 64.44 110.936 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 60.8 mt -59.71 -18.26 14.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 70.51 111.137 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.35 61.67 1.21 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.462 . . . . 63.53 110.919 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 54.9 t -51.44 136.8 10.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 74.02 111.119 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 88.75 14.17 61.61 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.721 -0.752 . . . . 72.43 112.533 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 52.2 m95 -139.68 149.04 43.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.729 0.3 . . . . 75.15 110.871 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 307' ' ' TRP . . . . . 0.61 ' CZ3' HD12 ' A' ' 325' ' ' LEU . 10.4 m0 -139.22 148.78 43.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 73.53 110.89 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -94.47 117.56 30.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 65.03 110.969 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -138.4 -168.87 11.42 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.711 -0.757 . . . . 54.1 112.509 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . 0.486 ' HB2' HD11 ' A' ' 297' ' ' ILE . 71.1 tt0 -138.49 148.1 43.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.834 0.35 . . . . 71.4 110.95 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.609 HD13 HG22 ' A' ' 294' ' ' VAL . 6.3 tp -158.6 129.55 6.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.19 -0.459 . . . . 64.55 110.953 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 58.94 30.0 19.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 60.41 110.864 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 84.47 -5.13 82.35 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.72 -0.752 . . . . 74.41 112.46 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -98.3 122.35 41.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.757 0.313 . . . . 73.1 110.915 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 63.0 mtm180 -106.97 132.03 53.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 73.22 110.835 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -168.04 -149.5 6.14 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.7 -0.762 . . . . 24.31 112.468 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.455 HG22 ' O ' ' A' ' 284' ' ' ASP . 18.7 m -127.17 146.45 33.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.896 0.379 . . . . 71.33 111.119 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 318' ' ' PHE . . . . . 0.714 ' CE2' HG11 ' A' ' 294' ' ' VAL . 14.3 p90 -144.95 157.37 54.43 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.656 0.741 . . . . 72.33 110.841 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.66 121.24 7.95 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.727 2.285 . . . . 71.11 112.344 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . 0.552 ' HA ' HG22 ' A' ' 323' ' ' VAL . 1.6 p-10 -60.66 -18.73 55.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 73.11 110.831 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -74.85 -6.7 50.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.481 . . . . 74.11 110.921 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -118.06 22.12 12.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 73.12 110.83 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . 0.552 HG22 ' HA ' ' A' ' 320' ' ' ASP . 17.5 m -149.02 145.12 18.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 74.42 111.15 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -111.19 117.38 33.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 64.33 110.919 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.61 HD12 ' CZ3' ' A' ' 307' ' ' TRP . 0.8 OUTLIER -64.87 125.47 24.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 51.23 110.932 179.943 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.589 HD12 ' HB3' ' A' ' 271' ' ' TYR . 20.3 mt -64.13 159.21 58.62 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.59 0.71 . . . . 52.14 110.936 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 167.7 23.63 Favored 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 122.741 2.294 . . . . 63.34 112.382 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 -15.99 37.56 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.693 2.262 . . . . 72.12 112.377 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -84.08 -42.9 15.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.457 . . . . 71.11 110.887 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 330' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -72.22 108.05 5.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 74.14 110.947 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -146.11 107.24 4.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 72.34 110.891 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 32.3 mttm -86.48 -74.47 0.42 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 63.33 110.843 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 72.12 110.869 -179.995 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.892 0.377 . . . . 54.12 110.86 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 10.6 mmt -113.79 176.55 4.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 65.42 110.908 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -116.8 26.69 9.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 72.35 110.832 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 53.9 p -139.69 -179.87 6.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 54.34 110.872 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 14.9 mmp_? -55.84 105.33 0.18 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.156 -0.474 . . . . 73.35 110.857 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 2.1 t -117.76 -40.53 3.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 63.32 111.163 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 30.6 mttp 52.38 33.1 12.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.454 . . . . 74.31 110.815 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 1.3 t -144.88 28.18 1.27 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.242 -0.435 . . . . 65.13 110.893 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -56.51 168.19 0.61 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.088 -0.506 . . . . 73.33 110.905 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -119.82 118.14 30.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.208 -0.451 . . . . 73.11 110.876 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' TYR . . . . . 0.703 ' CE1' HG23 ' A' ' 295' ' ' THR . 6.7 m-85 -124.1 156.61 36.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 50.34 110.917 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' CYS . . . . . 0.407 ' SG ' HD13 ' A' ' 296' ' ' LEU . 23.5 m -138.92 152.44 47.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.123 -0.489 . . . . 65.21 110.886 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt -108.21 126.67 53.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.141 -0.481 . . . . 74.22 110.916 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 38.9 t -63.21 109.32 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 72.15 111.107 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 30.0 pt -83.25 -31.53 8.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 75.4 111.14 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -140.84 159.2 63.22 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.654 0.74 . . . . 73.14 110.86 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 152.08 69.02 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.675 2.25 . . . . 54.53 112.318 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -174.38 105.96 0.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 65.12 110.839 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . 0.576 ' HA ' HG23 ' A' ' 287' ' ' THR . 1.4 mp0 -89.2 141.06 28.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.108 -0.496 . . . . 64.5 110.915 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -54.54 113.03 1.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 60.05 111.176 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -69.05 -26.45 64.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.303 -0.408 . . . . 75.44 110.945 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 18.9 m-80 -144.03 174.74 10.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.134 -0.485 . . . . 74.04 110.91 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -63.53 -26.13 68.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 75.31 110.854 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' ASP . . . . . 0.593 ' O ' HG22 ' A' ' 317' ' ' VAL . 14.6 m-20 -88.06 6.14 37.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 74.04 110.838 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -105.65 164.64 11.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.253 -0.43 . . . . 73.13 110.889 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.777 HD23 ' CD2' ' A' ' 318' ' ' PHE . 21.3 tp -115.75 131.23 57.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.491 . . . . 70.33 110.903 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.576 HG23 ' HA ' ' A' ' 279' ' ' GLU . 91.5 m -87.43 136.14 33.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 53.23 111.078 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' ILE . . . . . 0.478 HG21 HG21 ' A' ' 294' ' ' VAL . 0.1 OUTLIER -147.49 146.15 18.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 72.44 111.149 179.871 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 27.4 mtmm -120.64 145.98 46.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 72.14 110.945 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -52.0 131.82 31.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.27 -0.423 . . . . 73.14 110.847 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.03 -27.1 19.81 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.804 -0.712 . . . . 35.42 112.52 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -71.71 173.34 8.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.778 0.323 . . . . 73.02 110.839 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 28.5 mm -124.24 135.9 62.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 64.15 111.156 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . 0.634 HG11 ' CE2' ' A' ' 318' ' ' PHE . 19.5 t -111.69 132.43 60.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.247 -0.433 . . . . 62.24 111.067 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . 0.703 HG23 ' CE1' ' A' ' 271' ' ' TYR . 17.4 m -87.89 112.09 22.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.089 -0.505 . . . . 72.34 111.136 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.407 HD13 ' SG ' ' A' ' 272' ' ' CYS . 6.0 tp -69.59 119.69 14.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 74.4 110.977 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 58.9 mt -115.72 -25.18 3.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.283 -0.417 . . . . 53.43 111.095 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -158.29 176.84 11.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.014 0.435 . . . . 74.1 110.779 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 48.7 mttt -141.18 113.03 7.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.048 -0.524 . . . . 65.12 110.897 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.01 166.75 0.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 75.44 110.903 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.2 t -119.6 -69.35 0.85 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.241 -0.436 . . . . 64.3 110.919 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 36.0 mm -64.26 -14.72 16.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 71.11 111.133 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -96.51 74.47 2.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 72.34 110.848 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 58.9 t -51.37 117.36 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 71.01 111.129 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 88.89 29.68 17.32 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.793 -0.718 . . . . 45.24 112.477 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 58.8 m95 -140.67 135.05 31.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.68 0.276 . . . . 63.44 110.977 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 307' ' ' TRP . . . . . 0.726 ' CZ3' HD12 ' A' ' 325' ' ' LEU . 24.2 m0 -129.26 157.55 41.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.254 -0.43 . . . . 72.25 110.934 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -104.78 124.77 49.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.305 -0.407 . . . . 54.21 110.887 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -140.24 -164.82 10.05 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.706 -0.759 . . . . 51.54 112.451 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -142.94 143.68 32.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.915 0.388 . . . . 55.21 110.865 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.432 HD22 ' O ' ' A' ' 287' ' ' THR . 2.0 tp -146.56 122.77 10.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 61.23 110.959 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 58.55 29.94 19.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 73.15 110.892 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 89.61 -8.63 79.43 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.715 -0.755 . . . . 72.02 112.459 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 17.2 tpp180 -94.14 114.24 26.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.703 0.287 . . . . 75.53 110.913 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 36.7 mtm180 -98.86 138.19 36.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.202 -0.454 . . . . 73.44 110.828 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -171.93 -160.61 20.86 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.797 -0.716 . . . . 63.14 112.475 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 284' ' ' ASP . 32.6 m -118.36 154.0 20.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.857 0.36 . . . . 62.2 111.145 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 318' ' ' PHE . . . . . 0.777 ' CD2' HD23 ' A' ' 286' ' ' LEU . 26.0 p90 -156.04 156.34 30.31 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.639 0.733 . . . . 73.2 110.882 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 119.5 6.44 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.701 2.267 . . . . 63.23 112.351 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . 0.536 ' HA ' HG22 ' A' ' 323' ' ' VAL . 1.5 p-10 -60.89 -18.86 58.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.431 . . . . 73.33 110.888 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -74.55 -7.15 52.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.157 -0.474 . . . . 54.53 110.82 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -117.63 24.19 11.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 74.45 110.776 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . 0.536 HG22 ' HA ' ' A' ' 320' ' ' ASP . 18.1 m -148.89 153.13 11.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 44.43 111.122 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -116.8 113.39 22.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 64.12 110.957 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.726 HD12 ' CZ3' ' A' ' 307' ' ' TRP . 1.2 tt -65.1 126.48 28.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 72.33 110.906 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.459 HD13 ' CD1' ' A' ' 330' ' ' PHE . 20.3 mt -68.57 159.2 82.71 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.642 0.734 . . . . 72.24 110.855 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 167.73 23.52 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.701 2.267 . . . . 73.34 112.375 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 -16.6 37.34 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.694 2.263 . . . . 74.4 112.282 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -82.63 -28.35 30.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.219 -0.446 . . . . 64.34 110.861 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 330' ' ' PHE . . . . . 0.459 ' CD1' HD13 ' A' ' 326' ' ' LEU . 2.4 t80 -78.67 115.43 18.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.142 -0.481 . . . . 74.34 110.883 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -137.17 106.97 6.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.087 -0.506 . . . . 74.31 110.861 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.92 -73.73 0.09 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 70.51 110.864 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.284 -0.416 . . . . 75.4 110.877 179.969 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 3.0 p . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.91 0.386 . . . . 75.33 110.9 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 58.7 mtt -112.22 147.89 35.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 72.42 110.897 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -78.81 148.08 33.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 72.23 110.888 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 1.2 m -152.79 141.06 20.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 71.24 110.778 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -116.37 92.78 3.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.085 -0.507 . . . . 74.13 110.89 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . 0.617 HG22 ' H ' ' A' ' 268' ' ' SER . 95.2 m -60.62 -73.52 0.09 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.175 -0.466 . . . . 63.33 111.168 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 23.0 ttpt 54.3 38.98 30.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 71.31 110.889 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.617 ' H ' HG22 ' A' ' 266' ' ' THR . 58.7 m -135.73 31.05 3.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.265 -0.425 . . . . 44.12 110.801 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -124.47 -178.2 4.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.159 -0.473 . . . . 72.21 110.863 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -123.82 124.39 42.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 74.23 110.839 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 271' ' ' TYR . . . . . 0.485 ' CE1' HG23 ' A' ' 295' ' ' THR . 8.8 m-85 -129.26 150.99 50.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 74.22 110.857 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 26.4 m -139.19 150.7 45.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.058 -0.519 . . . . 64.43 110.911 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -107.77 122.92 47.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.447 . . . . 73.53 110.896 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . 0.458 HG11 ' C ' ' A' ' 289' ' ' LYS . 24.1 t -56.01 116.18 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.292 -0.413 . . . . 74.35 111.193 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 0.418 HG21 ' HB2' ' A' ' 324' ' ' LYS . 29.7 pt -97.95 -17.55 6.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 71.41 111.127 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -145.52 151.98 48.31 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.627 0.727 . . . . 71.53 110.903 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.67 151.52 69.62 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.655 2.237 . . . . 54.31 112.363 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -174.45 140.43 0.63 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.451 . . . . 73.14 110.932 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . 0.531 ' HA ' HG23 ' A' ' 287' ' ' THR . 49.5 tt0 -121.17 143.18 49.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.054 -0.521 . . . . 75.25 110.882 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -76.61 127.79 33.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 72.41 111.116 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -71.48 -25.82 62.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.242 -0.435 . . . . 74.13 110.878 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -155.75 177.54 11.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 51.1 110.887 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -56.94 -25.75 58.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.177 -0.465 . . . . 61.14 110.878 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' ASP . . . . . 0.449 ' O ' HG22 ' A' ' 317' ' ' VAL . 18.9 t0 -72.29 -24.85 61.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.474 . . . . 72.41 110.864 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . 0.482 ' OE2' HG23 ' A' ' 317' ' ' VAL . 19.8 mm-40 -94.97 163.5 13.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.172 -0.467 . . . . 62.52 110.895 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.616 HD23 ' CD2' ' A' ' 318' ' ' PHE . 20.3 tp -119.78 131.24 55.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.13 -0.486 . . . . 71.44 110.923 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.531 HG23 ' HA ' ' A' ' 279' ' ' GLU . 96.7 m -85.97 143.3 28.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.154 -0.475 . . . . 75.01 111.139 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' ILE . . . . . 0.461 HG21 HG21 ' A' ' 294' ' ' VAL . 47.9 pt -150.26 142.36 17.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 71.31 111.115 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . 0.458 ' C ' HG11 ' A' ' 274' ' ' VAL . 17.3 mmtp -122.07 144.73 48.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 64.54 110.897 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -51.5 128.81 23.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 74.31 110.863 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 101.43 -30.89 9.41 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.753 -0.737 . . . . 75.22 112.493 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -69.77 171.83 8.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.736 0.303 . . . . 73.53 110.917 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 67.4 mt -126.71 126.16 68.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 71.15 111.087 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . 0.71 HG11 ' CE2' ' A' ' 318' ' ' PHE . 64.6 t -104.37 138.21 30.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 74.02 111.135 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . 0.485 HG23 ' CE1' ' A' ' 271' ' ' TYR . 49.2 m -92.63 111.4 22.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.154 -0.475 . . . . 64.05 111.129 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.41 HD11 ' HB3' ' A' ' 307' ' ' TRP . 5.3 tp -69.82 122.28 18.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 71.42 110.937 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.55 HG22 HD22 ' A' ' 298' ' ' ASN . 67.6 mt -110.53 -39.8 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 73.01 111.124 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . 0.55 HD22 HG22 ' A' ' 297' ' ' ILE . 17.2 m-80 -145.71 171.67 14.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 65.55 110.872 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -136.09 111.87 9.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 72.1 110.899 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.08 177.5 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 71.42 110.938 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 1.9 t -126.46 -69.33 0.77 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 64.23 110.91 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 38.6 mm -62.64 -15.89 15.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 63.04 111.185 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.26 61.35 2.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 73.54 110.9 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 56.6 t -51.12 130.97 11.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 71.2 111.118 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.91 14.71 58.97 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.779 -0.724 . . . . 73.5 112.484 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 44.0 m95 -137.01 162.86 32.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.816 0.341 . . . . 73.21 110.872 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 307' ' ' TRP . . . . . 0.44 ' CZ3' HD12 ' A' ' 325' ' ' LEU . 5.0 m0 -151.0 156.44 41.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 70.31 110.866 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -102.66 119.06 38.17 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.246 -0.434 . . . . 73.33 110.903 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -140.55 -162.92 9.31 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.75 -0.738 . . . . 61.13 112.51 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -145.65 148.64 33.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.934 0.397 . . . . 65.03 110.834 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.438 HD23 ' O ' ' A' ' 287' ' ' THR . 14.5 tp -157.98 134.95 9.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.074 -0.512 . . . . 71.02 110.894 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 57.23 30.44 18.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 74.45 110.926 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 77.95 18.88 76.19 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.784 -0.722 . . . . 62.43 112.416 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 31.5 mmm-85 -124.99 121.01 33.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.867 0.365 . . . . 74.43 110.849 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 39.8 mtp180 -99.55 142.54 30.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 73.45 110.876 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -176.52 -160.06 23.09 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.793 -0.718 . . . . 71.54 112.523 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.482 HG23 ' OE2' ' A' ' 285' ' ' GLU . 29.5 m -115.51 151.07 17.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.923 0.392 . . . . 70.44 111.17 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 318' ' ' PHE . . . . . 0.71 ' CE2' HG11 ' A' ' 294' ' ' VAL . 10.5 p90 -154.69 155.77 30.83 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.64 0.733 . . . . 72.01 110.916 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 119.8 6.69 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.744 2.296 . . . . 64.11 112.31 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . 0.528 ' HA ' HG22 ' A' ' 323' ' ' VAL . 1.7 p-10 -61.06 -18.61 58.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.242 -0.435 . . . . 73.34 110.855 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 75.1 m-80 -74.88 -6.98 52.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 71.42 110.887 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -117.54 22.77 12.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 74.21 110.892 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . 0.528 HG22 ' HA ' ' A' ' 320' ' ' ASP . 18.3 m -148.82 144.28 18.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.464 . . . . 73.53 111.17 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . 0.418 ' HB2' HG21 ' A' ' 275' ' ' ILE . 52.6 tttt -109.45 116.95 32.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.464 . . . . 70.1 110.891 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.44 HD12 ' CZ3' ' A' ' 307' ' ' TRP . 0.6 OUTLIER -65.02 119.36 10.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 53.4 110.952 179.89 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.437 HD13 ' CG ' ' A' ' 330' ' ' PHE . 20.2 mt -66.61 159.22 75.46 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.615 0.722 . . . . 71.12 110.896 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 167.79 23.43 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.638 2.225 . . . . 64.13 112.408 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 -19.84 35.43 Favored 'Trans proline' 0 C--O 1.23 0.113 0 C-N-CA 122.707 2.271 . . . . 73.41 112.349 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.28 -33.19 49.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 74.41 110.93 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 330' ' ' PHE . . . . . 0.437 ' CG ' HD13 ' A' ' 326' ' ' LEU . 2.8 t80 -64.03 115.46 4.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 73.25 110.842 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -133.36 106.93 7.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 71.22 110.934 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.16 -46.83 8.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.183 -0.462 . . . . 71.32 110.907 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 21.5 pm0 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.253 -0.431 . . . . 72.14 110.871 179.985 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 1.3 t . . . . . 0 N--CA 1.458 -0.059 0 CA-C-O 120.892 0.377 . . . . 61.45 110.874 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 36.7 mtt -97.17 174.07 6.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.084 -0.507 . . . . 71.2 110.879 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -67.66 145.17 55.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 71.01 110.878 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 7.1 m -90.97 -58.96 2.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 70.22 110.81 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 47.6 ttp180 -94.51 123.48 37.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.108 -0.496 . . . . 72.23 110.866 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 3.7 m -113.97 141.15 47.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 72.32 111.154 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 36.0 mttt -76.25 -176.16 3.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 74.0 110.861 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 8.7 m -81.19 68.46 7.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 75.01 110.858 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 24.8 mtpt -102.58 -176.5 3.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.472 . . . . 72.0 110.905 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -163.18 154.11 16.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 72.14 110.845 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 271' ' ' TYR . . . . . 0.426 ' CZ ' HG23 ' A' ' 295' ' ' THR . 33.9 m-85 -142.85 147.19 35.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.452 . . . . 75.25 110.942 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 272' ' ' CYS . . . . . 0.446 ' SG ' HD22 ' A' ' 296' ' ' LEU . 23.7 m -135.26 149.22 49.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 73.23 110.85 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 47.4 tttt -103.49 115.17 30.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.181 -0.463 . . . . 75.31 110.886 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . 0.55 HG21 ' HB ' ' A' ' 288' ' ' ILE . 58.9 t -57.47 118.26 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.262 -0.426 . . . . 53.42 111.08 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 26.2 pt -93.42 -30.98 4.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.489 . . . . 62.15 111.13 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -136.56 159.4 70.63 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.642 0.734 . . . . 52.21 110.929 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 159.63 52.69 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.648 2.232 . . . . 62.31 112.367 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -172.76 110.02 0.21 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.27 -0.423 . . . . 72.33 110.948 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . 0.682 ' HA ' HG23 ' A' ' 287' ' ' THR . 34.0 tt0 -93.23 128.02 39.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 71.13 110.868 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -61.82 116.27 4.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 72.51 111.109 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -57.9 -26.73 62.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 74.31 110.99 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -152.43 173.87 14.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 61.23 110.949 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -58.78 -26.28 63.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 61.35 110.945 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -70.11 -24.92 63.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.1 -0.5 . . . . 65.13 110.856 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -95.07 167.32 11.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 75.01 110.865 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.636 HD23 ' CD2' ' A' ' 318' ' ' PHE . 15.1 tp -116.78 137.43 52.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 42.01 110.921 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.682 HG23 ' HA ' ' A' ' 279' ' ' GLU . 85.4 m -95.18 144.35 25.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 53.24 111.128 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' ILE . . . . . 0.651 HG21 HG21 ' A' ' 294' ' ' VAL . 41.8 pt -150.34 149.72 14.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 42.4 111.128 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -121.93 140.79 52.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 73.32 110.909 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 8.1 tm-20 -51.83 122.95 9.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 64.44 110.861 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 113.26 -23.16 14.33 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.726 -0.749 . . . . 15.41 112.466 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -88.42 152.14 22.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.817 0.341 . . . . 71.32 110.867 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 62.7 mt -104.55 123.65 58.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 71.34 111.147 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . 0.74 HG11 ' CE2' ' A' ' 318' ' ' PHE . 90.9 t -100.17 138.04 25.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 73.02 111.114 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . 0.426 HG23 ' CZ ' ' A' ' 271' ' ' TYR . 33.9 m -86.5 109.35 19.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.166 -0.47 . . . . 74.03 111.154 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.474 HD11 ' HB3' ' A' ' 307' ' ' TRP . 7.4 tp -69.86 117.76 11.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 70.01 110.904 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 69.0 mt -104.45 -48.41 9.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 73.21 111.086 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -134.38 178.13 7.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 41.23 110.895 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -141.46 112.77 7.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.157 -0.474 . . . . 73.31 110.91 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -50.56 165.77 0.09 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.229 -0.441 . . . . 72.41 110.805 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.8 t -115.69 -69.14 0.87 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.479 . . . . 74.04 110.864 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 2.0 mp -67.57 -12.61 15.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.434 . . . . 71.43 111.194 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.84 69.3 3.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 63.33 110.894 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 76.7 t -51.43 121.41 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 62.21 111.136 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.33 20.34 45.73 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.733 -0.746 . . . . 73.22 112.551 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 42.0 m95 -136.27 138.7 42.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.708 0.289 . . . . 75.13 110.909 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 307' ' ' TRP . . . . . 0.76 ' CZ3' HD12 ' A' ' 325' ' ' LEU . 19.5 m0 -134.3 157.19 46.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.454 . . . . 73.32 110.918 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -100.52 117.25 34.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.288 -0.415 . . . . 73.11 110.888 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -129.77 -170.13 12.67 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.768 -0.73 . . . . 62.24 112.505 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -143.83 146.82 33.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.864 0.364 . . . . 74.3 110.947 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.652 HD13 HG22 ' A' ' 294' ' ' VAL . 2.6 tp -155.77 132.27 10.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.181 -0.463 . . . . 73.22 110.92 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 56.81 29.86 16.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 72.32 110.854 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 84.76 -6.8 76.73 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.747 -0.74 . . . . 73.1 112.485 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 314' ' ' ARG . . . . . 0.543 ' HG3' HD13 ' A' ' 286' ' ' LEU . 14.1 tpp180 -96.09 108.6 21.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.773 0.321 . . . . 62.12 110.857 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 8.9 ttp180 -96.61 129.75 43.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 73.33 110.952 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -161.34 -157.96 9.11 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.78 -0.724 . . . . 70.53 112.507 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 15.8 m -117.25 154.59 18.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.843 0.354 . . . . 74.52 111.119 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 318' ' ' PHE . . . . . 0.74 ' CE2' HG11 ' A' ' 294' ' ' VAL . 7.6 p90 -162.19 155.83 17.9 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.648 0.737 . . . . 72.23 110.904 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.85 118.5 5.72 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.699 2.266 . . . . 72.14 112.293 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . 0.579 ' HA ' HG22 ' A' ' 323' ' ' VAL . 3.0 t70 -59.67 -20.32 55.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 71.41 110.83 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -68.4 -12.65 61.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 44.35 110.887 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -107.96 14.15 25.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 71.25 110.856 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . 0.579 HG22 ' HA ' ' A' ' 320' ' ' ASP . 17.7 m -148.56 145.21 18.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.487 . . . . 71.41 111.09 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 21.6 ttpp -106.52 118.77 37.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 65.34 110.958 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.76 HD12 ' CZ3' ' A' ' 307' ' ' TRP . 1.9 tt -64.98 132.0 48.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 63.4 110.934 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.566 HD13 ' CD1' ' A' ' 330' ' ' PHE . 20.4 mt -68.92 159.23 83.6 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.572 0.701 . . . . 73.11 110.936 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 167.67 23.84 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.715 2.276 . . . . 74.41 112.37 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.7 -17.29 37.95 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.709 2.272 . . . . 60.44 112.298 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -81.07 -30.19 34.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.303 -0.408 . . . . 70.21 110.888 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 330' ' ' PHE . . . . . 0.566 ' CD1' HD13 ' A' ' 326' ' ' LEU . 4.0 t80 -72.57 109.38 6.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 75.54 110.888 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -135.92 107.45 6.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 74.32 110.929 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.37 -60.96 2.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 73.13 110.844 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.213 -0.449 . . . . 74.43 110.909 179.975 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 93.2 p . . . . . 0 C--O 1.23 0.059 0 CA-C-O 120.88 0.371 . . . . 72.14 110.888 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 24.3 mmm -118.49 65.38 0.76 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 61.41 110.869 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -58.34 135.27 57.14 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.236 -0.438 . . . . 61.53 110.868 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 7.6 t -144.74 122.78 12.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 54.52 110.865 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 14.6 mmp_? -98.57 163.25 12.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.128 -0.487 . . . . 73.13 110.843 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . 0.407 HG23 ' HG3' ' A' ' 269' ' ' LYS . 14.7 t -106.09 143.24 34.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 62.11 111.122 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -97.17 -26.35 14.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 65.34 110.903 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 11.4 p -79.3 62.95 3.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 74.55 110.832 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.407 ' HG3' HG23 ' A' ' 266' ' ' THR . 73.8 mttt -101.47 -177.79 3.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.111 -0.495 . . . . 74.41 110.93 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -137.15 134.3 36.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 75.1 110.862 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 271' ' ' TYR . . . . . 0.536 ' CB ' HD12 ' A' ' 326' ' ' LEU . 10.3 m-85 -132.33 139.61 48.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 74.43 110.903 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 272' ' ' CYS . . . . . 0.508 ' SG ' HD13 ' A' ' 296' ' ' LEU . 36.0 m -127.76 148.61 50.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.479 . . . . 63.24 110.887 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 38.6 tttt -102.9 118.04 35.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 71.52 110.878 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . 0.652 HG13 HD12 ' A' ' 288' ' ' ILE . 61.6 t -58.82 112.99 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.252 -0.431 . . . . 61.2 111.15 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 0.422 HG21 ' HG2' ' A' ' 324' ' ' LYS . 30.9 pt -86.5 -31.47 6.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 74.45 111.099 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -139.71 158.14 68.56 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.603 0.716 . . . . 71.32 110.867 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 153.94 68.43 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.702 2.268 . . . . 60.22 112.361 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -171.48 105.95 0.22 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 71.44 110.927 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . 0.732 ' HA ' HG23 ' A' ' 287' ' ' THR . 9.7 tt0 -88.57 143.84 26.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 74.15 110.837 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -78.09 123.39 26.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.096 -0.502 . . . . 41.44 111.095 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -74.85 -26.13 59.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 74.13 110.943 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -144.49 170.07 16.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 74.03 110.883 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -57.35 -26.18 60.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.139 -0.482 . . . . 61.33 110.928 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' ASP . . . . . 0.559 ' O ' HG22 ' A' ' 317' ' ' VAL . 3.4 t70 -70.95 -25.56 62.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 52.24 110.922 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -95.16 161.28 14.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 64.43 110.928 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.599 HD12 ' N ' ' A' ' 287' ' ' THR . 13.4 tp -120.1 136.54 54.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.235 -0.439 . . . . 74.1 110.941 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.732 HG23 ' HA ' ' A' ' 279' ' ' GLU . 73.2 m -86.2 146.1 26.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 64.42 111.087 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' ILE . . . . . 0.652 HD12 HG13 ' A' ' 274' ' ' VAL . 44.3 pt -150.41 145.04 17.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.439 . . . . 73.22 111.106 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -117.64 136.98 52.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 62.01 110.873 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -51.76 126.15 17.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 62.24 110.88 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 108.51 -26.02 17.7 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.713 -0.756 . . . . 75.13 112.476 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -85.38 153.95 22.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.766 0.317 . . . . 73.24 110.917 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 29.2 mm -105.08 123.14 59.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.298 -0.41 . . . . 74.44 111.104 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . 0.722 HG11 ' CE2' ' A' ' 318' ' ' PHE . 87.8 t -93.25 138.04 21.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 72.01 111.123 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 89.4 m -86.46 108.55 18.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 51.14 111.156 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.508 HD13 ' SG ' ' A' ' 272' ' ' CYS . 3.3 tp -69.91 115.1 8.74 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.256 -0.429 . . . . 71.2 110.924 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 79.2 mt -103.71 -26.91 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 74.42 111.091 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -157.39 178.0 10.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 63.25 110.85 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 24.9 mttt -141.34 113.01 7.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.126 -0.488 . . . . 71.54 110.9 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -49.77 162.43 0.18 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.215 -0.448 . . . . 71.55 110.91 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.8 t -114.51 -68.99 0.88 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.261 -0.427 . . . . 61.12 110.931 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 40.2 mt -67.0 -13.12 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 73.53 111.063 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -95.77 71.04 3.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 74.35 110.876 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 42.1 t -51.28 119.99 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 74.0 111.178 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.32 24.79 30.31 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.715 -0.755 . . . . 51.12 112.463 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 55.6 m95 -139.67 138.26 35.9 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.743 0.306 . . . . 72.1 110.986 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 307' ' ' TRP . . . . . 0.762 ' CH2' HD12 ' A' ' 325' ' ' LEU . 20.8 m0 -132.53 158.45 42.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.278 -0.419 . . . . 71.22 110.857 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -103.03 115.18 30.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 73.1 110.949 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -130.34 -171.76 12.99 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.677 -0.773 . . . . 63.55 112.462 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -141.85 143.64 33.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.906 0.384 . . . . 74.12 110.878 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.6 HD13 HG22 ' A' ' 294' ' ' VAL . 1.8 tp -160.03 147.05 16.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 64.34 110.937 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 56.6 29.94 16.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 62.23 110.862 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 76.24 7.83 84.99 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.696 -0.764 . . . . 71.23 112.431 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.9 126.29 52.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.835 0.35 . . . . 71.13 110.877 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 7.8 ttp180 -100.9 141.21 34.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 74.11 110.928 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -172.78 -158.84 18.09 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.741 -0.742 . . . . 53.44 112.493 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 284' ' ' ASP . 35.4 m -117.86 162.99 15.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.932 0.396 . . . . 71.52 111.087 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 318' ' ' PHE . . . . . 0.722 ' CE2' HG11 ' A' ' 294' ' ' VAL . 7.1 p90 -166.71 157.04 10.54 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.66 0.743 . . . . 75.51 110.866 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.83 122.31 8.97 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.63 2.22 . . . . 71.44 112.365 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . 0.541 ' HA ' HG22 ' A' ' 323' ' ' VAL . 1.6 p-10 -59.2 -21.31 59.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.238 -0.437 . . . . 74.34 110.876 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -69.93 -16.99 63.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 71.22 110.898 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -102.95 15.13 30.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 64.41 110.863 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . 0.541 HG22 ' HA ' ' A' ' 320' ' ' ASP . 18.2 m -148.99 150.45 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 72.34 111.217 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . 0.422 ' HG2' HG21 ' A' ' 275' ' ' ILE . 17.2 mmtm -114.8 117.32 30.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 72.1 110.894 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.762 HD12 ' CH2' ' A' ' 307' ' ' TRP . 1.9 tt -64.92 127.38 31.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.246 -0.434 . . . . 72.22 110.908 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.536 HD12 ' CB ' ' A' ' 271' ' ' TYR . 20.4 mt -59.38 159.27 16.87 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.575 0.702 . . . . 63.41 110.932 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.84 167.76 23.6 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.656 2.238 . . . . 73.43 112.336 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.68 -16.76 38.05 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.728 2.285 . . . . 53.11 112.365 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -82.64 -40.87 20.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.182 -0.463 . . . . 74.21 110.911 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 330' ' ' PHE . . . . . 0.491 ' CD1' HD13 ' A' ' 326' ' ' LEU . 3.4 t80 -66.6 115.69 6.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 74.51 110.873 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -141.61 106.92 5.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.155 -0.475 . . . . 71.1 110.907 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.21 -65.34 0.97 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.097 -0.501 . . . . 54.33 110.965 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 72.43 110.879 179.961 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 31.0 t . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.898 0.38 . . . . 62.32 110.835 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 6.0 mmm -79.63 98.44 6.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 70.52 110.88 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.55 104.8 13.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 64.31 110.915 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 70.2 m -75.94 159.01 31.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.255 -0.429 . . . . 51.34 110.788 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.52 -28.54 8.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.092 -0.504 . . . . 74.24 110.858 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 3.0 m -71.88 117.17 13.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.199 -0.455 . . . . 70.54 111.165 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 23.8 mtpp -89.61 -53.99 4.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.226 -0.443 . . . . 75.21 110.857 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 1.2 p -122.04 129.08 52.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 64.21 110.812 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 3.0 mtpm? -112.23 -178.21 3.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.095 -0.502 . . . . 71.54 110.861 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -127.48 125.0 39.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 73.44 110.897 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 271' ' ' TYR . . . . . 0.484 ' CB ' HD12 ' A' ' 326' ' ' LEU . 7.5 m-85 -127.64 146.78 50.43 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.213 -0.449 . . . . 71.51 110.926 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 272' ' ' CYS . . . . . 0.524 ' SG ' HD22 ' A' ' 296' ' ' LEU . 45.5 m -133.64 147.9 51.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 40.41 110.863 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 28.9 tttt -102.9 119.23 38.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 74.15 110.928 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . 0.473 ' CG2' HG23 ' A' ' 294' ' ' VAL . 58.8 t -59.37 112.6 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.31 -0.405 . . . . 73.44 111.075 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 0.57 HG21 ' HG3' ' A' ' 324' ' ' LYS . 29.2 pt -86.59 -31.89 6.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 64.34 111.092 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -138.71 158.73 69.62 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.669 0.747 . . . . 74.35 110.91 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 161.49 45.72 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.679 2.253 . . . . 71.24 112.338 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -174.87 111.92 0.14 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.274 -0.421 . . . . 74.3 110.934 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . 0.727 ' HA ' HG23 ' A' ' 287' ' ' THR . 24.4 tt0 -92.17 131.97 36.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.101 -0.5 . . . . 75.43 110.872 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . 0.472 ' HB1' ' HB2' ' A' ' 285' ' ' GLU . . . -68.26 115.67 7.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 72.03 111.077 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -58.08 -30.35 66.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 72.34 110.936 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -149.72 175.18 11.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 73.14 110.9 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -58.65 -25.64 62.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 72.54 110.891 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -69.93 -25.88 63.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 75.2 110.897 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . 0.529 ' OE1' HG23 ' A' ' 317' ' ' VAL . 63.7 mm-40 -94.93 163.41 13.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 72.11 110.916 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.613 HD23 ' CD2' ' A' ' 318' ' ' PHE . 23.2 tp -116.08 131.54 56.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 62.42 110.949 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.727 HG23 ' HA ' ' A' ' 279' ' ' GLU . 60.4 m -88.24 144.61 26.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 73.54 111.141 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 288' ' ' ILE . . . . . 0.54 HG21 HG21 ' A' ' 294' ' ' VAL . 43.9 pt -150.34 146.87 16.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 70.21 111.12 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -119.11 139.57 51.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.478 . . . . 52.5 110.871 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -51.91 124.01 11.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.475 . . . . 71.55 110.878 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 111.65 -24.97 14.09 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.768 -0.73 . . . . 73.34 112.46 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -85.98 156.16 20.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.789 0.328 . . . . 73.43 110.893 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 36.7 mm -108.63 127.14 65.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.288 -0.415 . . . . 61.35 111.18 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . 0.708 HG11 ' CE2' ' A' ' 318' ' ' PHE . 61.1 t -102.59 138.1 28.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 74.14 111.121 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 97.8 m -82.38 103.8 12.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 74.33 111.139 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.648 HD11 ' HB3' ' A' ' 307' ' ' TRP . 9.0 tp -69.89 113.15 6.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.144 -0.48 . . . . 75.44 110.897 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 19.7 mt -92.8 -49.17 13.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 62.04 111.155 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -149.88 178.62 8.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 63.21 110.863 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -129.17 112.3 13.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 63.2 110.85 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -49.8 166.6 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 72.34 110.878 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.0 t -111.02 -69.11 0.89 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.203 -0.453 . . . . 43.35 110.894 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 51.4 mt -63.62 -15.3 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 72.01 111.192 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -93.31 65.26 3.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.112 -0.494 . . . . 64.32 110.897 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 57.7 t -51.19 118.69 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 74.23 111.119 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.54 23.07 34.84 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.788 -0.72 . . . . 50.42 112.496 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 52.8 m95 -139.06 133.01 31.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.735 0.303 . . . . 74.32 110.925 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 307' ' ' TRP . . . . . 0.758 ' CZ3' HD12 ' A' ' 325' ' ' LEU . 28.6 m0 -124.34 149.62 46.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.257 -0.429 . . . . 74.44 110.882 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -97.62 119.78 36.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.435 . . . . 73.11 110.944 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -136.74 -167.24 11.08 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.668 -0.777 . . . . 74.54 112.408 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -139.34 138.48 36.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.926 0.394 . . . . 74.31 110.844 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.657 HD13 HG22 ' A' ' 294' ' ' VAL . 13.2 tp -145.78 129.98 17.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.489 . . . . 64.41 110.895 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 58.89 29.95 19.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 71.23 110.805 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 84.03 -4.72 82.3 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.753 -0.737 . . . . 73.42 112.458 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 314' ' ' ARG . . . . . . . . . . . . . 9.5 ttp85 -100.44 120.15 39.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.842 0.353 . . . . 50.43 110.842 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 32.4 mtm180 -99.9 140.54 33.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.469 . . . . 73.2 110.847 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -173.29 -159.85 20.66 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.689 -0.767 . . . . 72.24 112.479 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.529 HG23 ' OE1' ' A' ' 285' ' ' GLU . 17.0 m -117.02 148.63 19.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.859 0.362 . . . . 65.34 111.098 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 318' ' ' PHE . . . . . 0.708 ' CE2' HG11 ' A' ' 294' ' ' VAL . 8.8 p90 -151.01 156.76 35.52 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.722 0.772 . . . . 54.34 110.847 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 120.01 6.87 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.71 2.273 . . . . 70.42 112.332 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . 0.567 ' HA ' HG22 ' A' ' 323' ' ' VAL . 1.6 p-10 -58.58 -21.91 54.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.276 -0.42 . . . . 71.44 110.844 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -71.14 -10.2 59.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.471 . . . . 74.3 110.877 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -111.88 17.68 19.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 73.13 110.905 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . 0.567 HG22 ' HA ' ' A' ' 320' ' ' ASP . 18.0 m -149.07 151.89 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.11 -0.496 . . . . 62.13 111.125 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . 0.57 ' HG3' HG21 ' A' ' 275' ' ' ILE . 8.9 mtpp -118.94 118.63 32.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 75.33 110.934 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.758 HD12 ' CZ3' ' A' ' 307' ' ' TRP . 0.7 OUTLIER -65.02 130.56 43.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.208 -0.451 . . . . 75.43 110.855 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.484 HD12 ' CB ' ' A' ' 271' ' ' TYR . 20.2 mt -63.96 159.21 57.05 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 121.631 0.729 . . . . 63.4 110.855 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 167.71 23.63 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.729 2.286 . . . . 40.22 112.38 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -21.35 33.72 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.657 2.238 . . . . 64.32 112.391 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -77.1 -37.73 53.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.46 . . . . 73.34 110.877 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 330' ' ' PHE . . . . . 0.419 ' CD1' HD13 ' A' ' 326' ' ' LEU . 4.5 t80 -75.37 114.37 13.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 50.24 110.873 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -151.2 107.38 3.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.169 -0.469 . . . . 61.44 110.868 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 19.2 mtpp -82.87 -72.12 0.46 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.11 -0.495 . . . . 73.21 110.886 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 63.02 110.861 -179.97 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 34.1 m . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.832 0.348 . . . . 61.15 110.847 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 2.6 mpp? -135.71 113.99 11.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 71.34 110.894 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -115.44 110.78 19.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.283 -0.417 . . . . 71.23 110.821 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 3.8 m -69.37 147.71 50.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 72.14 110.809 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 6.2 tpt85 -99.3 -26.62 14.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.113 -0.494 . . . . 72.12 110.852 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 7.5 t -105.18 143.64 33.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 71.31 111.107 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 17.9 tttt -88.48 -37.29 15.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 75.14 110.915 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 13.4 t -74.28 81.43 1.85 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.256 -0.429 . . . . 71.35 110.891 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 4.2 pttm -129.67 -174.27 3.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 65.31 110.869 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -152.77 130.13 11.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 70.33 110.844 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 271' ' ' TYR . . . . . 0.592 ' HB3' HD12 ' A' ' 326' ' ' LEU . 7.6 m-85 -115.94 142.78 46.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.243 -0.435 . . . . 75.13 110.943 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 272' ' ' CYS . . . . . 0.476 ' SG ' HD13 ' A' ' 296' ' ' LEU . 22.7 m -127.29 146.32 50.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.113 -0.494 . . . . 73.12 110.919 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -102.9 126.11 49.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 64.3 110.912 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . 0.43 HG21 ' HB ' ' A' ' 288' ' ' ILE . 47.8 t -64.84 112.23 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.309 -0.405 . . . . 72.42 111.136 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 27.0 pt -85.74 -32.09 6.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.269 -0.423 . . . . 54.41 111.127 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -138.53 157.96 71.28 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.624 0.726 . . . . 75.11 110.878 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 156.66 62.77 Favored 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 122.674 2.249 . . . . 62.33 112.345 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -172.41 108.21 0.2 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 63.34 110.924 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . 0.712 ' HA ' HG23 ' A' ' 287' ' ' THR . 25.2 tt0 -88.15 138.97 30.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 70.11 110.866 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -68.45 116.52 9.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 74.43 111.099 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -56.47 -28.08 58.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 73.23 110.907 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -153.73 175.93 12.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 70.22 110.885 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -58.8 -25.81 63.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.145 -0.48 . . . . 74.52 110.855 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.16 -23.57 61.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 65.32 110.86 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -94.96 167.96 11.08 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.179 -0.464 . . . . 73.41 110.909 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.626 HD23 ' CD2' ' A' ' 318' ' ' PHE . 14.6 tp -119.01 136.67 54.0 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.163 -0.471 . . . . 61.43 110.9 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.712 HG23 ' HA ' ' A' ' 279' ' ' GLU . 85.6 m -91.89 146.08 24.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.159 -0.473 . . . . 74.34 111.144 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 288' ' ' ILE . . . . . 0.43 ' HB ' HG21 ' A' ' 274' ' ' VAL . 33.7 pt -149.49 143.3 18.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.281 -0.418 . . . . 63.2 111.183 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 20.2 mtpp -117.26 140.05 50.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.148 -0.478 . . . . 70.04 110.919 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -51.43 121.84 6.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 71.4 110.924 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 115.2 -31.03 6.42 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.727 -0.749 . . . . 70.21 112.48 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -79.4 160.39 26.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.725 0.298 . . . . 74.23 110.889 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.463 HG23 ' O ' ' A' ' 272' ' ' CYS . 3.2 mp -115.95 128.05 73.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 63.53 111.115 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . 0.852 HG22 HD13 ' A' ' 311' ' ' LEU . 99.8 t -105.03 138.15 31.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 70.35 111.127 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . 0.569 HG23 ' CE1' ' A' ' 271' ' ' TYR . 3.3 m -85.98 117.7 25.0 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.174 -0.466 . . . . 61.34 111.151 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.476 HD13 ' SG ' ' A' ' 272' ' ' CYS . 5.2 tp -69.88 110.66 5.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.243 -0.435 . . . . 61.44 110.865 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 27.5 mm -100.12 -26.12 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 63.53 111.079 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -162.11 178.31 8.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 74.34 110.862 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 40.9 mttt -141.38 112.95 7.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 75.24 110.885 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -49.66 161.74 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 74.23 110.902 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 2.8 t -113.53 -69.05 0.89 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 74.44 110.86 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 38.6 mt -66.97 -12.98 15.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.432 . . . . 74.52 111.172 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -97.36 70.46 2.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.135 -0.484 . . . . 74.33 110.843 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.405 ' O ' HG13 ' A' ' 304' ' ' VAL . 6.3 p -51.35 121.89 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 73.54 111.176 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 89.24 21.0 43.14 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.695 -0.764 . . . . 54.24 112.461 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 42.5 m95 -136.42 134.27 37.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.781 0.324 . . . . 74.41 110.896 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 307' ' ' TRP . . . . . 0.444 ' CZ3' HD12 ' A' ' 325' ' ' LEU . 22.0 m0 -129.2 156.96 43.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.112 -0.495 . . . . 75.32 110.932 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -101.33 113.41 26.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.283 -0.417 . . . . 62.15 110.869 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -124.7 -173.93 13.89 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.802 -0.713 . . . . 54.24 112.493 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 72.8 tt0 -137.74 136.22 37.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.897 0.379 . . . . 73.41 110.91 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.852 HD13 HG22 ' A' ' 294' ' ' VAL . 3.1 tp -149.2 134.4 18.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.454 . . . . 63.35 111.003 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 58.86 29.94 19.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 64.35 110.901 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 81.2 -0.91 86.81 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.733 -0.746 . . . . 34.52 112.457 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 314' ' ' ARG . . . . . 0.435 ' HG2' HD13 ' A' ' 286' ' ' LEU . 9.5 ttp85 -103.5 111.46 23.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.869 0.366 . . . . 74.34 110.893 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 9.5 ttp180 -96.66 117.03 30.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 75.22 110.861 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -146.89 -155.23 6.45 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.793 -0.717 . . . . 72.52 112.539 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 23.1 m -118.48 155.41 20.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.817 0.342 . . . . 73.54 111.159 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 318' ' ' PHE . . . . . 0.745 ' CE2' HG11 ' A' ' 294' ' ' VAL . 6.7 p90 -163.72 156.11 15.23 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.569 0.7 . . . . 62.45 110.92 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.82 119.24 6.21 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.682 2.255 . . . . 62.42 112.337 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . 0.584 ' HA ' HG22 ' A' ' 323' ' ' VAL . 2.7 t70 -60.42 -18.97 54.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.191 -0.459 . . . . 74.14 110.841 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -68.24 -12.51 61.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 74.45 110.884 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -108.29 14.47 24.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 62.54 110.872 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . 0.584 HG22 ' HA ' ' A' ' 320' ' ' ASP . 18.0 m -148.86 149.54 14.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 74.0 111.085 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 10.2 ttmm -121.49 134.17 55.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 64.1 110.876 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.444 HD12 ' CZ3' ' A' ' 307' ' ' TRP . 0.0 OUTLIER -64.95 126.42 27.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 64.32 110.91 179.965 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.751 HD13 ' CD1' ' A' ' 330' ' ' PHE . 20.4 mt -63.53 159.16 53.66 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.611 0.72 . . . . 72.42 110.909 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 167.6 23.96 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.742 2.295 . . . . 74.14 112.373 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.73 -16.15 37.53 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.632 2.221 . . . . 72.43 112.306 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -84.95 -42.07 15.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 75.34 110.868 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 330' ' ' PHE . . . . . 0.751 ' CD1' HD13 ' A' ' 326' ' ' LEU . 8.9 t80 -63.93 118.57 8.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 72.3 110.889 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -136.89 106.78 6.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.081 -0.509 . . . . 75.43 110.836 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 18.3 tttm -60.57 -45.56 93.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.08 -0.509 . . . . 71.41 110.94 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 63.2 110.904 179.914 . . . . . . . . 0 0 . 1 stop_ save_